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ABSTRACT
The primary objective of this study is to measure the effects of providing just-in-time (JIT) information to nurses
during the medication administration process. While the expectation is that having access to JIT information is
beneficial for healthcare providers, other factors such as the information being distracting, misinterpreted, difficult
to use, or even have a detrimental effect, could be of no value, or lead to adverse consequences.
A clinical study was performed to evaluate the effect of JIT information on error occurrence during the
administration of medication. A smartphone app was designed to convey information to the nurses on an "ondemand" basis. The clinical study used a control group which had access to conventional information resources
including a laptop based electronic medical records system and Medication Administration Record, and an
experimental group which had access to the smartphone app. The University of Tennessee Health Innovation
Technology Laboratory was used as the test environment. The results indicated that the availability of JIT
information made a significant difference in reducing the occurrence of the error, as well as improving the
understanding of patient chart information and decreasing the time for administering medication.
An agent-based computer simulation model (ABM) was developed using the information generated from the
clinical trial to validate that a model of the medication administration process could be developed. This model was
used to estimate the likelihood of the occurrence of the error at various levels of information input.
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Chapter 1
Background and Overview
Background
It is estimated that between 210,000 and 420,000 hospital patients suffer harm as a result of medical errors that
contribute to their death each year [1]: a separate study has corroborated this estimate [2]. To provide some
perspective regarding the scope of this problem, medical errors are the third leading cause of death following
heart disease and cancer, accounting for about 10% of all deaths in the United States (Figure 1. 1). Medication
errors, defined as “any preventable event that may cause or lead to inappropriate medication use or patient
harm…” are a major contributor to this statistic [3]. Providing medication to a hospital patient is a complex,
adaptive process that includes writing the medication prescription (i.e., ordering), preparation, dispensing of the
medication by the pharmacy, and administering the medication to the patient typically by a nurse (Figure 1. 2). The
focus of this study is on the potential of applying lean concepts to information and using just-in-time (JIT)
information to influence dynamic decision-making as it affects the occurrence of hospital inpatient Medication
Administration Errors (MAEs). A MAE is defined as, “a deviation from the prescriber’s medication order as written
on the patient’s chart, manufacturers’ instructions, or relevant institutional policies” [4].
This study follows the Industrial & Systems Engineering (ISE) approach that humans are an integral part of the
overall system and that the design of the system needs to consider and accommodate the error performance of
the human element in order to improve overall system performance, including any effort to decrease the
occurrence of medication errors.

Figure 1. 1: Proportion of annual deaths due to medical errors in hospitals [2]1
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Images included under title 17 section 107 U.S. Copyright Law Fair Use Doctrine as educational material distributed for use without profit.
Adapted from: BMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2139 (Published 03 May 2016)
https://www.bmj.com/content/353/bmj.i2139
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Figure 1. 2: The medication administration process and how it relates to medical errors
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Rationale/Purpose of Study
A 1999 report by the Institute of Medicine concluded that as many as 98,000 annual deaths, among Americans, are
associated with medical mistakes [5]. A more recent study in the Journal of Patient Safety concluded the number
to be much higher, claiming that each year between 210,000 and 420,000 of those who are hospitalized suffer
harm that contributes to their death. A significant number of these deaths are a result of medication errors.
These reports did not consider the nonfatal implications of medical error and the short and long term personal and
economic costs associated with these errors.
The primary objective of this study is to measure the effects of providing just-in-time (JIT) information to nurses on
the occurrence of a medication administration error. While the expectation is that having access to JIT information
is beneficial in executing the MAP, it is quite conceivable that other factors such as the information being
distracting, misinterpreted, difficult to use, or another detrimental effect, could occur [6, 7].
As an example, electronic medical record (EMR) systems are enterprise-level computer systems that provide
integrated patient information, including diagnostic reports, medical charting, physician orders, drug prescriptions,
medical treatments, etc., were heralded as a resource that could provide significant process
Improvement for healthcare and have positive impacts on healthcare costs and the quality of patient care.
However, studies indicate that EMR systems are not necessarily delivering the breadth of positive benefits
originally attributed to them and, in some instances, have resulted in various unintended negative consequences
[8-10].
In their report, “Building a Better Delivery System: A New Engineering / Healthcare Partnership”, published in
2005, the Institute of Medicine (IOM) notes that while other industries have embraced systems engineering tools
to improve performance, the healthcare industry has been slow in adopting these methods. In particular, the IOM
identifies “Human-information/communication technology system interfaces” as a fundamentally important area
for improvement in healthcare operations [11].
The implementation of technology into end-user settings, such as EMRs, is typically fielded with exuberance and
the promise of the technology to directly solve key problems. As referenced previously however, the challenges
and unintended consequences resulting from the implementation of new technology demonstrate the reality of
the actual difficulties and challenges faced when inserting technologies in a real-world setting. The proposed
research intends to begin to address the challenges of insertion of this technology into healthcare.
Hospital staff nurses are faced with numerous challenges in executing their tasks. Nurses are the frontline of
providing patient care, serving as the backbone of the healthcare system: their performance is a key factor in
determining patient outcomes. Interestingly, the impacts of nursing care have not been given the same
consideration in terms of impact on systems performance of healthcare as other areas. From an I&SE perspective,
much of the research and dialogue to-date has been related to nurse staff levels, workload, scheduling, or
conventional ergonomics issues, such as back injury. Significantly less research has been done on how nurses
execute their job functions and the associated considerations of performance [12-15]. The proposed research
considers how nurses function from a system point of view and intends to determine how providing lean JIT
information can improve nurse performance and enhance the quality of patient care by reducing MAEs.
Most decisions by healthcare providers in acute settings require dynamic decision-making (DDM), a process that
occurs in continuously changing environments with multiple interdependent factors that are common in acute
medical situations. A decision on one factor will impact the behavior of the other factors or decisions made in realtime. Using the right method of information delivery is key to making correct decisions in a dynamic environment,
as well as receiving the right information at the right time.
The advent of affordable and powerful mobile computing technology (MCT), such as smart phones, provide the
means to deliver key information in a just-in-time (JIT) fashion. This type of mobile technology has the benefits of
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being programmable and versatile, unobtrusive, commercially available, relatively inexpensive, and easy to use.
There also might be potential drawbacks of MCT in its current form such as limited battery life, information input,
and computer security.
The Research Problem
Medical errors, especially MAEs, happen surprisingly frequently, with results ranging from having no consequence
to patient death. The overarching question is, what can be done to mitigate the occurrence of MAEs? In particular,
we are asking if JIT information can reduce the number of errors and improve dynamic decision-making when
tailored to address specific types of medication administration errors. This undertaking raises several other
corollary questions: How can systems engineering methodologies be applied to the nurse medication
administration process to identify and mitigate errors? Can the error types of medication administration be
identified and ranked or prioritized, and if so, how can it be used to improve the content of JIT information to
reduce the likelihood of error occurrence? Lastly, computer modeling and simulation has found utility in many
areas in healthcare, including evaluating the impact of changes to healthcare processes [16-18], however, based
on extensive literature review, despite its utility and benefits, computer simulation and modeling, has not been
used as a methodology to assess nurse performance in MAEs.
Objectives of the Study
The primary objective of this research is to develop a more fundamental understanding from an Industrial and
Systems Engineering (I&SE) perspective of what causes MAEs by nurses and to explore possible strategies to
reduce the incidence of these errors.
At its core, the purpose of this study is to measure the effect of using just-in-time information on the occurrence of
medication errors in acute care settings and, as a result, on the quality of care a patient receives, which is a key
metric for healthcare performance. Specifically, we are attempting to evaluate how, or if, providing nurses with
just-in-time (JIT) patient or medication information might affect the occurrence of a MAE. While the expectation is
that having access to JIT information is beneficial for nurses in reducing the occurrence of errors, other factors,
such as the information being distracting, misinterpreted, difficult to use, or even have a detrimental effect, could
happen from the use of JIT information from a smart phone app. A key element of this effort will be to develop and
demonstrate a model that simulates the nurse Medication Administration Process and the impact of process
changes on MAE.
Efforts contributing to the overall objective of this research effort are to:
• explore and apply the concepts of JIT information delivery to determine their effects on MAEs and
support dynamic decision making,
• apply lean information concepts to determine the best subset of information content to provide,
• assess the applicability of building a simulation model (e.g. Agent-based model, Bayesian network, or
other modeling approach) to model MAEs from the context of nurse processes to a) determine if an
acceptable model can be created and b) if such a model can simulate and measure the effectiveness of
error prevention techniques, such as JIT information, on MAE occurrence.
Additionally, with this study, I intend to demonstrate:
• the use of MCT or a similar device in a simulated acute care setting,
• the ergonomic advantages of personal mobile technology in a healthcare setting,
• a qualitative/quantitative assessment of the effect of using JIT healthcare information delivered in a
convenient and unobtrusive way, and
•
using feedback from students and faculty, determine how the use of this technology could be improved
in a healthcare setting.
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Research Question
We make the following propositions:
• Nurses receive increasing amounts of information to process and act upon.
• Effective “just-in-time” transfer of information to and from nurses improves decision-making and
enhances the quality of care, patient safety, and, if done correctly, can reduce costs.
• Information transfer and utilization can be studied through a system engineering approach (much like a
manufacturing process) and, as a result, can be analyzed, modeled, and optimized.
These propositions can be distilled down to the following core research questions:
• What are the effects of just-in-time (JIT) information on improving the quality of care, patient safety, and
decreasing costs via nursing care?
• Can the organizationally and functionally complex JIT information dynamics, within clinical operations of
nursing, be effectively modeled to determine the performance of systems operations by using advanced
I&SE techniques and methodologies?
• If so, what are the effects of employing specific mobile computing technologies (MCT) (e.g. smartphones)
in an operational setting?
Null Hypothesis (H0): JIT information will not make a measurable difference in the occurrence of MAEs.
Hypothesis (H1): Providing key (e.g. lean) information to nurses in a JIT fashion will have a direct effect on nurse
performance during the delivery of patient care as measured by QoC and PC; it will also have the benefit of
reducing the cost of delivery of care.
This hypothesis will be tested by: 1) defining the process(es) to identify the actual JIT information inputs/variables
that influence the ability of nurses to execute operations; 2) considering the systems drivers that effect
information transfer and integration, and defining methods to enhance and improve the efficiency of information
utilization; 3) developing a systems model(s) using computer simulation that provides a mechanism to evaluate the
effect of JIT information utilization on overall systems operations; and 4) identifying and implementing a prototype
technology approach using technology in the form of a smartphone app.
Research Design and Methodology/Proposed Approach
Data Collection Approach
The nature of this study directly lends itself to using a randomized control trial (RCT), which is the gold standard for
clinical trials. To this end, three groups were defined: a control group receiving no intervention, a design group to
assess the intervention protocol (aka pre-training group), and an experimental group to test the final intervention
approach (aka post-training group). The intervention in this case is the delivery of JIT via Mobile Computing
Technology (MCT) in the form of a smartphone app.
A specific scripted training scenario on medication administration was constructed in conjunction with the
University of Tennessee (UT) College of Nursing faculty. The scenario was conducted as a simulation in the UT
Health Innovation Technology and Simulation (HITS) laboratory. This protocol provides an experimental
environment that allows control for most variables. University of Tennessee fourth year student nurses
participated as test subjects. Student nurses were presented with a scenario using the instrumented mannequins
of the HITS lab and their performance was unobtrusively observed via the HITS monitoring cameras. All of the
simulations were video and audio recorded for a detailed review. The process of medication administration will be
evaluated for errors and near misses for each of the key steps of the medication administration process.
The simulation scenario concerns a juvenile who is hospitalized for a tibia/fibula fracture. The patient has been
prescribed too much acetaminophen and is in the early stages of hepatotoxicity. The scenario is structured to see if
the nurses detect the medication error/dosing error. While seemingly simple, this is a complex scenario and
requires the nurses to exercise considerable critical thinking and dynamic decision-making. The decision tree
consists of over 100 nodes.
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The video recordings of the student nurses will be reviewed to determine the set of variables to include in
assessing errors and support building the computer model. Potential variables could include:
•
•
•
•
•

Total number of errors committed
Specific errors committed
Near misses, i.e., behavior they self-corrected before the error was actually committed
Use of External information resources (e.g. DocuCare—A simulated medical records system provided as
part of the simulation system)
Utilization of MCT

A key component of this research effort is to construct a computer model that simulates the medication
administration process (MAP) performed by nurses in a hospital. The goal is to have the model reflect the
interaction of nurse(s), medication(s), and patient(s). This simulation will consider the generation of potential
errors (e.g. near misses) and actual errors, and the effects of possible interventions in the form of JIT information
on the mitigation of error occurrence.
Expected attributes of the data generating process and resultant data and analysis of the process includes the
following:
•
•
•
•

•
•
•
•

Limited data set—50-70 data points
Data will be obtained from a control group and an experimental/intervention group
The medication administration process is essentially a discrete-time random process
The medication administration process should follow a prescribed sequence of steps; in reality, the
sequence of steps can change. It is possible the sequence of events could change the probability of error
occurrence; this is particularly true for downstream events.
The process is assumed to not be recursive
The data includes the occurrence/non-occurrence of events, and the probability of their occurrence with
the initial assumptions that all occurrences are detectable
The decisions/actions within the MAP are assumed to be binary (e.g. Yes/No, Perform/Don’t perform)
The process is at a minimum a function of the nurse’s actions, but could also be affected by the
medication type, patient attributes, and environmental elements.

Based on the attributes of the data and the MAP process, three modeling techniques have been identified along
with their potential advantages and limitations as they relate to this effort: agent-based model (ABM), Bayesian
Network (BN), and Markov model. The final modeling approach will be defined by the system attributes and
attributes of the data collected. Figure 1. 3 is a graphical representation of the research approach.
Agent Based Model Design Approach
A standard methodology will be used to construct an agent-based model for simulating nurse MA. Figure 1. 4
provides a high-level flow chart describing the elements of the design approach. The development process is
iterative as noted by the red line indicating the flow of effort back to previous steps as additional insights are
gathered in the development process.
Agent Based Modeling has been initially selected as the approach to simulate the processes of nurses in delivering
medications and assessing the occurrence of MAEs and approaches for mitigations. A variety of modeling
approaches have been considered, including discrete event simulation, Bayesian networks, and Markov chains.
The ABM approach to modeling was selected because of its unique features that were described previously.
The modeling approach will be to iteratively design more complex models exploring the feature set and functions
of the model in order to determine the optimum combination of function, performance and complexity.
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An initial step in constructing an ABM is the definition of the agents. Potential agents could include nurses
delivering medication, other nurses, medical staff (e.g. physicians, administrators, supervisors, pharmacists, etc.),
equipment and/or facilities (e.g. mediation carts, work stations), patients, family members, and medications.
Within each agent there can also be classes of agents. For example, the agent patient can be subdivided into
pediatric and adult or by hospital ward (e.g. surgical, cardiac, obstetrics/gynecology, etc.).
Following the definition of agent types, the potential states that each agent can be in will be considered. Using the
patient as an example, states to be considered include, pain level, severity of malady, location (in room or not),
consciousness, emotional state, etc. States will be determined for each agent based on the factors identified in
existing literature, model complexity and the model performance. State charts will be developed for each agent.
Other features of agents will be explored. Considerations for agent features will include the ability to learn,
interaction with other agents, adaptability to the environment, goal direction, and heterogeneity.
Considering modeling of human behavior, specifically in HC using ABM, brings in an interesting construct. Based
on my effort evaluating the research to date, very little research has been identified during this literature search
that relates specifically to considering the behavior, specifically cognition emotion or mental state, of healthcare
providers as part of the ABM structure. A considerable body of work exists on the modeling of patient behaviors
at the macro level, such as in epidemics, or actions related to healthcare or similar venues. Contributory factors
have been studied that influence the error occurrence with nurses These include, for example, stress, workload,
and experience. Table 1. 1 represents how these factors would look if they were mapped into the PECS structure.
Little work has been done to understand the underlying causes of errors by nurses: it could be possible to draw
analogies on underlying error causes from other areas such as aviation or nuclear facility operations.
The environment within which the agents operate will be defined. While conceptually simple, this can become
quite complex. In the instance of the research, the environment will be the “hospital”, but other environment
features will need to be defined ranging from floor layout (effecting travel times perhaps) to elements that affect
interaction of agents or the states of agents themselves. Other environmental factors, such as policies, protocols
and procedural boundaries, will be considered. Considerations for the development of the model environment
will include static vs. dynamic, complexity, emergent behavior, adaptiveness and self-modulation vs. external
control.
Agents can interact with their environment, as well as other agents as noted in the survey of the literature. The
two key features that will be explored are determining which agents will interact and the dynamics of the
interactions. Similarly, the environment-agent interaction will be defined as well. It is assumed, at this point, that
a network topology will be the initial construct for agent interaction.

Table 1. 1: Notional mapping of nursing error contributors into PECS structure
Social Status
Seniority
Nurse type
Education level

Cognition
Stress
Fatigue
Distracted
Motivation
Critical thinking
Awareness
Self confidence

Emotion
Frustration
Overwhelmed
Indifference
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Physical
Experience
Workload
Work area
Patient type(s)
Knowledge
Training
Communication

Model verification and validation will be based on comparing the output of the model simulations with observed
performance of the nursing students. Comparison will be done on the pre and post intervention trials to
determine the alignment of the simulation results with the results of the student nurse outcomes. Recall that the
intervention for both the simulation and the student nurse exercise is the insertion of information at key moments
of the MA process. The final result being measured is the degree to which medication errors are mitigated. Also,
under consideration are near misses and alignment with the 5-rights of medication administration.
Contribution
This research provides a unique approach to understanding and potentially mitigating errors committed during the
medication administration process. This study will provide a more complete understanding of how mistakes occur,
the cognitive engineering drivers of the errors, how the errors might be mitigated by providing JIT information, and
the development of a computer model that represents the medication administration process and the associated
errors.
This research is intended to demonstrate the utility of training simulation as a mechanism to provide a controlled
environment for patient-related research. Performing similar research would have proved difficult for a variety of
reasons, including an inability to provide a controlled experimental environment. Integrating systems engineering
with the nurse training simulation has also increased the fidelity of the training simulation environment by
providing a cognitive ergonomics approach to the design and execution of the simulation resulting in a better
training experience for the students.
Boundary of Research
The boundary of this research is established along two vectors: the types of errors it examines and the way in
which they are studied. At its most general, this is a study on errors in system-processes and how to attempt to
prevent them. Errors in complex adaptive systems are evaluated from a bottom up perspective or in a
component-oriented, hierarchal modeling approach as noted by Urban [19]. Hence, within the construct of the
modeling, I am considering the behavior at the agent or individual level. Specifically, this research uses the
approach of looking at each process step and modeling the process based on the actions of the agent that is part
of an overall system at the level of the individual carrying out the process.
This research does not necessarily make a distinction between HE and non-HE as the triggering element of the
error. Rather, it is considering the cause and the cure as independent. As an example, if the pharmacy has
delivered the wrong medication or the infusion pump is broken does not matter, the study hopefully reflects on if
the nurse recognizes the error. However, HE is a focus of the research from the perspective of the agent executing
the tasks.
As JT Reason explained, the human is an integral part of any system. I have adopted this philosophy, so in effect,
the research focus is on how one element of the system, the human, functions in the overall sub system, the
medication administration process (MAP).
There are many ways to minimize or prevent error. Providing appropriate information is one mechanism to do
this. This research goes several steps further in narrowing considering, specifically, the role of JIT information at
the stage of task execution in preventing error. Furthermore, as a conceptual boundary, I am attempting to build
on the concept of poka-yoke to build a safety net of JIT information that helps to prevent errors.
The boundaries of this research are (Figure 1. 5):

1) The approach – considers an integrated or systems approach for looking at errors [Reason]
2) The topical area – for the purposes of this research, it only looks at nurse MAE, but could be
more broadly applicable
3) The context – Looks at process systems components, i.e. elements of larger systems [think of
systems dynamics]
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4) The model - Considers the application of ABM as a way to model the performance of individuals
in the error matrix
5) The tools - Engages specific IE tools to deconstruct the potential causes of errors (i.e. FMEA)
6) The intervention - Considers Just in Time information as the way of mistake proofing processes
Similarities/Differences of this Research
This research is based on a firm foundation of existing work from many sources. Mark Twain had an uncanny
ability to get to the point in a very poignant way:
“There is no such thing as a new idea. It is impossible. We simply take a lot of old ideas and put them into
a sort of mental kaleidoscope. We give them a turn and they make new and curious combinations. We
keep on turning and making new combinations indefinitely; but they are the same old pieces of colored
glass that have been in use through all the ages.”
So, while the same is undoubtedly true for this research, the following highlights what I believe to be the
similarities and differences of the research I have uncovered to date (Table 1. 2).2

2

Quote from Mark Twain, Mark Twain’s Own Autobiography: The Chapters from the North American Review
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Figure 1. 5: Boundaries of research

Table 1. 2: Similarities and differences of research
Similarities
Use of process and error analysis tools to identify key
areas for improvement
Considering systems approach for error mitigation
Evaluation of Nurse MAE
Application of simulation approach to model a system
Randomized control trial for healthcare studies
Considering Lean applications to healthcare

Differences
Combination of process, error and information to
mitigate error impact
JIT as error mitigation “safety net”
Systems approach to Nurse MAE error
Use of ABM for error evaluation especially for MAE
Simulated environment (HITS Lab) to create controlled
condition for nurse MAE
Using JIT information as an approach to Lean and poka
yoke
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Chapter 2
Literature Review
Approach
This literature review will provide an overview of what medication administration errors are, what causes them
and how they might be mitigated. A comprehensive review of the literature was performed. The structure of the
search for research articles focused on the mitigation of medication administration error (MAE). The databases
used included Google Scholar, PubMed, Web of Science and Academic Search Complete. Search terms included a
variety of approaches and combinations to ensure a comprehensive review:
• “Systems Engineering” mitigation
• “Systems Engineering” “medication administration” also with “Medication administration errors”
• “Industrial Engineering” “medication administration” also with “Medication administration errors”
• Medication administration error factors (along with various combinations)
• Medication administration error reduction (along with various combinations)
• Other terms in addition to factors included tools, techniques, approaches and efforts
• Focused searches on medication bar-coding, nurse MAE, medication delivery, medication delivery,
medication error, adverse drug reactions
• Other search terms and approaches were also used when specific references identified other research
target areas
As part of framing the research problem and defining a research approach, considerable effort has gone in to
identifying and evaluating previous research and industry efforts related to this study. One of the interesting and
challenging aspects of this endeavor is the multidisciplinary nature of the proposed research. The topic of interest
is at the interface of a number of disciplines, which greatly expands the body of literature that is relevant.
Research areas that have been identified, that are pertinent in some form to this study, are noted in Table 2. 1.
Column one depicts the area of research reviewed, the indented research areas are subcategories of a broader
area and each of these has been explored to some degree in the course of preparing for this research. Those
annotated with check marks have been deemed of direct relevance. The research literature has been explored in
depth for these areas: more than 400 citations have been referenced, considerably more were reviewed. The
following literature review will provide a much-truncated version focusing on:
•
•
•
•
•
•
•
•

Overview of the application of industrial and System Engineering (ISE) concepts to Healthcare
The current state of point of care clinical decision support tools (POCCDST)
Human error and its mitigation as related to the administration of medication and medication
administration errors (MAE)
Just in time (JIT) information and the contribution to system performance
Application of agent-based modeling (ABM) to the modelling behavioral systems
Existing methods and technologies for mitigation of MAEs
Consideration of Lean concepts for improving the delivery of information
Industrial and Systems Engineering tool application to defining and preventing systems errors as related
to MAEs
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Table 2. 1: List of relevant literature area topics that were evaluated
Research Area

Applicability

Lean Concepts

✓

Human Performance

✓

JIT Information (Knowledge Management)

✓

Process Map
Human Factors

✓

Systems Engineering

✓

Systems Modeling

✓

Systems Monitoring

✓

I&SE Tools and Methods

✓

Systems Dynamics

✓

Soft Systems

✓

Complex Adaptive Systems

✓

Nurse Functions/Tasks

✓

Nursing Errors

✓

Factors Influencing Nurse Performance

✓

Physical Factors

✓

Environmental Factors

✓

Cognitive Factors

✓

Organizational Factors

✓

Patient Centered Care

✓

Quality of Care

✓

Simulation/Training

✓

Failure to Rescue

✓
Dynamic Decision Making

✓

Decision Engineering

✓

Risk Management
Group Decision Making
Behavioral Decision Theory

✓

Decision Analysis
Classical Decision Theory

✓

Decision Making Models
Cognitive limitations
Heuristic Limitations
Information integration theory

✓

Cognitive Engineering
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Table 2.1: List of relevant literature area topics that were evaluated (continued)
Research Area

Applicability

Statistical Analytics
Bayesian

✓

Predictive

✓

Frequentist

✓

Decision Models
Multi-criteria Decision Making
AHP

✓

ANP

✓

Fuzzy VIKOR
PROMETHEE
ELECTRE
Simulation Models
Agent Based Model

✓

Bayesian Network

✓

ABM/Bayesian

✓

System Dynamic Model

✓

Monte Carlo
Markov Chain
Failure Modes
FMEA

✓

FMECA

✓

HFMEA

✓

Process Tree

✓

Fault Tree
Event Tree Modeling

✓

Decision Tree
Root Cause
Cognitive Reliability and Root Cause Analysis

✓

Causal Analysis
Cause-consequence
What if
Relative Ranking
Preliminary Hazard
Probability Risk Assessment

✓

Error Definition
Mental Workload Modeling
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Table 2.1: List of relevant literature area topics that were evaluated (continued)
Research Area

Applicability

Design of Experiments

✓

Random Clinical Trial

✓

Human Factors/Ergonomics

✓

Cognitive Ergonomics/Engineering

✓

Risk Assessment
Human Error Analysis

✓

Human Error Models

✓

Latent Risk (Swiss Cheese Model)

✓

Human-Computer Interface

✓

Human Reliability Assessment
Absolute Probability Judgment
Human Error Assessment and Reduction Technique
Human Reliability Analysis

✓

Cognitive Reliability and Error Analysis Method (CREAM)

✓

Human Factors Analysis and Classification System

✓

Technique for Human Error Rate Prediction (THERP)

✓

Operator Action Tree Analysis

✓

Justified Human Error Data Information
Success Likelihood Index

✓

Technique for Human Error Prediction
Standardized Plant Analysis Risk
Accident Sequence Precursor
Dynamic HRA
Situation Awareness
Mental Models
Natural Language
Distribution Cognition
High Reliability Organizations
Patient Safety

✓

Medication Error

✓

Medication Administration Error

✓

Medical Error

✓

Adverse Drug Events

✓
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Medication Administration and Medication Administration Error Overview
The administration of medication is an essential function for the care and treatment of hospital inpatients. The
process flow of delivering a medication is, at face value, not particularly complex. However, it does have any
number of process steps that are subject to the vagaries of human and system errors. The process can be
described by a simple process flow diagram (Figure 2.1). A healthcare provider orders a medication which gets
sent electronically or is faxed to the pharmacy for preparation. The medication, once prepared, gets delivered to
the patient floor where it is typically administered by a nurse. Somewhat surprisingly, while the process flow for
nurse medication administration is well defined, it apparently has not undergone tremendous study or review
from an I&SE perspective. Each healthcare facility will have their own unique approach depending on medications
and equipment available. Ghenadenik et al describes a general process for administering medications in Figure 2.1
and Figure 2.2.
Figure 2.2 breaks the administration process into additional detail. The four general categories of Medication
Administration (MA), patient assessment, administration provisos, delivery prep and delivery highlight the major
considerations for the major elements in the reliable administration of medication. Each of these elements, in
turn, can be expanded into their respective constituent elements (Table 2. 2).
Medication administration comprises 25%-30% of typical nursing shift; this varies across various clinical settings
and patient types. The tasks associated with administering medications are: information retrieval, obtaining and,
verifying medications, medication delivery, documentation of medication administration, and management of
physician order entry (Figure 2.3) [20].
Medications are an essential component of modern medicine’s arsenal to mitigate disease and illness. Medications
are defined as “a substance intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease;
a substance (other than food) intended to affect the structure or any function of the body; and a substance
intended for use as a component of a medicine but not a device or a component, part or accessory of a device”
[21]. Medications include, but are not limited to, any product considered a drug by the Food and Drug
Administration (FDA). Given the number and variety of definitions for medication errors, the Institute of Medicine
(IOM) has recommended that international definitions be adopted for medication error, adverse drug events, and
near misses [22].
As noted previously, at its surface, MA would seem to be straightforward, but the actual process is much more
complicated requiring multiple inputs and steps from the initiating step of prescribing a medication to the point of
administering it to the patient. Along each step, error can be introduced potentially resulting in inappropriately
administering medication. While there are varying definitions of what medication error is, the National
Coordinating Council for Medication Error Reporting and Prevention (NCCMERP) definition of a medication error is:
"…any preventable event that may cause or lead to inappropriate medication use or patient harm while
the medication is in the control of the health care professional, patient, or consumer. Such events may be
related to professional practice, health care products, procedures, and systems, including prescribing;
order communication; product labelling, packaging, and nomenclature; compounding; dispensing;
distribution; administration; education; monitoring; and use…” [23].

Figure 2.1: Simple flow chart of hospital medication administration process
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Figure 2.2: Process flow for medication administration

.
Management of Physician
Orders, 3.9%

Information Retrieval,
3.8%

Documentation of
Medication Aministration,
2.8%

Medication Delivery, 6.7%

Avg. Time Spent for NonMedication
Medication
Administration, 26.8%
Administration, 73.5%

Uncharacterized by
Observer, 2.0%
Obtaining and Verifying
Medications, 7.4%

Inefficient Waiting, 0.2%

Figure 2.3: Average percentage of time spent on medication related activities by type
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Table 2. 2: Description of medication administration elements
MA Elements
Patient Assessment

Administration Provisos

Delivery Prep

Delivery

Evaluate medication effect
/Follow-up

MA Steps

Description

Assess for Pain/Need for Med

Includes greeting the patient and initial
assessment of patient's condition (e.g.
vital signs, cognitive state, etc.)

Review Orders/MAR/EMR

Check the patient’s latest orders, lab
results and other relevant records

Patient Condition Suitable for
Med

Determine medical appropriateness of
medication administration

Correct time for Med

Based on orders and MAR determine if it
is the right time to administer medication

Suitable Form Factor/Route

Based on orders and patient condition
assess the correct physical form of the
medication including the route in which
the medication should be delivered (IV,
orally, liquid, solid, etc.)

Dose Calculation Performed

Using the current information calculate
the correct medication dosage

Retrieve Med/Verify

Retrieve the medication and verify that it
is the correct medication in the right form
and amount, including preparation of the
dosage amount

Label Med for Delivery

Label the medication with correct
information (e.g. dose, patient name,
etc.)

Verify Patient

Bring medication to the patient and verify
that it is the correct patient through the
approved process (barcode, query name
or DOB, etc.)

Verify Med

Verify that the correct medication is at
the correct dose and the correct form

Deliver Med

Provide the medication to the patient

Assess Patient Response to Med

Check on the patient (via direct
interaction or telemetry) to determine if
the medication has had the desired
response or has had a deleterious effect
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Medication Administration Errors (MAEs) are a subset of medication errors. As with the definition of medication
error, MAE has a variety of definitions. Most typically the definition of a MAE is “any deviation from the
physician’s medication order as written on the patient’s chart”. This definition, however, misses the perspective
that physicians are no longer the only prescribing entity and does not consider the entire systems perspective of
causative factors for MAEs. In a review of literature, the definition typically cited, that is authored by nurses, is
that of Wolf who defined MAE as “mistakes associated with drugs and intravenous solutions that are made during
the prescription, transcription, dispensing, and administration phases of drug preparation and distribution” [24].
The operational definition of MAE, for this study, will focus on the nursing process functions of medication
dispensing. Errors in medication administration can include[25]:
• Prescribing the incorrect medication or dose
• Writing or typing the wrong medication or dose
• Illegible writing resulting in the wrong medication or dose being given
• The wrong medication or dose is prepared by the pharmacy
• The wrong medication or dose is delivered to the patient floor
• The medication is not checked for contraindications with other medications or patient conditions
• The medication order is misunderstood because of lookalike names or sound alike medication e.g.
• Dose miscalculation
• Medication is given at the wrong time
• Medication is given in the wrong form or by the wrong route
• Mistakes resulting from misreading of measurement units e.g. micrograms vs. milligrams
• Misinterpreted or miswritten orders
The MA process can be viewed as a system with inputs, outputs, resources, and controls. Figure 2.4 diagrams the
interactions of this process [26]. Ghenadenik also provides a detailed process map for the nurse medication
administration process (Figure 2.5 and Figure 2.6). While the medication administration process can vary
significantly based on hospital specific procedures, available technology available resources, hospital ward and
other factors, the process map is illustrative of a notional set and the interaction of medication administration
process steps.
MAEs can typically be classified as either acts of omission or commission. These acts are frequently described in
the context of the “rights” of medication administration. The most frequently used list of the rights are the five
rights consisting of the right dose, right route, right patient, right medication, and right time.
There are multiple definitions and classifications in the literature about types of medication errors, they however
fall into a number of standard causal factors as shown in Table 2. 3[27].
The Ishikawa diagram in Figure 2.7 represents proximate and latent causative factors of preventable adverse drug
events (ADE). Note that ADEs are a direct result of medication errors. The literature indicates that that ADEs, in all
health care settings, arise from a combination of contributing elements including patient, organizational, provider,
policy, and procedure factors. While the items identified in Figure 2.7 may not play a role in all settings they
certainly should be considered as possibly contributory elements [28].
In a limited study using a semi-structured survey, Tang explored the causes for MAEs from the nurse’s perspective.
The great majority (76.4%) believed that there was typically more than one factor contributing to the occurrence
of MAEs. The 75 nurses, participating in the study, identified the following as major contributory elements in
order of the percent of the nurses identifying each factor with ‘Personal neglect’ (86.1%), ‘heavy workload’ (37·5%)
and ‘new staff’ (37·5%) which were the three main factors in the eight categories. ‘Need to solve other problems
while administering drugs, ’advanced drug preparation without rechecking,’ and ‘new graduate’ were the top
three of the 34 conditions. Medical wards (36·1%) and intensive care units (33·3%) were the two most error-prone
places. The errors common to the two were ‘wrong dose’ (36·1%) and ‘wrong drug’ (26·4%). Antibiotics (38·9%)
were the most commonly mis-administered drugs [29]. In a study using a somewhat similar methodology, the
authors sought to uncover MAEs using a different set of questions. Table 2. 4 highlights the results.

19

Pilot
Floor Nurse

INUPTS
Physicians(s)
Nurse(s)
Professional skills/knowledge
Medications
Best practices

PROCESS
Drug
administration by
nurses at CHUSJ

RESOURCES
MAR
Pen
Calculator
Telephone
Medication cart
Containers
Cups
Labels
Gloves
Needles
Syringes
Liquids for dilution
ID bracelets
Disinfectant
Soap, water

CONTROLS
Accuracy of MAR vs. intended Rx
Double verification (if needed)
Patient bracelet & other ID information
Drug name/dose/route validation vs. MAR
Access code to cart

OUTPUTS
• Medication administered as
intended – 5 rights:
1. Right patient
2. Right medication
3. Right dosing
4. Right route
5. Right time
• Patient satisfied with process
• Absence of accidents/error
• Safe administration for nurse

Figure 2.4: Inputs to the medication administration process3

3

Image included under title 17 section 107 U.S. Copyright Law Fair Use Doctrine as educational material distributed for use without profit.
Source: http://www.cjhp-online.ca/index.php/cjhp/article/view/1161/1552
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Figure 2.5: Elements of the medication administration process Part 14

4

Images included under title 17 section 107 U.S. Copyright Law Fair Use Doctrine as educational material distributed for use without profit
Source: http://www.cjhp-online.ca/index.php/cjhp/article/view/1161/1552
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Figure 2.6: Flowchart of mediation administration process Part 25

5

Images included under title 17 section 107 U.S. Copyright Law Fair Use Doctrine as educational material distributed for use without profit.
Source: http://www.cjhp-online.ca/index.php/cjhp/article/view/1161/1552
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Table 2. 3: Categorization and definition of medication errors
Types of errors
Dosage errors

Time errors

Unauthorized

Technique error

Route errors

Wrong dose

Prescription error

Omissions

Definition
Medications administered in doses
greater or smaller than what had
been prescribed
Medication administered to patient
in a time different from that which
had been prescribed or
predetermined (e.g. more or less
than a 1-hour difference)

Example6
Prescription for 25mg of captopril
and a 50mg dose was administered

Administering medication that has
not been prescribed by the
physician
Medication incorrectly formulated
or manipulated, before
administering or using
inappropriate procedures or
techniques to administer a
medication

Administering amoxicillin instead
of amoxicillin combined with
clavulanate
Not measuring doses
appropriately, or not using the
infusion pump for the
administration. For instance,
to administer iron sulfate after
meals or not verify the systemic
arterial blood pressure before
administering hypertensive
medication
Prescription for intravenous
administration and administered
orally
Administering captopril that later
was suspended in the prescription

Administering medications using a
route different from what had been
prescribed
Administering an extra dose to
what had been prescribed or a
medication that had been
suspended
Incorrect selection of the
medication, dosage, presentation,
administration route, infusion
speed, inadequate use of
instructions by physician and not
registering a verbal prescription
Not administering the medication
to the patient

Wrong patient

Administering the medication to
the wrong patient

Wrong form

Administering medication in a way
different from what had been
prescribed

6

Prescription for vancomycin at 6
pm and administered at 7:20 pm or
prescription for enalapril at 10 am
and administered at 8 am

Prescribing omeprazole for 8 pm,
when it should be administered at
6pm, before dinner

The professional prepared the
aerosol with saline at 0.9% and
berotec and did not add the
ipratropium bromide that had also
been prescribed
Phenytoin was prescribed to
patient A but was administered to
patient B
Furosemide tablets were
administered instead of an
ampoule

Captopril – ACE inhibitor for high blood pressure; vancomycin – antibiotic; elapril – blood pressure medication; captopril – high blood pressure
medication; omeprazole – medication for acid reflux; berotec – bronchodilator; ipratropium bromide – bronchodilator; phenytoin – antiseizure
medication; furosemide – diuretic.
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Figure 2.7: Ishikawa diagram of medication administration error 7

Table 2. 4: Causative factor of nurse MAE
Causes

% of Nurses

Nurse fails to check name band with MAR

45.8

Nurse is tired and exhausted

33.3

Physician prescribes wrong dose

30.4

Nurse miscalculates dose

29.2

Confusion between 2 drugs with similar names

29.2

Physician's writing is illegible

28.0

Nurse distracted by patients, co-workers, and events in the unit

25.0

Nurse confused by different types and functions of infusion device

25.0

Medication labels/packaging is poor quality/damaged

25.0

Nurse sets up/adjusts infusion device incorrectly

24.0

Source: [30]

7

Images included under title 17 section 107 U.S. Copyright Law Fair Use Doctrine as educational material distributed for use without profit.
Source: https://health.gov/hcq/pdfs/ADE-Action-Plan-Prevention-Approaches.pdf
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How and why MAEs occur has been studied extensively. Research in the 1960’s evaluated MAE as part of
implementation of drug distribution systems [31]. Over the ensuing almost 60 years technology has changed but
MAEs and the associated causes have not changed significantly. The statistics on errors vary depending on the
study methodology. A review of research on MAE occurrence evaluating 66 studies concluded Medication
administration errors among inpatients is frequent with the median error rate estimated at 10% of medications
administered not including wrong time errors [32].
Individual areas, such as slips and lapses, are the most commonly reported unsafe acts, other factors include
knowledge-based errors and deliberate violations of procedures. Conditions leading to errors in medication
administration include communications (verbal orders, poor writing), medication supply, unusual medication (offlabel, special order), patient factors (acuity, availability), staff factors (shortages, floating nurse), staff health status
(fatigue, stress) and interruptions/distractions during drug administration.[4].
Medication errors are typically divided into four categories: prescribing, transcribing, dispensing and
administration. Various studies provide slightly different rates of error in these categories; however, the rates are
relatively close[33], [34, 35],[35]. MAE is consistently represented as one of the top causes of medication errors
(Figure 2.8).
A systems level evaluation of systems factors identified various causative factors contributing to errors in
medication administration. Drug distribution systems, including scheduling, delivery and dispensing of
medications, are a key source of errors. The Medication distribution system can be described as a system of
systems. Included in this would be medication delivery from the pharmacy, medication preparation, scheduling of
medications, and (e.g. Monday-Friday System vs. out of hours system) [36].
Many activities in healthcare are process dependent, executing tasks in a specific manner is required to achieve
the desired outcome. Deviation from procedures, both intentional and unintentional, results in errors. These
deviations can result from increased workload, understaffing, stress, long hours, inexperience and lack of
knowledge [36].

Other, 1%

Precribing , 12%

Transcribing, 38%
Administration, 43%

Dispensing, 5%

Figure 2.8: Allocation of error type for medication errors

25

When focusing specifically on causative factors of how nurses fall victim to MAEs, a number of factors come to the
forefront. The studies are consistent in identifying underlying factors, such as personal neglect, heavy workload
and new staff [29, 37].
Nursing is a dynamic and complex process. On average nurses are interrupted between seven and ten times per
hour, that is once every six minutes, and these breaks in concentration and workflow are known to be significant
factors influencing error occurrence[38-40]. In virtually all cases, more than 90%, these interruptions resulted in
negative outcomes effecting efficiency and error rates [40].
Other factors are obviously at play for effecting MAE rates by nurses. Tang et. al. summarizes these factors in
Table 2. 5. As a point of definition, Personal Neglect could perhaps be more aptly termed personal distractions and
includes such elements as: must solve other problems while administering drug, advance drug preparation without
rechecking, poor mood that day, interruption, physical discomfort, tired, etc. Sears observes that in addition to
the “5 Rights” that work, environment plays a key factor in the occurrence of MAEs [41].
In a research literature review by Robinson of medication errors made by students during the medication
administration phase, their findings provide a number of important observations (Table 2. 6). Most medication
errors were those of omission; patients did not receive the ordered medication. Wrong dose errors occurred with
the next most frequency followed by providing the medication to the wrong patient. Table 2. 11 summarizes their
results on the type and frequency of MAE by students. [24]
Also relevant to our study is the underlying cause of MAE as it relates to student performance. Zane lists the
causes and frequency of Student’s medication errors. Notable in terms of relation to this dissertations’ research
are the top three causes of error listed in Table 2. 6. Also significant, in terms of errors, are drug dose calculation
and contraindications: these factors would be ideal candidates for JIT information or knowledge management
approaches to reduce MAEs.
In a study, using a somewhat similar methodology, the authors sought to uncover MAEs using a different set of
questions. Table 2. 7 highlights the results:
This study focused on medical-surgical nurses and as with the study by flung, used a survey to gather the
perception of nurses on the causes of medication error [30].
Westerbrook et al focused-on interruption in the clinical setting as a cause for an increase in the occurrence and
severity of MAEs. In their study they noted a 12.1% increase in procedural failures and a 12.7% increase in clinical
errors resulting from the influence of interruptions. As part of their study, they also baselined the general
occurrence of MAEs independent of interruption.
Of course, training and education play an important role in reducing MAEs. Pauly-O’neill explored simulation in
training as a means to improve patient safety in pediatric medication administration. Master’s level Nursing
students were cycled through a training simulation in an education simulation center. The training scenario
included calculating IV dose and rate. One set of students performed the simulation prior to specific training on IV
delivery while a second group of Junior BSN Nursing students were provided training on IV administration
(intervention group). Results indicated that the post intervention group had consistently fewer MAEs. [43].
One of the challenges in studying MAE is the inconsistency or lack of event reporting. While certain seminal events
are widely publicized and well known, MAEs are considered to be largely under-reported [44, 45]. Perhaps equally
as important are the near-misses which are known to be indicators or predictors of the occurrence of actual errors
[46, 47]. The issue of under-reporting errors directly impacts the fidelity of simulations that might be constructed
to model the occurrence of MAEs and using these models to measure the effect of modifications to the MAE
process.[48]
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Table 2. 5: Nurses' report of the cause of medication error (N = 72; multiple response)
Category
Personal Neglect
Heavy Workload
New Staff
Unfamiliarity with Medication
Complicated doctor-initiated order
Unfamiliarity with patient’s condition
Complicated prescription
Insufficient training
Others
Total
Source: [29]

Nurse (n)
62
27
27
23
17
16
15
11
1
199

Percentage
86.1
37.5
37.5
31.9
23.6
22.2
20.8
15.3
1.4

Table 2. 6 Medication administration error types by students (N=1208)
Type
Omission error
Improper dos/quantity
Wrong time
Extra Dose
Wrong patient
Unauthorized drug
Wrong route
Wrong administration technique
Wrong drug preparation
Wrong dose form
Prescribing error
Not classified by type
Total
Records in which types of errors were reported
Total no, of types of errors
Source: [42]

n
248
242
221
184
120
110
47
44
40
5
1
61
1305
1208
1244

27

%
19.00
17.16
16.93
14.09
9.19
8.42
3.60
3.37
3.06
0.38
0.07
4.67
100.00
92.56

Rank
1
2
3
4
5
6
7
8

Table 2. 7: Causes of students' medication errors (N=1,135)
Cause

n

Performance (human) deficit

579

51.01

Procedure/protocol not followed

362

31.89

Knowledge deficit

301

26.52

Communication

192

16.92

System safeguard(s)

90

7.93

Documentation

88

7.75

Monitoring inadequate/lacking

46

4.05

Dose form confusion

33

2.91

Calculation error

29

2.56

Written order

24

2.11

Incorrect medication activation

21

1.85

Drug distribution system

19

1.67

Handwriting illegible/unclear

18

1.59

Dispensing device involved

16

1.41

Transcription inaccurate/omitted

16

1.41

Packaging/container design

14

1.23

Abbreviations

10

0.88

Brand names look alike

10

0.88

Brand names sound alike

10

0.88

Pump improper use

9

0.79

Brand/generic names look alike

7

0.62

Computer entry

7

0.62

Generic names look alike

7

0.62

Information management system

7

0.62

Preprinted medication order form

7

0.62

Brand/generic names sound alike

6

0.53

Diluent wrong

6

0.53

Equipment design

6

0.53

Labeling

5

0.44

Generic names sound alike

4

0.35

Label (manufacturer's) design

4

0.35

Prefix/suffix misinterpreted

4

0.35

Computer software

3

0.26

Label design

3

0.26

Measuring device

3

0.26

Reference material

3

0.26

Similar packaging/labeling

3

0.26

Verbal order

3

0.26

Contraindicated-drug allergy

2

0.18

Contraindicated- drug/drug

2

0.18

28

%

Table 2. 7: Causes of students' medication errors (N=1,135) (continued)
Cause

n

%

Decimal point

2

0.18

Pump- failure/malfunction

2

0.18

Storage proximity

2

0.18

Contraindicated in disease

1

0.09

Contraindicated<comma> drug/food

1

0.09

Fax/scanner involved

1

0.09

Leading zero missing

1

0.09

Nonmetric units used

1

0.09

No cause identified

170

Records in which types of cases were reported

1,135

Total no. of causes reported

1,990

86.97

Source: [42]

Mitigations of Medication Administration Errors
While much study has been conducted on approaches to the reduction of MAEs, it appears fractured and
disjointed. Additionally, the approaches have been largely based on considering the elements of the process and
not considering the overall medication administration process as a system. Systems factors have been identified
by several authors [49-51] in considering approaches to remediating MAEs. However, at the risk of sounding
critical, the inclusion of systems thinking is at a somewhat superficial level. It is perhaps interesting to note that at
the time of this writing, a systems model or simulation has not been identified in the published literature.
Most of the remedies to MAEs are focusing on elements of the process, such as barcoding of medications [52],
reduction of interruptions [53, 54], and automated medication delivery systems [55]. The challenge with each of
these individual approaches appears to be missing the underlying systems (as defined in a Systems Engineering
context) causes contributing to MAE occurrence.
Industrial and Systems Engineering Context for MAE
Many of the issues and challenges in HC are a result of how HC workers conduct their work. The same factors
influencing performance in sectors such as auto manufacturing, airlines, shipping, and aerospace, have also been
found in HC (Kullberg). While each sector can argue they are different, the fundamental features are the same. ISE
is in a unique position to find the remedies to the ills of the HC system as we have done for these other sectors.
The consideration of using Industrial and Systems Engineering (ISE) in HC are traced back to Dr. Lillian Gilbreth. In
the original foreword to the book Hospital Management Engineering, Gilbreth wrote:
“Many hospital people who hear of industrial engineering and the possibility of its application to their
work react by claiming that their work is different. However, when such people see the similarity between
their work and work in other areas, a good start has been made – a start which permits objective review
and evaluation” [56].
While the practice of ISE is said to have started in the 1940’s, the efforts of Gilbreth and Smalley go back to 1952.
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The challenges faced by the HC system Smalley identified in the first edition of his book in 1966, matched what he
wrote in the revision in 1982, and are the same today. He talks to the consistently large increases in cost
referencing $13B in 1950 to $200B in 1980. Not surprisingly, as an industrial engineer, he states:
“Improvements in the operation of hospitals depend, in large measure, on the capabilities of those who
manage hospital affairs and, on the methods, procedures, and systems used in striving towards hospital
goals. Thus, hospital improvements are realized through both management improvement and methods
improvement” [56].
Smalley’s book goes over many of the key areas one would consider appropriate when considering ISE applications
to HC (hospitals in this case). One will find Table 2. 8 contents edifying.
The contents of this book from the 1960’s, with only changing a few dollar figures and references, could be
reprinted today and be equally as relevant. The book also considers elements such as lean, total quality
management (TQM), modelling and simulation, integration of information systems into day-to-day management
efforts of hospitals and multidisciplinary approaches to management of HC operations.
In 2010 the U.S. Agency for Healthcare Research and Quality (AHRQ) held a workshop to “develop a research
agenda at the intersection of industrial and systems engineering and health care” [57]. This background report,
along with the associated documents, identified a number of key themes, items particularly relevant to this
research are italicized:
1.
2.
3.
4.
5.
6.
7.

The current health care delivery system is both unsustainable in terms of cost and suboptimal in
terms of value.
The current health care delivery system cannot adequately respond to changes in the larger
environment and within the medical sciences.
Solving the problems of the health care delivery system is complex and will require approaches that
are multidimensional, multileveled, and inclusive of multiple stakeholders.
Information technology will play a key role in the future health care delivery system.
Incentives are needed to promote change, including the use of systems engineering tools,
information technology, and evidence-based medicine.
Opportunities are needed for cross-education and collaboration between health care professionals
and scientific and technical professionals such as engineers and computer scientists.
Research funding is needed to explore the intersections between health care and the use of systems
engineering tools, computer science methodologies, and information technology.

Table 2. 8 Contents of Hospital Engineering: A guide to the improvement of hospital management systems
Chapter 1 Introduction (need for improvement)
Chapter 3 The Nature of Hospitals
Chapter 5 Modern Professional Programs
Chapter 7 Management Problem areas
Chapter 9 Measuring Performance
Chapter 11 Sampling Hospital Activities
Chapter 13 Dealing with Variability
Chapter 15 Managerial Control
Chapter 17 Facility Planning
Chapter 19 Resource Allocation
Chapter 21 Health Systems Planning

Chapter 2 Hospital History
Chapter 4 The Methods of Improvement
Chapter 6 Foreign Programs
Chapter 8 Improving Work Methods
Chapter 10 Staffing and Scheduling
Chapter 12 Personnel Management
Chapter 14 Forecasting
Chapter 16 Waiting Lines
Chapter 18 Economic Evaluation
Chapter 20 Information Systems
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This report provides detailed discussions of developing and implementing a research agenda for improving the
operational efficiency of HC. In particular, it focuses elements that can be conducted within the next 5-7 years
with implementation in less than 15 years. The output from this workshop provides a reasonable outline of
research areas matching the needs of HC. The summary of these research areas is summarized below. Table 2. 9,
reproduced in total from the final report, highlights areas of research for ISE in HC.
The tedious replication of this information was for the benefit of highlighting those key areas of research that
considers sensor data integration. Of special interest are those areas that integrate real time data acquisition
along with modelling and simulation.
The observation to be made by considering the 1950’3-1980’s view and efforts of applying ISE techniques to
healthcare and those of 2010 is that despite six decades of effort to improve, HC we still face many of the same
challenges. In many circumstances the problems are even more complex and challenging.
With this in mind one is left to wonder why, after 60 years of effort, has there not been what appears to be
satisfactory progress in improving HC operations. While a comparison of operational progress between industries
has not been found yet (e.g. improvements in the automobile or airline industry vs. HC) it appears, at least
anecdotally, that HC is lagging behind other industries (although I have not seen an objective quantitative
comparison). Considering the work identified in Hospital Management Engineering, it appears that attempts have
been ongoing in HC well before the first printing of the book in the 1966.
The Institute of Medicine produced a Report “The Path to Continuously Learning Health Care in America” which
identifies that a learning system is needed where incentives are actively aligned to encourage continuous
improvement and reduce waste [58]. They recognized the need for an integrated approach both at the micro but
also operational level portrayed below in Figure 2.9.
Just-in-time, Real-time, Lean Information in HC
The advent of lean has slowly progressed into HC. Given the pressures for increased performance and lower cost,
lean has gained a strong foothold and has generally been embraced by larger medical facilities in the early 2000s
[59]. A survey of internet websites using “Lean “healthcare” or “health care” resulted in over a million hits. Phillips
Health Care, Deloitte, McKinsey, Price Waterhouse, Kaiser, Boston Consulting Bain and virtually every other HC
management consulting firm advertises an ability to support lean efforts in HC. A simple search of Amazon .com
for books on lean healthcare resulted in more than 280 titles. There are certifications available for lean healthcare
management and many organizations and universities offer short courses or for credit courses for it.
The realities of implementing lean are being experienced by HC as they have previously by other industries. It is
not uncommon to have over-inflated expectations, receding results and resistance to implementation of lean
processes. Although lean offers considerable potential benefits, the challenges and issues that it is facing in the
complex environment of HC are resulting in the recognition that lean “might not be the easy remedy for making
both efficiency and effectiveness improvements in healthcare” [60].
Lean has been applied to many aspects of HC mostly focusing on narrow albeit a broad array functions such as
surgery [61, 62], emergency departments [63, 64], and laboratory operations [65]. These are just a few examples
of the applications of lean in healthcare. Notable is the application in narrow fields and the lack of implementation
of a system that will semi-automatically are automatically provide reporting of status on performance or a means
to provide reporting across functions to determine cross functional impacts. That is, no research has been found
yet in HC that identified a system that provides real-time information on the process to allow its effective
monitoring.
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Table 2. 9: Areas of research for ISE in HC8
Area of Application
System Monitoring
(Knowledge Innovation)

System Modeling
(Knowledge Innovation)

System Modification
(Knowledge Innovation)

Description
• Identification of best practices for dissemination and
adoption of ISyE knowledge
• Identification of best practices for spreading new ISyE
knowledge between research and industry institutions
and among industry institutions
• Methods to characterize processes, inputs, and
outcomes
• Methods to collect and present information that is
valuable to diverse stakeholders such as patients,
nurses, primary care and specialty physicians,
pharmacists, and social workers
• Theories and methods for the translation of
numerical, analytical, and computational results into
understandable and actionable information that
multiple stakeholders (nurses, primary and specialty
care physicians, pharmacists) and lay people can
seamlessly retrieve to ensure the human monitoring of
the system
• Models to mitigate uncertainties about the future
• Models to explore the role and consequences of
automation, and provide guidance about what can be
fully, partially, or not at all automated
• Optimization models
• Models that incorporate errors and interaction of
events
• Improving lay people's understanding of analytical
results by developing enhanced data visualization
techniques
• Determining the benefits, limitations, and appropriate
use of national, regional, and institutional forcing
functions within the health care setting
• Determining the role of culture as a necessary
element of health care improvement, including the
national political conversation and at the level of the
patient and provider

8

Source: Valdez RS, Ramly E, Brennan PF. Industrial and Systems Engineering and Health Care: Critical Areas of Research--Final Report.
(Prepared by Professional and Scientific Associates under Contract No. 290-09-00027U.) AHRQ Publication No. 10-0079. Rockville, MD: Agency
for Healthcare Research and Quality. May 2010.
http://healthit.ahrq.gov/portal/server.pt?CommunityID=666&spaceID=399&parentname=&control=SetCommunity&parentid=&PageID=0&spa
ce=CommunityPage&in_tx_query=Industrial+and+Systems+Engineering+and+Health+Care&Submit.x=11&Submit.y=4&parentid=&PageID=0&s
pace=CommunityPage&in_tx_query=Industrial+and+Systems+Engineering+and+Health+Care&Submit.x=11&Submit.y=4
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Table 2. 9: Areas of research for ISE in HC (continued)
Area of Application
Knowledge Transfer

Description
• Identification of best practices for dissemination and
adoption of ISyE knowledge
• Identification of best practices for spreading new ISyE
knowledge between research and industry and within
industry
Meta-Knowledge
• Mapping the usefulness of ISyE knowledge to
Integration
different health care contexts
• Characterizing research frontiers and directions at the
intersection of ISyE and health care
Research Agenda Items That Support Breakthrough
System Monitoring
• Consumer-facing health IT solutions that allow
(Knowledge Innovation)
patients to self-support their observations, that track
and report on trends, and that interact with providers'
annotations
• Technologies which enable data to flow quickly and
securely through the whole health care delivery
system and be available in real-time when and where
needed
• Methods to operationalize contextual knowledge
• Methods to effectively collect and share data in realtime to foster situational awareness of all individuals
involved in patient care
System Modeling
• Frameworks that explore the integration of many care
(Knowledge Innovation)
sources in the production and delivery of care services,
and the coordination among these sources ( e.g., end
of life care)
• Methods to model systems as set of flows and
processes not just sets of components
• Models that explore the effective use and allocation
of different vehicles of health care delivery (e.g.,
“focused factories” versus integration, such as Mayo
Clinics and Kaiser Permanente)
• Models to evaluate entire systems and large-scale
system changes before they are implemented
• Models of collaboration and competition among
health care stakeholders
• Models that consider how health IT can be integrated
into decision making processes, how evidence-based
knowledge can be integrated into practice
• Models of collaboration and competition among
health care stakeholders
• Methods to build models from incomplete,
inaccurate, and unreliable data
• Methods to build models from inconsistent data
coming from disparate sources
• Methods to model unstable systems
• Methods to model large-scale distributed systems
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Table 2. 9: Areas of research for ISE in HC (continued)
Area of Application
System Modification
(Knowledge Innovation)

Description
• Determining ways to modify public and private
incentives to influence patients to stay healthy,
providers to work in the best interest of their patients,
and organizations to be efficient, without unintended
negative consequences
• Exploring payment structures that accommodate
technologically-mediated interactions between
providers and patients ( e.g., text messaging, email, or
visits by teleconference)
• Determining appropriate approaches to stimulating
system-wide change, exploring ways to coordinate
between bottom-up integration and top-down
decomposition
Meta-Knowledge
• Exploiting synergies within ISyE knowledge derived
Integration
from different sub disciplines
Research Agenda Items That Support Sustainability
System Monitoring
• Identification of best practices for use of ISyE
(Knowledge Innovation)
knowledge
• Efficient and pervasive methods of data capture
• New automatic data collection technologies to
capture observations from patients and their
environment ( e.g., sun exposure and food intake)
• Theories and methods beyond natural language
processing for the translation of lay person language
into structured computable data
• Efficient methods for integrating large amounts of
data from disparate sources • Adequate integration of
data collection into workflows in manners which
ensure data validity while minimizing interference
with clinical workflows
• Efficient means of integrating information generated
from different perspectives ( e.g., different providers,
patients, administrators)
• Methods to characterize how the outcomes relate to
the processes
System Modeling
• Models of trust between patients, providers, and
(Knowledge Innovation)
technology
• Models that provide guidance about when
standardization or customization is necessary
• Models that appropriately consider the conflicting
objectives of multiple stakeholders and make systemoptimal recommendations
• Methods to model the dynamics between microchanges (at the provider level) and macro-changes (at
the market and policy levels)
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Table 2. 9: Areas of research for ISE in HC (continued)
Area of Application
System Modification
(Knowledge Innovation)

Meta-Knowledge
Integration

Description
• Iterative knowledge development and transfer
between research and practice
• Improving translation from mathematical and
technical languages into lay person terminology
• Testing of change and implementation theories, and
exploration of the tension between pushing for the
application of existing knowledge and trying to
develop more usable new knowledge
• Exploring how social network theories can be used to
trigger and facilitate culture change
• Characterizing health care challenges
• Identification of best practices for use of ISyE
knowledge

Figure 2.9: Interactions required for a learning system in Healthcare9

9

IOM (Institute of Medicine). 2012. Best care at lower cost: The path to continuously learning health care in America. Washington, DC: The
National Academies Press.
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The view of the success of lean, in contributing to process improvement, is mixed. A recent review of the literature
suggests, based on 177 articles on six sigma and lean, that there is weak evidence that Six sigma and lean improved
HC quality [66]. Another survey article indicated that, while there is apparent significant benefit from
implementing a lean process, the rigor of the evaluation was lacking and suggested performing comparative
studies like that sued in evidence-based medicine (rigorous randomized studies) [67]. So, based on its limited
review of reviews, it appears that while there is significant anecdotal evidence for the improvements resulting
from lean in HC, the HC community is still not convinced of its benefits.
Pressures to improve the healthcare operations and the rapidly changing environment, within which healthcare
operates, is driving all segments of the healthcare industry to focus on how to improve performance.
Conventional approaches, such as financial analysis to reduce costs, application of lean and other similar principles,
insertion of new technologies, mergers and acquisitions, and others are being used. The reduction of cost, referred
to here, is defined as reduction of the systems level cost of providing the actual healthcare service. Simply put, it is
reducing the cost of the bill for providing a service.
There are thousands of journal papers on the implementation of Lean/six sigma in HC. The effort here is not to
provide a comprehensive evaluation of these, but rather to gain an understanding of what the lean /six sigma
approaches might benefit from in order to improve its implementation and sustainability of the assumedly
improved outcomes. At its fundamental level, HC is not different than other service industries; generalizing more
it is the same as other complex sectors as noted previously. An article in the Wall Street Journal documents the
outcome of over 100 improvement events, half of which failed over time. The causes for the failures were
generally attributed to the hysteresis of the system (i.e. old habits die hard, people slipped back to their old way of
doing things after the boss stopped watching) and also the response of the system to the increasing pressures
induced by the change to the point of failure. Once the drive to improve is removed, the system goes back to near
its original steady state [68]. One reason for this could be the lack of adequate metrics and the ability to easily and
frequently measure the intended performance. While it might be straightforward to measure the output of
manufactured items and set objective evaluation criteria for measuring quality, it is much more difficult to do the
same for human performance related to how they perform in a HC setting. That said, the integration of data from
multiple data sources, such as EMR and RTLS, might provide some support in this area.
Lean has been considered as a means to improve medication administration safety. The overall outcome, when
implementing lean, appears to be positive with a significant reduction in the number of errors as measured by
safety violations [69]. General quality improvements, including reduction of medication errors, have also been
noted [70]. That being said, the longer-term benefits of lean are still uncertain with effective recidivism, flipping
back to old methods, and reducing longer term benefits of lean implementation [66]. This again argues for taking a
systems level perspective on efforts to reduce MAE.
Another concept of lean is its application to information management. As noted earlier, among the challenges
faced by nurses, is the amount of information, including non-essential information, along with difficulty in
accessing the desired information at the time it is needed. Applying the principles of lean to information
management supports the concept of providing the information that is needed at the time it is needed [71].
Stainback considered the use of lean communication techniques to increase the effectiveness of communication of
race teams which can be considered similar to medication administration in terms of the high consequence risks,
dynamic nature and complexity of operations [72].
Delivering information, or knowledge, at the time it is needed follows the same principles as Just-in-Time (JIT) for
manufacturing processes. With the goal of providing the right material to the right people at the right time we
relieve the dependency on memory or requiring the practitioner to integrate information from multiple disparate
data sources. The challenge is to meet the system requirements of meeting the unique needs of the user,
providing an appropriate interface to convey the information, and integrating the data sources in a meaningful and
efficient way.[73]. While the consensus is that healthcare suffers from a glut of information, perhaps a more
appropriate view is that it lacks an appropriate mean to select and search for the right information, cull the
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currently extraneous information and analyse the available information to support the care giver in decision
making [74].
In the context of healthcare, JIT information affords the promise of literally putting the information in the hands of
the HC provider as they need it. The truth is that many of the systems actually make it harder, not easier, to do
their jobs [75]. Electronic Medical records Systems, Medication Administration Records, and virtual displays of
vital signs have all been sued with limited success and adoption. They still face the challenge of providing an
integrated information system that meets the needs of the floor nurse particularly as it relates specifically to
mediation administration. The concept of JIT information management in HC is not new; reference to the concept
and consideration of the promise it holds goes back to the 1990’s [76].
Knowledge management tools are well established in a variety of other fields such as aerospace, defence, and
manufacturing. Their application to HC is relatively recent. Empirical data indicates that healthcare needs a
personalization approach focusing on using interactive knowledge while other disciplines use somewhat different
approaches [77].
Specific MAE Mitigation Approaches
Effort to mitigate MAEs can take several forms principally administrative, process and engineered solutions.
Administrative mitigations would include efforts such as checklists, increased education/training, procedures,
signage, and decreasing interruptions. Engineered approaches to decrease MAEs would include medication
dispensing equipment, bar coding, and Radio Frequency Identification (RFID) tagging. Process changes to reduce
MAEs would include lean efforts and systems design changes. Noted below are the primary areas identified in the
literature that have been addressed in the literature for the mitigation of medication administration errors.
•

Engineered approach MAE mitigation:
o Bar code medication administration (BCMAR)
o Medication dispensing equipment
o Smart IV/Infusion pump
o eMAR/EMR
o Radio Frequency Identification tagging
o Clinical Decision Support Software tools

•

Administrative approach MAE mitigation:
o Training/education
o Interruption mitigation
o Improved work environment
o Check lists

One review of the literature focused on the application of technology to reduce MAEs. Of the observations, one
insight matched my perception of reviewing over 100 articles for this question: The research related to measuring
the effectiveness of using technology to reduce MAEs is generally positive towards their benefits but the evidence
overall is equivocal. The majority of studies were not theoretically driven, were limited in breadth of data (i.e.
used one to several hospitals) and were limited to the quantitative. The review goes on to report that the majority
of studies reported the development of workarounds with medication administration that could compromise
patient safety. This infers that the technologies from the studies were lacking in their overall benefit and
introduced conditions for the nurses that prompted them to search for approaches that would make their jobs less
difficult and avoid the sue of the technology [78].
Drug Dispensing Systems
Unit dose medication dispensing was first used in hospitals in the 1960’s to increase efficiency and decrease MAE.
A descriptive definition of unit dose is [79]:
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“those medications which are ordered, packaged, handled, administered and charged in multiples of
single dose units containing a predetermined amount of drugs or supply sufficient for one regular dose
application or use… system for preparation and distribution of drug served in a single dose and made
ready to be consumed once”.
In one study, the potential that unit or patient dose systems can have on reducing missed doses verses
administration from a ward stock (imprest system10) was evaluated. Four hospitals with similar wards were
utilised; three used the imprest system, one the unit dose system. Of the three hospitals using the imprest (stockbased system) 5.7% of total doses were identified as missed. In the one hospital using unit dose approach 4.1% of
total doses were identified as missed (p<0.005) [80]. The authors noted that hospitals switching from bulk
medicine ward-based systems to unit dose systems reduced missed doses from 17% to 1.6%.
Similar results were observed in a study in a geriatric facility where a unit dose dispensing system was
implemented. The researchers observed a 53% reduction in MAEs. While the study only considered one facility
with a small number of observations and a limited patient type (geriatric patients), a considerable decrease in
errors, including wrong dose and wrong drug, was observed [81].
In another application, an automated drug dispensing system was installed in four hospitals. The authors
evaluated for efficiency and error reduction. The process was assessed in terms of drug inventory, drug
distribution, pharmacy staff requirements, missed doses, clinical interventions and nurse satisfaction. The number
of pharmaceutical line items available in in-patient care areas was increased by 324% using the controlled storage
and delivery of the automated system. Over 95% of required items were available at ward level during the trial.
Pharmacists' time was reduced by 46% and technicians' time was increased by 36%. The overall staff cost
increased by 2.5%. Missed doses declined from 29% to 24%. The prescription turnaround time for items in Med
stations was decreased by 88% compared to pharmacy-based dispensing. Dispensing interventions by pharmacists
increased by 16%. Most nurses (91 %) in the wards preferred the automated system and 54% of nurses in the
intensive care areas thought the system should be adopted [82].
While automated dispensing provides increased efficiency in MA, reduction in MAE has not been uniformly
realized, and some studies have noted increases in errors with some forms of automation. As might be suspected,
there is considerable nurse-nurse variability in the error rate between an automated system and conventional unit
dose. Interesting unintended consequences have arisen with these machines including increased nurse need
during busy administration times, removal of doses ahead of time to circumvent waiting and overriding the device
when a dose was needed quickly. These issues demonstrate that, as in other industries, new technologies are not
necessarily a remedy for inadequate or faulty processes or procedures [51, 83]. While there are issues with
automated drug dispensing systems, the consensus in the literature is that they generally have a beneficial effect
on MAEs and improve the MA process [55, 84-86]
Bar Code Readers
Bar code readers have been employed to help reduce MAEs. It was estimated that 24% of hospitals in the US have
adopted bar code scanning technology for medication administration [87]. The bar code readers serve several
functions during the MA process including patient verification, enhancing access to the EMR system, and validating
the correct drug. One general study by Anderson noted that MAEs decreased 59%-70% on individual nursing units
[88]. However, not all results from use of bar code Medication Admiration (BCMA) are positive. Numerous studies
have identified issues resulting in MAEs, including a decrease in critical thinking, bypassing technology, and
occurrence of new errors [89-91]

10

An imprest system is a form of inventory management where a fixed amount is reserved which after a certain amount of stock is used the
inventory will be replenished. It has its roots in financial accounting where an example would be a petty cash system where the cash is used
until it hits a base limit and then is replenished.
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A study by Bowers et al proposed that implementing barcode readers for MA would increase real-time medication
administration documentation, decrease medication administration-related errors, increase Workstation on
Wheels usage at the bedside for medication administration, and increase use of the electronic medication
administration record for medication retrieval. After conducting a pre-post comparative design, they concluded
that there was an increase in use of the computer on wheels at the bedside, as well as real-time documentation.
However, they noted that the use of the electronic medication administration record to retrieve medications did
not increase. Medication errors showed a slight rate increase after bar-code medication administration was
introduced [92].
As with many technology implementations in Healthcare (HC), BCMA was introduced into practice without a
comprehensive understanding of what the actual impacts would be. Hassink et al performed a comprehensive
literature review on the impacts of BCMA on MAE. In summary, the observations were that the frequency of
decrease in errors from the pre-BCMA implementation to the post-BCMA implementation ranged from 56.0% to 20.4% (an increase in MAE rate). If MAEs related to time errors were excluded, the range changes to 56.9% to 16.3%. Two-thirds of the studies in the first category showed a decrease in MAEs and nine-tenths in the second
category showed a decrease in MAEs. Of the studies in this review there was a beneficial effect of BCMA on
decreasing the severity of the MAE. The review did not observe any increase in nursing efficiency for medication
delivery [93].
With any type of engineered approach, there is a human interface that will ultimately determine overall
effectiveness of the solution. An example of this consideration is a study done by Gooder that evaluated nurses’
perceptions of BCMA. The conclusion of the study was that there was a decrease in the overall satisfaction with
the medication process after the BCMA system was implemented. This emphasizes the need for an understanding
of the overall impact of a system such as BCMA on the actual performance of a process such as MA.[94].
Song et al evaluated the technology acceptance based on behavioural intentions toward BCMA. The study
considered nurse feedback and communications which had a positive impact, not the use of the technology;
increasing age of the nurse had a negative correlation. The degree of teamwork within the nursing unit and
perceived usefulness of the technology also contributed to the adoption of the technology [95]. A corroborating
study by Holden considered the effects pre- and post-BCMA implementation at a hospital: he used a second similar
hospital that was not implementing BCMA as a control. Holden summarized the results as follows [96]:
“Nurses' perceptions of the administration process changed at the hospital that implemented BCMA,
whereas perceptions of nurses at the control hospital did not. BCMA appeared to improve the safety of
the processes of matching medications to the medication administration record and checking patient
identification. The accuracy, usefulness, and consistency of checking patient identification improved as
well. In contrast, nurses' perceptions of the usefulness, time efficiency, and ease of the documentation
process decreased post-BCMA. Discussion of survey findings is supplemented by observations and
interviews at the hospital that implemented BCMA.”
PubMed identified 127 possible relevant citations; Scopus identified 136 for the application of bar coding to
medication administration. Not surprisingly there is significant overlap between the two data bases. The
conclusions to be drawn from reviewing these studies can be summarized as [97-100]:
• BCMA has a generally positive effect on MAE
• The severity of MAE is generally decreased by BCMA
• Human factors considerations play an important role in the use and benefit of BCMA
• BCMA does not appear to have a negative effect on process efficiency
• BCMA has a mixed effect on decreasing errors among the “5 rights” of MA
• BCMA is not a comprehensive solution for the reduction of MAEs
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As with any engineered solution, end-users will develop workarounds if they find the use of the technology or
solution cumbersome or problematic. Koppel et al studied workarounds to the use of barcode medication
administration systems. The authors identified 15 types of workarounds including affixing patient identification
barcodes to the computer cars, doorjambs, scanners or delivering “pre-scanned” medications to patients. The
causes driving the nurses to work around the barcoding were varied but generally included issues related to bad
patient or medication barcodes or equipment issues [90]. The implication of this study is that any technology that
might be used for the mitigation of MAEs must be simple, convenient and robust.
Electronic Medication Administration Record
Use of electronic medical records systems (EMR), including electronic medicine administration records (eMAR),
have been in various stages of implementation for several decades. The use of these systems is being driven now
by mandate of the US Government to implement these systems and be able to demonstrate meaningful use by
2014 [101]. eMARs are typically included in EMRs by hospitals in an attempt to provide comprehensive patient
charting and are under the impression that this reduces MAEs. One study that considered the effectiveness of
eMARs in mitigation MAEs in combination with other technologies concluded that they are in fact beneficial in
reducing errors [102].
Another before and after study considered the implementation of eMAR but considering both performance and
cost implications. The researchers in this study observed an overall increase in patient safety and timeliness of
care noting a remarkable total elimination of prescription transcription errors, and modest to slight reduction in
cost of services. The authors did not appear to control the effect of other activities that might have been occurring
that could have affected costs nor was there any type of control group noted [103].
A more comprehensive study was performed, Appari et al, where they conducted a retrospective cross-sectional
analysis of data from three Federal healthcare Information Technology database sources Computerized Physician
Order Entry (CPOE)/eMAR usage from HIMSS Analytics, medication quality scores from CMS Hospital Compare,
and hospital characteristics from CMS Acute Inpatient Prospective Payment System). They concluded that the
implementation and duration of use of eMARs are associated with improved adherence to medication guidelines
at US hospitals thus indicating reduction of MAEs. The benefits are evident for adoption of eMAR systems alone
and in combination with CPOE [104].
A primary medication delivery mechanism is via intravenous (IV) infusion. The HC industry has developed IV
pumps as an approach to provide consistent medication delivery. MAE associated with IV pumps occur frequently,
have the potential to cause injury, and are diverse. Smart pumps are an important component of a hospital’s
medication delivery system. However, while envisioned to be a means to mitigate MAE, the incidence of error is
high. In one study 66.9% of observed medication deliveries using smart pumps had errors associated with their
delivery. Currently available smart pumps will fail to generate meaningful improvements in patient safety until
they can be interfaced with other systems such as the electronic medical record, computerized prescriber order
entry, bar coded medication administration systems, and pharmacy information systems. Future research should
focus on the effectiveness of new technology in preventing latent and active errors, and on new types of error that
any technology can introduce [105-107].
Radio Frequency Identification
Radio Frequency Identification (RFID) technology is ubiquitous in a wide variety of industries for the tracking and
logging of items. One long-discussed application is the use of RFID in HC and in particular MA [108]. There are
numerous studies that have assessed the impact of RFID on MAEs: the virtually universal conclusion is that RFID is
effective in reducing the occurrence of MAEs, particularly when included as part of an overall dedication delivery
control and monitoring system [109-112].
One can envision what could, in effect, be an error-proof medication delivery system based on RFID and eMAR,
EMR, barcoding and wireless telemetry. RFID would be used to track the medication and the dosage, its delivery,
identify the patient, identify the nurse delivering it to the patient, ensuring that the patient and nurse are in the
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correct room, and verifying the time of delivery. The issue with RFID is not the potential benefit of the technology,
rather it is with the prohibitive cost, infrastructure requirements, potential liability concerns, privacy concerns,
user and patient reluctance and cost and effort to fully integrate and maintain the system [113-116].
Clinical Decision Support Software tools
The Just-in-Time (JIT) delivery of medical information for health professionals is being revolutionized through the
use of mobile computing apps. While software programs exist as part of a hospital’s enterprise level Electronic
Medical Record system, including clinical decision support systems that help manage portions of the MA process,
they are limited in their utility because they are typically tied directly to the computer stations and are still
considered to be in their early stages of deployment despite being around for several decades. These systems are
noted to be cumbersome and problematic to use with mixed reports on their benefits [117, 118].
A clinical decision support tool is an application that provides information to a clinician that assists in taking action
or making judgment in support of the care of a patient. There are a large number of clinical decision support tools
(CDST) with a broad range of complexity, functions and applications. While they have found some use in
healthcare settings, their use is not as ubiquitous as you would find in other settings, such as finance and
manufacturing. For healthcare, the range of CDSTs ranges from relatively simple smartphone applications that
include checklists, reminders, calculators or information sources (e.g. epocrates®) to complex, robust systems that
provide extensive knowledge processing and artificial intelligence integration into the decision making process
(e.g. IBM Watson®)11
While there are chronic issues with implementation of EMRs, they offer direct benefits for application of decision
support tools. Various CDST applications have been developed for medication administration. Research related to
those CDST have concluded benefits arising from their use, notably improving workflow, improving patient safety,
as well as more attention to alerts, and less impact from interruption [119-121].
The evolution of mobile computing using tablets, smartphones or similar devices is creating a dynamic
environment for the creation of apps12 for healthcare professionals. The area of interest for this study, medication
administration, has a relatively limited number of applications. Apps in this area have the same challenges as apps
for other areas of healthcare, specifically: uncertain regulatory framework, liability concerns, accuracy and
performance validation, providing current information, standardization, and cybersecurity [122-124].
There are relatively few apps developed for medication administration. As of this writing, only a modest number
of apps specifically for medication administration were identified as commercially available apps for small mobile
computing devices:
Micromedex13
Medhost14
PatientTouch15
Medrills16
Allscripts17

11

Extracted from a portion of the answer to Comprehensive Examination question 1 from Dr. Tami Hodges and developed by T. A. Berg. The
complete answer can be provided upon request.
12 Apps refers to software programs developed for use on mobile computing devices that are self-contained programs usually designed to
address a particular need or set of needs.
13
iTunes app aligned with larger healthcare management software
14 iTunes app aligned with larger healthcare management software
15 iTunes app aligned with larger healthcare management software
16 iTunes app aligned with training software
17
iTunes app aligned with larger pharmacy management software
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Other of apps are available that provide comprehensive drug information including:
Epocrates
Merck Manual
A2ZDrugs
iPharmacy
WebMD
Davis’s Drug Guide
The apps noted above could include general medication reference, dose calculation, contraindications, drug
interactions, etc. They do not include decision support tools that guide practitioners through the medication
administration process.
The question can be asked: do apps actually provide a benefit in the form of improved patient safety and more
specifically a reduction in MAEs? The best, but unfulfilling answer is that it depends. Most of the research on the
uses and benefits of mobile apps is anecdotal or the research is not based on controlled studies which weakens the
described benefits [125].
Mobile apps provide benefit for health care providers (HCP) mostly by providing information at point-of care
(POC). Improving access to tools at POC is recognized as improving patient outcomes [126-128]. As noted
previously, there are a wide range of apps that support HCPs including [129]:
o Information and time management
o Health record access and maintenance
o Communication and consulting
o Reference and information gathering
▪ Literature search
▪ Drug information
▪ Physiology and test values
o Calculators and support aids
• Patient management
o Clinical decision-making support
o Patient monitoring
• Medical education and training
The benefits associated with mobile app tools for HCP include convenience, decision making support, reduction of
errors, enhanced communication between the provider and patient, and increases in efficiency and productivity
[129-132].
At the time of this writing no mobile apps have been identified that are designed specifically to support the
administration of medications and having the intent of improving patient safety and reducing the occurrence of
medication administration errors.
Education/Training
The level of training and education has been evaluated as a potential influence on the occurrence of MAEs,
particularly with regard to medication calculation and pharmacology. In an overarching review, the effectiveness
of a range of training and education programs focused on medication administration were examined. The results
of these programs provided mixed results: it was found that while these programs increased general knowledge,
they did not translate directly into the reduction of MAEs. The study goes on to report that more hands-on
training through simulation-based approaches and multifaceted approaches that involved combinations of risk
management strategies and education, resulted in some decrease in MAE occurrence [133].
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Using nurses trained specifically in the MA process and using them as a dedicated resource to administer
medications is one approach that has been considered to lower MAEs. Greengold et al conducted a randomized
trial to assess the use of medication nurses to administer medications to mitigate MAEs [134]. Her conclusion was
that there was no statistically significant value in using dedicated medication nurses over the control group. It
should be noted that this was a limited study using two hospitals and 16 nurses in total.
Interruptions Reduction
An area of interest to mitigate MAEs is to reduce interruptions of nurses while going through the MA process.
Numerous studies have been done to associate interruptions with an increase in MAEs [29, 39, 53, 135-137]. A
variety of studies have been performed to evaluate the impact of interruption mitigation methods [138-141].
While interruptions and other distractions are well recognized as sources of error within healthcare, as well as
other high consequence, the literature for healthcare in the effect or benefit of interruption mitigation efforts is
mixed.
In a systematic survey of ten studies, Raban et al concluded that there is weak evidence on the effectiveness of
interventions to reduce the effect of interruption on the rate of MAEs. They concluded that while there is modest
indication of the reduction of errors, that other interventions were also used and that no controlled studies were
performed to ensure the effectiveness of interruption mitigation techniques. As with other MAE mitigation
techniques, the authors commented that more research is required to better understand the complex integrated
system of MA and the effect of these methods [142]. This was also supported by O’Shea in a similar review of
available research [138, 140, 143].
Improve Work Environment
It is often reported that work conditions, such was shift length, stress, and overwork, can lead to increased MAEs
[4, 50, 144]. Lessons learned from other industries have been explored from other industries such as airline,
nuclear, chemical operations and other high consequence operations [145-147].
Nurse workload continues to be an ongoing area for debate: for the purposes of this review, workload is used as a
general topic area covering areas including stress, fatigue, burnout, etc. While one could argue that this is not
entirely accurate, the literature generally groups these areas. On one hand the literature clearly relates high
workload and its corollary element, fatigue, as a direct cause of decreased patient safety and increased MAEs [29,
144, 148-151]. This risk is offset by the real-world issue of higher costs associated with increased nurse staffing
levels: note that the correlation of increased nurse staffing levels and increased patient safety is well documented
[152-157]. The most relevant comment on this topic came from an interview conducted with the Dean of the
College of Nursing at the University of Tennessee-Knoxville, Dr. Niederhauser. Dr. Niederhauser stated “the
primary reason someone goes to the hospital is for professional nursing care”.
Included in the discussion of the work environment is the level of education of the nurses. Similar to reduced
workload, increased nursing education, particularly baccalaureate and advanced practice nursing education,
contributes directly to improved patient outcomes and a decrease in MAEs [158-161].
While a straightforward solution to address medication errors would be increased staff levels, better scheduling
and better educated nurses, the economics of healthcare would generally not support this. Hospitals are driven to
lower staffing levels, including registered nurses, in order to address financial challenges [162]. Healthcare has
used various industrial engineering tools to help mitigate the balance of the need for improved scheduling and
increased staffing levels by applying various scheduling and staff balancing techniques [163-165].
The disconnect between the desire to improve product quality (in the case of healthcare this means increasing
patient safety and improved outcomes) and the drive to reduce costs is not unique to healthcare. What is unique
to healthcare has been the resistance to drive change forward including or especially engaging technologies that
can augment performance such as using just-in-time information.
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Checklists
Seemingly mundane and simplistic, checklists seem to be an obvious solution to address some of the more typical
oversights that cause MAEs. In his book, The Checklist Manifesto, Atul Gawande takes the concept of checklists,
particularly in healthcare, and describes how in this increasingly complex field it is too easy to miss a step that
results in some form of error. Checklists, either in the form of computer base instruction or hand-written notes,
are recognized as successful in reducing MAEs [135, 166, 167]. Studies corroborating this cover various forms of
checklist implementation. In one instance, simple checklists were effective in reducing pump programming errors
for oncology treatments between 38%-55% [168, 169].
Human factors/Cognitive Engineering and Systems Engineering for MAE
Human factors engineering (HFE), which also includes usability engineering, cognitive engineering (CE) or userinterface engineering, integrates the areas of psychology, ergonomics, human dynamics, man-machine interface
and engineering [170]. Systems engineering (SE) is a multidisciplinary approach to applying engineering principles
to the operation of the integrated composite of people, products and process that provide a capability to satisfy a
stated need or objective (aka a system) [171].
Human factor and systems engineering have enjoyed application to healthcare as a means to improve operations
and ensure the wellbeing of patients and providers. The application of these disciplines is somewhat more limited
in the study of MAEs.
While not at the core of this research, HFE studies on CPOE have demonstrated the benefits of considering HFE
and SE issues as part of the protocol in designing or assessing these systems. One study assessed the project
lifecycle of a CPOE in the re-engineering of the system and was reported as a case study. Various issues and
potential solutions were identified, which resulted in a redesign of the system to increase patient safety and
human performance [172].
Another HE study on CPOEs identified 22 types of medication errors associated with CPOE systems including
double dosing, incompatible orders, generating wrong orders and missing contraindications due to a lack of
integration with other systems. This study considered the cognitive engineering aspects of CPOEs and noted the
causes of errors as 1) information errors generated by information fragmentation errors leading to a lack of
information and 2) human-machine interface flaws reflecting rules that do not correspond with work processes
[173]. A similar study by Wettemeck had similar conclusions [174]. These same factors would clearly hold true for
nurses as well as physicians.
It has been noted that EMRs and CPOE systems have had unintended impacts on nurse-physician interaction [6,
175, 176]. This phenomenon is a multifactor issue including work behaviours, work polices and software design. A
HE/SE evaluation that effectively evaluates an often overlooked and underestimated key factor could conceivable
have identified and defined solution options for this issue.
A limited amount of research has been done on HFE and SE specifically related to the physical distribution portion
of the medication administration process. Some effort has gone into the understanding of causes of MAE as noted
earlier. At the risk of repetition these are [177-180]:
• Stress
• Workload
• Fatigue
• Emotional/cognitive issues
• Interruption/working conditions
• Slips
• Lapses
• Education/Training
• Rule violations
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•
•
•

Poor communication
Lack of critical thinking
Poor equipment design

Various studies have been done on attempts to find HFE/SE insight on potential solutions to these factors. While
not comprehensive the following table provides a representative listing of the research I the field (Table 2.10).
At its core, healthcare is a service industry with human interface being the overriding method of work execution.
This includes provider-provider, provider-patient, provider-equipment, provider-computer, provider-organization
interactions along with all of the other permutations and combinations. With humans as the key element of the
healthcare system, it is curious that healthcare has found relatively little use for HFE including cognitive
engineering in medication administration.
Some applications of HFE/CE that have an effect on MAE have already been explored in this review including bar
coding, work interruptions, medication infusion equipment, MAR software, and computerized order entry. One
application of HFE/CE is on the naming, labelling and packing of medication. One study reports that up to 25% of
medication errors are a result of name confusion errors, and 33% are a result of packaging or label confusion. The
US Federal Drug Administration and US Pharmacopeia provide direction naming conventions, labelling and naming.
However, these guidelines have not lead to an elimination of errors. In this paper, Berman provides a set of
guidelines which could reduce the incidence of MAEs, however does not provide studies to back up her
suppositions [211]. Other industries have considered the use of CE and HFE for these purposes and could be
applied to healthcare. While changing labelling, names and using text size, font and packaging colour differences
can be beneficial, it can also result in unintended consequences and errors as well [212]. Also confounding this
area are the restrictions placed on changes to packing, naming and labelling by the regulatory agencies. Clearly
this area is a source for future research support in HFE/CE.
Another paper provides an interesting insight on the effect of package design on accuracy recognition for
medications. In this study the research evaluated the error incidence of the standard medication packaging
against packaging that was designed with modified colours, text form and size, and emphasis of medication type.
The redesigned packages lowered the incidence of error by a factor of five [213]. Appendix 9 provides a depiction
of the similarity of drug packaging that could lead to MAE based on the similarity of packaging resulting in
providing the wrong medication to a patient.

Table 2. 10: Listing of reviewed literature HFE/CE and SE
MAE Error Factor
Workload
Fatigue
Emotional/cognitive issues
Interruption/working conditions
Slips/Lapses
Education/Training
Rule violations
Poor communication
Lack of critical thinking
Poor equipment design

Citation
[181-184]
[185, 186]
[187-189]
[40, 146, 190-194]
[195-197]
[42, 154, 198, 199]
[34, 200]
[201-203]
[204-207]
[208-210]
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Decision Support Tools
This question actually poses two thoughts. First is the consideration of the recent research contributing to the
advance or understanding of Point of Care (POC) Clinical Decision Support Tools (CDST) and in considering this
information, how it will impact consideration of my future research related to POCCDSTs. This is decoupled but
relates directly to the second part of the questions which considers the temporality of the information.
Clinical decision support systems (CDSSs) provide clinicians, staff, patients or other individuals with knowledge and
person-specific information, intelligently filtered and presented at appropriate times, to enhance health and health
care. CDS encompasses a variety of tools to enhance decision-making in the clinical workflow. These tools include
computerized alerts and reminders to care providers and patients; clinical guidelines; condition-specific order sets;
focused patient data reports and summaries; documentation templates; diagnostic support, and contextually
relevant reference information, among other tools.
CDSSs have a number of important benefits, including:
• Increased quality of care and enhanced health outcomes
• Avoidance of errors and adverse events
• Improved efficiency, cost-benefit, as well as provider and patient satisfaction
A CDS is a sophisticated health IT component. It requires computable biomedical knowledge, person-specific data,
and a reasoning or inferencing mechanism that combines knowledge and data to generate and present helpful
information to clinicians as care is being delivered. This information must be filtered, organized and presented in a
way that supports the current workflow, allowing the user to make an informed decision quickly and take action.
Different types of CDS may be used for different processes of care in different settings.
Health information technologies designed to improve clinical decision making are particularly attractive for their
ability to address the growing information overload clinicians face, and to provide a platform for integrating
evidence-based knowledge into care delivery. The majority of CDS applications operate as components of
comprehensive EHR systems, although stand-alone CDS systems are also used.
While POCDST applications are unique in terms of setting and specific application, the science and theory behind
them are similar to decision support tools (DST) in general (i.e. covering all aspects of their application). The
research on DSTs is extensive and varied. Their development and application go back decades, preceding the
advent of artificial intelligence starting with the use of operations research and statistical modeling during WWII to
support logistics (now called supply chain), troop movements and submarine hunting [214]. The complexity of
operational decisions requires a systematic approach to decision making, which can sift through numerous
(interacting) options, trading off multiple (quantitative and qualitative) objectives, incorporating conflicting inputs,
helping to minimize the impact of distractions and non-value-added information, while minimizing risks and
handling huge amounts of data. Such decisions can greatly benefit from state-of-the-art decision support tools.
Decision support tools found wide adoption, primarily in the area of manufacturing, to improve operations and
productivity. As computing capabilities, the applications of computer-based decision support found more varied
applications, growing rapidly from the 1960s. Decision making tools of all types have found their way into finance,
tourism, entertainment, transportation, sports, etc. [215].
These varied applications and the related research serve as the foundation for the application of DST in healthcare.
Wu et. al. reviewed types of decisions and DSTs from a number of areas outside of healthcare and noted
considerable similarities between the types of decisions that are made, the functions of the associated DSTs as
well as the factors that influence the performance of DSTs. They concluded that “complex, high-level decisionmaking has common features across disciplines as seemingly disparate as defense, business, and healthcare.
National efforts to advance the health information technology agenda through broader CDS adoption could benefit
by applying the DST principles identified in this review” [216].
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A serviceable definition of a decision support tool (DST) is:
A tool or set of tools that facilitates the use of data, models, and employs a structured decision process to
help answers question, solve problems and supports or refutes conclusions [217].
For this discussion no distinction will be made between a decision support system and a decision support tool.
While one could make a conceptual distinction of a decision support “tool” as having specific or limited application
focused on providing support in a narrow area and a decision support “system” as having broad application
covering a variety of areas, the literature does not seem to make a clear distinction bin the use of “system” or
“tool”. For our purposes the terms will be used interchangeably.
CDSTs are a natural extension and subset of DSTs. HealthIT.gov defines a CDST as:
…a system that provides clinicians, staff, patients or other individuals with knowledge and person-specific
information, intelligently filtered or presented at appropriate times, to enhance health and health care.
CDS encompasses a variety of tools to enhance decision-making in the clinical workflow [218].

POCCDSTs are a subset of CDSTs. While the application of POCCDST is narrower, the elements are the same as the
overarching DSTs. These basic elements and their interaction are highlighted in Figure 2.10. When adding the
concept of POC the focus is on those tools used by the clinician immediately during or proximate to an encounter
with a patient. Adding the feature of POC application to CDSTs creates extra demands for the tool’s functionality
including enhanced ease of use, succinctness of information, integration into user workflow, and collection of
information from various sources and provide in an integrated and appropriately processes fashion.
With the state of the science of DSTs being the superset including CDSTs, the domain of DSTs will be considered in
reviewing the state of the elements of science to contributing to progress in POCCSTs. An important element of
POCCDST is the need to have the information from the CDST provided in near real-time which emphasizes the
aspects of human-computer interface, cognitive engineering, mobile computing, and mobile healthcare.
State of the Science of Just in Time (JIT) Point of Care Clinic Decision Support Tools (POCCDSTs)
At its essence this research is exploring how JIT information might influence decision making with the hopes of
decreasing the rate of error in the MAE process. JIT information must be delivered through some mechanism, in
this approach a simple POCCDST will be used to provide the information to the research subjects. There is a
considerable corpus of research on POCCDSTs and a vast array of POCCDSTs that have been developed many of
which are used in clinical practice.

Clinical
Decision
Support Tools

Decision
Support
Tools
POC Clinical
Decision
Support
Tools

JIT POC
Clinical
Decision
Support Tools

Figure 2.10: Clinical decision support tools are a subset of the family of decision support systems
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A clinical decision support tool is an application that provides information to a clinician that assists in taking action
or making judgment in support of the care of a patient. There are a large number of clinical decision support tools
(CDST) with a broad range of complexity, functions and applications. While they have found some use in
healthcare settings their use is not as ubiquitous as you would find in other settings such as finance and
manufacturing. For healthcare the range of CDSTs ranges from relatively simple smartphone applications that
include checklists, reminders, calculators or information sources (e.g. epocrates®) to complex, robust systems that
provide extensive knowledge processing and artificial intelligence integration into the decision making process
(e.g. IBM Watson®).
The dawn of CDST is reported to have started in the 1960s with commercial application occurring in the early to
mid-1990’s [219-221]. CDSTs take on a wide variety of forms, applications and levels of complexity ranging from
disease specific applications (e.g. cancer), application specific (e.g. medication administration) to general use
decision making tools. As the robustness and complexity of CDSTs increases, so do the challenges of their
implementation, operation, maintenance and utility for the end-user.
The need and resulting desire for CDSTs is clear. The complexity of delivering efficient and error free care that
engages evidenced based medicine is overwhelming. The belief is that using CDSTs will improve overall clinical
performance by providing the clinician with tools that will help process information leading to better decisions and
outcomes. Effective CDSTs have the following attributes [222]:
• speed in processing information,
• anticipation of user needs and delivery of information in real-time (aka Just-in-time information),
• ease of use,
• fit with the user workflow and other information systems,
• limit required input from the end-user to a minimum,
• simple man-machine interface (e.g. ease of switching between screens and limited information per
screen),
• information is current and correct.
A fundamental part of the evaluation of testing a new drug is to validate that it is efficacious. Similarly, a first step
in considering POCDSTs is to perform the same assessment and answering the question: do CDST improve clinical
practice and what are the critical features that contribute to performance? A review conducted by Kawamoto
demonstrated that CDSTs significantly improved clinical practice in 68% of randomized control trial performed on
individual CDSTs. Four features were identified as contributing to improved clinical practice: automatic provision
of decision support as part of clinician workflow, provision of recommendations rather than just assessments,
provision of decision support at the time and location of decision making, and computer-based decision support.
Of the systems with all four features that were evaluated, 94% significantly improved clinical practice [223].
Clinical Decision Support Tool Structure
A Clinical Decision Support Tool (CDST) can be thought of as having two basic components. One is the part that
interacts with the user, referred to as the user interface (UI). The other component can be considered the
Decision Engine, it is the set of algorithms, data, and behind the scenes processing that takes the queries from the
UI, processes them and then provides the desired information to the user via the UI. The basic architecture of
PCDST provides a structure on how to parse the functional elements relevant to PCDST. The key elements for our
discussion here are the cognitive elements related to the user interface, the user interface itself, the knowledge
base and the decision engine. The other elements like the use of cloud computing and interfacing to the data are
certainly important, but not directly germane to the science areas of interest.
The need and resulting desire for CDSTs is clear. The complexity of delivering efficient and error free care that
engages evidenced based medicine is overwhelming. The belief is that using CDSTs will improve overall clinical
performance by providing the clinician with tools that will help process information leading to better decisions and
outcomes. Effective CDSTs have the following attributes:
• Speed in processing information,
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•
•
•
•
•
•

Anticipation of user needs and delivery of information in real-time (aka Just-in-time information),
Ease of use,
Fit with the user workflow and other information systems,
Limit required input from the end-user to a minimum,
Simple Man-machine interface (e.g. ease of switching between screens and limited information per
screen),
Information is current and correct [222].

Figure 2.11 provides a simple diagram of a generic decision support system. “Data” refers to any information input
into the system without regard to its origin including electronic health record, manual input, sensor input, etc.
“Model” can be considered as the set of algorithms, heuristics or functions that process the inputted information.
The user interface provides the user the mechanism to input information and access the processed information, a
typical graphical user interface in a computer-based Decision Support Application. The Decision Support
Application is the integration of the three previously mentioned elements to provide the user with the desired
function(s).
Figure 2.12 provides an expanded view of the possible interfaces for a CDST[224]. The interfaces and their
interactions depend on the functions and design of the CDST. Sophisticated CDSTs will be fully integrated with a
number of databases, will have robust decision engines, will provide multiple functions and will require significant
computing requirements. Advanced networking technology, cloud computing and more powerful mobile
computing platforms allow more advanced POCCDST functionality, notwithstanding the man-machine interface
and cognitive ergonomic limitations of smaller platforms, as well as the operating environment for PCDSTs.
The user interface (UI) in Figure 2.12 includes user input, type of platform (e.g. smartphone, laptop, portable
workstations, etc.), and the UI. The decision engine combines the logic programming, model, rules or a statistical
program of the knowledge base with the patient knowledge based data [219, 225].
A fundamental part of the evaluation of testing a new drug is to validate that it is efficacious. Similarly, a first step
in considering POCDSTs is to perform the same assessment and answer the question: do CDST improve clinical
practice and what are the critical features that contribute to performance? A review conducted by Kawamoto
demonstrated that CDSTs significantly improved clinical practice in 68% of randomized control trial performed on
individual CDSTs. Four features were identified as contributing to improved clinical practice: automatic provision
of decision support as part of clinician workflow, provision of recommendations rather than just assessments,
provision of decision support at the time and location of decision making, and computer-based decision support.
Of the systems with all four features that were evaluated, 94% significantly improved clinical practice[223].
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Figure 2.11: Simple diagram of generic decision support system
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Figure 2.12: Expanded point of care clinical decision support diagram

POCCDSTs can be applied throughout the medical management cycle to optimize safety and other relevant
outcomes. Not surprisingly the 5 rights of medication administration have been duplicated to create the POCCDST
5 rights noted below [226].
• The right information: evidence-based, suitable to guide action, pertinent to the circumstance.
• To the right person: considering all members of the care team, including clinicians, patients, and their
caretakers.
• In the right CDS intervention format: such as an alert, order set, or reference information to answer a
clinical question.
• Through the right channel: for example, a clinical information system (CIS) such as an electronic medical
record (EMR), personal health record (PHR), or a more general channel such as the Internet or a mobile
device.
• At the right time in workflow: for example, at the time of decision/action/need.
While these elements are necessary in building an effective POCCDST, they are not necessarily sufficient to ensure
optimal performance of the system. Elements that are frequently missed in designing such systems include user
interface and cognitive ergonomics perspectives that provide the appropriate functionality, compliance with
procedures, consideration of information security protocols and usability of the tool based on the actual needs of
the end user.
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Summary of Decision Engine Research
CDST’s are divided into two general categories, knowledge-based-systems (KBS) and non-knowledge-based
systems (NKBS) (Figure 2.13). KBS based CDST’s are in essence expert systems that use rules such as IF-THEN
statements to process the user input and in combination with the decision engine process, use this input to
develop the desired output such as suggested actions for the user.
NKBS use machine learning, a form of artificial intelligence. As opposed to constructing rules and using expert
input, this architecture allows the system to find patterns in clinical algorithms or examples of information or learn
from past experiences. Artificial neural networks and genetic algorithms are examples of this type of system. This
duality provides flexibility in their interpretation and provides both the ability to track the decision process and
incorporation of new data hence is a learning system.
Extensive research has been done on KBSs. Rule based expert systems, decision trees, and Bayesian models are
examples of KBSs. These types of systems are preferred for clinical implementation because the performance can
be more accurately validated in contrast to NKBSs that are considered “black-box” having logic trains and
processing that cannot be as easily traced.
Bayesian networks employee conditional probability and new knowledge to produce updated output. A Bayesian
network can be viewed as both a knowledge based and statistical system. A Bayesian network can be constructed
to a system that uses expert input. Bayesian networks also represent a multivariate probability distribution with
the assumption of independence. The integration of the domain knowledge from the expert along with the
statistical framework and ability of Bayesian networks to update themselves usually results in better performing
systems [227].
Rule based systems (RBS) typified by the IF-THEN rule sets were one of the schemes used in the early days of
expert system development and remains one of the main approaches for design of CDSTs. The standard RBS has
been modified by adding features that add fuzzy rules. Genetic algorithms have been used to identify rules in
addition to using experts [228].
Conventional Rule Based Systems (RBS) have inherent limitations because of the inflexibility of the rules. In other
words, a standard IF-THEN rule does not allow for vagueness or uncertainty. A rule-based inference methodology
using evidential reasoning (RIMER) for knowledge representation has been developed and applied in CDSTs. In this
approach, a set of rules is designed with degrees of belief in all possible consequents of a rule. This approach is
capable of capturing incomplete information, vagueness and nonlinear causal relationships [229].
NKBSs are made up of a variety of tools and approaches. Artificial neural networks (ANN) have been used
extensively in CDSTs. They are used frequently because the developer is not required to understand the
relationship between the output and input variables. ANNs are considered a “black box” technique that models
relationships by learning from historical information, whereas approaches like Bayesian networks require
adequate domain knowledge including probabilities of occurrence of events. A comparison of ANN with
mathematical models was performed on a traumatic brain injury decision support system. The results suggested
that ANN may be better at providing decision solutions for complex non-linear CDST than conventional statistical
techniques [230]. ANN are not used as extensively in direct clinical applications because of their black box nature
and the logic train of the decisions they provide are not directly traceable.
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Figure 2.13: Methodologies for CDST decision engines

Genetic algorithms work by working through possible solutions reiteratively to find the optimal solution which is
the most fit. Defining solution fitness is a challenge for genetic algorithms [219]. Genetic algorithms tend to be
less greedy in processing, which provides global optimal solutions as opposed to locally optimal solutions. This is
because genetic algorithms can identify cases using subsets of cases and consider cases which are influential enbloc which may not be influential alone [227]. Genetic algorithm models are used in domains where the existing
knowledge is difficult to encode, or traditional mathematical models are not appropriate [231, 232].
While many CDST based on ANN and genetic algorithms have been developed, their application is mainly in the
realm of academic research and not continuous clinical application. ANN and genetic algorithms are
computationally expensive for more complex systems and they lack the assurance of more conventional
knowledge-based systems [219].
Cognitive Engineering
Cognitive engineering (CE) (also called cognitive ergonomics) seeks to understand how people make decisions in
real settings and is an important element of decision support tools. Included in this domain are the ways in which
people perceive and then process information under varying conditions such as time stress, high risk, group
settings, organizational influences, etc. It is considered part of human factors as part of industrial and systems
engineering disciplines. CE integrates aspects of cognitive and behavioral science, human factors, humancomputer interaction, psychomotor response, and systems engineering.
Human factors cognitive engineering has focused on the psychomotor and perceptual aspects of how humans
receive and process information or interact with their environment. More recent work begins to develop the
understanding of how information is processed and understood in the context of how it is presented with respect
to the overall system. This research is providing an understanding of what is needed to design DSTs. This is
particularly relevant to healthcare and its dynamic decision-making environment. This research is providing
answers to why cognitive behaviors occur including what causes errors/mistakes, how information is interpreted
and processed, propensity to use DSTs, how DSTs can best support critical thinking, human processing of
information from multiple disparate data sources, as well as optimizing decision performance in complex
environments (interruptions, high cognitive work load, stressful, time critical, etc.) [233, 234].
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Kushniruk has explored the analysis of complex decision-making processes in health care with regard to applying
cognitive approaches to health informatics. To summarize this exploration, an improved understanding of
cognition is essential for evaluating the effects of CDSTs and for improving them. Decision making, and as a result
the effectiveness of decision making tools are influenced both by the individual and the environment: a novice in a
high stress environment working with ill-defined information will engage a decision-making tool in a different way
than an expert with well-defined information in a routine environment. Decision performance can be complicated
by a dynamic environment which includes interruptions and shifting requirements. A CDST will be more effective if
its design incorporates consideration on how the user will perceive, understand and act on the information
provided by the system.[235].
Providing support in decision making (DM) is a primary function of POCCDST. The study of DM is integral to
cognitive engineering. There are three perspectives of research in DM: psychological, normative and cognitive
[236-238]. The cognitive aspects consider DM as a continuous process integrated with interaction with the
environment. The psychological perspective considers decisions in the context of values, preferences and needs
that the individual needs or has. Research in the realm of normative assessment analysis DM based on logic and
rationality in the DM process. Each perspective has an extensive body of research supporting it and can play a role
in the design of an effective POCCDST.
How someone makes decisions can change as the environment they are operating in changes. For example, logical
decision making where the decision maker uses their knowledge to assess the situation, evaluate options and
make rational choices based on this information would be an approach used in medical decision making when the
environment is not stressful. However, as the situation changes to one with higher time pressure, more
interruptions, greater ambiguity and more interruptions, the decision maker likely shifts to intuitive decision
making using prior experience and simple heuristics to make decisions. Understanding this dynamic, the design of
a POCCDST can accommodate this change or fill the gaps in judgment inherent to each DM approach [234, 239242].
The question directly impacting this research is the construction of a CDST that provides the appropriate
information needed by the user in a fashion that is understood. Adding POC into the construct of cognitive
ergonomics for CDST increases the pressure to provide information tailored in a way that enhances understanding
and supports decision making or task execution in a focused area in a timely fashion. The cognitive engineering
aspects at play are:
• data visualization – how the data is presented in a form that is most meaningful, and
• knowledge representation – integration and presentation of information that is most meaningful.
Extensive literature exists on the psychomotor aspects of human-computer interface. Elements such as eye
tracking, font size, color highlights, dynamic emphasis (e.g. flashing text, popups), physical user interface (e.g.
touchscreen, screen size, mobile vs. portable), screen swiping, etc., have been studied extensively. While
considerable research exists on how these types of factors effects usability and understanding of computer
applications, much less work has been done on how this might specifically affect POCDSSTs. While many of the
tools from human computer interface (HCI) are applicable, lessons learned from recent research indicates that it is
also likely domain dependent.
Human-Computer Interface
If a POCCDST uses a computing device, an important consideration in the design and application of the technology
is the design and functionality of the interaction between the human and the device and associated software.
Human-computer interaction (HCI) is an area of research and practice that emerged in the early 1980s, initially as a
specialty area in computer science embracing cognitive science and human factors engineering (Figure 2.14).
While HCI is a broad field, our interests are focused on how to improve the physical interface between the POCDST
user and the backend system providing the information. Computers in a clinical setting include various form
factors and physical user interfaces ranging from stationary workstations to “computers on wheels” transportable
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works stations to truly mobile platforms including laptops and hand-held devices. The form factor of the computer
plays a role in its usability for different purposes. A workstation with a larger screen and keyboard offers easier
input for notes and charting purposes, as well as easier reading of large documents or detailed data. Whereas, a
smartphone provides easy portability and quick reference to summary level information and the ability to respond
quickly to alerts and just-in-time information but the smaller screen size limits the its functionality for some
applications [243, 244].
The user interface (UI) defines how the user interacts with the system and is paramount in determining the
effectiveness of the system’s usability. This is particularly true for smaller form factor computing devices such as
smartphones. Many factors influence the user interface experience. For example, smaller screen devices impose
more difficulties for children and middle-aged or older adults who were sensitive to cognitive demands imposed by
current smartphone GUI designs [245].
Extensive research exists on graphic user interface (GUI) including layout, font, color active graphics, data entry,
etc. [246, 247]. A number of studies have investigated text-based approaches versus GUIs for computerized order
entry. The general results indicated that GUIS increased accuracy and were more efficient than text based entry
[248, 249].

Figure 2.14: Interaction of elements influencing human-computer interface18
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Sources: http://www.kickerstudio.com/blog/page/34/
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Developing an interface that provides an appropriate user experience that accommodates both the challenges of
the environment and meets the ergonomic criteria for the target population of users is challenging. The interface
will ideally be intuitive, simple, match the workflow, be compliant with procedures, and provide ease of input as
well as readability. Consideration could be given to haptic feedback to augment other types of notifications. End
user testing and evaluation of the GUI, while it is in development, is an important step of the GUI design. Physical
considerations such as infection control, physical handling of the device, patient perception, durability and other
factors.
Mobile Computing
POCCDST requires a dynamic interface and the ability to provide a number of simultaneous interfaces principally
between the user and the information resource but also the user and the patient. Optimally, the interface and the
information exchange must be in real time. Ideally the information content will provide the correct information in
the right form in the correct amount to allow easy interpretation. Mobile information communication
technologies (MICTs) have considerable promise in patient care settings. That promise can only be realized if the
MICT applications are used by the medical staff. This paper reports on a study examining nurses' decisions to
utilize MICTs. A mixed-methods approach is used, consisting of both qualitative and quantitative elements, that
reveals and empirically tests the significance of novel constellations of fit (i.e., identification, information, patient
interaction, physical, time criticality, user comfort, and workflow fit) and individual characteristics, presented as
basic human drives (i.e., drive to acquire, bond, defend, and learn). Findings indicate that fit is a multi-faceted
construct and that archetypical human drives have an influence on these various notions, which in turn, impact
technology adoption in the healthcare context.[250]
The potential for handheld devices to support healthcare providers is well recognized [251-253]. Point of care
clinical support systems targeting bedside nurses have positive effects on outcomes and hold promise for
improving care quality; however, this research is lagging behind studies of CDS targeting medical decision-making
in both volume and level of evidence [254].
Interestingly, no research has been found related to the ideal features for mobile computing devices in healthcare
and how these would influence adoption of mobile devices for use in healthcare. These considerations might
include size, battery life, features and functions, haptic interface, voice recognition, video capture/playback, GPS,
network features, processing, wear-ability, provider/patient interaction considerations, durability, infection
control, to name a few features that might influence the ultimate design of a mobile device for HC.
Considerable study has been done in the areas of utilization of mobile devices, mobile device applications and
acceptance of mobile device use. Wu has evaluated the acceptance features of MCT in HC and found that
perceived usefulness and perceived ease of use contributed significantly to the use of MCT by HC providers [255].
As part of another study he found that adoption of this technology was driven by the healthcare provider’s traits of
innovation adoption and the perceived availability of the technology [256].
Research literature on the applications of mobile devices, particular smartphones, is becoming ubiquitous. The
research covers both specific applications such as medical reference material, disease diagnosis and general areas
such as smartphone use for patients or HC professional education and training [252].
Smartphone-like devices provide an array of sophisticated sensors that can provide information related to location,
speed of movement, activity, and social interaction, proximity/interaction with other devices or equipment and
more. This information can provide the ability for anticipatory computing where the device provides appropriate
information to the user based on the context of interactions and other data without requiring action from the user
[257].
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Figure 2.15: An example of Mobile Computing Technology -Google Glass- with augmented reality capability19

Just -in-Time Information
Just-in-time information borrows from the context of Lean. For the sake of completeness, Lean is the concept of
maximizing customer value while minimizing waste. JIT is a system of delivery that provides just what is needed,
just when it is needed, just in the amount that is needed. JIT relies on three operating concepts: takt time, the pull
system and continuous flow.
JIT information differs from real-time information in at least one important way. Real-time refers to the delivery of
information as it is generated and does not necessarily have additional processing to restrict the volume of
information, enhance its value to the end user or control its time of delivery based on the needs of the user. In
accordance with Lean principles, JIT information is adjusted to meet the needs of the user by providing the
information in a contextual form, only the information that is needed is provided, and it is provided as needed.
A simple example is monitoring stock prices. Real-time information would be represented by a stock ticker as a
continuous rolling display without regard to temporal need or specific information needs by the end user (Figure
2.16, image 1). A JIT information delivery system would provide information based on predefined requirements or
user query. The JIT information would be preprocessed to provide only the key information the user needed at
that time, e.g. significant price change, forecasted change, company news, market influences, trends, etc. (Figure
2.16, image 2).

19

Image included under title 17 section 107 U.S. Copyright Law Fair Use Doctrine as educational material distributed for use without profit.
Source: http://www.u1group.com/blog/article/working-with-google-glass

56

Image 1

Image 2

Figure 2.16: Real-time vs JIT information3, 20

One of the best examples of JIT information is the Google Maps application for driving. Google Maps is a
Geographic Information System based mapping system that provides current updates to the user, or this example
a driver. Google Maps takes input from the user in the form of destination and things like preferred route,
integrates it with historical knowledge base information including traffic patterns, and input data from multiple
sensor sources like data from other cell phones in the area that fit certain criteria (e.g. speed, proximity to other
phones, location, etc.), accident information from other sources, etc. It integrates all this information and provides
the driver with route information, indicates potential issues (e.g. road construction, disabled vehicle, debris in
road), suggests reroutes if there is a traffic slowdown, provides the estimated time delay if there is a slowdown,
and estimates the time of arrival. Upon additional query Google Maps will provide nearest location, and route to
nearby destinations of interest like gas stations, coffee, rest stops, etc. Audio output in the form of direction
information, such as turns or exits, is provided to the user to aid in driving without having to refer to the
smartphone. As a turn or exit is approached, the display will change to provide an expanded more detailed view of
the turn. All this information is updated in real-time and more importantly just-in-time (Figure 2.17).
Google Maps provides the driver with a large amount of information in a simple one screen format. Running
behind the scenes is a massive decision support system that integrates multiple data sources. This information is
processed and integrated to provide the user with just the information they need at the time, just when it is
needed, and just the amount that is needed (including the contextual information to help provide insight on
potential future decisions that might need to be made).

20

Images included under title 17 section 107 U.S. Copyright Law Fair Use Doctrine as educational material distributed for use without profit.
Sources: stocksticker.com, http://www.shutterstock.com/video/clip-1769624-stock-footage-stock-market-data-tickers-board.html
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JIT information integrates various disciplines including cognitive ergonomics, decision science, computer science,
Lean, systems engineering, as well as the discipline specific areas that JIT information is being applied to as in our
case, healthcare.
Davenport discusses the potential that JIT information delivery provides for healthcare and suggests caution on
some of the challenges such a system will face based on an early implementation of a JIT information system at
Brigham and Women’s Hospital in Boston. Davenport highlights the application of JIT information to decrease the
occurrence of error as part of POC activities by making information “so readily accessible that it can’t be avoided”.
The JIT system described is a POCCDST with an extensive backend logic system that combines information from
various EHR sources

Figure 2.17: Google Maps implementation as a JIT information source21
Key insights provided were that: only processes and knowledge domains that are critical in the sense they have
overarching importance due to drivers such as safety, cost, or risk; appropriate management and end-user support
including the ability to measure utilization and performance; and, appropriate data sources and technical ability
that can provide current and accurate information [75].
The concept of lean or Just-in-Time information fits squarely in the domain of patient centered point of care
clinical decision support tools. JIT information aligns with delivering the right information at the right time in the
right way to enable optimal use by the user. Barnesteiner argues that for nurses, JIT information contributes
directly to improving patient safety when used as a POCDST, especially when integrated into organizational and
operational priorities.
Information for decision making needs to be available at the point of care. This includes easy access to drug
formularies, evidence-based-practice protocols, patient records, laboratory reports, and medication administration
records. Many organizations now have drug formularies and practice protocols available as applications for smart
phones, thus providing for just-in-time information availability [258].
There are a large number of applications of JIT POCCDST. One study considers the application of a POCDST to
antibiotic use and patient outcomes in a critical care unit concluded that point of care handheld computer-based
decision support contributed to a significant reduction in patient length of stay and antibiotic prescribing in a
critical care unit [259]. This corresponds with the observations from Davenport mentioned previously.

21

Image included under title 17 section 107 U.S. Copyright Law Fair Use Doctrine as educational material distributed for use without profit.
Source: http://www.cnn.com/2013/08/20/tech/mobile/google-waze-mobile-maps/
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One recent area of research focuses on the technology and tools underpinning JIT POCCDSTs. Linan explored the
development of clinical decision support rules that are based on computer interpretable guidelines. In this
application, pharmacogenomic guidelines were used to represent the semantics and decision logic [260]. This
research highlights recent advances in building a common format for metadata, actions, events, and conditions as
well as an expression language. This common format construct was driven by the National Coordinator for Health
Information Technology. This common format, Health eDecisions (HeD) interchange format also defines a
methodology or schema for validation of compliant documents containing guidelines. Together, the HeD model
and its schema represent the workflow and decision logic of interventions such as CDS rules, order sets and
documentation templates. The HeD editor has features that assist in modeling and testing clinical decision logic
[261, 262]
Another interesting area of active research on JIT POCCDSTs is medical education. A review by Mi analyzed the use
of mobile devices by health profession students. Summarizing this review, mobile devices such as smartphones,
tablets and the now somewhat obsolete PDA, found significant benefit in supporting the performance of health
profession students in areas such as POC decision support, accessing healthcare information (e.g. online reference
material, manuals, procedures, etc.). The review indicated that students increased their use of JIT information
sources as their familiarity with the system and information available increased. This was particularly true for POC
use [14].
Rees et. al. considered use of JIT POCCDST specifically for nursing education. According to Rees, student nurses use
mobile devices in clinical settings to look up specific and abbreviated information to support decision making
primarily during direct patient care. Information areas include medication administration, best practices, and
mobile apps (calculators, reference material, etc.) [263].
JIT information and POCCDST are, or should be, integrated concepts. A POCCDST will rely on a steady stream of
timely, contextually relevant, appropriately structured information (AKA JIT information) as input to support the
processing it does in order to provide the user with the best set of solutions to act upon. Conversely, one can also
argue that it is the role of a POCCDST to provide JIT information to the user for the same purpose. So, different
types of JIT information can act as both input and output for a POCCDST.
Relationship of JIT to POCCDST
Figure 2.18 shows the relationship of some of the primary elements of POCDSTs relative to JIT information delivery
for healthcare. What it hopes to show is that healthcare JIT information is directly influenced by advances in each
of these areas. Of particular interest, and I believe relevance, are the roles of cognitive ergonomics, data
integration and adaptive/learning computing as it relates to the roles and functions of nurses in acute care
settings. Research and applications in other areas such as smartphone GIS systems (e.g. Google Maps), Pandora
Music, advanced avionics systems (formerly known as - Pilots Associate), and NEST home automation, have
commercial applications that exhibit utilization of varying degrees of JIT information integrated into DSTs.
Similar to how behavioral economics has dramatically changed the view of micro and macroeconomics; cognitive
engineering will optimize the human-computer interface for POCDST. Behavioral economics create a fundamental
shift from the classical economic core belief of rational markets and objective behavior to what Dan Airely has
coined predictable irrational, which views economic forces driven by the idiosyncrasies of human beliefs and
behaviors. In the same way cognitive engineering will accommodate human behaviors, perceptions and abilities to
optimize utility and function for the end user. I believe that applications of cognitive engineering will define how,
and very likely if, any given POCCDST will find its way to implementation.
Decision theory, decision science and systems engineering, along with their respective sub disciplines, have a very
well-developed research base that will influence JIT POCCDSTs. With a few exceptions, developers of JIT
POCCDSTs will focus on how to apply the current science in these areas to healthcare. A key consideration is how
to integrate these areas in the overall system to provide a decision support tool that is seamless for the end user
and will instill confidence in performance. Worthy of note is that use of POCCDST will be tempered as much by
organizational and individual behavior factors, as by technical functionality.
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Figure 2.18: Major elements of JIT information interface

The advent of mobile computing in healthcare, especially in the form of engaging smartphones or tablets, will find
diverse applications. The limit, I believe, will not be technology based either in the form of hardware or software,
rather the limit will be defined by organizational, administrative and behavioral causes. Rees notes that the use of
tablets and smartphones are in one sense a cultural phenomenon and the use by student nurses as an inherent
part of their behavior will positively impact the use in the clinical setting [263]. Phillippi and Wyatt, renowned
nurse educators and dreadnaughts of nurse education research, highlight the potential of smartphones as learning
devices and clinical tools [264]. Exactly how mobile computing will be implanted in healthcare over time is difficult
to predict. While the commercial sector is rapaciously expanding its adoption of the technology, structural
limitations inherent (or perhaps endemic) to healthcare, will act as a brake on the infiltration of the technology
into the acute healthcare setting as formal decision support tools. Interestingly, users of apps such as epocrates®
do so at their own risk as indicated by the terms of the User Agreement with no warranty that the information is
accurate. Other apps describe their products as Educational Use Only.
Augmented reality (AR) is the live integration of digital information with the user’s environment. It is the natural
extension of the kind of JIT information systems that have been discussed here. Where JIT information tends to
focus on providing information in a particular area, augmented reality is envisioned to provide a suite of
information as the user moves through their environment. Hollywood provides the best instantiations of
augmented reality with examples from the vision system of the Terminator and Ironman. As with POCCDDSTs, AR
processes, integrates and presents information to the end user, the difference is in the way the information is
presented, namely, as a digital overlay of the user’s environment. While there are significant concerns on
incorporating AR into a clinical environment, it also holds the potential for tremendous advantage. Some of these
advantages are:
• The integrated view provided by AR provides a more contextually rich environment for users, translating,
hopefully, into fewer errors and a better patient experience;
• AR should improve direct interactions with patients by providing the clinician with information such as
vein location, areas of pain, etc. that would not otherwise be immediately available;
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•

AR is predicted to have a significantly positive impact on the training and education of healthcare
providers by providing a richer more realistic experience.

With the previous discussion as a backdrop for considering future work on JIT POCCDSSs, several other
generalizations can be made:
• POCDSS are making inroads into application by healthcare providers but there does not appear to be any
uniformity of approach notwithstanding the efforts of various organizational bodies,
• Specific features focusing on usability, timeliness of information and aligning the application with specific
need is crucial for end user adoption,
• The backend or “intelligent” part of the system, while not seen by the user, will define the performance of
the system including accuracy (e.g. correct diagnosis, valid laboratory result ranges, etc.), integrative
functioning, and direct benefit to the end user,
• How the user interacts with the system, the UI, needs to be carefully thought out and tested to ensure the
desired performance and utility for the user. Items to consider are text input, screen manipulation (e.g.
swipe vs. tab vs. button), alerts/alarms, haptic responses, screen layout, colors, text style and size,
customizability (for display, alerts, information layout, etc.), and ultimately (also my favorite
consideration) the use of predictive and prescriptive analytics (including adaptive computing) to guide the
user.
Limitations/Considerations on Use of JIT Information Based POCCDST
The rapid rate of change of software and hardware technology will create a lagging environment between
implementation and development unless more flexible approaches can be used for integration of new technology.
Cybersecurity is an example of where such flexible approaches have been accommodated.
As noted by Phillippi and Wyatt, use of mobile platforms can be expensive. The expense can be particularly
prohibitive if the smartphone platform is pushed down to individual users (each user has their own device). With
technology obsolescence occurring at an increasing rate and the cost of capital investment becoming more
difficult, the insertion of new POCCDST can be problematic.
Regulatory matters remain an issue for CDSTs. An assumption would be that the more dynamic the tool in the
sense of getting input from multiple data sources, such as JIT information, the more complicated the regulation of
the associated tool. The Federal Drug Administration (FDA) is the regulatory authority for CDSTs. Part of the issue
is that these systems fall into several categories depending on how the tool influences clinical outcome. Lower
level solutions, such as Body Mass indicators or medication reminders, are not likely to create regulatory issues.
Tools that support intervention or decisions that have the potential to harm patients are subject to regulation.
With no clear time frame for congress to act, many commercial developers have moderated their efforts. While
this will not likely directly influence research, it could dampen clinical evaluation and implementation.
Risk/liability is another factor that could have an overarching effect similar to regulatory issues. Even with
regulatory clarity, research on systems that could impact patient health in a negative way carries the potential for
legal concerns. One consideration is that JIT POCCDSTs that use some form of statistical, or rule-based approach
by definition will create some wrong decisions. Then the question will be how administrators will deal with this
uncertainty.
As we recognized the advent of other forms of JIT information, delivered mainly through smartphones, such as
social media inputs, text messages or even apps designed to assist performance, can be a significant distraction to
performing complex tasks such driving equipment operation. They can also degrade performance of the more
mundane or rote tasks such as walking. Based on sound research, the myth of the human’s ability to multitask has
been shattered many times over.
Lean approaches, such as JIT, have their own inherent problems. JIT systems require either a predictable even
flow or robust on demand capability. Performance of the JIT system degrades as these factors decrease. The core
assumption of JIT is that whatever is provided is what is needed. For healthcare JIT information, it is easy to
conceive of circumstances, that due to the complexity of the situations, the information is not entirely sufficient or
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worse yet, inappropriate under the circumstance. JIT inventory relies on its supplier sources for timely and
accurate delivery, the same holds true for JIT information.
No system is infallible. It is conceivable that information provided by the JIT could be wrong either for an
individual patient, which could propagate errors quickly creating serious unknown potential consequences. This
raises the question of what fail-safes could be built into the system to prevent or at least identify errors?
A sociotechnical issue is that users, especially those with less experience in the area off interest, could become too
reliant on JIT information and do not balance the information the JIT POCCDST provides against their critical
decision skills. In other words, the user could blindly follow the recommendation of the tool and they do not
evaluate the information from the tool against their experience and judgment.
Human Error
Humans are engineered to make mistakes, and they make the preponderance of errors in contrast to sources of
non-human errors (Figure 2.19). Perhaps more aptly put, we were not engineered to be infallible. Our neural
connections, mental processing, perceptions22 and even DNA is prone to mistakes. As we begin to understand the
neuro-physiological basis for human error processing [265, 266] it becomes clear that there is an organic or
physical basis for humans to be consistent in their lack of performance, that is making mistakes is inherent to being
human [267].
The increasing interest in the areas of cognitive engineering and behavioral aspects of the science is shedding
more light into the intricacies of how and why humans make mistakes. The concept of the rational consumer, or,
the logical scientist, does not exist, at least in pure form. Dan Ariely and others have considered the effect of
emotion, biases and perceptions on errors in decision making. The considerable body of work by Ariely and his
colleagues contributes to the general observations [268-271]:
• Humans are inherently irrational, while we believe are behaviors and actions are logically based on good
judgement and reason we are driven largely by emotion and misperception ;
• People are different with different capabilities, experience and biases [this is an important consideration
in error-proofing since errors occur at the level of the individual];
• Performance is, at least in part, determined by the work environment;
• Performance is influence by peers, an individual’s past and circumstances;
• Motivation for improving performance (including reducing errors) is a complex mix of rewards, incentives,
peer pressure, and a notion of team;
• People have inherent mental blocks that contribute to consistent and continuous error generation;
• People have limited capacity to effectively acquire and process all relevant data; they have difficulty in
determining which data is actually important or even relevant.
An extensive body of literature exists on human error (HE) with the earliest citation noted being from 1900 on the
maneuvering of ships. Interestingly, this author, Balestrieri, considered the effect of emotional influences, in
particular fear and anxiety, on a ship pilot’s ability to maneuver a ship and recommended the use of simulators to
enhance performance [272]. This is remarkable in the sense that much of the early literature focused on the
mechanistic of human error. That is, they considered factors such as mental slip lapses, inattention, forgetfulness,
etc. and the potential remedies for these fallibilities. Balistreri viewed HE from the systems perspective and
evaluated the human as a part of the overall ship maneuvering system. The fact that he was before his time might
explain, in part, why his work was cited only three (and after this four) times since 1900.

22

As an interesting digression the following video is good for use in class or for your own entertainment to see how attention and perception
affect error. www.theinvisiblegorilla.com/videos.html
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Non-Human Error

Human Error

Figure 2.19: Human error greatly exceeds the occurrence rate of physical or mechanical error

As inferred from the previous paragraph, there are two general approaches to considering HE; the person
approach and the system approach as coined be Reason [273]. The Person Approach focuses on the psychomechanistic performance of the individual. That is, it attempts to consider the cognitive and psychological
capabilities of humans as they relate to performing tasks. In doing this, it evaluates elements such as memory,
attention, understanding, emotional states, awareness, motivation and other factors relative to error occurrence.
In simpler terms, the person approach views human error from the perspective of how people make mistakes.
Different types of errors have different types of causes. Reason parses errors or mistakes in execution failures
(slips, lapses, trips and fumbles) and planning or problem-solving failures (aka mistakes). Mistakes are divided into
rule-based mistakes and knowledge-based mistakes. Reason also makes a distinction that errors result from
information-handling problems and violations which are purposeful deviations from rules or procedures. The state
of errors/mistakes can be active and latent: active errors are those that are committed by those directly involved
with the activity, latent errors are those that are organizational, procedural or in some other way not immediately
coupled to the direct performance of work[274] (Figure 2.20).
The systems approach J. Reason speaks of considers the human with all its fallibilities as an element of the system.
The design of a system with humans in the loop needs to consider that errors are to be expected and as a result,
the design of the system needs to accommodate these errors. An interesting shift in perspective with this
approach is that human errors are seen as a consequence of the system design. A system designed under this
approach would build in error proofing both as part of the operation of the system but also the organizational
Human errors have been classified as:
• Errors of omission (tasks that are skipped, forgotten, missed)
• Errors of commission (tasks that are performed incorrectly)
• Sequential errors (tasks performed out of sequence)
• Compensating error (multiple errors that have an offsetting effect, they cancel each other out)
• Temporal errors (tasks performed too early too late or not within the required time)
These types of errors can obviously take on many forms across many disciplines. Each of these error classifications
can be separated into their own respective taxonomy which will partially depend on the area to which is being
applied.[275]
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Figure 2.20: General taxonomy of human error

There are a variety of factors that influence human performance as it is related to the occurrence of errors. These
include factors such as fatigue, disorientation, training, motivation, stress, lack of skill, confusion, boredom,
knowledge/experience, and inadequate or impaired perceptual or cognitive ability. processes that influence the
operation of the system. A basic concept of this approach is that human performance as it relates to errors cannot
be changed, rather the conditions under which human’s work need to be designed to accommodate human
performance [276].
Extensive research has been done on the types and causes of human error and how to attempt to prevent it. This
is particularly true for potentially high consequences such as aviation, nuclear facility operations, healthcare, mass
transportation, and pipeline and oil rig operations [277-281]. While every error is unique, the contributing factors
can be classified based on the behaviors leading to the error.
It is widely recognized that most errors do not happen in isolation. Instead, they are a result of a chain of events or
conditions that lead to the occurrence of the error. From Heinrich’s work first published in 1931, Industrial
Accident Prevention: a Scientific Approach [282], to its further development by Bird and Germain in Practical Loss
Leadership [283], as well has Bird’s “Domino Theory, and Reason’s “Swiss Cheese” model of human error [284]
(Figure 2.21), the integrated and multiple interactions of causative factors have been embraced by most in the
field of human error [285].
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Figure 2.21: Reason’s Swiss cheese model of error occurrence

Situation Awareness
An important element of HE occurrence is Situation[al] Awareness (SA). A particularly applicable definition of SA is
provided by Endsley [286]: “Situation awareness is the perception of the elements in the environment within a
volume of time and space, the comprehension of their meaning, and projection of their status in the near future”
Endsley goes on further to define specific levels of SA, which is provided in expanded form [287]:
Level 1 – Perception of the elements in the environment – in this level the agent recognizes the status,
attributes, and dynamics of relevant elements in the environment.
Level 2 – Understanding the current situation – building upon the disjointed elements of Level 1, the
agent comprehending the significance of these elements and how they might relate in the present
situation.
Level 3 – Projection of future statue – here the agent understanding of the potential impacts that the
combined elements form Levels 1 and 2 might portend and formulates courses of actions that avoid or
mitigate the error.
Cognitive Error
Cognitive error (CE) can be defined as mistakes made resulting from faulty mental models, heuristics,
misinterpretation of information or other types of conscious error in decision making. Cognitive error can be
classified into two general categories:
• Faulty assessment of the likelihood of something happening (e.g. overestimating disease likelihood)
• Failure to consider all relevant possibilities
The Merck manual categorizes cognitive error as follows [288]:
•
•
•
•
•
•

Availability error – misestimating the prior probability of a condition because of recent experience or
event
Representation error – when the likelihood of a solution is based on how closely the event fits a typical
pattern without considering all of the alternatives
Premature closure – failure to consider other possible solutions and stop collecting data (jumping to
conclusions)
Anchoring error – when an initial conclusion or decision is clung to even when contradictory or conflicting
new information is accumulating
Confirmation bias – When data confirming one’s decision is considered and contrary data is ignored or
under-weighted
Attribution error – negative stereotypes that lead decision makers to misjudge or minimize other factors
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•

Affective error – avoiding generating additional information because it will create a negative or distasteful
situation

Similar in both aviation and healthcare, the procedural and diagnostic errors have been observed to be the
greatest source of cognitive type error [178, 290-292].
O’Hare defined a decision-making approach that led to a multistep process for diagnosing cognitive failure. This
model assumes that information is being processed from the start of the action using detection cues in the
environment and ending with action execution (Table 2. 11) [289].
While HEs are recognized to be a result of broader system errors, they are exhibited by the frequency of their
occurrence. There are many factors that influence the human error rate; the values listed in Table 2.13 are only
representative of error rate. The value of this table is that it does provide some insight in the stochastic nature of
human error rates and that, in a general sense, human error is both predictable and, in some ways, unavoidable.
Review of this table indicates that humans do not perform well when tasks require precision or great care and
doing complicated non-routine tasks. Adding increasing levels of stress increases the error rate [293].
Smith provides the broad guidelines in Table 2. 13. He states that in any particular situation, the human-response
reliability will be shaped by any number of factors which include:
• Environmental factors
o Physical
o Organizational
o Personal
• Intrinsic
o Individual idiosyncrasies and selection
o Training
o Experience
• Stress Factors
o Personal
o Circumstantial
Without much imagination, one can think of how these errors and probabilities would relate to medication
administration errors. Errors, such as failing to respond to an annunciator, reading an indicator incorrectly,
attaching a connector (e.g. IV tube) incorrectly, are all directly applicable to healthcare. While the actual
probabilities might be different, Smith’s work has man analogs in healthcare.
Reduction/Elimination of Errors
There is a seemingly endless variety of methods and techniques to reduce or eliminate errors. In the conventional
realm of industrial engineering, reliability/quality engineering and mistake/error proofing are the central areas.
There are two basic approaches to reduce or eliminate errors - assessing how the errors occur in a process, and
building approaches prevent them from occurring.
The Institute for Safe Medication Practice (ISMP) has provided a rank order of error-reduction strategies (Table 2.
12). The heading “Power” indicates the effectiveness of error reduction for system changes for safe medication
use. The list starts at engineered controls without humans in the loop down to activities that rely solely on direct
action by humans. This table is a succinct commentary on the practices industrial and systems engineer’s use in
implementing reliability and maintainability practices [293-295]. The ISMP list of error-reduction strategy can be
generalized to most other areas.
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Table 2. 11: Categorization of cognitive error types
Error Type

Error Description

Non-Human Error (structural, mechanical, electrical,
S/W, other

Agent intervention could not prevent the error or is
directly impacted by the error

Information Error

The agent did not detect cues arising from the change
in the system states

Diagnostic Error

The agent did not accurately diagnose the state of the
system based on the information available

Goal Setting Error

The agent did not choose the appropriate goal that
was reasonable given the situation

Strategy Selection Error

The agent did not choose a strategy (means of
attaining) that would achieve the desired outcome
without error

Procedure Error

The agent did not execute procedures consistent with
a correct strategy or approach

Action Error

The agent did not execute the procedures as
intended

Table 2. 12: Rank order of error-reduction strategies23
Error-Reduction Strategy

Power (leverage)

Fail-safes and constraints

High

Forcing functions
Automation and computerization
Standardization
Redundancies
Reminders and checklists
Rule and policies
Education and information
Suggestions to be more careful or vigilant

23Source:

Low

https://www.ismp.org/newsletters/ambulatory/archives/200602_4.asp
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Table 2. 13: Human error rates [293]

Task
Simple possible task
Fail to respond to annunciator
Overfill bath
Fail to isolate supply
Read single alpha-numeric incorrectly
Read 5-letter word with good resolution incorrectly
Select wrong switch
Fail to notice major cross-roads

Read/Reason

Physical
operation

Everyday
yardstick

0.0001
0.0001
0.0001
0.0002
0.0003
0.0005
0.0005

Routine simple tasks
Read a checklist or digital display incorrectly
Set multi-position switch incorrectly
Calibrate dial by potentiometer incorrectly
Check or wrong indicator in an array
Incorrectly carry out visual inspection for a defined
criterion (e.g. leak)
Select wrong switch among similar switches in a set
Read analog indictor incorrectly
Read 10-digit number incorrectly
Leave light on

0.001
0.001
0.002
0.003
0.003
0.005
0.005
0.006
0.003

Routine tasks with care
Mate a connector incorrectly
Fail to reset valve after some related task
Record information or read graph incorrectly
Let milk boil over
Type character incorrectly
Do simple math incorrectly
Wrong selection-vending machine
Incorrectly replace detailed part
Do simple algebra incorrectly
Read 5-letter word with poor resolution incorrectly
Put 10 digits into calculator incorrectly
Dial 10 digits incorrectly

0.01
0.01
0.01
0.01
0.01
0.01-0.03
0.02
0.02
0.02
0.03
0.05
0.06

Complicated non-routine tasks
Fail to notice adverse indicator when reach for a wrong
switch or item
Fail to recognize incorrect status in roving inspection
New work shift - fail to check hardware unless
specified
General (high stress)
Fail to notice wrong position of valves
Fail to act correctly after 1 min in emergency situation

0.1
0.1
0.1
0.25
0.5
0.9

In failure rate terms the incident rate in a plant is likely to be in the range of 20(10)-6 per hour
(general human error) to 1(10)-6 per hour (safety related incident).
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Error Analysis and Evaluation Methods
There is a voluminous and sweeping amount of published work on error analysis and evaluation methods. For
both my sake and the sake of the reader, we will cover only a very limited amount of the material. The following
outline highlights some of the better-known techniques. A comprehensive description of this material is covered
in the literature review of the dissertation and the answers to the Comprehensive Questions related to this
research.
Error Analysis Techniques and Evaluation Methods24
a.

b.

c.

d.
e.
f.

Failure Modes Assessment
i. FMEA
ii. FMECA
iii. HFMEA
Sequence Diagrams
i. Ishikawa (fish bone)
ii. Fault Tree
iii. Event Tree Modeling
iv. Decision Tree
v. Influence Diagram
Root Cause
i. Cognitive Reliability and Root Cause Analysis
ii. Causal Analysis
iii. Cause-Consequence
iv. Process Maps
What-if Analysis
Pareto Charts
Humans Reliability
i. Human Error and Safety Risk Analysis (HERSA)
ii. Human Error Assessment and Reduction Technique (HEART)
iii. Cognitive Reliability and Error Analysis Method (CREAM)
iv. Generic Error Modeling System (GEMS)
v. Probabilistic Risk Assessment
1. Technique for Human Error Rate Prediction (THERP)

Human Factors Analysis and Classification System (HFAC

Failure Modes and Effects Analysis
Failure Modes and Effects Analysis (FMEA) is perhaps among the most well-known techniques for risk evaluation
and assessment. Developed by the military in the 1940s, it gained wide application in the 1990’s and has been
used extensively in a wide range of fields include aerospace, automotive, construction, and HC. [296, 297] FMEA
has undergone many modifications and has been modified for unique application in certain disciplines: The
Healthcare (HC) industry has created its own version of FMEA known as Healthcare FMEA or HFMEA developed
originally by the Veterans Administration National Center for Patient Safety [297]. HFMEA combines the
detectability and criticality steps of the traditional FEMA into an algorithm presented as a decision tree. It also
replaces the calculation of the risk priority number with a hazard score. Failure Modes and Effects and Criticality
Analysis adds a criticality function that determines the relative severity of the potential effects of the failure
through either qualitative or quantitative methods.

24

For the sake of brevity only an outline of error analysis will be provided
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FMEA is a process to assess risks of failure or errors within a system by breaking it down into its constituent
elements and assigning risk priority numbers (RPN). The Institute for Healthcare Improvement IHI) defines FMEA
as:
“…a systematic, proactive method for evaluating a process to identify where and how it might fail and to assess the
relative impact of different failures, in order to identify the parts of the process that are most in need of
change.”[298]
While not surprisingly, the IHI defines FMEA in the context of analyzing errors from healthcare processes, FMEA is
applied to a varied set of activities. The following diagram from Ambekar highlights the types of FMEAs. It has
been modified to reflect additional process FMEAs (Figure 2.22).[299]. FMEA provides a number of benefits in
terms of understanding the source and potential mitigations of errors and their associated impacts (or risks), the
FMEA process:[300-303]
• Captures the collective knowledge of the team
• Provides a methodical and structured process for identifying process areas of concern
• Provides a model for evaluating the impact of changing the assumptions related to the elements of the
FMEA
• Provides documentation of the risk reduction activities
• Helps identify critical-to-quality characteristics
• Provides a risk-based prioritization of safety items/risks
• Can be used with qualitative or quantitative data
The Risk Priority Number (RPN) is a product of three separate values, namely the occurrence of the failure mode
(O), the severity of the occurrence (S) and the chance that the occurrence is detected (D). The elements of the RPN
are multiplied together to provide a composite score which provides an overall risk ranking. So,
RPN = O x S x D
Various approaches have been taken to rate the risk for O, S and D. Most typically, the scale is similar to a Likert
scale such as applying values based on a 5, 7 or 10 point scale[304]. Subject Matter Experts (SMEs) are engaged to
assign risk scores for each failure mode or if the system has defined probabilities for the failure modes, such as
historical quality or reliability data< those can be used to assign risk values[305]. “D” can be based on variety of
measures, most typically it relates to the odds or likelihood of detection defect items, such as percent or odds
ratios. “S” can be a subjective assessment where a subject matter expert assigns a qualitative score to the degree
of impact of the error or a quantitative approach may be devised such as actual mortality ranges or number of
homes without power. “O” as with the other factors has quantitative measures based on historical data such as
the frequency of defects of a particular component, or the number of time a medication dose calculation is not
performed.[306-310]
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Figure 2.22: Types of FMEAs
With the long history and wide use of FMEA, there have been many permutations to the implementations of the
process, particularly related to developing the RPN, which is at the heart of the risk ranking. While developing the
RPN can be relatively straightforward, the RPN can also create challenges. Significant and diverse efforts are
reported in FMEA literature to address shortcomings of the traditional RPN [311-313]. One of the challenges is for
the SMEs to assign discrete values to the RPN factors making it difficult to evaluate the risk factors precisely. Some
of these criticisms include, but are not limited to, the following:
• Different values of O, S. and D might produce the same value of RPN, but their actual risk implication
might be different
•

The relative importance of O, S and D is not taken into consideration in a conventional FMEA, whereas the
three risk factors are assumed to be equally important, that might not be the case in a practical
application of FMEA.

•

In practice, the actual values of O, S and D can be difficult to be precisely estimated: the value of the risk
factors can be expressed “linguistically” such as Infrequent, Occasionally Likely, Somewhat Important,
Very Important, and so on.

•

Certain of the risk factors, typically S, cannot be reduced in practice, for example death is terminal and
difficult to reverse therefore its consequences are difficult to mitigate. This makes the FMEA a theoretical
exercise as opposed to a practical one.

•

The RPN presupposes that the scale used is an interval scale where each interval is equal and consistent.
This might not be the case in practice, for example the value 10 might have 7 times the implication of 5 as
opposed to twice the value.

One approach used to help remedy this is a fuzzy approach to define the RPN factors. Ambiguous or vague
information and/or subjectivity in the ranking scales add inconsistency in FMEA. This deficiency has been
addressed by introducing fuzzy logic as part of the RPN decision process. Another approach to providing more
perspective for the RPN value is to use Multi-Criteria Decision Making (MCDM) which also includes the Analytic
Hierarchy Process (AHP) as well as other methods (Table 2. 14). “Fuzziness” in this context refers to establishing
risk factors that reflect a range of likely values as opposed to a single discrete value. This approach considers the
most likely values for a risk value and represents the values as a composite score. This part of the method is
referred to as “defuzzifying” the data.
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Table 2. 14: References for incorporating fuzzy logic into FMEA
Authors and
Year
Meng, Peng
2006 [319]

Kahraman, Kaya,
Senvar 2012
[316]

Chin, Chan, Yang
2006 [320]

Xu, et. al. 2002
[321]

Kumru, Kumru
2013 [322]

Garcia, Schirru,
E'Melo 2005
[323]

Guimareas, Lap
2004 [324]

Title
Fuzzy FMEA
with a guided
rules
reduction
system for
prioritization
of failures
Healthcare
Failure Mode
and Effects
Analysis
Under
Fuzziness
Development
of a Fuzzy
FMEA based
Product
Design
System
Fuzzy
assessment
of FMEA for
engine
systems
Fuzzy FMEA
application to
improve
purchasing
process in a
public
hospital
A fuzzy data
envelopment
analysis
approach for
FMEA
Fuzzy FMEA
applied to
PWR
chemical and
volume
control
system

Computational
Technique
fuzzy rule based
(if/then) guided rules
reduction system

Application
Area
NA

Description

linguistic variables ifthen rules

Healthcare

Application of fuzzy RPN to HC

fuzzy knowledge-based
system

Product design

Design of FMEA prototype
system using fuzzy methods

Fuzzy rule-based
system

Automotive,
diesel engine

Application of fuzzy logicbased method with diesel
engine example

Fuzzy rule-based
system

Purchasing

Application of fuzzy FMEA to
Hospital Purchasing
Department

Data envelopment
analysis

NA

Determine ranking indices
among failure modes using
fuzzy sets

Fuzzy inference system

Nuclear
Engineering

Nuclear reliability modeling
using fuzzy IF-Then rules
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Overview of fuzzy RPN
approach

Table 2.14: References for incorporating fuzzy logic into FMEA (continued)

Zaili, Bonsall,
Wang 2008
[325]

Abdelgaward,
Fayek 2010
[326]

Fuzzy RuleBased
Bayesian
Reasoning
Approach for
Prioritization
of Failures in
FMEA
Risk
Management
in the
Construction
Industry
using
Combined
Fuzzy FMEA
and Fuzzy
AHP

Bayesian Fuzzy System

Aerospace

Fuzzy rule-based Bayesian
approach for prioritizing
failures in FMEA

Fuzzy AHP and Fuzzy
FMEA

Construction

Use of fuzzy approaches for
AHP and FMEA to improve
selection of RPN
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This has been done with both ordinal and interval data. The use of ordinal data typically employs a fuzzy linguistic
approach and a fuzzy rule-based approach to determine the criticality/riskiness level of the error. Interval data
requires a somewhat different approach where the values are weighted and a means to find the central tendency
is used. There are a wide variety of approaches and much has been written for each. With this increase in
perspective comes a significant increase in complexity and difficulty in implementation [314-316]. Another
approach to providing more perspective for the RPN value is to use Multi-Criteria Decision Making (MCDM) which
also includes the Analytic Hierarchy Process (AHP) as well as other methods.
Sequence Diagrams
Sequence diagrams come in a variety of types and flavors. Ishikawa or fishbone, or cause and effect diagrams
were originally used as part of quality control methods but are also used in root cause analysis and process analysis
[317]. Normally the diagram starts with a problem statement on the right side of the diagram. Flowing from left
to right the developer identifies influencing factors, for example: site, task, people equipment, and control. Along
each of the factors, the possible causes are identified per the noted example [318].
The fishbone diagram has a number of benefits:
• It can take a complex problem and provide a relatively simple visitation of it
• It can permit an in-depth analysis and evaluation considering the entire mix of cause and effects
• Demonstrates weaknesses in understanding of the problem
• Allows integration of all the factors that influence the problem
Disadvantages of fishbone diagrams are:
•
•
•

Can lead to divergent problem solving (chasing rabbits down the wrong path)
There is a tendency to base the causes on opinion rather than fact
Can “blow-up” from a list of too many causes

Decision Trees
Decision trees, for the purposes of this discussion, include the set of acyclic graphs that function as decision
support tools. They include, but are not limited to, fault trees, event tress and influence diagrams. Decision trees
fault trees, and event trees are all very similar in structure and function. They use trees, directed acyclic tree-like
graphs to model decisions or error events and their possible outcomes including probabilities, event outcomes,
and costs or utility as represented in Figure 2.24[327-329]. Decision tress and their siblings have multiple uses
including classification, data mining, decision making, and hazards analysis [330]. Decision or event trees can be
combined with other tools such as Monte Carlo to add uncertainty for the occurrence of the node (i.e. fuzziness)
[331].
Among decision support tools, decision trees (and influence diagrams) have several advantages. Advantages of a
decision tree:
•
•
•
•
•
•

Are straightforward to understand and interpret.
Have value even without much data.
Allow the addition of new possible scenarios
Help determine worst, best and expected values for different scenarios
Use a “white box” model: the decision path and methodology is readily apparent
Can be used for different data types including categorical data
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Figure 2.23: Fishbone or Ishikawa diagram25

25

http://www.ck12.org/section/Elements-of-Agent-based-Models/
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Figure 2.24: Representation of Binary Fault Tree [329]
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Disadvantages of decision trees:
•
•

Trees can get very complex particularly if many values are uncertain, and there are multiple links (i.e.
more than binary) between nodes
The size of decision trees can grow large very quickly and become computationally intensive.

Root Cause Analysis
Root Cause Analysis (RCA) enlists various tools and techniques to trace problems to their origins. It attempts to
identify the origin of an error or problem using a specific set of steps. RCA assumes that systems and events are
interrelated. This is a key consideration since a systems perspective is crucial for a systems level assessment of the
actual underlying cause(s) of the error. Typical areas for evaluation include physical causes, human causes and
organizational causes. Root cause analysis is a technique on its own, but also has a variety of techniques that
contribute to the approach.
The Cognitive Reliability and Error Analysis (CREAM) technique is a Human Reliability Analysis (HRA) technique that
allows examination of agents’ actions through the context of performance-shaping factors. The CREAM also
employs a cognitive model to explain cognitive failures. In this way it considers the context in which the agent
operates and also considers the cognitive nature of the agent [332, 333]. CREAM will be described in more detail
later.
Causal analysis (CA), is the subset of techniques that contribute to performing RCA [334]. Techniques included in
CA include the, Five Whys, and Cause-effect diagram (a tree diagram used to break down cause into a treestructure to define possible causes).
Cause-Consequence Analysis (CCA) is a methodology for assessing the chain of consequences leading to an error.
CCA combines two different tree structures together, a consequence tree and the associated fault tree. In this way
it is similar to event trees or fault trees. Similar to other trees or sequence structures, it can grow quickly and
become unwieldy especially since it combines several tree approaches [335].
Process maps (PM) are a ubiquitous approach for laying out the sequence of steps of an activity: it is a workflow
diagram to help in understanding a process or series of parallel processes. PMs are used in six sigma applications
for improvement (value stream mapping) and can also be sued to define areas of potential error. It is typically
used in conjunction with other techniques such as FMEA. The lean process maps underpin the DMAIC (Design,
measure, analyze, measure, improve and control) process and provide the structure for further analysis.
What if Analysis
What if analysis (WIF) is a form of sensitivity analysis used to evaluate the impact of various alternatives. In the
context of error analysis, it assesses the effect of potential errors or factors that could influence errors. WIF is a
useful tool not only for evaluating the quantitative aspects of decision options; it also has application in computer
simulation models. For computer simulations, WOF can be used to establish confidence with respect to changes in
parameters of inputs [336].
Pareto Charts
Pareto Charts (PC) are a form of impact analysis providing a graphical representation of the relative differences
among groups. They are based on the Pareto principle that states, in a general sense, 20% of the input or cause
creates 80% of the result (the 80:20 rule). While this rule is not universally applicable, its application has great
utility [337]. PCs are combination diagrams with both line and bar depictions of the relevant data. The bars
represent the frequency or amount of the event or item of interest such as occurrence, value, time, etc. The bars
are arranged in descending order. The line is a cumulative total of the representative function (Figure 2.25). PCs
can be used as part of RCA, value stream development, and decision making.

77

80
70

81%

60

73%
65%

50
54%

40
42%

30
20

88%

93%

22%

10
0

98%

100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%

Figure 2.25: Medication administration record error Pareto chart26

Human Reliability/Error
Human reliability, or the lack thereof, as a source of error, has been studied extensively and a wide variety of tools
have been identified to analyze and reduce these errors. A high-level summary will be provided for the techniques
identified. The United States Department of Transportation, Federal Aviation Administration has done extensive
review and research in the areas of human error and reliability. They have evaluated many of the techniques
noted above; their assessment will be provided here largely intact as suitable summaries of these techniques.
HERSA
HERSA is a proactive tool for assessing the risk of human error. HERSA is based on FMEA but specifically considers
human errors and is based on tasks. It has the same scales that FMEA does, namely Likelihood of occurrence;
severity of outcome and Likelihood of detection. The goal of using HERSA is to produce an ordered list of
errors/outcomes. As with FMEA, HERSA as the following attributes:
• Identifies the relative likelihood of particular errors
• Does not depend on past history, but can use this information
• Relies on relative, ordinal scaling
• Rank orders error modes
• Identifies critical single component failures
• Can utilize detection/mitigation (or not: similar to FMEA)
• Produces a task breakdown as a byproduct

26

Source: http://www.infoworks-tn.com/lean-six-sigma-healthcare/
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The methodology for HERSA is the same as FMEA.: error modes are identified by experts or data; ratings are
assigned for each of the scale areas using a 1-5 scale, and ratings are calculated by –
Hazard Index (HI) = Likelihood X Severity;
Risk Priority Number (RPN) = Likelihood X Severity X Detection.
HEART
HEART is a technique to assess and define human error probabilities by matching the task being assessed to one of
the nine generic task descriptions from a given database and then to modify the human error probabilities (HEPs)
according to the presence and strength of the identified error producing conditions (EPCs) The nine generic task
types used in HEART:
1) Totally familiar, performed at speed with no idea of likely consequences
2) Shift or restore system to new or original state on a single attempt without supervision or procedures
3) Complex task requiring high level of comprehension and skill
4) Fairly routine task performed rapidly or given scant attention
5) Routine highly-practiced, rapid task involving relatively low level of skill
6) Restore or shift a system to original or new state following procedures with some checking
7) Completely familiar, well designed, highly practiced routine task occurring several times per hour
8) Respond correctly to system command even when there is an augmented or automated supervisory
system
9) None of the above
HEART has the advantages of being recognized as a proven tool for predicting human reliability and identifying
methods of reducing human error. It can be applied to many different types of processes across different
industries since its methodology is based on the human rather than a technical process. As with other similar
processes, HEART suffers from relying on significant judgment from the user [338].
THERP
THERP was originally developed to aid military strategists to determine expected failure rates for nuclear weapons.
It has also been applied to the analysis and design of human-machine interactions. THERP provides human
reliability data for probabilistic risk assessment studies; namely, to predict human error probabilities and to
evaluate the degradation of human-computer systems likely to be caused by human errors alone or in connection
with equipment malfunctioning, operational procedures, or other system and human characteristics that influence
complex system (i.e., joint human-machine) behavior. The basic assumption of THERP is that the operator’s actions
can be regarded in the same way as the success or failure of a piece of equipment. The theory is that the reliability
of the operator can be assessed in essentially the same way as an equipment item. The operator’s activities are
broken down into task elements and an estimate of the probability of an error for each task element is made,
based on data or expert judgment [338] .
CREAM
CREAM is a Human Reliability Assessment tool, as described by the Federal Aviation Administration (FAA) that
allows:
1) Identification of those parts of the work, as tasks or actions, that require or depend on human cognition,
and which therefore may be affected by variations in cognitive reliability,
2) Determination of the conditions under which the reliability of cognition may be reduced, and whether
these tasks or actions may constitute a source of risk,
3) Provision of an appraisal of the consequences of human performance on system safety which can be used
in a PRA/PSA, and
4)

Development and specification of modifications that improve these conditions hence serve to increase
the reliability of cognition and reduce the risk[333].
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This approach serves the purpose of ensuring that the proper conclusions are drawn from the analysis, and that
the necessary changes to the system are correctly specified. CREAM provides the core functionality of these
services, i.e., the concepts, the classification system, the cognitive models, and the methods. In order to be
properly used it is necessary to supplement with application specific information, e.g. in the form of values for
specific performance parameters, detailed operational and process knowledge that defines the context, etc. It is
based on the principles of context dependent cognitive models (COCOM)[338].
GEMS
GEMS is an error classification scheme developed by Reason that focuses on cognitive factors in human error as
opposed to environmental or other context-related factors. It is based heavily on Rasmussen’s three major
categories of errors: skill-based slips and lapses, rule-based mistakes, and knowledge-based mistakes (SRK). GEMS
is a more general description of the cognitive “black box”, which can be used to address the mechanisms of both
slips and mistakes. GEMS taxonomy of error types is a useful method to assess cognitive determinants in complex
technological environments [338, 339].
PRA
PRA is actually an integration of FMEA, fault tree analysis, and other techniques to assess the potential for failure
and to help find ways to reduce risk. It involves the development of models that defines the response of systems
and their associated participants to error initiating events. Additional models are generated to identify the
contributing failure modes required to cause the error mitigating systems to fail. Each component failure mode is
represented as an individual “basic event” in the systems models. Estimates of risk are obtained by propagating
the uncertainty distributions for each of the parameters through the PRA models [338]. PRA is used extensively in
aviation, nuclear, healthcare and other industries [340-342].
HFACS
HFACS is a system to categorize both the latent and immediate factors that have been identified in errors,
originally aviation accidents. Its purpose is to provide a framework for use in error analysis and as a tool for error
accident trends. HFACS use four levels of failure including (1) unsafe acts, (2) preconditions for unsafe acts, (3)
unsafe supervision, and (4) organizational or cultural influences. HFACS permits the analyst to identify specific
types of human error at various levels in the organizational hierarchy [343].
Advantage of HFACS includes consideration that although designed originally for use within military aviation,
HFACS has been shown to be effective for the identification and analysis of in other areas as well. 2) Permits the
analyst to identify specific types of human error at various levels in the organizational hierarchy. 3) May be used
after an event has occurred.
HFACS has several disadvantages. It is similar to other HRA tools in that it can be labor intensive and dependent on
the availability of detailed quality data. Its’ use can be restricted because it requires knowledgeable human factors
safety analysts to use. Finally, it relies on the overt actions and sequence of actions of the operator, supervisor, or
manager rather than the deliberations (the intentions and expectations) that underlay them [344].
Agent Based Modeling Systems
An Agent Based Modeling System (ABMS), also known as agent-based systems (ABS), or multi agent modeling
systems, is a relative newcomer to modeling and simulation. ABMS is an approach to modeling systems comprised
of interacting autonomous agents. Computational advances make possible a growing number of agent-based
applications across many fields. Applications include modeling agent behavior in the stock market and supply
chains, to predicting the spread of epidemics and the threat of bio-warfare, from modeling the growth and decline
of ancient civilizations to modeling the complexities of the human immune system, and many more [345, 346].
In the case of application of ABM to this research, the interest is to assess if a complex system like MA can
effectively be modeled. Macal et al considers how ABM can model a system that incorporates difficult to simulate
attributes like human behavior, the collective effects of agents (agent interaction), and emergent behavior [346].
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While research and application of ABMS in healthcare is becoming more widespread, its application to medical
error and specifically errors related to the administration of medication is modest at best. Of the research that
exists, it appears to be focused in narrow areas of application. Santos has developed an architecture for an ABM
that supports doctors’ decisions by “guaranteeing that all required clinical data is available and capable of
predicting the patients’ condition” over the course of the next hour. Santos, in this referenced paper, provides a
high-level description of how an ABM might be sued for this application but falls short of describing the
implementation of a system [347].
Similar in concept is the application of ABM to risk assessment. While most risk assessment approaches use a
linear approach, considering each risk at a time, an agent-based approach allows the simultaneous and dynamic
consideration of risk. The use of ABM for risk assessment of routine clinical processes was explored by Wobcke et
al [348]. In a more general example, Bonabeau describes the application of ABM for simulating humans systems
[349]. More specifically he considers real-world application including organizational simulation along with several
other uses.
Somewhat further afield from medical application is the use of ABM to model supply-chain risk. That said, the
ABM of supply chain appears to have some similarities to the application of MAE simulation. Notably there are
various interactions that are non-linear and interactive (networked) and the errors in many instances are a
function of external influences and information flows [350].
ABMs specifically considering Medication Errors are quite limited. Clancy explored the concept of complex
systems in the context of nursing including consideration of medication errors. While modeling approaches such
as ABM and Systems Dynamics are discussed, specific applications are not developed [351].
A preliminary study by Vasquez-Velez used NetLogo to construct an ABM attempting to model the influence of
nurse behavior on medication administration. A simple model was developed that demonstrated nurse
interaction, nurse multi-tasking and interruption. The study of MAE was not noted in this study [352].
Considerations for which ABMS might be appropriate are 27:
• When there are decisions and behaviors that can be defined discretely (with boundaries)
• When it is important that agents adapt and change their behaviors
• When it is important that agents learn and engage in dynamic strategic behaviors
• When it is important that agents have a dynamic relationship with other agents, and agent relationships
form and dissolve
• When it is important that agents form organizations, and adaptation and learning are important at the
organization level
• When it is important that agents have a spatial component to their behaviors and interactions
• When the past is no predictor of the future
• When scaling-up to arbitrary levels is important
• When process structural change needs to be a result of the model, rather than a model input
The list above overlays directly with the operations of hospitals and clinics. Whereas many of the other simulation
and modeling techniques have difficulty in modeling hospitals or clinics at the systems levels, ABMS offer the
advantage of being directly applicable to them.
Sibbel et. al. describes how ABMS might be applied in the hospital setting. They outline the various factors in
consideration of application of simulation in this environment and state that ABMS is an ideal approach for dealing
with the unique issues facing hospital operations simulation. The authors discuss how the model could be applied,

27

( Macal, L., North, M., Tutorial on Agent-Based Modeling and Simulations Part 2: How to Model with Agents, Proceedings of the 2006 Winter
Simulation Conference )
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however, but do not apply such a model. Herrler et. al. discusses the application of ABMS to scheduling and
provides an example.
As a summary, Mustafee et. al. prepared a profile of literature in HC simulation. They discussed the methodology
of their article selection and review techniques. The simulation types they considered were Markov Chains (MCS),
Discrete Event Simulation (DES), ABS and System Dynamics (SD). Their assessment, fortunately for me, is in
lockstep with this response. A brief summary follows:
•

•

•
•

MCS: A main approach used in HC overall with the applications mainly in the areas of clinical science (e.g.
treatments, drug results, prognosis, etc.). About 25% of the papers they reviewed had something to do
with non-clinical operations such as the cost-effectiveness of competing technologies or HC strategies
DES: They found this approach well suited to problems to areas of interest to this author (increasing
efficiency of operations). They state that DES provides more insight in the area of health economics than
MCS.
SD: This is more frequently used to model at a more top-level or policy level
ABS/ABM: This approach is not as widespread as the others.

ABM Building Blocks
There are a variety of perspectives on the building blocks that make up ABMs. Wall views ABMs as having a core
of three building blocks (1) the agents, (2) the environment in which the agents reside, and (3) interactions among
the agents [353]. This can be expanded to include time, rules, properties, actions, goals, beliefs, policies,
messages, mental models, and states. Figure 2. 26 represents a more comprehensive view of the building blocks
contributing to the structure of ABMs [354].
The following provides a brief description of many of the characteristics of ABMS28:
•
•
•

•
•
•
•

•
•

Self-explaining: an intelligent system can explain how it came to a certain conclusion that led to the
observed reaction of the system.
Emergent behavior: behavior of a system that does not depend on its individual parts, but on their
relationships to one another.
Non-linear: The interactions that occur in AB models are inherently non-linear meaning that they are not
inherently or consistently predictable. Additionally, non-linear feedback loops exist between micro and
macro levels.
Robust: Slight changes in the environment do not lead to a failure.
Fault tolerant: Even when some parts are broken, the system can still function. This characteristic may
include the concepts of self-evaluation and repair.
Adaptive: A system can adapt to a new environment that may be significantly different from the original
environment.
Self-organizing: Intelligent systems are able to find a way to organize themselves to optimize their tasks
without an internal or external authority. The structure is discovered by the systems, not programmed by
their developers.
Deductive: Based on a set of axioms or general knowledge, intelligent systems can derive new knowledge
for a particular case.
Learning: Intelligence-based systems are able to learn. They not only learn from their mistakes, they also
learn from success and the communication thereof with others.
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Source: http://www.ck12.org/section/Introduction-%3A%3Aof%3A%3A-Agent-based-Modeling-%3A%3Aof%3A%3A-CK-12-Modelingand-Simulation-for-High-School-Teachers%3A-Principles-Problems-and-Lesson-Plans/
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•
•
•

Cooperative: Intelligent systems work together with others to solve a problem.
Autonomous: A system is able to continue to pursue its objectives without human guidance, even in
unfriendly environments.
Agile: Intelligent systems can rapidly and efficiently adapt to changes in the environment.

Agents will to one degree or another have the following functionality:
•

•

•

•

•

•

•
•

Perception-The agent receives signals from his environment based on the links or sensor it has. It
processes this information using the rules to interpret the input signal. The agent can be designed to
learn, so, with more and more observation its behavior or interaction with the environment can adapt –
and exchange of results with other agents that do the same – the closer the perception gets to the real
situation.
Sense Making-As noted in Perception, in order for observations to make sense, they need to be mapped
to an internal representation. The internal representation is the picture the agent has about itself within
the environment it is in (the situated environment). The internal representation does not have to be
complete or can be “wrong”. It is possible that the agent only uses a limited set of attributes to capture
observations, such as "calculates dose" or "does not calculate dose," as a Boolean parameter that cannot
capture values and accuracy. Sense making can also be fuzzy in the sense of interpreting different values
under different conditions.
Memory-the rules and algorithms that define how sense making and later decision-making are done are
stored in the memory. Short-term and long-term memories and even forgetfulness (which is especially
relevant if an agent were designed to be Tom Berg), can be modelled. The memory domain is the
repository for all information needed for the agent to perform the tasks and includes all forms of memory
ranging from data to behavior.
Communications-Agents can interact and share information: they share results with agents or agent
types. Agents can communicate directly or influence another agent through behavior (including proximity,
actions, or physical interaction).
Decision Making: -Agents can support reactive as well as proactive methods. If-then rules or complex
decision algorithms based on plans, goals, and value systems can be used. Decision making can result in
actions including more information seeking.
Action- The agent can take action based on its decision-making function and these actions can influence
the situated environment. This includes the agent moving itself, as well as acting on active and passive
objects including other agents. The action can have a feedback effect on the agent taking the action.
Adaptation-Agents can learn and adapt; this includes both behavioral change as well as a change in
physical attributes.
Cognition: Agents can interpret a specific environment and process the information it provides through
various “filters” or with different perceptions. This filters or perceptions can be different depending on
the conditions in the specific environment.

ABM Building Elements
Agent - Agents are the heart of ABMs. They, among other things, are autonomous, decision-making entities with
goals and the ability to interact with their environment and other agents. Agents are considered to be
autonomous because their actions are not determined directly by a central function, although, they can interact
with a central function that they have some independence from. As noted, the agent receives information from
their environments and other agents and they react to, and, interact with this information. Agents have the ability
to pro-actively initiate actions in order to achieve their goals/objectives. Figure 2.27 stylizes the functions of an
agent including its functions, inputs, outputs and interactions.
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Figure 2.26: Diagram of building blocks (or features) of ABMs
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Figure 2.27: Architecture framework for agents
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Images included under title 17 section 107 U.S. Copyright Law Fair Use Doctrine as educational material distributed for use without profit.
Modified from source: http://www.ck12.org/section/Elements-of-Agent-based-Models/
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As noted previously, an agent is defined as an object that can take action. They can represent individuals, groups
of individuals, inanimate objects such as machines or elements such as investments or projects. Agents differ in
their characteristics, that is, they are heterogeneous. They can show differences with respect to most any type of
dimension such as knowledge, objectives, rules, or abilities.
Environment - The environment of an ABM characterizes the tasks or problems the agents operate within: the
environment represents the global constraints and, “rules of engagement” the agents have when attempting to
fulfill their tasks. At the risk of being somewhat metaphysical, the environment can be a physical or geographic
space, or, a conceptual space which is somewhat harder to comprehend (at least for me).
Hammond states the Environment in an ABM can [355]:
• Range from simple to relatively abstract
• Contain “agent types” itself with their own properties, actions and rules
• Can change over time for example as a result of agent action or from exogenous drivers such as policy
change.
The Environment is the virtual world in which the agents act as simply stated by Gilbert. As noted previously, the
Environment may be geographic or spatially explicit or using some other feature such as knowledge. The location
of agents can be defined by various means such as coordinates or relative positions based on proximity to other
agents in a network [356].
Time - Time is a core element in dynamic simulation. Simulation approaches like ABM have a fundamental unit of
time that represents one cycle of the simulation. This is often referred to as iteration. Consideration for the time
component includes [355]:
• Calibration to some unit of measures e.g. real-world time or something more abstract (e.g. dog years,
which would be easy to adjust for vs. model of chronic disease incidence driven by smoking or a model of
opinion-change dynamics may require more work to calibrate[357]);
• Potential involvement of multiple distinct speeds e.g. the time change of a patient’s health vs the spread
of a virus through the population, vs. the mutation of the virus;
• Defining the units (and rate of change) for the rules, actions and changes in agent properties or
environment.
Rules – The behavior of agents is conditioned on their rules. Rules are the central drivers of the dynamics of the
model and define how agents choose actions, modify properties and interact with other agents and their
environment. In the simplest sense, rules can be thought of as “if-then” statements, e.g. “if age > 18, then able to
vote”. Note that properties affect the rules, serving as their input. Rules can also be dependent on time and may
involve learning, change or adaptation – e.g. probability of mediation administration error changes for a
nurse/agent after 100 times of administering a certain medication.
Rules can vary significantly in complexity ranging from simple statements to subprograms or optimization
processes or other calculations. Part of the rule structure can include stochastic and deterministic probabilities.
Rules can also define the creation, removal or modification of agents.
Properties - Properties are another core building block of ABMs. Whereas rules represent the behavior of agents,
properties reflect the characteristics of individual agents (e.g. age, sex, breed, disease state, wealth, income,
membership status, functional status (e.g. broken, fixed)). As noted under Rules, Properties can change over time
or remain the same (e.g. height as a result of growth over time). The construct of the model can allow properties
to either be entirely visible, not visible or only partially visible to other agents.
States - States are similar in some ways to properties, in that they refer to conditions or status that the agent is
allowed to be in. States can be formally represented in the form of a state chart. A state chart is a “graphical
state-transition construct based on exchanging messages or events between the system and its environment”
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[358, 359]. Three key elements of a state chart are the State, the transition and the resulting relationships
between States. Figure 2.28 and Figure 2.29 provide a representation of state charts [360, 361].
Urban and his colleagues used the PECS reference model (physical. emotion, cognition, social status) for
construction of human-like agents. PECS follows to basic principles: 1) it uses component-oriented hierarchical
modeling which is in essence building the model up from smaller constituent sub elements; 2) using a systemtheoretic approach the model takes on a temporal basis where each internal state of the agent has a set of
conditions at any point in time and can change as the simulation progresses. Figure 2.31 [19] illustrates the
architecture of a PECS agent30. In our case the nurse will be an operative agent with these features.
As examples, the nurse agent might be represented as follows:
• Physical – Experience, knowledge, information state, workload;
• Emotional – Stress, fear, anxiety, confidence;
• Cognition – Situational awareness, error recognition, decision making, learning;
• Social status – Seniority, organizational position, respect.
Marsella and colleagues used an ABM system, PsychSim, designed specifically as a social simulation tool. As such,
it is used to explore individuals and groups and how those interactions can be influenced.

Figure 2.28: Description of statechart elements31

30

The red arrow indicates a line added by the author: it seems like this would be a logical interaction. Images included under title 17 section
107 U.S. Copyright Law Fair Use Doctrine as educational material distributed for use without profit.
31 Images included under title 17 section 107 U.S. Copyright Law Fair Use Doctrine as educational material distributed for use without profit.
Ref: https://help.anylogic.com/index.jsp?topic=%2Fcom.anylogic.help%2Fhtml%2Fstatecharts%2FStatecharts.html
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Figure 2.29: State chart for simple manufacturing process32

The attached video provides a reasonably
good overview of the elements
mentioned above (via link on photo
Figure 2.30).

Figure 2.30: Agent based model for the zombie apocalypse. 33

Figure 2.31: PECS agent architecture34

32

Images included under title 17 section 107 U.S. Copyright Law Fair Use Doctrine as educational material distributed for use without profit.
Images included under title 17 section 107 U.S. Copyright Law Fair Use Doctrine as educational material distributed for use without profit.
https://www.youtube.com/watch?v=M7PeYyUczh8
34
The redline was added to indicate an additional interaction not included in the original reference
33
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A PsychSim starts with a generic agent from which the modeler constructs unique agents that represent groups
with specific attributes. Each agent maintains independent beliefs, goals and rules (policies) for achieving those
goals. The PsychSim agent has the following elements: State, Actions, Goals, Beliefs, Polices, Messages and Mental
Models. The following list maps elements into this research model [362]:
• State – Patient status, medication, information available, experience, knowledge, capability
• Actions – Similar to other ABM actions
• Goals – Safety, rushing/urgency, relieving pain, avoiding criticism/errors, accuracy
• Beliefs – Assumptions of patient condition, medication assumptions
• Policies – Similar to rules
• Messages – information passed from one agent to another (e.g. pain level, corrections, influence
from family, doctors’ orders
• Mental Models – This is best described as preconceived notions: a child can’t accurately describe
pain, Tylenol is not toxic, lab results (information type as an agent) are of little value.
Both PECS and PsychSim provide interesting and potentially valuable architectures for building “humanness” into
the final ABM simulation. PsychSim will have the added challenge of being a custom ABM software system that
does not appear to be currently available. That said it provides unique insight into constructing emotion and
cognition into agents.
Healthcare ABM Behavior Approach
Considering modeling of human behavior specifically in HC, using ABM, brings in an interesting construct. Based
on my effort to date, very little research has been identified during this literature search that relates specifically to
considering the behavior, specifically cognition, and emotion or mental state of healthcare providers, as part of the
ABM structure. A considerable body of work exists on the modeling of patient behaviors at the macro level, such
as in epidemics, or actions related to healthcare or similar venues [363-365].
While there are a number of approaches to building human behavior traits into agents [362, 366], the PECS
approach provides an initial useful structure to design a structure for modeling behavior of healthcare providers –
including nurses.
Contributory factors have been studied that influence the error occurrence with nurses. These include: stress,
workload, experience, work conditions, familiarity with work area, patient type, slips and lapses, equipment, and
communication [4, 29, 367].
Little work has been done to understand the underlying causes of errors by nurses: it could be possible to draw
analogies on underlying error causes from other areas such as aviation or nuclear facility operations [368-371].
Extending the PECS model, with only superficial consideration at this point, the general formula is:
F ≡ transfer function
Z(tn) ≡ current state
tn ≡ time
z(tn+1) ≡ Future/subsequent state
x(tn) ≡ input
Z(tn+1) = F(tn , z(tn), x(tn))
Urban and Schmidt state that the state variable z is not typically directly related to observable behavior function as
an independent variable. Dependent variables are constructed that depend on the sate variables that ultimately
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drive an agent’s behavior. The relationship between the state variable, z, and the dependent variable, w, can be
described by a function H [372].
W(tn+1) ≡ dependent variable influencing behavior derived from the stat variable
H ≡ function relating state variables and the dependent variable(s)
W(tn+1) = H(z(tn+1)
The output function G determines how the new internal state of the agent, defined by the state variables z(tn+1)
and the dependent variables w(tn+1), is transformed into an externally observable output y(tn+1).
G ≡ output function that determines expression of the new internal state
y (tn+1) = G(tn+1, z(tn+1), w(tn+1), x(tn+1))
The fundamental assumption of PECS is that an agent’s personality is conditioned on the form of F and H, the state
variable and its function that transitions the state variable to expression respectively.
The transfer function F modifies the internal state variables of the agent. This happens either as the result of an
input from the outside world, or it can be self-generated. The state variable could be Fatigue, for instance. This
state variable could be changed by the external input x, where the agent experiences a longer than normal shift.
Fatigue(tn+1) = F(Fatigue(tn), Shift-length(tn))
A different example of a state variable change would be Stress level. This state variable could change based on
outside influences or on its own depending on the actions the agent takes
Stress(tn+1) = F(Stress(tn), Action performed(tn))
Stress could be constructed not to directly influence the agent’s behavior. The function H, which relates Stress to
the drive Workload, acts as a motive. This means that the state variable Stress is modified by the dependent
variable Workload.
Workload(tn+1) = H(Stress(tn+1))
Two additional points will be mentioned, but they will not be explored here. One is to include “fuzziness” in certain
state variables that can be “de-fuzzified” by JIT information. The other point is to use exiting statistical occurrence
of states to inform the behavior of the agents: in other words, use the likelihood of a state to define its occurrence
in the agent.
Lean for MAP
Considering MA and the associated errors (medication administration error) from the Industrial and Systems
engineering perspective of Lean and Reliability is surprisingly unique and rare. A number of studies were identified
that evaluated the use of lean methodology for medication administration. One study analyzed intravenous (IV)
medication orders for 30 days to identify the specific times when medications were changed or discontinued. The
researchers performed a value-stream mapping to define the current state and identify efficiency states. After
evaluating the value-stream map they performed and optimization, they provided modest improvement as
measured by wasted doses and cost reductions [373].
Lean principles have been applied to MAP with some success, although, the application of Lean seems rather lean
(sorry I couldn’t help myself). As part of a cooperative effort from the Virginia Mason Medical Center (Seattle), the
Collaborative Alliance for Nursing Outcomes (CALNOC) Medication Administration Accuracy Quality Study was
used in combination with Lean quality improvement efforts to address medication administration safety. The
effort targeted improving several functions including the medication room layout, applying visual control (Kanban)
and standardizing nursing work related to MA. Their efforts concentrated in six safe practice areas:
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•
•
•
•
•
•

comparing medication with medication administration record,
labeling medication,
checking two forms of patient identification,
explaining medication to patient,
charting medication immediately, and
protecting the process from distractions/interruptions.

The result of this effort was a fivefold reduction in MAEs down to 2.8% of all Mas and “safe practice” violations
decreased from 83/100 doses down to 42/100 doses. This study covered 18 months; no long-term longitudinal
data was provided. This study indicates that Lean process improvements can contribute to decreases in nursing
medication administration [69].
Another approach studied the application of Lean to hospital pharmacy operations and included the perspective of
nurses. The study discussed overall error performance and mutual perceptions of the pharmacy and nursing staffs
and the implementation of various error reducing strategies mostly concentrated around improving information
flow and communications [70].
In a modest sized application of lean for IV medications, the authors noted increased performance in terms of the
delivery of doses dispensed and a decrease in returned items. There was no discussion of error rates [373].
While this is not intended to be a comprehensive literature review of the application of Lean principles for the
administration of medication by nurses, a fairly extensive search was conducted. As noted previously, the research
is scarce for this application. The reasons for this could be varied including: efforts are going on in this area but
they are not finding their way into the research literature, or, little research has been conducted in this area.
One of the challenges in this area is the difficulty in getting accurate reporting or recording of medication
administration errors [24, 374, 375]. Not surprisingly the consensus is that MAEs are under-reported and that
nurses avoid reporting errors due to the perceived repercussions.
One methodology researchers have used is having observers monitor nurse MA activities to detect if errors occur.
This appears to provide a reasonably good approach to objectively gather data. As with other direct observation
approaches, there can be an effect of the observer on the behavior of the subject being observed. Another
challenge is the limit of the breadth of the data being collected, that is, the amount of data being collected is a
function of the number of observers. As a result, these types of studies are limited to a relatively few
organizations in any given study [142, 375-378].
Information System of MAP
If one critically assesses what a nurse processes during the MAP, the conclusion would be information. Consider
the administration of medication as a production process with the finished product being the successful delivery of
the correct medication in the right dose to the right patient.
One can envision an assembly line, where at each station along the assembly line another component of
information is added. This information work in process continues until, if all goes well, a complete information
product is assembled to ensure correct medication administration (Figure 2.32).
It would be naïve to assume that by simply addressing the issues around information that it would solve the issues
with MAE and the efficiency challenges with the MAP. However, by addressing the issues with information, it
provides the foundation for addressing the surround challenges such as timeliness of medications being available,
changing medication orders, impact of procedures, work interruptions, etc. To be clear, there are many factors
that affect the MAP beyond information, however, by treating MAP as a dynamic information system, the MAP
should be able to adapt to change from other systems based on the input of Just-in-time information (i.e. Kanban).
The key to providing benefit to the nurse and developing a truly functional system is to decrease the nurses’
workload, make it easy to use and to have most of the operations transparent.
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Figure 2.32: Infographic of the MAP and related information flow

Complex Adaptive Systems
Complex Adaptive Systems (CAS) have direct applicability to the study of processes and systems in healthcare and
are a core concept in ABMs. CAS are part of the broader field of study of complexity theory also known as
complexity science. Complexity science is an approach to studying systems representing a collection of concepts,
tools and methods that takes advantage of combining a spectrum of disciplines including social sciences,
mathematics, computer science, and systems engineering[379].
While the underpinnings of the study of complex systems go back many years, the coalescing of the concept of
complex systems occurred in the 1980s-1990s. The Santa Fe Institute, an organization that focuses on the study of
complex systems defines complex systems and complex adaptive systems as follows 35.

Complex system
A system composed of a large number of interacting components, without central control, whose
emergent ``global'' behavior---described in terms of dynamics, information processing, and/or adaptation--is more complex than can be explained or predicted from understanding the sum of the behavior of the
individual components.
Complex adaptive system
A complex, nonlinear, interactive system which has the ability to adapt to a changing environment. Such
systems are characterized by the potential for the emergence of new structure with new properties.
Complex adaptive systems (CASs) can evolve by random mutation, self-organization, the transformation
of their internal models of the environment, and natural selection. Examples include living organisms, the

35

https://www.santafe.edu/engage/learn/resources/complexity-glossary (Date Accessed: June 23, 2018)
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nervous system, the immune system, the economy, corporations, and societies. In a CAS, semiautonomous agents interact according to certain rules, evolving to maximize some measure like fitness to
their environment.
Characteristics of CAS, not surprisingly, align with ABMs: ABMs are a software embodiment of CAS. The
characteristics of CAS are noted below.
• Emergence – The enacting of lo-level rules among agents to create entirely new properties and behaviors
with no single entity directing and no way to completely foresee the new properties from what is known
of the constituents alone[380, 381].
• Co-evolution – The phenomena of the interplay of mutual changes of entities within the system. The
environment and entities interact and influence behavior and change with the intent for achieving best
fit.
• Connectivity – Entities within a CAS have the ability to share messaging, information, interactions through
connections that can be permanent or temporary.
• Nested Systems – Systems can be embedded within other systems either on a hierarchical basis or on a
non-hierarchical basis. This is often referred to as a system of systems
• Simple rules – Elements within a CAS often follow simple rules for behavior such as birds maintaining a
certain distance during flocking behavior.
• Sub-optimal – CAS can work towards a common purpose, but, dynamics and competing needs thwart
ideally optimized performance.
• Requisite variety – By its nature a CAS is made of individual entities with unique variation at the
subsystem or system level.
• Self-Organizing – Entities may coordinate as a group or subgroups for example flocking behavior.
• Edge of chaos – System exists in a range of conditions ranging from chaos to equilibrium as defined by the
level of order in the system, and is a “region of bounded instability that engenders a constant dynamic
interplay between order and disorder”[382].
Many have considered healthcare as a CAS. Begun generally explores the application of CAS to healthcare and
highlights the similarities of the properties of CAS, particularly the consideration of emergence and the structure of
healthcare as represented by networks [383]. Rouse takes another approach by considering incentives and
information as the two core elements of healthcare as a CAS. He makes the points that hierarchical decomposition
does not work for CAS and that complex adaptive systems self-organize, and as a result an organizational design
cannot be imposed. This supports the property of co-evolution of CAS [384]. Sturmberg et.al. provides a
visualization of CAS in healthcare as a vortex to understand the CAS nature of healthcare systems and to illustrate
the interaction of the system-of systems that characterizes healthcare [385].
CAS have been considered with respect to nursing. Chaffee and McNeill consider CAS at a broad level and
constructs a metaparadigm view of nursing as a CAS. They start at the highest level of nursing and parse the
system down to the down to basic subsystem level of nursing [386]. Clancy, Effkin and Pesut considers the
applications of complex systems theory in nursing education, research and practice and explores areas of
application of CAS n the environment of nursing care [387].
CAS has been used at various levels of application to understand operations and performance by nurses. The
prevention of surgical site infection by using a CAS approach was studied by Sitterding [388]. A study of ED
operations found that a CAS approach was beneficial in understanding the delivery of integrated care because “the
processes of categorization, diagnosis and discharge are primarily about the linkages between services, and the
communication and negotiation required to enact those linkages, however imperfectly they occur in practice”
[389]. CAS was applied to the challenge of nurses in daily documentation tasks. This study reports 13% to 28% of
total nurse shift time is spent documenting. The authors studied the documentation of nursing care a CAS
approach and then analyzed the benefit of using a standardized nursing language. A case study of a nursing
improves nurse and system performance in care planning by adopting a standardized nursing language was
performed [390].
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A brief overview of CAS in nursing and an associated case study cautions that CAS should be used cautiously and
not overextended beyond reasonable limits and encourages considering CAS at local levels (e.g. wards and teams)
as opposed to large systems such as a National Health System [391]. While there are some merits to the author’s
point, they seem to be missing the ability of systems engineering to accommodate broader and more generalized
systems via formal systems engineering tools and approaches such as systems dynamics.
While references are made to medication administration being complex and that it is a complex system few
specific references were identified that explores the medication administration process as a complex adaptive
system. The under reporting or lack of reporting of medication administration errors was identified as a highly
complex responsibility in separate studies by Lane and Wakefield [392, 393]. Patterson and Cook describe
medication in the acute care setting as a complex system [33], and references the complex interconnected nature
of the medication administration process [394]. The behavior of nurses during the MAP and their use of barcoding
was briefly considered by Matlow [395]. Ebright used medication administration and nurse decision making as an
example of a CAS [396].
Much has been written on CAS in healthcare. The literature appears to remain largely at the conceptual level of
considering CAS and systems engineering methodologies to the study of healthcare. As noted earlier there has
been some research done on using approaches like systems dynamics and ABM to model the healthcare.
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Chapter 3
Methods and Approach
Overview
There are two fundamental parts to this research, a clinical trial, or case study measuring the effect of JIT
information on the occurrence of medication administration error in a simulated environment and developing an
agent-based computer simulation to determine if such a simulation can effectively model the effect of injecting
information into the medication administration process in an attempt to mitigate Medication Administration error.
There are four components to the clinical trial. The first was the use of the Health Innovation Technology
Simulation (HITS) Laboratory at the University of Tennessee- Knoxville. The second was the development of a
teaching simulation scenario using the HITS laboratory equipment and facilities. The third was engaging student
nurses as research subjects. The forth was the development of a smartphone app that would provide information
to the student nurses while they were student nurses.
Student nurses were selected as an element of this study for a number of reasons:
• Use of student nurses provided a readily available pool of interested research subjects.
• They were a relatively uniform group in terms of education and nursing experience at approximately the
same point in their academic progression.
• As part of their normal curriculum, student nurses participate in training simulations at the HITS lab.
Treating this as a training simulation fit easily into their coursework and did not require extra time or work
for the students.
• They have significant familiarity with the use of a smartphone as source for information and were
amenable to using the technology.
• The role of the student was as a mechanism to assess the performance of JIT information on medication
error occurrence.
The HITS lab provided a controlled environment for running the training simulations, as a result, extraneous events
that would have occurred in an actual clinical environment were not a concern. The patient (mannequin) was
consistent in that the behavior, condition and other features were the same among each simulation run. The
room and environment (equipment, supplies, EMR/MAR interface, etc.) were the same for each simulation run.
Subjects
Subjects were comprised of University of Tennessee senior year nursing students participating in standard
simulation training as part of their required curriculum. Nursing students go through a number of training
simulations using instrumented mannequins. There were 93 nursing students used in the study over the course of
two semesters. These students comprise the entire class for each semester; as such there are no other selection
criteria for the participant other than being enrolled in the class. In other words, participation in the study was
open to all students within the class participating in the simulation. The study was designed to use the entire
complement of students from the class, approximately 45 students to be part of the study in the fall semester of
2015 and a similar number in the spring semester of 2016. The students in the fall semester served as the control
group. These students will participate in the normal training simulation without using the smartphone app. Their
performance was observed during their simulation class and the key performance indicators noted. The student
nurses participating in the spring semester trial used their personal smart phones, to provide real-time information
based on the student’s query via the app that was developed for this study. The total time for each student to
participate in the simulation was nominally between 6 and 15 minutes. The students using the device had an
additional 20-30-minute tutorial and familiarization prior to the simulation in order to learn how to use the JIT.
The University of Tennessee Institutional Review Board was engaged and a human research proposal was
submitted and approved to use nursing students as research subjects for this part of research. All protocols and
guidance suggested by the IRB were followed and informed consent was obtained by each student that
participated in the study. No personal information, regarding the research subjects, was required as part of this
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study nor was any of the performance information linked to individual students as it relates to this study. The
option on whether they do or do not want to participate in this study prior to the start of the simulation was
provided to the students and a briefing on the study was also be provided. Compensation will not be provided to
the students as part of the study nor will it have an impact on their grade.
The selection of participants was equitable because:
• All students within the class were invited to participate
• The control and experimental participants are separated by semesters thus making both groups uniform
• The experience and education level of the student nurses is approximately the same limiting concern for
biased performance
Clinical Trial/Case Study Methods and Procedures
Student nurses perform a number of training simulations using instrumented mannequins as part of their normal
curriculum. As noted previously, we used senior of Tennessee University nursing students who were in a class
(N404) where simulated training was part of the course curriculum. The instructors prepared and observed the
students in this study in the same way that they normally would. They briefed the students on the scenario for the
simulation and provided them relevant background information that prepared them with background facts and
information. A simulation scenario that provides the student the various options in decision making and care
execution while using JIT information was developed by the CON in conjunction with the researcher to support this
study. This scenario is typical of other scenarios used by the simulation facility. No personal information of
students was collected and all performance information was de-identified.
Two groups were decided upon: the control group, and the intervention group. The control group (fall semester
2015 nursing students) went through the simulation but did not use the JIT app. The intervention group (spring
semester 2016) went through the simulation using the app via their smartphones, with each member of the group
participating in the simulation. The experimental group was broken into two separate groups; the Pre-training
intervention group and the Post-training intervention group. The purpose of the Pre and Post-training subgroups
was for the ability to control the familiarity, or lack thereof, of using the information app.
Both the pre-training and Post-training intervention groups were provided a tutorial for the app which included a
10-15-minute demo done by the researcher, followed by the students using the devices to familiarize themselves
with the functions for another 10-15 minutes. In addition, the Post-training group was asked to complete a
worksheet that had questions requiring use of the app. Both the demo and worksheet used a training app that
looked identical to the simulation app but had a different patient with different information such as medications,
lab values, contraindications, history, and so on.
The app was designed to provide similar information as the other resources that are available to the students in
the simulation. The difference between the app and the EMR/MAR DocuCare based resource available via the
desktop system in the patient room, is that the app provides the information in a concise and simplified manner
while the EMR/MAR is more involved36. It also highlights key information that is temporally germane to the
nurses’ decision-making process consistent with the concept of JIT information.
Two to three students participated in each scenario (i.e. each simulation is done as a small group). All student
performances were observed at the individual level and their performance cataloged. All data was de-identified at
the end of the scenario by removing any identifiable characteristics. Data was then collected via researcher notes
and transferred to a computer. The Key Performance Indicators are based on the decision tree for the scenario
and are as follows:

36

The EMR/MAR DocuCare system is a robust and complex medical records system with a comprehensive compilation of patient information
and reference material similar to full EMR/MAR system found in hospital settings
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•
•
•
•
•
•

Total Errors committed
Medication administered correctly
Specific errors committed
Time for simulation completion
Use of External information resources (e.g. DocuCare –A simulated medical records system provided as
part of the simulation system, available drug reference manuals, medication labels)
Utilization of the JIT smartphone app

For the purposes of evaluation errors defined as not executing the key elements of the MAP process including:
• Failure in checking the MAR correctly
• Failure in checking the medication type correctly
• Failure in checking the patient ID
• Failure to validate the correct route
• Failure in checking the dosage correctly
• Incorrect checking the time for medication administration
• In appropriate administration of medication
Scenario Development Methodology
The College of Nursing faculty and HITS staff developed a specific simulation scenario for this research (see
appendix 2 for staff background and experience). The faculty, staff and researcher developed the key objectives
that met the needs of the training and research aspects for both the students and the researcher. These
objectives included a scenario with key aspects of the MAP; ability to inject information as the intervention into
the scenario; ability to conduct the simulation with the students in 15 minutes or less; ensured repeatability and a
controlled environment; met the skills and capabilities of the students; provided a realistic experience for the
students; provided a means to measure subject performance objectively relative to the MAP; errors could be
scripted in to the scenario to assess the subject’s performance and critical thinking.
Based on the experience and judgement of the faculty and HITS staff, a pediatric simulation that met all of the
study and class objectives was developed. A pediatric medication administration scenario was developed because
it required the need for accurate dose calculation; limited the need for nurse-patient information; allowed a
surrogate information source (the child’s mother) to help guide the execution of the simulation; and realistic
potential medication administration errors could be crafted into the scenario with limited medications listed in the
MAR, and; the scenario created conditions that could lead to typical medication administration errors including
dose calculation errors, wrong medication, not checking the patient records or MAR, wrong medication route and
not checking the patient identification.
The HITS staff has had specific training and extensive experience in developing training simulation using the
mannequins. They use a standardized approach to develop the scenarios that includes the needs of the faculty
teaching the course, the objectives of the course curricula and other factors such as the research objectives of this
portion of the research. Appendix 2 provides the developmental outline of the training scenario.
The key aspect of this training simulation revolves around the dosing of acetaminophen, which is susceptible to
overdosing and particularly toxic in chronic overdosing.
Scenario Description
The training simulation scenario consisted of a six-year-old 22kg pediatric patient named Frank that arrived at the
emergency department (ED) of a local hospital. The following excerpt from the final scenario documentation
highlights the key points. This briefing is between a nurse going off-shift and the nurse coming on shift that will be
caring for the patient, Frank.
Frank is 6 y/o male who was brought in yesterday to the ED by Mom and Dad after falling off the
trampoline at home three days ago. His parents did not realize the severity of the injury and thought he
just had a bad bruise. They treated his injury with elevation, ice and Tylenol for pain. X-ray revealed a
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right tibia/fibula fracture. Pt had surgery yesterday to repair the fracture. Frank has a 22G angiocath in his
right AC with D5 1/2NS with 20KCL infusing at 55 ml/hr. He has been getting scheduled morphine q2
hours and Tylenol q4hr PRN for breakthrough pain. Frank is complaining of pain. His mom just called right
before report and I have not had a chance to assess his pain yet. I gave him his morphine an hour ago but
he hasn’t had Tylenol in 6 hours. Labs were drawn last night and they are in the computer but I haven’t
look at them yet.
The key points of this scenario background are that:
• Frank is a six-year old pediatric patient
• He has been given Tylenol (acetaminophen or ACA) by his parents for pain prior to arriving at the ED
• He has just had surgery to repair the broken bones in his lower right leg
• He is on medications to manage pain including Lortab every two hours and Tylenol every four hours
• Frank received his Lortab (morphine and acetaminophen (ACA) combination) dose an hour ago but has
not received his Tylenol
• Frank’s pain level is unknown at the time of this briefing, this will determine if pain medication will be
needed
• Recent laboratory results are available but have not yet been reviewed
The students read the brief history above at the start of the simulation. There is a standard “Mom” present played
by one of the HITS staff or CON faculty. The mom’s interactions with the students are scripted for consistency.
The mom will inform the students that she had been giving the patient Tylenol in a largely unconstrained fashion
while at home just prior to entry into the hospital. That is, she had been significantly overdosing the child.
If the student(s) query the MAR (DocuCare), they will find that the patient has been prescribed Lortab, along with
acetaminophen for breakthrough pain. An anti-emetic was also ordered but the order was discontinued. If the
student does a correct dosing calculation, they will find that the physician has prescribed an over-dose of
acetaminophen based on use of an incorrect weight. Additionally, if the student checks the laboratory results for
the patient, they will find laboratory test values that indicate overdosing from acetaminophen.
The simulation scenario is complex and has a variety of challenging facets:
• An overdose amount of acetaminophen was prescribed by the physician based on a wrong weight at the
time the medication was prescribed.
• Two medications have the same active substance (Lortab and acetaminophen) creating an instance for
exceeding the total allowable daily dose of acetaminophen.
• The patient’s laboratory values indicate an adverse drug event – elevated hepatic laboratory results
indicate liver damage possibly due to acetaminophen toxicity.
• The “mom” infers she has been giving the child overdose amounts of acetaminophen after the injury and
before coming to the hospital.
• The patient is complaining of symptoms that indicates a drug reaction (nausea), a possible confounding
situation exists because the child could also be experiencing nausea due to anesthesia from a recent
surgery, however the nausea related to this should have abated.
• The nurse should do a weight-based medication dose calculation because this is a pediatric patient.
• The situation can proceed down a large number of different pathways, having a decision tree of several
hundreds of nodes.
As the student progresses with the scenario, they will find that the patient has moderate to significant pain from
the surgery. The mom will agitate to have the patient get medication quickly since the child is crying and in pain.
As noted in the scenario detail in appendix 2, the students have an up to date EMR/MAR with all of the patient’s
vital signs, correct body weight, medication orders, and medication information. A bound version of a drug
reference is also available. There is a bedside computer with a hand-held scanner for validating patient ID, along
with scanning in medications that are being administered.
The patient room set up matches that of a typical hospital medical/surgical ward. One exception is that there is a
screen at one end of the room that serves as a divider to simulate a medication prep area. This area has the
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material needed to prepare medication doses and includes cups, syringes, and med cups or a bottle of Tylenol
syrup, Tylenol caplets and ibuprofen syrup. The medication preparation area has a computer for accessing the
patient records and MAR, a calculator, and medication reference manuals. The patient room shown in Figure 3. 1
has multiple video cameras positioned throughout the room. These cameras provide the ability to visually monitor
the execution of the scenario from multiple positions within the room. The rooms also have microphones to allow
observers to listen to the simulation.
The patient is an adolescent mannequin capable of representing a six-year-old male (Figure 3. 2). The mannequin
is described by the manufacturer as being “designed for skill and scenario-based training and a complete range of
pediatric scenarios” 37. While the focus of this scenario is not to use the many functions of this device, the
students may take vital signs. The environment is set up so that the patient can vocalize pain and speak. The
instructor in the HITS lab control center provides the vocalization of the patient.
The researcher and HITS staff monitor the execution from the control room (Figure 3. 3). As depicted in the
associated image (Figure 3.3), the control center provides control of the mannequin, video cameras in the patient
room, the patient monitors, access and updating of the EMR system. Observers can watch the execution of the
simulation unobtrusively, as well as listen via in-room microphones.
The researcher viewed each of the simulations from the control room. The simulations were video recorded to
allow follow-up review.

Figure 3. 1: Photos of patient room

37

Laerdal mannequin description: https://www.laerdal.com/us/products/simulation-training/nursing/nursing-kid/
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Figure 3. 2: Photo of Frank, instrumented pediatric mannequin

Figure 3. 3: Photo of HITS control room used during performance of training simulations

Figure 3. 4: Student nurses using app during training scenario
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Execution of Training Scenario
At the beginning of the semester, each group of students/test subjects was briefed on the research project
approximately one month before the simulation at the end of the scheduled class time. The briefing covered a
general description of the scope and purpose of the research, they were offered an opportunity to participate in
the research and provided a copy of the IRB consent form to sign should they be willing to participate in the study.
Prior to the simulation training event, the researcher met with the instructor and simulation staff to review the
final simulation scenario and coordinate the pre-simulation instructions, and to plan for the simulation event and
post-simulation follow-up. The pre-simulation included instruction by the simulation staff to the students which
included advising the students not to discuss the simulation event with their classmates in order to ensure the
education value of the simulation was not comprised and did not affect the integrity of the data generated from
the research. It included a high-level overview of the simulation avoiding discussion of the clinical and procedural
skills required. A discussion of the research would be reiterated by the researcher, and students that had not
signed the consent form were provided an opportunity to participate in the research and sign the consent form.
The students were divided into groups by the instructor based in part on the student’s interest in participating in
the research. That is, students who desired not to participate would be placed into the same group or multiple
groups depending on the number of students not participating in order to avoid potential conflict. Participating
students would also be broken up into groups ranging in size from two to three as selected by the HITS faculty.
On the day of the simulation training, just prior to the start of the simulations, the instructor provided a high level
over view of the simulation event without providing detail on the actual scenario. Specific details of the scenario
were not discussed.
Immediately upon the completion of the scenario, as determined by the faculty, the students are debriefed as a
group: this is considered an integral part of the training environment. The room used for the debriefing was a
small exam room close to the patient’s room. The researcher observed the debriefing and was able to ask followup questions specific to the research at the end of the simulation debrief.
The course of the scenario can follow a number of different paths and associated outcomes similar to the decision
tree in appendix 8. These paths can range from the nurses simply dispensing the medication per the physician
order, to not dispensing the medication and calling the physician because of the high hepatic laboratory values. As
in a real-world situation, there are multiple approaches that lead to correct or incorrect outcomes. From a training
scenario perspective, the nurse would have observed the errors built into the scenario, specifically the incorrect
dose, the multiple medications with acetaminophen and the high laboratory values, and would then contact the
physician, and would have provided correct dosing information to the mom.
The use of the JIT app is intended to determine if providing information in a fashion that could be considered
easier to assimilate and in a specific timeframe that it was optimum for its purpose and would reduce the
occurrence of errors. To this end, we are not measuring optimal outcomes, rather, measuring whether or not we
decrease the occurrence of errors as measured by app usage and the five rights of medication administration.
Facilities and Equipment
As part of their education and training at the University of Tennessee College of Nursing (CON), student nurses
participate in a number of training simulations to evaluate and improve their skills. These simulations use
instrumented, life-like patient care mannequins coupled with control computers that can modify a wide variety of
parameters including physiologic variables, sound, physical response and manipulation. The simulations are
conducted at the Health Innovation and Technology Simulation (HITS) facility on campus at the University of
Tennessee (http://tntoday.utk.edu/2014/03/27/nursing-enngineering-health-simulation-lab/).
The simulations take place in a variety of rooms configured as hospital rooms within the HITS lab. These rooms are
outfitted with a complete array of hospital furniture and equipment. The faculty selects the room based upon the
requirements of the selected scenario. The rooms also have video cameras that provide the faculty a means for
unobtrusive observation of the students during the simulation along with two-way audio for listening to the
students as well as for faculty to provide direction. The medical equipment, mannequin and video feeds are linked
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to a separate central observation room apart from the hospital rooms, where the faculty controls the parameters
of the scenario. The researcher observed the simulations from this control room.
App description
The app was specifically designed to exhibit the features of JIT information. The design of the app went through
multiple iterations to ensure ease of use and the optimal visualization of the information. The design criteria for
the app is found in Table 3. 1.
The University of Tennessee College of Communications and Information was used to help with the final design of
the app format. Their support was instrumental in meeting the design objectives and ensuring optimal usability of
the app.

Table 3. 1: Criteria for smartphone Just-in-Time information app
Design Criteria
Easy to read

Design Approach
Font size and screen layout optimized, colors used
to indicate crucial information
Pages accessible via swipe or buttons at the
bottom
Limited to three screens that scroll up or down
and limited to two pages
Highlighted banners or colors to indicate
important information. Only the most recent
information or changes are presented
Dose calculators specific to the medication
ordered, with patient information (e.g. weight)
already entered
Use of a QR code to access the app
Specific screens for each of the primary areas:
patient encounter, MAR and EMR/Lab
Highlighted lab information and suggestions if
results are out of normal range

Easy ergonomics for screen manipulation
Minimal number of screens
Succinct presentation of information

Simplified calculation of medication doses

Easy access
Rapid access to medication information and MAR
Provides some function as a decision support tool

While the JIT app plays an important role in assessing what role, if any, JIT information plays in reducing
medication administration error, the goal of this research is not the development of the app as a tool. This app
serves simply as a mechanism to deliver the information in a way that is intended to approximate JIT information.
The app was evaluated by the CON HITS faculty and staff to assess its functionality, ensure the information in the
MAR and EMR and that it had appropriate utility for the intended purpose. The JIT app is a web-based application.
The screens were constructed as web pages. Since the functionality of the app is an information source and not a
tool to be used in an actual clinical setting, it does not have direct links into the DocuCare system. That is to say,
the JIT app is a virtual shell that provides static displays of information, as well as, a means to do medication dose
calculations; it is not tied to any information system to allow live updates (see appendix 4-5).
Those student nurses participating in the intervention group were asked to download a QR reader app to allow
quick access to the JIT app. The QR reader interprets the QR code, which is the JIT app webpage link hosted on an
ISE server.
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The QR code was on the patient’s wrist band hospital ID, as well as on the medication preparation table in the
patient’s room. The nurse simply had to scan the QR code and the JIT app with all of the JIT information for that
patient would load automatically.
Data Collection and Assimilation
The data to be collected during the trials was determined by the evaluation of the available research on the study
of MAE, the training scenario design and guidance by the CON faculty. Allowance was also made to identify
emergent data that arose during execution of the trial. Data includes a control group and
experimental/intervention/response group. The experimental group used the JIT app (Figure 3. 4) to access key
information while performing the scenario.
The data to be collected prior to beginning the trials included, the occurrence/non-occurrence of events principally
each of the five rights, use of the MAR, observed near misses, use of the MAE app.
Population and Sample Size
There was a total of 38 groups for both semesters. Eighteen groups were from the first semester and 20 from the
second semester. The first semester served as the control group and the second semester as the treatment group.
The treatment group was divided further into the training group and the experimental group with 11 groups in the
training cohort and 9 groups in the experimental cohort. A retrospective power analysis was done to confirm
appropriate sample sizes using Minitab 18. A conservative estimated standard deviation of 1 (calculated sample
standard deviation was 0.4) was used along with a difference of 1; a sample size for the cohorts of 8 was calculated
with a power of 0.81. For comparison a cohort size of 11 is required to reach a 0.90 power level.
Computer Simulation of MAP
The other component of the research effort was the development of a computer simulation that approximated the
performance or likelihood of error by nurses during the MAP as measured by error occurrence and its potential
moderation by the injection of information.
This research effort has constructed a computer model that simulates the medication administration process
(MAP) performed by nurses in a hospital. The goal is to have the model reflect the interaction of nurse(s),
medication(s) and patient(s). This simulation will consider the generation of potential errors and the effects of a
possible intervention in the form of JIT information on mitigation of error occurrence.
Computer simulation and modeling has been performed on a broad array of healthcare topics ranging from
disease diagnosis and management to nurse staffing models. Discrete event simulation, Markov models, Bayesian
networks, agent-based models, decision trees, Monte Carlo simulations, artificial neural nets, and systems
dynamics models are a representation of the various approaches used in healthcare computer simulation. Of
course, there are hybrids and variations of these modeling approaches e.g. hidden Markov models, Monte
Carlo/Markov models, agent based/Bayesian models, and others.
For the purposes of our efforts, computer simulation and modeling will be used interchangeably to refer to
emulating the activities and behaviors of the administration of medication with nurses, mediations and patients
along with their consequent interactions and resultant outcomes based on use of different states or changing
operating conditions.
Each simulation approach has its respective application niche based on several factors
• The type of data available
• The desired end-result or objective of the model
• The attributes of the system being modeled
• The computer modeling approach that best fits the aspects of medication administration
As a result, the features of the data, and what is trying to be accomplished, drove the final type of modeling
approach selected.
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Computer Model Functional Requirements
The functional requirements for this computer simulation model are a direct function of the aspects and
considerations of the MAP process. The available literature on the structure and function of the MAP process, as
well as, the clinical study performed as part of this research, help to shape the following functional requirements
of the model.
• Results and insights from the earlier clinical trial influenced the type of model based on the outcome of
the trial, the general process flow and outcomes. A key conclusion of the clinical aspect of the research
was that the order of the sequence of the events was relatively constant and process steps appeared to
be generally independent of one another.
• The model should resemble the major aspects of the MAP process and the interaction of the entities
being modeled with their environment.
• The various possible entities and their interactions could lead to a particularly complex model. The goal
will be to limit the complexity of the model to the greatest extent possible in order to focus on the major
aspects of the MAP process.
• While the sequence of events in the MAP can in practice occur in any sequence, a sequence that is most
representative of the standard approach, as described in the literature and clinical guidelines, will be used
in order to reduce model complexity.
• It is possible that the outcomes in any given process step could influence the activity in another MAP step;
this phenomenon has not been found to be addressed in the literature and will not be considered in this
model. The outcome of a process step is assumed to be independent of other process steps.
• The medication administration process is treated as essentially a discrete time random process in the
model.
• It is assumed that the process is not recursive, i.e. the nurse would not backtrack in the process of
delivering a medication.
• The decisions/actions within the MAP are assumed to be binary (e.g. yes/no, perform/don’t perform).
• The process is at a minimum a function of the nurse’s behavior, but could also include the medication,
patient and environmental elements.
• Each nurse is an individual entity with their own set of unique attributes.
• Similar to nurses, medications and patients are also unique entities with individual attributes.
• Emergent behavior, while not expressly designed into the system, is an acceptable outcome.
• Variability in the number of entities (nurses, patients, medications) and/or their interactions is important.
• The interaction between agents representing nurses and patients is dynamic and random, the interaction
between patients and their medications is static.
• The model is dynamic in the sense that states can change and influence outcomes in other areas.
• The focus of the modeling effort is on the MAP process, specifically the actions of the nurse. The
medication and patient entities relevance are a function of how they affect nurse performance.
• Measures of interest will have an overall likelihood of error occurrence calculated; the influence of JIT
information on error occurrence, and the effect of nurse attributes (e.g. experience) on error occurrence.
• Steps in the MAP process can vary independently, simulating the effects of other independent influences
on each part of the MAP process.
• The MAP process combined with its actual method implementation has attributes of process flow,
network, stochastic, and deterministic activities.
• The number of patients per nurse and the number of medications per patient can vary between
simulations.
• Medications attributes vary in type, difficulty in administering medications and the relative hazard of the
medication and may have an impact on the possible MAE rate.
Based on the attributes of the data and the MAP process, three modeling techniques have been considered along
with their potential advantages and limitations as they relate to this effort.
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Discrete Event Simulation
• Based on a series or sequence of events
• Assumes no change in the system between the events
• Entities (e.g. patients) may be given individual attributes
• Performs well for process flow models
• Accounts for use of resources
• May be discrete or stochastic
• More difficult to deal with changes within or among individual entities such as nurses
Bayesian Network
• Stochastic
• Explicit management of uncertainty/tradeoffs
• A variable is conditionally independent of its non-descendants given its parents (no memory)
• Singly connected directed acyclic graph (DAG) (no feedback)
• Incorporates prior knowledge
• Only as good as the prior knowledge
• Computationally expensive
• Requires prior knowledge for each event
• Can cope with incomplete data sources
• Belief updates based on receipt of new information
• Provides a theoretical framework to incorporate expert knowledge (as prior information)
• Directly applicable to decision theory
• Not dynamic
• Potential ubiquity of model structures
• Difficult to describe individual behavior
Agent Based Model (ABM)
• Stochastic/deterministic
• Can be combined readily with other modeling approaches (e.g. equation-based, Bayesian, Markov,
Systems Dynamics, etc.)
• Models at the elemental or individual level
• Provides insight into causes of emergent phenomena
• Generally based on the changes of an entity’s state
• Provides more natural description of the process
• Possible to model agents making decisions with incomplete knowledge and information
• Easily accommodates complex interaction among model elements (agents)
• Accommodates nonlinear behavior, rule-based, "coupling" and discontinuity
• Allows for direct interaction of model elements
• Individual behaviors can exhibit, memory, path-dependence, non-Markovian behavior, learning and
adaptation
• Well suited for activity -based modeling
• Incorporates expert judgment for validation and calibration
• Supports heterogeneity of elements as opposed to aggregate models
At the highest level, the model will emulate the performance of the nurse during the MAP. As part of this
consideration it is contemplated that the model will include factors that influence nurse performance during the
medication process including: interruptions, experience, adherence to procedures, dose calculation skills,
medication type, fatigue, work load, shift change, clinical or procedural errors in medication administration steps.
Review of the data, observation of the MAP scenarios (student nurse simulation), and likelihood of occurrence
based on observation and the literature and model complexity will provide the criteria for down selecting the error
factors to a more tractable subset of factors to be used in the model.
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Based on the attributes of the data and MAP, ABM was ultimately selected to be the most suitable modeling
approach. Several modeling approaches were considered in the early stages of model development in order to
evaluate the best fit of the simulation approach with the data and desired functions of the model. ABM was
selected because of the fit of the operational characteristics of ABM with the actual MAP process and the goals of
the research. The notional comparative assessment, provided in Table 3. 2, contrasts the characteristics of
modeling approaches potentially suitable for the nurse MAP process modelling effort.
The considerations for which ABM are appropriate include38:
• When there are decisions and behaviors that can be defined discretely (with boundaries)
• When it is important that agents adapt and change their behaviors
• When it is important that agents learn and engage in dynamic strategic behaviors
• When it is important that agents have a dynamic relationship with other agents, and agent relationships
form and dissolve
• When it is important that agents form organizations, adaptation and learning at the organization level
• When it is important that agents have a spatial component to their behaviors and interactions
• When the past is no predictor of the future
• When scaling-up to arbitrary levels is important
• When process structural change needs to be a result of the model, rather than a model input

Table 3. 2: Comparison of computer modeling simulation approaches
H: High, M: Medium, L: Low

Agent Based

Dynamic

H

Bayesian
Network
H

Low level of abstraction

H

M

L

H

Flexibility

H

M

M

M

Multiple environments

H

M

H

M

Process based

H

M

L

H

Scalability

H

L

H

M

Multiple autonomous entity types

H

L

L

L

Ease of application

H

L

M

H

Effective for moderately complex models

H

M

M

H

38

Systems
Dynamics
H

Discrete Event
M

( Macal, L., North, M., Tutorial on Agent-Based Modeling and Simulations Part 2: How to Model with Agents, Proceedings of the 2006 Winter
Simulation Conference)
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ABM Model Design and Construction
The key elements of an ABM include:
• Agents
• Time
• Environment
• Rules
• Properties
• States
Agents
Three agents were defined for the model: nurses, patients and medications. Other agent types were considered as
well, such as information, other health providers, and policies. While adding these certainly would have
contributed to the overall complexity and might have added to the fidelity of the model, the decision was made to
limit the number of agent types in order to have a better understanding of the functioning of the primary agent
types.
These agents interact either directly or indirectly among other agent types based on their respective functions
(rules) and properties (attributes). That is nurses do not interact with nor are they influenced by other nurse
agents but do interact with patients and/or medications. This is the same for patient-patient interactions and
medication-medication agent interactions.
Agents are assigned attributes to help determine how they function (Table 3. 3). For this model, the types of
attributes are set as part of the structure of the model. However, the value or degree of the impact that the
attribute can change as the model runs depending on the function of the attribute. For example, the nurse starts a
shift without any level of fatigue; as the shift progresses, fatigue sets in and diminishes performance for the rest of
the MAP processes.
Agents are connected during run-time via a network-type of arrangement to the other agent-types. This is
detailed later and is portrayed graphically in Figure 3.5.
Nurse Agents
The agent type, nurses, are the most complex agents and play the central role in the model. The attributes
determine the unique characteristics of an agent and can influence how they function. Table 3. 4 highlights a
nurse’s attributes.
The function of the nurse, quite simply, is to administer medications. The nurse agent is connected to a set of
patient agents in what resembles a network as represented in Figure 3. 5. A nurse connects randomly to a set of 212 patients. The literature indicates the typical nurse to patient ratio is 5-7 patients to nurse in a medical-surgical
hospital ward. This number can get as high as 12-14 or as low as 1-2 patients per nurse depending on a wide
variety of factors.
Nurses are randomly divided into two roughly equal groups to resemble the way hospitals structure their staffing.
Hospitals have devised various approaches for nurse shift staffing, an approach simulating two, 12-hour shifts were
used to simplify programming. A more conceptually accurate description of how the model handles the period of
time that the nurses administer medication would be termed the MAP time period instead of shift. The approach
of how shift time is handled in the modeled is discussed in more detail in the Time section.
The nurse-patient connections are reassigned randomly at the end of each MAP time period. At the end of the
MAP time period, the connections between any given nurse agent and the currently connected patients are
terminated. New connections between this nurse and the population of patients are reformed at the beginning of
the next MAP time period. This approach approximates how a hospital would assign nurses during a shift. This
approach also has the effect of removing potential statistical biases from having the same nurse attached to the
same patient for the entirety of a simulation run.
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Table 3. 3: Attributes used for ABM agents
Agent Attributes
Nurse

Data type

Type

Description

Interruption

boolean

p

Experience

experience

o

if the nurse has experienced an interruption while
administering medication
the level of nurse experience/education/capability

Shift

shift

o

the shift the nurse is assigned to

Fatigue

double

v

the impact of fatigue on a nurse

Patient Load

double

v

Medication Load

double

v

Patient

Data type

Type

the impact of the number of patients assigned to a
nurse
the impact of the number of patient's medications
administered by a nurse
Description

Medications per
Patient
ADR (adverse drug
reaction)
Patient medical
state
Medication
delivered
Medications
missed
Medication

integer

p

the number of medications ordered for each patient

boolean

p

patientmedicalstate

o

value for the reaction a patient has to a delivered
medication
patient severity of illness/condition

integer

p

the number of medications administered

integer

p

the number of medications missed

Data type

Type

Description

Medication
double
p
difficulty
Medication
double
p
severity
Medication
boolean
p
delivered
Medication not
boolean
p
delivered
Agent attributes p=parameter, v=variable, o=option list

N1,17

M M
M M
M
M
M
M

P
P
MP
M

M
MM
M M
M
M
M M
M MM M M
M
M
M
M
M
M
M
MMM
M

P

P

N1,1 MM
M M
P
M MM

P P

P
N2,23 M M
PMMM
M
M
PMM

N2,9

value that is associated with how hard it is to
administer the medication, e.g. an IV vs a capsule
value associated with the hazard of the medication to
the patient e.g. warfarin vs a vitamin
indicates if the medication has been administered
indicates if the medication has not been delivered

The interaction between nurse, patient
and medications resembles a network.
Each nurse agent is connected to a range
of patient (~2-10). Each patient is
connected to an average of 4
medications. Agents can “communicate”
and connections are reformed randomly
at set times through model execution.

Figure 3. 5: Interconnections of nurse, patient and medication agents
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Table 3. 4: Nurse agent characteristics
Nurse Attributes

Factor

Condition

Effect

Interruption

true/false

random, probability 53%

multiplier 0.95

Experience

novice, moderate, senior

multiplier 0.95, 1.0, 1.05

Shift (MAP Time Period)

first/second

25%, 50%, 25% to 10%,
70%, 30%
random assignment 50%

Fatigue

yes/no

multiplier 0.95

Patient Load

low/medium/high

med admin time > 50% of
shift
<5, >=5 & <8, >=8

Medication Load

low/medium/high

<=10, >10 & <=25, >25

multiplier 1.1, 1.0, 0.95

no effect

multiplier 1.1, 1.0, 0.95

Nurse Agent Attributes
The nurse agent has six different attributes that define its behavior and propensity for causing a medication error
as noted in Tables 3.4 and 3.5. The following provides background on the attributes for the selected computer
modeling approach.
Interruption: A key factor in causing errors by nurses while administering medications. This attribute is
either true (occurs) or false for each pass a nurse goes through the MAP process. An interruption has a
likelihood of occurrence of 53% based on the literature. The effect of an interruption is to decrease the
chance of successful medication administration by 5%. An interruption has the same effect for all nurse
agents.
Experience: Is operationally defined as an amalgam of education, talent, work experience and training. It
is intended to reflect the overall capability of a nurse to execute the intended task. There are three levels
of nurse experience: novice, moderate and senior. The typical mix of this skill set is 25%, 50% and 25% for
novice, moderate and senior experience levels respectively. While the literature has some conflicting
information on the association of years of experience, education and training on the occurrence of
medications errors, the general conclusion is that more of each of these factors tends to reduce overall
MAE’s. The error multipliers for each of these experience levels is 0.95, 1.0 and 1.05 for novice, moderate
and senior respectively.
Shift (MAP time period): Nurse Agents are assigned to a shift at the beginning of the simulation and will
stay in that shift for the duration of the simulation run. For this current version of the model, the shift
does not have an influence on nurse behavior or performance. A shift, in the context of this model, is a
programming construct to allow for the effect of some influence within a conceptual construct of a day.
The term first or second does not necessarily imply a sequence, rather just a differentiator between
sequential runs. The model period is from the perspective of the medication delivery period, for example
300 minutes. At the end of this medication delivery period the simulation will terminate the existing
medication administration process and start a new one even if the nurse agents have not completed the
delivery of medications. Process delays are built into the steps of the MAP process to influence the
amount of time it takes the nurse agent to complete each pass through the process.
Fatigue: Is a physio-emotional state with a well-documented effect on decreasing human performance.
The occurrence of fatigue in the model is a function of each nurse agent’s time-state in the model. The
onset of fatigue occurs at 50% of the MAP time period. While the literature discusses the effects of
fatigue, information has not been found when fatigue occurs. The onset of fatigue was notionally set at
half way through the MAP process in order to ensure an indication of its effect. In reviewing the
associated literature, the negative impact of fatigue is copious, a quantitative specific measure of fatigue
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on the nurse administration of medications is vacant. Error rates on overall rates were found and ranged
from several percent to over 20% [397]. An impact of 0.95 (that is, a 5% decrease in performance) was
selected to serve as an indicator for a decrease of performance.
Patient Load: The number of patients a nurse has in their care is defined as patient load and can be
measured by the nurse-patient ratio. There is a clear correlation between nurse-patient ratio, nurse
performance and medical error rates. That is as the number of nurse-patient ratio increases, nurse
effectiveness deceases and error increases [398]. Many studies indicate this negative relationship, in
reviewing them, a quantitative measure was not found. An impact of 0.95 was selected to serve as an
indicator for a decrease of performance. The number of patients per nurse ranges from 2-12 with the
typical range of 5-7 as established by law in a number of states. The number of patents per nurse is
randomly assigned during each shift change in the model. This attribute also infers that having more
patients creates additional workload for the nurse besides medication administration (e.g. charting,
treatments, etc.).
Medication Load: This is another measure of a nurses’ workload. As part of the design of the model it is
possible that a nurse might have more than an average number of patients but less than the average
number of medications. Similarly, they might have a smaller collection of patients with only several
medications each. No specific literature has been identified on medication load and its effects on
medication administration errors. However, some research exists on the effects of patient complexity
and nurse workload on medication error [399, 400].
While the number of medications per patient generally reflects the average of what has been found in the
literature, the actual number of medications should be viewed from a more conceptual perspective. That is, the
consideration that there are low, medium and high amounts of medications per patient, which increases the
workload of the nurse, is the important aspect, not what the actual amounts of the medications are. For the
purposes of this model, the number of medications is used to set up the three groupings of medication load (low,
medium, high).

Patient Agents
Patient agents or, simply, patients, serve the purpose of being the recipient of the nurse’s actions during the MAP.
When the nurse is in the process of administering medications, it is the patient that will ultimately be the agent
that changes the state from the pre-administration to post-administration status; administration references the
step of administering medication. The step of administration in the MAP process indicates that the patient has
gone through the step of being able to receive a medication. The determination of whether they receive the
medication is a uniform random distribution that is set as part of the model. In changing these states, the patient
will either have or not have received a medication that was assigned to them not receiving the medication results
in a missed dose. Once the patient is assigned this post-MAP state, it will revert back to the pre-MAP status
waiting for their next medication
While not a central part of the model, a patient also demonstrates that ability to react to medications. These
adverse drug reactions (ADR) are a function of the patient receiving a medication. The ADR state is built into this
model for future applications.
Patient Agent Attributes
Medications per Patient: Each patient is randomly assigned a number of medications ranging from 1-9.
The range is based on the typical range a patient might have ordered on a medical/surgical ward. The
actual range is somewhat incidental to the purpose of the range which is to provide several categories
that indicate the relative workload a nurse has based on the number of medications the nurse agent has
to distribute. Recall that both patient load and number of medications will influence the overall likelihood
of error based on the number of times a nurse traverses the MAP flow, including the increased impact of
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fatigue by having a longer work period. The medication load was broken into three categories: low, 2-4
medications per patient; medium 5-7 medications, and; high 7-9 medications per patient. Each of the
medication load categories is associated with a likelihood of error – or more accurately a likelihood of
correctness of 1.1, 1.0 and 0.95 for medication loads low, medium and high respectively.
Adverse Drug Reaction (ADR): An ADR likelihood is calculated for each MAP revolution. This was added to
the model as a conceptual demonstration of potential impact of a MAE. Some research has been done to
estimate the likelihood of the occurrence of an ADR based on a MAE. This correlation is not
straightforward and dependent on a large number of variables. Given this, the literature was reviewed
and a simple algorithm was developed to estimate the occurrence of an ADR based on the probability of a
MAE [401-403]. This relationship was developed by curve fitting the relationship of MAE to ADR’s and
deriving the associated line. This equation was then used in a function to compute the estimated
likelihood of an ADR. The prediction is based on the following calculation:
ADR = -0.233* Likelihood Index2+0.7942*Likelihood Index+0.403
Likelihood Index39 is the product of the error likelihoods of each of the elements of the MAP state chart.
The ADR is a calculated probability based on the information that was derived from literature values.
While this is worthy as a thought experiment and could have value as part of a simulation tool, this
preliminary algorithm requires more development to ensure accuracy and applicability.
Patient Medical State: This attribute was included for future model development.
Medication Delivered: Medications are unique to each patient. The status of each medication having been
delivered is tracked to build a medication administration profile for each individual patient. The model can
run in various configurations to include a discrete probability of medication delivery set at 0.974 or a
stochastic approach using a truncated beta distribution as detailed in Table 3. 5. The beta distribution is
configured to emulate an extreme value event truncated at the upper end at 99% and a lower end of 50%.
The shaping functions p (aka alpha), q (aka beta), shift and stretch of 0.999, 0.009, 0.0005 and .99
respectively provide a curve resembling Figure 3. 6.

Figure 3. 6: CDF of beta distribution used for establishing variable values

39

The Likelihood Index, also referred to as statsCalcP is a composite probability that is the product of the individual probabilities of each of the
MAP process steps and the probability modifiers from the agent attributes
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Table 3. 5: Patient agent description
Patient

Factor

Type

Effect

Medications per
Patient

integer

random assignment between
2 through 3 categories: low,
medium, high with 1.1, 1.0,
0.95 multiplier respectively

influences nurse agent medication
load

ADR (adverse drug
reaction)

True/False

probability of 0.01

provides notional indication of MAE
occurrence

Patient medical state

good, fair,
serious, critical

random assignment based on
normal distribution

no effect - future application

Medications Missed: It is possible for medications to go through the MAP cycle and not be administered to the
patient. These missed doses have a likelihood of 1.0 - Medication Delivered. The beta distribution was selected
because it is particular suitable for modeling the random behavior of proportions and percentages. It has found
application in modeling the probability of success or failure of an event. It has been described as a distribution
that is suitable for modeling the probability of probabilities. It is a very flexible distribution allowing great degree
of flexibility in establishing the shape of the probability density function (PDF), as was done for this study. In this
application the PDF was given the shape of a curve similar to and extreme value function given the nature of the
likelihood of error at each step of the MAP. In particular, the probability of an error at each step is relatively low
(or the likelihood of performing the step correctly is quite high).
The AnyLogic program provides this beta distribution as part of its collection of probability functions. The
estimated mean for this set of parameters is estimated at 0.94; AnyLogic does not provide a calculated mean,
rather it must be determined empirically. The 0.5 and 0.99 for lower and upper bounds were established to
represent a lower end 50:50 chance of performing the MAP step correctly and the upper bound of 0.99 was set to
represent that there is not a 100% of successful occurrence of performing a MAP step.
Medication Agents
Medication agents, often simplified to medications, represent the set of drugs assigned to each patient at the start
of the simulation. Each patient is randomly assigned a number of medications from two to nine. The patientmedication assignment does not change during the simulation. The number of medications determines what the
nurse agent goes through each cycle of the MAP for every patient. The nurse will iterate through the MAP cycle
for a particular patient until that particular collection of medications is exhausted. For example, if a patient agent
has four medicines, the nurse will cycle through the MAP four times before moving to the next patient. Each shift
will deliver the medications to each patient. The available research reviewed indicates the average number of
medications per patient per day to be five to seven different medications per day. The actual number of
prescribed medications vary widely depending on patient age, condition, as well as other factors [404]. It was
assumed that there were two doses per day (coinciding with each shift).
Medication Agent Attributes
Medication Difficulty: Each medication has an attribute that quantifies how hard it is to administer the
medication. Consider the difficulty of delivering a vitamin capsule versus an intravenous medication that
is both time and rate dependent. The literature discusses differences in error rates of administering
different via different routes (e.g. intravenously) and that certain type of medications have a higher
incidence of error. A comparative assessment of delivery route and type of medication was not found in
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the literature. A simple ratio was used (Table 3.6) to establish a relative difficulty index for administering
medications. The impact to MAE was set at 0.95, 1 and 1.1 ranging from most difficult to least difficult
respectively.
Medication Severity: This attribute is constructed in a very similar fashion to Medication Difficulty. Its
function is to assign a value to the likelihood of error occurrence based on the potential risk associated
with a medication type and the magnitude of a negative overall impact. The severity relates not just to
toxicity of the medication, but the ease of errors such as overdosing, contraindications, masking of
effects, and others. As with the Medication Difficulty attribute, in the real-world setting, this attribute is
complex and is influenced by a variety of factors [405-407]. Finding a severity index and probabilities of
MAE associated with it proved problematic. A 30%, 40%, 30% ratio for three levels of medication severity
was used. The impact to MAE was set at 0.95, 1 and 1.1 ranging from most severe to least severe.
Medication Delivered/Not Delivered: As with the patient agent, medication tracks the state or measure of
a medication having been delivered to the patient or not. As the medication moves from its original state
in pre-Medication Administration to post-Medication administration, the attribute is changed from false
to true depending on if it is a delivered dose or a missed dose. This change also sends a message back to
the nurse agent that is attached to the patient with this unique medication that the attribute for this
medication has been changed. The medications’ delivery state is reset at the end of each shift.
The modeling approach is intended to simulate the medication administration process. The duration for
administering medications varies based on a variety of factors. An average time period for administering
medications, based on research that performed time studies, is approximately eight minutes [20, 408].
This duration was used in the estimate for the administration of each medication. The maximum number of
medications per patient was set at nine. The total duration, without consideration of delays in the model, is 72
minutes. Various points in the model have built in delays to ensure coordination of the exaction of the model. The
total shift time set for the administration of medications was initially set at 120 minutes to ensure all medications
would be administered prior to the change in shift. The model is structured for the nurse to complete the
execution of their portfolio of medications prior to the 120 minutes (in model time). On the final pass, as the
nurse completes the administration of its medication portfolio prior to the shift reaches its 120-minute limit, the
nurse diverts to the nonMAPActivity state. From there it will move to the off-Shift state. At the beginning of the
appropriate shift the collection of nurses in the current shift are transitioned to nonMapActivity and then back to
the MAP process.

Table 3. 6: Medication agent description
Medication

Factor

Type

Effect

Medication
difficulty

minimal,
intermediate,
difficult

assigned randomly
according to a 40%, 45%,
15% ratio

value that is associated with how hard it is to
administer the medication, e.g. an IV versus a
capsule

Medication
severity

low, medium,
high

assigned randomly
according to a 30%, 40%,
30% ratio

value associated with the hazard of the
medication to the patient e.g. warfarin versus
a vitamin

Medication
delivered

True/False

probability based on beta
distribution

beta (0.5, 0.99, 0.999, 0.009, 5.0E-4, 0.99)

Medication not
delivered

True/False

probability based on beta
distribution

beta (0.5, 0.99, 0.999, 0.009, 5.0E-4, 0.99)

112

The model is designed to run in an asynchronous fashion within each agent environment. The various agents
coordinate activities via messages (a feature in AnyLogic40 to transmit unique signals to other parts of the
program). So, while the model runs asynchronously its execution is coordinated.
Environment
A unique aspect of an agent-based model is the construct of an environment that agents exist within. The
environment is simply a physical or virtual space that agents exist within as they execute their operations.
AnyLogic has global environment frequently called Main. Figure 3. 7 graphically represents the relationship of the
environments for this model. Main was used when constructing the function and defining the variables and
parameters that would be used within the other environments. Computer code that is needed at the start of the
simulation, such as creation of global arrays, and nurse-patient-medication networks, are housed in Main as well.
In AnyLogic, generally speaking, functions are executed for each agent. So, if the model requires the function to
execute only once during a given time increment it resides in Main. For this reason, event transitions related to
overall execution of the model, were placed in Main. There are functions that exist in Main that reach into other
agent environments (i.e. Nurse, Patient Medication) to obtain information.
The interconnected set of states for nurse agents resides in the Nurse environment. The functions and parameter
specific to the nurses reside in the environment. The programming elements (e.g. functions, events, parameters,
controls, etc.) will operate or be executed for each individual agent. The effect of this is for each agent to be a
unique entity within the model. Elements within Nurse can reach into other environments and acquire
information. Nurse uses Patient information numberOfMedications, medications, medicationAdminDifficulty,
medicationSeverity, and Medication information to include medication counter information.
The Medication and Patient environments are less complex as well. The Patient environment has two simple state
charts and Medication has one simple state chart. Contrasted to Main or Nurse, there are relatively few
programming elements. As noted in the Time section, the two state charts in Patient, in essence, run
asynchronously.

Figure 3. 7: MAP ABM environment

40

Future references to AnyLogic are inferred to include the registered trademark symbol
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Model Construction and Execution
General Operating Parameters and Conditions
A number of foundational requirements needed to be established early in the development of the model.
Number of patients: The number of patients was set at 100 and is an inputted parameter. This
approximates the number of patients in a large medical/surgical ward 41. The model is designed to allow
changes to this value.
Number of nurses: The number of nurses is also an inputted parameter but is calculated based on the
desired average number of nurse-patient ratio. For the purposes of this model the average nurse-patient
staffing level was set at 542. This value is used to calculate the range of nurse-patient ratios.
Number of shifts: A variety of shift durations and approaches was considered. As noted previously, a twoshift approach was used for simplicity. The way this model is designed, this actually means that a shift is a
counting or labeling function. A shift is normally thought of as existing within a day. However, there is no
“day” within this model. In the case of this model, shift 1 starts at the start of the execution of this model,
after a specific period the first shift ceases and the start of the second shift. This process is repeated for
the duration of the execution of the model.
Random Seed: The model was developed using a fixed seed to allow reproducibility during model design,
validation and verification. The seed was changed to a random seed for running experiments.
The model can be broken into four main elements as noted in the Environment section; these are Main, Nurse,
Patient and Medication. While each of these elements are separate, there is, significant interplay between them.
The execution of functions in one environment rely on information or operations from another environment.
Main Environment
Model execution In AnyLogic begins with a number of functions in an environment it defines as Main (Table 3.7).
While other environments have this capability, it was not used. At startup, the two-primary group of functions are
executed which relate to the random allocation of agents within their respective networks and the creation of V&V
mechanisms to evaluate the execution of the simulation. Data sets in the form of arrays (AnyLogic calls the type of
arrays used collections) are also created to support execution tracking and medication administration processes in
the model.
These startup functions set the stage for execution of the next key step in the program. An AnyLogic function
called an Event was used to control the shift dependent actions. An Event executes a set of actions or computer
code based on a signal or time interval. The time interval was used and is tied to the duration of shift length. Each
time the duration of shift is reached (i.e. 120 minutes) the event “fires” and the associated functions are executed.
This Event resets a number of collections for the next shift and resets the random assignment of patients to
nurses. The experimental design of the simulation changes two key parameters, the injection of JIT information
effect and the impact of the attributes of the nurse, patient and medications agents.
The Event consecutively changes the state of one of the two items every model cycle; the model cycle is defined as
the length of shift times twelve or twelve shift iterations, which is about 7,000, passes through the MAP. The
number of samples selected was 7,000 with a power of 0.80, a standard deviation of 0.302, the overall response
value, and a difference of 0.01. This has the effect of controlling each condition of JIT Information and Attributes
to get a measure of their effects described in Table 3. 8. The false-false condition is, in-effect, the control, the
true-false state measures the effect of all of the attributes without being affected by the information, the false41
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true state provides the effect of just information without influence from the attributes, and true-true is a
composite of both information and agent attributes.
Nurse Environment
Following startup and the initial Event in Main, which sets the stage for the rest of the model’s execution, the
other environments begin their processes. Figure 3. 8, duplicated here for convenience, represents the state
charts and their interaction for Nurse. There are three general sets of states. The first set includes the off-shift
and nonMapActivity states of the mapProcessStatechart. This environment begins its process when nurses process
in through the off-shift state. This state functions as a holding area for nurse agents prior to and after their active
shift. Connected to off-shift is the state nonMapActivity which receives nurse agents prior to going to off-shift and
coming from off-shift. The transitions to off-shift are actioned by the same messages. Note that the transition
from the compound state to off-shift ensures that an agent in the compound state at the designated shift change
time (e.g. 120 minutes) will be immediately moved to off-shift in order to ensure all current shift agents are
transitioned to off-shift at the appropriate time.
The compound state is the next set of states. These states represent the actual MAP process. The first two states
are interim states. The preMapProcess receives nurse agents from nonMapActivity. The mapProcess state
receives the nurse agents after a slight delay and allocates them to either continue through the MAP process or
diverts them to the missed dose state based on a random event at a 1% rate. This 1% rate is derived from the
available literature on the frequency of missed doses early in the MAP process. The mapProcess is a gateway state
that is the location where the attributes, and overall coordination of the MAP process is done.
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Table 3. 7: Primary Main startup functions
Startup Function
nurseAgentShiftColllectionCompiler();
nursesInShiftCollectionFunction();
nurseConnectionsByShiftMainEXPERIMENT();

Description
Creates collection (array) of all nurses
Creates collection of nurses by shift
Creates netwrok connections to patients by
shift
Randomly assigns levels of experience to
nurse agents
Creates collection of nurses by experience
Randomly assigns (via network) medications
to a patient agent
Tracks the number of medications per
patient
Creates collection for tracking
administartion of medications by patient
Counts the total number of medications
Creates tracking collection for distribution of
medications by nurse
Creates collection for tracking medication
adminstration by medicatin per shift
Builds the intial random connections
between patient and nurse agents
Tracks the connection between patients and
nurses
Counts the total number of medications
assigned to nurse via connected patients
Calculates the number of nurses for each
shift
Builds the list of meds for each patient
Builds the collectin counter for trcking meds
process for each patient
V&V function that provides visual (i.e. runtime messages) for model execution

NurseExperienceAllocation();
addNurseExperienceCollectionFunction();
numberOfMedsPerPatientGenerationFunction();
numberOfMedsPerPatientCounterFunction();
nurseMedDistributionCheckCollectionBuildFunction();
medicationCounter();
nurseMedDistCCounterCollectionStarter();
shiftMedCounterCollectionBuildFunctionMain();
randomConnectionsFunction1();
medicationToPatientNetwork();
totalMedSumPerNurseFunction();
numberOfNursesInEachShift();
MedPerPatientCollectionFunction();
medCountingPerPatientCollectionBuildingFunction();
bigCheckingFunction();

Table 3. 8: JIT and Attribute state changes during model execution
JIT Information
Off

On

Off

False-false

True-false

On

False-true

True-true

Attributes
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Figure 3. 8: Nurse state map

The core of the MAP process is embodied by the next state sets. A nurse agent enters the next MAP state,
marNotChecked. Within this state a randomTrue() function is used to determine the fate of the next step of the
agent. If the function returns a True then the nurse proceeds to the marChecked state indicating that the MAR
was checked correctly. If the function returns a false then the MAR was not checked correctly for this medication.
The likelihood of a True occurring can be a deterministic value set at 0.975 or a deterministic value tied to a beta
distribution as described earlier. The deterministic value is an approximation based on the overall MAE error rate
of approximately 88%. The beta distribution is somewhat more tailored. The remaining five state sets proceed
identically to the marCheck state sets. Table 3. 9 details the likelihood of error occurrence from a number of
different literature sources [29, 409-414]. A beta distribution (Equation 3.2) was developed to approximate these
values. AnyLogic has a truncated beta function; this was set to range between 0.5 and 0.99 (50% and 99%). This
function does not have a means to insert the median or average value or standard deviation. The various factors
(p, q, shift and stretch) were input to approximate the desired values (see previous figure). In the case of this
model, the beta function is designed as an extreme value probability function to align with the typical occurrence
of MAEs. The deterministic version is used in obtaining the values for this study as noted below.
𝑥 𝛼−1 ∗ (1 − 𝑥)𝛽−1
𝐵(𝛼, 𝛽)
𝑤ℎ𝑒𝑟𝑒 𝐵(𝛼, 𝛽) =

Γ(𝛼) ∗ Γ(𝛽)
Γ(𝛼 + 𝛽)

Where Γ is the gamma function: Γ(n) = (n-1)!
α & β > 0 represent shape variable

The agent proceeds from within the compound state to the medAdminProcessComplete state which is an interim
state prior to medication delivery. As the nurse agent exits the medAdminProcessComplete state, it passes
through a decision node which directs the nurse to having either delivered the medication or not delivered the
medication. This is also determined by a randomTrue() function and similar to previous discussions, the model
allows for either a stochastic probability of 0.95 or a beta distribution as determined above. The deterministic
version is used in obtaining the values for this study.
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Table 3. 9: Likelihood of MAE by cause
Dose Omitted

Wrong Dose

Wrong Time

Wrong Patient

Wrong Route

Wrong Drug

8.1%

37.1%

12.5%

2.0%

17.7%

5.7%

20.0%

24.1%

3.0%

1.9%

1.0%

1.0%

16.0%

12.0%

26.0%

0.0%

1.5%

1.0%

10.6%

10.0%

16.9%

1.0%

1.0%

1.0%

50.0%

7.6%

2.7%

0.7%

1.0%

5.0%

4.1%

9.0%

1.0%

2.0%

1.1%

7.7%

8.7%

14.4%

0.0%

13.9%

5.0%

11.7%

10.0%

Mean

14%

13%

11%

1%

4%

2%

SD

14%

11%

6%

1%

6%

2%

11.6%

After the medication delivery states, the nurse agent is evaluated to determine if all the medications it was
assigned has been administered. This is done via using array counters that compare the list of medications per
patient per nurse that have been delivered to what has been assigned. Table 3. 10 provides an example of how
the model determines if the nurse agent has completed medication administration. Recall that each patient is
assigned a specific number of medications. The nurse will start with the first patient in its array, in this example it
is patient number 12 which is assigned 9 medications. It will continue going through the cycle of the MAP process
until the nurse has delivered 9 medications; each time it goes through a cycle it will compare the assigned number
to the delivered number. When the Assigned value for a particular patient equals the Delivered number for that
patient, the nurse will move on to the delivery of medications for the next patient. In the example below, the
nurse agent has one more medication to deliver to patient 63 before the nurse moves to patient 88. When the
entire array of Assigned values and the counter array of Delivered are equal, the nurse is diverted from re-entering
the compound state for MAP to the nonMapActivity state where it awaits to go off-shift.
The AnyLogic functions Events() are used as timers to determine when a particular shift should be dispatched to, or
brought from home. Events() are functions that can be controlled by times are signals. These functions turn on at
pre -determined intervals to execute specific tasks (in the form of computer code or other AnyLogic functions).

Table 3. 10: Example of medication distribution counter
Patient Number

12

18

35

63

88

Assigned

9

8

6

2

5

Patient Number

12

18

35

63

88

Delivered

9

8

6

1

0
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Patient Environment
The patient states reflect the two primary considerations for the patient: where it resides in the overall MAP
process and has experienced an ADR (Figure 3. 9). The patient moves between the preMAP and postMAP state by
receiving communication from its current nurse. This communication also informs the patient if it has received its
medication or not. In a separate set of states, the patient possibly experiences an ADR as a result of receiving a
medication. This is determined probabilistically based on the likelihood of a MAE resulting in an ADR as referenced
in the literature. The patient cycles back to its previous state after it reaches the postMAP and ADR states.
The number of medications assigned to each patient is determined through an AnyLogic table function that
establishes the number of medications ranging from two to nine. A function then randomly assigns a value from
the table function to a patient.
Medication Environment
The state for medication is discussed in the relevant V&V section. After medication agents move from the premed
(pre-Medication administration) to the other states, they reside in that state until the end of the state. Agents
move from preMed to the other states by receiving communication from the patient. Figure 3. 10 reiterates the
statecharts for the medication agent.
Medication Severity and Difficulty distributions are determined by the AnyLogic custom distribution function.
Medication Severity values are set at a frequency of 30%, 40% and 30% for low, medium and high severity
respectively. Difficulty in delivering medication is set at a frequency of 40%, 45% and 15% for minimal,
intermediate and significant difficulty respectively. Each value is assigned a likelihood of error (0.95, 1.0, 1.1)
which is used in calculating the overall probability of MAE occurrence.

Figure 3. 9: Patient statecharts

Figure 3. 10: Medication statechart
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Selection of Modeling Software System
AnyLogic Professional from the AnyLogic Company, was selected as the development platform for the computer
simulation model. AnyLogic is a robust, comprehensive multi-method modeling tool that supports agent-based
modeling, discrete event simulation and systems dynamics modeling. A unique feature of AnyLogic is that it has
the ability to integrate each of these modeling methods in a given model should the need arise. It is built upon the
Eclipse integrated development tools (IDE) using java. As such, it has superior flexibility for creating specialized
computer code and it will work across various computer operating system platforms.
AnyLogic has a well-developed graphical user interface (GUI) that speeds the software development process. The
basic program structure is created by dragging icons from the menu on to an agent’s palette (Figure 3. 11). Agent
states are created by dragging the state icons on to an agent environment and inserting flow connections for the
changes of state. This approach provides for the verification of the logical connection between agent states.
AnyLogic provides a depth and breadth of functionality for the design and construction of ABM models. The
program provides easy creation of the typical functionality of variables, parameters, and states (Figure 3. 12). In
addition, it supports the ability to insert standard probability distribution functions (PDFs), create custom PDFs,
and develop and insert functions (segments of customized java code).

Figure 3. 11: Description of AnyLogic graphic programming 43

Figure 3. 12: AnyLogic graphic programming palette

43

Images included under title 17 section 107 U.S. Copyright Law Fair Use Doctrine as educational material distributed for use without profit.
Ref: https://help.anylogic.com/index.jsp?topic=%2Fcom.anylogic.help%2Fhtml%2Fstatecharts%2FStatecharts.html

120

Java code may be inserted into many of the programming icons of AnyLogic allowing for customization including
creation of unique actions of the element. The AnyLogic professional version has added features for enhanced
debugging, extended user interface functions, and easier integration with output files.
The features of AnyLogic include the advanced user interface, being implemented on an open development
(Eclipse) java platform, having a relatively large user base and structured help and support, includes an extensive
predefined library of functions and elements.
Model Verification and Validation
Verification and validation (V&V) of agent-based modeling poses unique challenges with ABM’s compared to other
more established approaches, such as discrete event and statistical models. ABM approaches, somewhat like
artificial neural networks (ANN), have intrinsic “black-box” features that increase the difficulty in understanding
what transpires during the simulation. ABM is still a relatively recent newcomer as a modeling and simulation tool;
there are a limited number of formalized tools for the V&V of ABM models. The available literature suggests a
process-oriented approach confirming the structure of the model logic and the alignment of the design with the
desired output as an approach for V&V of ABM simulation models. This is the approach used for the V&V of the
MAP model. Figure 3. 13 provides a graphic of the general consideration used in the V&V effort.
Considerable effort was invested in ensuring the model was delivering the information that was required, that the
information was correct. That is “that the model was built right” and “that the right model was built”. To revisit
the model’s purpose, it is intended to generate the likelihood of a potential MAE per nurse for each medication
that is delivered for each patient. Various factors affect the likelihood or probability of the overall MAE based on
the attributes of the nurse, the medication, the patient and if any information was provided to the nurse via the JIT
intervention of information (i.e. information injection).

Figure 3. 13: Verification and Validation description 44

44

http://www.easterbrook.ca/steve/2010/11/the-difference-between-verification-and-validation/
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Verification – Building the Model Right
Two approaches were used to support the verification of the model: static analysis of the system where the
structure of the computer code is evaluated, and dynamic analysis which assesses the model based on exercising
and observing model behavior (dynamic verification).
Based on the available literature and clinical trial, the following Model Requirements Specification Functional/Operational Requirements have been established. The overall design of the model is set forth in the
definition of the requirements. These requirements are outlined as follows:
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

Accurately reflects the MAP steps of the 5-rights of medication administration
Traces the steps of the MAP for each nurse
Provides an accurate statistical representation of the probability of each step of the MAP
Provides a consolidated likelihood or probability index of MAE
Provides MA tacking at the nurse-patient-medication level
Allows for the changes in agent behavior as determined by agent attributes
The medication MAP is configured for adjustable time frames based on minutes for time units
The model should account for the ability to have multiple nurse shifts
The patient-nurse ratio should be able to be controlled
The nurses should be randomly assigned to the patients they are caring for during each shift of the run
The medications for each patient should be consistent through each run
There should be a mechanism to allow for a missed dose
The probabilities of the likelihood of error are independent for each step of the MAP process
Provides a probabilistic indication of MAE and ADR for each medication administration
There is a mechanism to account for the individual medication administration events at both the nurse
and patient level

The AnyLogic platform provides a straight forward mechanism for the high-level static verification of the model.
The graphical design allows for a comprehensive review of the logic of the programming. Once the states for each
of the agent types have been defined, they are placed on the respective canvas. The flow of the agent through the
mode, along with the intended action, can be visualized by stepping through each of the states. This high-level
verification or tracing of the program flow also sets the stage for designing the requisite definition of parameters,
variables, functions, etc. to more specifically construct the model’s operations. The flow for each of the agent
types was evaluated for logic and alignment with desired outcomes. As was mentioned previously, this was done
by tracing the agent flow through the various agent states and connections. Figure 3. 14, Figure 3. 15 and Figure
3. 16 provide the high-level architecture of the three agent types defined for this model.
The verification of the nurse flow can be done by tracing the respective diagram. The nurse enters the initial state
and passes through a number of initial “staging” states. The nurse agent then moves to the compound state for
the medication administration process. Again, the nurse agent passes through a number of initial stages. At the
mapProcess state, the programming logic dictates that the nurse will either omit giving the medication or continue
down the map process. From this point, the MAP activities proceed through each step of the MAP. Each of these
steps function as a binary switch based on the likelihood of either performing the step correctly or not performing
it correctly. As described in the functional requirements, the process is linear with no recursive elements nor is a
later state occurrence a function of the likelihood of an earlier state. At the completion of the MAP section, the
nurse agent proceeds out of the compound state. The nurse agent then goes through a decision step that once
again allows the nurse agent to complete the medication administration or terminate it. The purpose of this step
is to accommodate the likelihood of a failure to administer a medication during the earlier states of the map. Once
the nurse passes through the decision element, it passes through the medication delivered or medication not
delivered state then routes around to another model decision element. This element evaluates if the nurse agent
has completed the administration for each of the medications it has been assigned via the patients it is connected
to. If the nurse has not completed all of its medication deliveries, it re-enters the compound state and goes
through the map process until the list of medications that it is assigned matches the list that it has delivered. Once
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the agent nurse delivers all of its medications, it passes the upper decision node and moves to the postMAP state
where it awaits a signal to start the entire process again based on the shift change time. At the end of the shift the
nurse agents are directed back to the off-shift state either via the nonMapActivity state of the overall mapState
compound state in the unlikely event a nurse agent is in the compound state when the shift changes.
This logic aligns with the flow chart by Ghenadenlik et. al. that represents the medication administration process as
referenced in the literature review.
With the focus being on the nurse agent model the other environments are comparatively simpler.
The patient agent presents a much simpler set of states. There are two fundamental properties of concern for the
patient agent; did the patient agent receive the medication and did an Adverse Drug Reaction occur after a
particular medication was received? The MAP state chart receives a message from the nurse state chart indicating
whether a dedication was or was not received and then it transitions from the preMAP state to the postMAP state.
The patient agent then cycles back to the preMAP state to wait for another message from the nurse state chart.
The ADRStatechart is also simple with the patient agent moving between noADR and ADR states. The movement
between states is a function of the patient having received a medication as determined from the MAPstatechart
and a probability of a patient experiencing an ADR as determined by a probability function elsewhere in the code.

Figure 3. 14: Nurse statecharts

Figure 3. 15: Patient statecharts
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Figure 3. 16: Medication statechart

The medication statechart logic represents a trio of states. The first state is a holding state where medications
reside prior to the administration. The medication can go to one of two states depending on the message received
from the nurse state chart. The medication can either move to the dose state which indicates the medication was
administered or it can go to the missedDose state indicating that the medication was not administered.
A large portion of the code is inherently verified by the structure of the AnyLogic program and its real-time error
checking and debugging capability. The graphic representation of AnyLogic elements and their representation is
pre-coded and automatically entered into the program when icons are dragged from the pallet to the canvas.
AnyLogic automatically debugs the model at run time as the model compiles, checking for any syntax errors.
Functional errors that result during execution of the code result in run-time errors. When these occurred during
the development of this model, it was the result of overflow errors of the arrays used for validation and control of
the program: in essence the model would be trying to overfill an array for any number of reasons.
Model run-time verification was built into the programming plan. The key elements for verification of this model
were to ensure that the correct number of medications passed through the administration process, that the
medications were aligned correctly with the nurse and patient based on the patient and nurse network
assignments, and that the nurses and patients were randomly reassigned to each other at the change of each shift.
To ensure random association between patients and nurses between each shift, all the connections and nurses
were broken for a particular nurse shift, the patients were placed randomly into an array and then selected at
random without replacement from the array and assigned to each nurse based on a distribution that calculated
patient load for each nurse. The randomness of patient assignment to nurses was validated by doing both scatter
plots and run tests.
The verification of the random assignment of patients to nurses was done by collecting the assignments for each
shift via collection of the patient index into an array for each individual nurse. These arrays were then compared
for randomness by using a runs test. The runs tests were performed by analyzing 24 consecutive nurse-patient
assignments for each nurse. The P-values in Table 3. 11 indicate that nurse-patient combinations are random,
ranging from 0.053 to 0.923. Note that the runs test is a function of the sequence in which the values are placed
within the array so it is only a general indication of randomness for the purposes of this model.

124

Table 3. 11: Random test
Random Runs Test
Nurse

Observed

Expected

P-Value

Nurse

Observed

Expected

P-Value

0

66

57.46

0.106

20

72

69.32

0.645

1

52

51.5

0.92

21

97

84.99

0.063

2

81

78.95

0.742

22

46

50.49

0.364

3

78

74.41

0.552

23

71

72.33

0.823

4

59

56

0.565

24

49

45.49

0.455

5

55

50.98

0.419

25

54

57.39

0.521

6

89

91.96

0.66

26

49

45.49

0.455

7

65

54.98

0.053

27

97

90.16

0.303

8

62

56.93

0.335

28

51

54.5

0.497

9

89

80.99

0.204

29

55

48.37

0.17

10

52

47.91

0.396

30

45

44.8

0.965

11

62

56.93

0.335

31

89

88.44

0.932

12

47

52.11

0.308

32

80

86.9

0.291

13

89

88.36

0.923

33

91

85.95

0.437

14

50

50.98

0.844

34

81

79.8

0.847

15

81

78.5

0.687

35

37

37.57

0.893

16

43

50.45

0.132

36

46

55

0.082

17

83

75

0.187

37

91

85.95

0.437

18

73

75.42

0.691

38

50

51.46

0.771

19

63

62.5

0.927

39

40

46.91

0.146

The verification of the functionality of the influences of both the nurse attributes and injection of information can
best be seen by a graph of the composite probability outcomes which is a measure of overall effect on each
individual medication administration event. The graph in Figure 3. 17 demonstrates four distinct phases. The
furthest left phases are with no influence by either the nurse attributes or added information, this is affectionately
referred to as the zombie effect; that is, the nurse agents proceed through the MAP process with no variance
being created by information or attributes. The next phase, to the right, demonstrates the influence of the
information injection; the effect is a significant compression of the variance since additional information increase
performance pushing the likelihood of completing tasks correctly towards 1.0. The third from the left
demonstrates the effects variance from the addition of nurse attributes creating wider variance swings since nurse
behavior and effects of patient load and medication influences are broader. The segment furthest to the right
show influences from both information injection and nurse attributes thus indicating graphically that there is some
effect from these influences.
Another aspect to consider for verification of the model is establishing the performance of the medication
distribution methodology. That is, verifying that the computer code allows for the nurse agent to interact with the
intended patient agent and the intended medication. Considerable effort went in to building in a verification
schema during computer code development, including the following.
• Built a base array for each nurse that contained their currently assigned patient
• Built a base array for each patient that contained the assigned medications
• Used tracking arrays that counted the number of medications process by patient and nurse
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•
•

Compared the tracking array with the base array
Indicate that an execution error has occurred if there is misalignment during simulation execution

Using this approach, the computer code is self-monitoring. It is comparing the nurse-patient assignment and
medication-patient assignment to the medication administration progress being made during the execution of the
simulation.
Specific verification functions were developed to support the verification process including:
• Nurse-patient connections status
• Patient-medications connections status
• Nurse shift assignment
• Allocation of medications per patient per nurse
• Random assignment of patients to nurses by shift
• Assignment of medications to patients
• Transition of nurses into and out of the MAP process
• Completion of MAP process by each nurse
• Assignment of attributes to nurse
• Stepwise progression of nurse through the MAP process
• Individual tracking of patient-nurse-medication admiration status
• Transitions between shifts
• Message passing between agents (nurses, patients and medications) along with the time of the message
• Random nurse loading function
These functions were monitored either after sample simulation runs or during model execution to verify that the
model was executing according to the functional design criteria and expected results for the model output. For the
sake of comparison of different simulations, a fixed seed was used to limit random variance between simulations.
During computer code development, another mechanism that was used for verification was runtime messages and
pauses to visually inspect output and messages. Specifically, a traceln() function was used at key code segments to
return string or object values for inspection. Functions were developed (e.g. threadStopPause(),
pressAnyKeyToContinue()) to temporarily pause or stop program execution for detailed evaluation of tracking
information. Figure 3. 18 is a snippet of traceln() output used to verify computer code during run-time.
Validation – building the right model
The fundamental requirement of this simulation model is to, in some fashion: 1) replicate the MAP process aligned
with the probability of error occurrence found in the literature, and; 2) indicate the effect that JIT information
might have. The validation process, for the purposes of this effort, is in many ways an extension of the verification
process.
The validation of the model is ultimately determined by evaluating the actual output of the model against the
expected values. As described in the verification section, the overall composite probability of MAE is a good
general indicator of the performance of this model since this output is a function of the individual probability
inputs from each of the MAP steps as well as the effects of the variance of nurse and medication attributes.
Revisiting Figure 3. 17, the significant changes in error probabilities, as the model progresses, indicates the effect
of inclusion of information or nurse attributes. Figure 3. 19 indicates changes in the inclusion of information or
nurse attributes during specific time sequences. The graph aligns with the design expectation that when
information is added, the likelihood of error should decrease. When variance in the attributes of nurse agents are
included, the variance in the likelihood of error increases. When both nurse attributes and information is included
in the simulation, the probability range is broader than with just information but narrower than either the
attributes/no information or neither information/attributes, also as expected.
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Figure 3. 17: Graph of overall correct Medication Administration likelihood

Figure 3. 18: Run-time messages for V&V
testCollection [14, 22, 10, 23, 37, 19, 35, 24, 27, 8, 37, 47, 15, 10, 18, 40, 45,
20, 17, 33, 34, 9, 25]
sum of all meds: 569
test fired
bigCheckingFunction
medication count
569
medicationCollection [1, 1, 1,…]
collectionBuilderForMedications
Total Meds by Patients (in startup): 569
medication count
569
medicationCounterCollection [0, 0, 0,…]
collectionCounterBuilderForMedications
A SLIGHT PAUSE ONLY 5 SECONDS - TAKE 3 DEEP BREATHS
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
!!!!!!!
byShiftNurseMedsFunction
totalMedSumPerNurseParameterFunction
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Figure 3. 19: Factors influencing likelihood of successful medication administration

Many of the variables in the model “auto-generate” their value, in that, a random or probability function
determines what the variables’ value is as the simulation executes. A tool was developed to help validate the
model which collected the key monitoring variables into a large spreadsheet. This allowed visual inspection of
each variable during each time step of model execution. Table 3. 13 shows the variables contained on this
spreadsheet. Seventy-one separate variables were tracked. This tool allows assessing the validity of the model as
it relates to the interaction of the various variables at a low level. Based on use of this tool, the assessment is that
the model performs as expected with high confidence.
Evaluation of the occurrence of MAP errors during the medication process (i.e. the 5-right steps) provides insight
on the validity of the computer code and operation of each of these elements. By checking the occurrence of
calculated errors and comparing them against the standard error rate put into the model indicates if the model is
executing correctly. Table 3.12 provides the output of this comparative assessment. The calculated value should
be between 90-95 percent. Each of these values falls within that range.
Animation was used to graphically represent network connection changes (nurse-patient connections) during shift
changes. At each shift change, the animation of the network map was redrawn indicating the planned random
disconnecting and reforming of nurse-patient connections.
The relative effect of the JIT information effect and agent attributes is validated during each simulation run for
each level of information injection.
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Table 3. 12: Percentage occurrence of errors in MAP steps
marCheckP

Count

Percent

CumCnt

CumPct

medCheckP

Count

Percent

CumCnt

CumPct

0

46

9.20

46

9.20

0

39

7.80

39

7.80

1

454

90.80

500

100.00

1

461

92.20

500

100.00

N=

500

N=

500

doseCheckP

Count

Percent

CumCnt

CumPct

patientCheckP

Count

Percent

CumCnt

CumPct

0

49

9.80

49

9.80

0

35

7.00

35

7.00

1

451

90.20

500

100.00

1

465

93.00

500

100.00

N=

500

N=

500

routeCheckP

Count

Percent

CumCnt

CumPct

timeCheckP

Count

Percent

CumCnt

CumPct

0

48

9.60

48

9.60

0

38

7.60

38

7.60

1

452

90.40

500

100.00

1

462

92.40

500

100.00

N=

500

N=

500
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Table 3. 13: Key model elements for assessing model performance (V&V) agent attributes
Key metrics

Data type

Type

Description

Main.nextId

integer

v

counter for total passes through the system

Nures ID (this.getIndex())

integer

agent

index of current nurse

variableControlIndicator

string

v

informationInjection

boolean

v

godFunctionControlVariable

boolean

v

currentShift

shift

v

composite indicator showing the collective
status of information injection and the
godVariable: that is, it indicates if these
functions are "turned on"
turns on or of the function for information
injection benefit "true" indicates the function
multiplier is on
turns on or of the function for godVariable
affect "true" indicates the function multiplier
is on
the currently active shift (2 shifts total)

time()

time

v

current model time

this.patientsPerNurse

integer

p

number of patients per nurse

this.getIndex()

integer

agent

index of current nurse

this.currentPatient

integer

p

activePatient

integer

v

this.medsPerNurse

integer

p

the connected patient that the nurse is giving
the medication to
the connected patient that the nurse is giving
the medication to
total medications per nurse

this.nurseMedDisributionCounter

integer

p

this.patientLink

integer

p

medLinkConnections.size()

integer

p

this.medicationsLink()

integer

p

Main.medicationTotalSum

integer

v

this provides the current counter for the
number of meds a nurse has administered
this identifies the current patient for a given
nurse
this is the size of the array for monitoring
each medication being administered
This identifies the current medication being
given to the patient
total number of medications in a shift

this.marCheckP

boolean

v

indicates if the MAR has been checked

this.medCheckP

boolean

v

this.doseChckP

boolean

v

this.patientCheckP

boolean

v

indicates if the med has been checked (is it
the correct med)
indicates if the dose has been checked
correctly
indicates if the patient has been verified

this.routeCheckP

boolean

v

this.timeCheckP

boolean

v

medicationsLink

integer

p

medsPerPatientGiven

integer

p

VariableControlIndicator
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indicates if the route has been provided
correctly
indicates that the med has been given at the
correct time
This identifies the current medication being
given to the patient
per patient counter for medications given to
each patient

Table 3. 13: Key model elements for assessing model performance (V&V) agent attributes (continued)
medsPerPatientMissed

integer

p

selectionOfNumberOfMeds()

integer

p

per patient counter for medications NOT
given to each patient
medications per patient

ADRPerPatient

integer

p

counter for ADR per each patient

this.patientsPerNurse

integer

p

the total number of patients for each nurse

this.medsPerNurse

integer

p

this.interruption

double

p

the total number of medications for each
nurse
probability of interruption occurring

informationInjectionBenefit

double

v

godVariable

double

v

this.missedDoseV

boolean

v

multiplier value that is applied to each 5-right
probability so the likelihood of that activity
increases
integrated probability of occurrence of nurse,
patient and medication attributes
direct missing of dose

Main.nursesInCurrentShift

integer

v

number of nurses in current shift

totalStatsCalcV

double

v

medSeverity

MedicationSeverity

p

medDifficulty

MedicationDifficulty

p

informationInjection

boolean

v

multiplication of probability of each of the
probability parameters
indicator of relative hazard of medication of
current medication being administered
indicator of difficulty in correct
administration of the medication of current
medication being administered
was information injected

medsperPatient

integer

p

number of medications of current patient

nurseExperience

integer

p

fatigueOutput

double

v

medicationLoad

double

v

relative indicator of nurse experience,
education and proficiency
measure of level of fatigue based on duration
of time into the shift
factor influencing impact of medication load

interruption

boolean

v

did an interruption occur

patientLoadOutput

double

v

factor influencing impact of patient load

lengthOfShift

time

v

duration of each shift

MAR Checked

double

p

Med Checked

double

p

Dose Checked

double

p

Patient ID Checked

double

p

Route Checked

double

p

Time Checked

double

p

Probability of MAR being checked by nurse
agent
Probability of Med being checked by nurse
agent
Probability of Dose being checked by nurse
agent
Probability of Patient being checked by nurse
agent
Probability of Route being checked by nurse
agent
Probability of Time being checked by nurse
agent

p=parameter, v=variable, o=option list
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The model, judging by the performance from a number of perspectives, appears to have acceptable performance
in terms of executing in the fashion that it was designed for. The output of each of the key variable was assessed
and the ranges of output are in the limits of what would be expected form the design parameters. Multiple
sample runs were performed with different parameters and the results were consistent and within the expected
values. The assessment is that the MAP model meets the expectations for verification and validity.
Key Assumptions and limitation
Several assumptions were made as part of the development and conduct of this research. These key assumptions
were explored to consider the potential impact and are noted below
Clinical Trial
A fundamental premise of the clinical portion of this research is that the application of JIT information via the
smartphone app translates directly to actionable steps based on the understanding or knowledge conveyed by the
JIT information. This implies several operational assumptions:
In the context of this research it was assumed that information and knowledge are in essence synonymous. The
conveyance of information via the app is assumed to provide the appropriate contextual framework leading to the
appropriate action. The reporting on this research has used the term information to represent not only the data
that is passed to the end user in a JIT fashion, but also with the right contextual framework that provides
understanding for whatever task might be appropriate. In short it was assumed that when the content of the app
was delivered to the nurse they had the requisite capability to understand the relevance of the information and
respond.
The test subjects were specifically selected for this research because the represented a general uniformity of
training, background and experience with regard to nursing skills. This was based on the academic and practical
training they had received up to participation in this study. While this is believed to be generally true it is also
understood that as individuals each of the participants brings with them different capabilities that could differ
from the standard assumption. Similarly, the clinical portion of this research used students that were executing
the MAP scenario as part of a class, it is assumed that being part of the class did alter the outcome of the clinical
trial.
This research used, as a key resource the University of Tennessee HITS facility. HITS had the benefits of providing a
controlled clinic-like environment that was a virtual environment for both a hospital setting and patient encounter.
As a simulation the assumption is that it conducting the scenario in this environment does not adversely impact
the subjects’ behaviors.
Computer Simulation
Any computer simulation is a limited representation of the function(s) it is trying to represent. It is reported
George Box, the renowned statistician had said “All models are approximations. Essentially, all models are wrong,
but some are useful. However, the approximate nature of the model must always be bourn in mind”.
The use of an information multiplier is used to sequential increase the effect of information on the statistical
likelihood of error outcome. While this multiplier is simply an indexing represent a notional effect of information,
it is assumed that this approach represents how incremental increasing of information would perform.
As an agent-based model, various attributes were assigned to the agents used as part of the model’s structure.
The attributes selected for the agents used represent attributes in the research literature that impact medication
administration performance. Little research has been done on the interaction of these attributes in an actual
clinical setting much less a computer simulation. Furthermore, computer modeling of human behavior has
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inherent limitations. The subset of attributes used in this simulation is assumed to provide and adequate
representation of those that effect MAE performance.
Medication Administration is a complex adaptive process influenced by many factors including the practitioner
administering the medication, the patient, the medication, procedures, other health providers influencing the
process both directly and indirectly, related computer systems, family members, and the medication itself. By
design, this simulation included a subset of these factors. While these other factors can impact the MAP, the
working assumption is that the current model is a reasonable approximation of the MAP.
Limitations
The sample size for the clinical study was determined by the class size of the course used that the subjects were
drawn from. The size of the sample provided adequate numbers of test subjects as confirmed by the sample size
analysis.
Student nurses were used as test subjects. This provided the benefit of a relatively uniform education level and
experience base
Because the scenario used for the clinical trial was part of a Nursing class, its design needed to include both
educational component as well as addressing the research objective
The use of the HITS facility provided a controlled environment that allowed direct, unobtrusive observation.
However, with this environment it did not have other influences that would occur in an actual clinical setting.
For the clinical portion of the research, small groups or teams of nursing students carried out the scenario and the
student nurses interacted during the execution of the MAP scenario. This clearly influenced their performance
during the MAP scenario.
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Chapter 4
Analysis
Scope and Analysis
Analysis Introduction
Various data analyses were performed on the two components of this research, first, the CCS which defines what
the impact of JIT information on MAP might be through a clinical trial, and second, developing an ABM that uses
data from the literature and the CCS to simulate the MAP. The data set for the CCS is modest and is based on the
number of subjects divided between the control and treatment groups. In contrast, the data set obtained from the
model simulations is extensive and composed of multiple trials, control and treatment groups.
Model Analysis
The primary function of this model is to simulate the process of medication administration by nurses. The overall
measure of nurse performance is a composite statistic, defined as the Likelihood Index (LI), which indicates the
likelihood of the nurse agents’ successful completion of the MAP. Recall from an earlier section that this single
statistic is a function of many other variables within the model which contributes to the output for each
medication processed through the medication administration process by the nurse agent. The model was
constructed to provide a broad collection of data output on the operation of the simulation. Figure 4. 1 represents
the combination of inputs, effects, probabilistic effects and how the combine via the MAP process steps to form
the likelihood output.
The analysis will focus on validating the performance of the model through evaluation of simulation outputs and
its alignment with values found in the related literature and the clinical case studies performed as part of this
research. The analysis of the model first considers the overall system level model performance, followed by
considering specific output functions and then focusing on a more detailed analysis of a specific trial
representative of the model’s operation.

Beta distribution
probability

Information Injection
Amount (1-1.9x)

Product of inputs used
in calculation of
composite likelihood
statistic

MAP Process Step
(e.g. MedCheck

Individual Agent Attribute Multipliers
(Nurse: experience, fatigue, patient
load, medication load, interruption
effect
Medication: medication severity,
medication difficulty)
Figure 4. 1: Model elements contributing to overall data outputs for the model
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Analysis of the model includes assessing the output of control variables data generated during the runs of the
simulation against the variable representing the model conditions for the agents while executing the
administration of medications. Comparative and descriptive statistical analysis is used to demonstrate model
functioning and to compare expected versus actual performance of the model. The variable control analysis
establishes overall benchmark performance of both the role of adding JIT information and gauging the effects of
inserting the attributes of agents into the model.
The level of information injection is examined for each of the control-variables (false-false, false-true, true-false,
true-true). The analysis of the model uses the composite performance indicator, Likelihood Index as the overall
performance metric.
The true-true group, the group of simulations with both information injection and agent attributes being active,
contains the data sets of interest for comparing the performance of the model relative to the clinical case study
and actual clinical settings. Said another way, whereas the other control-variables are internal controls to validate
model performance, true-true generates data that is intended to represent “real-world” nurse performance for
administering medications. The information-medication trials are evaluated as with the control-variables; a
representative trial is selected, as noted later for more detailed statistical evaluation.
Specifically, the effect from agent attributes is calculated by the product of the values assigned for each attribute:
Attribute Variable = exp*fatigue*patientLoad*medicationLoad*interruptionEffect*diff*medicationSeverity.
exp = nurse experience: overall experience of a nurse including education, years of experience and
practical knowledge
fatigue = nurse fatigue: overall effect of fatigue based on hours worked for a nurse
patientLoad = patient load: number and difficulty of patients for a nurse
medicationLoad = medication load: number of medications
interruptionEffect = effect of interruption measured in hours worked
diff = medication difficulty: inherent difficulty of administering a medication
medicationSeverity = potential effect of a medication that would influence medication administration
The overall composite statistic is:
Likelihood Index = Information Injection value * beta distribution value* attributeVariable.
General Data Consideration:
Likelihood index45 = 𝐼𝑛𝑓𝑜𝑟𝑚𝑎𝑡𝑖𝑜𝑛 𝐼𝑛𝑗𝑒𝑐𝑡𝑖𝑜𝑛 𝑉𝑎𝑙𝑢𝑒 × 𝑏𝑒𝑡𝑎 𝑑𝑖𝑠𝑡𝑟𝑖𝑏𝑢𝑡𝑖𝑜𝑛 𝑣𝑎𝑙𝑢𝑒 𝑠 ×
∏𝑛=1 ∏𝑝=1 ∏𝑚=1 𝐴𝑡𝑡𝑟𝑖𝑏𝑢𝑡𝑒 𝑉𝑎𝑟𝑖𝑎𝑏𝑙𝑒𝑛𝑝𝑚 .
Where n=nurse agent number, m = the subset of medications belonging to patient p for nurse n, s = each
consecutive step in the MAE process
Recall that each nurse agent, patient agent and medication agent, form a combination of agents that function
similarly to a small network. This small triplet network enters into the MAP and shuffles its way down the process
chain stopping at each functional box where the likelihood of successfully completing that particular step is
calculated. At the end of this process chain, the nurse agent returns to the beginning of the process where it
figures out if the patient agent it is currently dealing with has any more medications to process, if it does, it starts
down the path with the new medication; if not, it switches to its next patient to start the process anew. This is
graphically represented in Figure 4. 2. The variables that are used in assessing the operation of the model are
detailed in Table 4. 1.

45

Also referred to as statsCalcP
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Table 4. 1: Key variables in monitoring MAP model operations and assessing agent performance
Variable/Factor

Description

Primary Dependent Variable
Likelihood Index (LI)

Overall likelihood of nurse successfully completing each
MAP element

Primary Independent Variables
Information Injection

Measure of JIT information provided to the agent in
completing the overall MAP

Agent Attributes

Combination of contributions influencing the behavior and
performance of individual agents to each MAP element

Contributory Variables
MarCheckVariable

Likelihood of a nurse checking the mar for each patient

MedCheckVariable

Likelihood of a nurse checking the medication for each
patient

DoseCheckVariable

Likelihood of a nurse checking the dose for each patient

PatientCheckVariable

Likelihood of a nurse checking the ID for each patient

RouteCheckVariable

Likelihood of a nurse checking the route for each patient

TimeCheckVariable

Likelihood of a nurse checking the time for each patient

Interruption

Nurse agent attribute for determining the impact of
interruption

Medication Severity

Medication agent attribute for the impact of medication
on likelihood of error

Medication Difficulty

Medication agent attribute for the impact of medication
on likelihood of error

Nurse Experience

Nurse agent attribute for determining the impact of the
level of nurse experience

Variable/Factor

Description

Patient Load

Nurse agent attribute for determining the impact of the
number of patients per nurse

Medication Load

Nurse agent attribute for determining the impact of the
number of medications per nurse

Nurse Fatigue

Nurse agent attribute for determining the impact of the
level of nurse agent fatigue

Comparative Factors
Log

Continuous count of the number of medications that have
passed through the MAP

Time

Continuous measure of the time elapsed of the MAP
process during the simulation
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Table 4. 1: Key variables in monitoring MAP model operations and assessing agent performance (continued)
Variable/Factor

Description

Shift Number

Continuous measure of the number of shifts during a
simulation

Patients per nurse
Nurse ID

The number of patients assigned to individual nurse
agents
The unique number identifier of individual nurse agents

Current Shift

The shift the simulation is currently in

Medications per Nurse

the sum of the number of medications a nurse agent has
based on the patients it is assigned

Model Parameters
Length of Shift

The duration of each period of the shift

Number of Nurses

Total number of nurses entered into the model at the
simulation

Number of Medications

The total number of medications passing through the MAP
during a shift-established by model

Number of Patients

Total number of patients entered into the model at the
simulation

Patient11

Patient12
Nurse1

Med121
MAR Checked

Nurse1

Patient11

Med113

Med
Checked

Nurse1

Med112
Time
Checked

Nurse1
Figure 4. 2: Creation and flow of data generated by the model
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Patient11
Nurse1

Med111

MAP Complete

A comprehensive simulation was designed as an approach in evaluating the MAP model. The simulation was
structured to cover the essential operating parameters of the model, namely: amount of information injection,
total number of medications, and duration of the MAP process by shift. The variables, the operating parameters
are designed into the model and they vary within these boundaries based on predefined probability functions as
described in the Materials and Methods section. The model allows for change, the overall number of nurses and
patients are kept at one hundred and twenty respectively to allow the average nurse:patient ratio to be
maintained at 1:5 (nurses to patients) as referenced in the literature.
The simulation iterates through various levels of information injection levels. The increments were: 1, 1.1, 1.3, 1.5,
1.7. 1.9. These levels were selected based on previous trial simulations that indicated this spread was adequate to
demonstrate sufficient detail on the effect of the increase of information and its effects on the dependent variable.
The 1.9 maximum was selected based on the trial simulation output that demonstrated this value reached a high
level of saturation of effect of information on model performance. That is, at a multiplier of 1.9 for information
injection, the Likelihood index was at 0.999 or greater for more than 97.5% of the medications processes.
Meaning that there was a near 100% chance of at least 97.5% of the medications being administered. While
higher levels of likelihood would be attainable, the plausibility of reaching this level in actual clinical application is
unlikely.
Time duration for the MAP and the total amount of medication for each shift was also used as a measure in
evaluating the model. The full data set represents two levels of total medication amounts, within three shift
durations. The nominal amounts of 500 and 600 for total medications to be distributed was established by
reviewing the literature for the average medications per patient for an acute care setting. As noted earlier, the
actual medications per patient is determined stochastically. This property is also the reason that the actual
medications amounts range from 598 to 503 for the low value and 595 to 600 for the high value. The total number
of meds cannot be manually set by the user at run-time, rather the probability distribution function must be
modified and tested until close to the desired total number of medications is reached. The fact that I hit 600,
exactly the desired number, twice, was a testament to my blind good luck.
The shift duration was developed empirically through running multiple simulations to observe what durations
provided the best clarity on the effect of shift duration boundary conditions. Durations of 120, 300 and 480
minutes were selected as the best candidate times. Table 4. 2 provides a summary table of the total medication
number and shift duration combinations.
The model is constructed to provide three separate control groups, each with a different function, and one active
measure. The collection of these values is referred to as variable-control. These control groups allow for
examination of the independent effects of the delivery of JIT information and the attributes of the agents and
other model effects. Table 4. 3 summarizes the various controls and active measure groups: the first three
columns are control and the final column on the right is the effects group. The “false” indicates that the particular
information injection or agent attributes are not being used. So, “false-false” indicates that neither information
injection nor agent attributes are used during that portion of the simulation. This serves as the baseline to, in
essence, evaluate the agent performance without any effects from attributes or information. The “false-true”
control indicates model behavior with attributes functioning, but without information. Similarly, the “true-false”
indicates that information injection is engaged and agent attributes are not being used. The value “true-true” is
the portion of the simulation where the effects of both information injection and nurse attributes are being
evaluated. It is important to note that the active measure (i.e. the true-true variable-control) is the variable-control
state that represents the desired output for measuring the influence of both the information injection and agent
attributes – it is the output from this variable control that generates the information that is used in evaluating
agent performance. The other variable-controls provide baseline indication of model performance to ensure the
model is performing as expected. The Information Injection Level indicates the level or intensity of the information
provided to the nurse agent. In the Table 4. 4 you will note that 1.0 indicates no information is provided or used by
the nurse agent, while 1.9 indicates a maximal amount is used.
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Table 4. 2: Total medications per shift and shift duration combinations (medications-duration

No. Meds

Shift Duration (minutes)
Short

Medium

Long

120

300

480

Low

500

498-120

503-300

501-480

High

600

595-120

600-300

600-480

Table 4. 3: Description of variable control variables
Variable Control variable values

Description/Function

false-false

Overall control value, the information injection and
use of agent attributes is turned off

false-true

Control for information injection, agent attributes is
turned on, information is turned off

true-false

Control for agent attributes, information is turned on,
agent attributes is turned off

true-true

Experimental value with information injection and
agent attributes both turned on. This measures the
impact of information under the condition of the
agents exhibiting active attributes

Table 4. 4: Distribution of variable controls by information injection level and functional description

Info Injection Level

Information Injection on/off and Agent Attributes on/off
no info/no attribute

no info/attribute

info/no attribute

info/attribute

1.0
1.1

false-false
false-false

false-true
false-true

true-false
true-false

true-true
true-true

1.3

false-false

false-true

true-false

true-true

1.5

false-false

false-true

true-false

true-true

1.7

false-false

false-true

true-false

true-true

1.9

false-false

false-true

true-false

true-true
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The length of shift is used as a basis for calculating the variable-control selection and information injection
durations for the length of the simulation run for a particular value for information injection. As an example,
assume a shift length of 480 minutes is set. As demonstrated in the top part of the diagram of Figure 4. 4, the
model will go through 12 shift changes after which it changes to the next step of variable-control moving from
false-false, true-false, false-true and then true-true. After the simulation iterates through each of the four
variable-control states, it will then change to the next level of information injection and complete the same cycle.
Variable-control selection is calculated by using (length of shift) * 12 and information injection duration is
determined by (length of shift) * 48. So, in the example simulation shown in Figure 4. 4, a 480-minute length of
shift spans 5,760 minutes and 23,040 minutes for variable-control duration and information injection duration
respectively. Another way to consider this is that there are four variable-control states for each level of
information injection. The variable-control states represent three separate experimental control groups and the
active measure. Each level of variable-control state is made up of 12 shifts. The shift durations are set at the start
of the model based on the goal of the simulation. The graphic in figure 4.4, portrays the sequencing of time
related model elements.
One perspective of how the simulation trials can be represented by the categorical tree map is shown in Figure 4. 3
which combines the information injection and variable control variables. Starting on the right-hand side of the
diagram, there are three different control runs (ff, ft, tf) and one response run (tt) for each level of information
injection represented in the diamonds. These are each done for a high (600 medications) and low (500) amount of
medications. Each of these are repeated for three different time durations (120, 300 and 480 minutes).
The simulation designed for the analysis generated a data set of 945,570 rows with more than 100 fields. That is
over nine million data elements. This large data set contains each of the six trials. The analysis initially assesses the
overall data set allowing a comparative assessment of the various information injection levels, shift lengths and
controls on model outcomes. Following this assessment, a representative trial set was selected for the assessment
of the variables for agent attributes and their effect on the overall likelihood of medication error. Three factors
influenced the selection of the sub-dataset for the final selection:
1) The consistency of the data throughout the ranges of each of the shift duration/medications per
shift/information injection combinations
2) The use of the data set(s) that reflected the application of the agent attributes and injection of
information
3) Balance of the influence of the other factors across the data subset such as shifts, medication loading per
nurse, agent attribute effects and others
As a first step in the analysis, the data was evaluated to explore the model’s overall behavior by assessing key
elements of the model. A distribution analysis, shown in Table 4. 5, indicates minor differences between the
number of data elements within the time/med categories and the variable-control fields. The expected result
would be that each row would be the same value among each of the columns. Some of the differences between
rows, the meds per shift-minutes per shift column, are a result of the slightly different number of medications for
each of the trials. Two notable differences are for the 120-minute runs and the true-true variable-control column.
The 120-minute shifts have differences among each of the columns, while the remaining shifts have consistent
values for each of the columns except for the true-true column, with the exception of the 503-300 trial. The
difference for 501-480 and 600-300 is 23 medications, and the difference for 600-480 is 28 medications. The
differences were evaluated for these three trials and were determined to be a truncation of the last several rows
of data resulting from the means of data transfer. The reason for the differences at the 498-120 and 595-120 will
be explored in a future section. Each of the data subsets was generally congruent with the literature on MAE
performance and the clinical case study, and the 503-300 data-subset more closely fit with the criteria.
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This tree diagram represents the
approach to using High and Low
medication (Med) amounts as part of the
trial schema. Trials are run for the High
(~600) and Low (~500) Med amounts.
Each trial goes through the same levels of
information injection (triangles) and
control groups (ff, ft, tf, tt). This is
duplicated for each of the three shift
durations analyzed.

1.5
1.7
1.9

Figure 4. 3: Sequence of shifts, processing controls and information injection

Information Injection span (e.g 4x12x480 minute shifts)

1
2

2

1

2
1

FF

1
2

1

1
2

2

1

2

2

1

2

TF

1
2

1

2

1
1

2

2

1

1

2

1

2

FT
2

1

2

1

1
1

2

2

1

2

1

2
1

TT
2

1

2
2

1

Shift Duration (e.g. 480 minutes gray and white slices)
Variable-control (e.g. 12x480 minute shifts)
Shift changes

Shift time
Variable-control
change
Info inject 1.0

Info inject 1.1

to

Info injection
increase
Info inject 1.9

Figure 4. 4: Depiction of the relationship of the variable-control, shift duration and information injection variable
during simulation execution
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Table 4. 5: Counts of medications processed during separate trials for control and response groups
Med-min
498-120
501-480
503-300
595-120
600-300
600-480

false-false
35734
36072
36216
42053
43200
43200

false-true
35837
36072
36216
42647
43200
43200

true-false
35628
36072
36216
41480
43200
43200

true-true
35677
36049
36216
41836
43177
43172

Med-min represents the number of
medications per shift and the number of
minutes per shift respectively. Note the
relative consistencies of the values except
for the 120-minute durations.

Figure 4. 5 evaluates the number of medications that have gone through the MAP considering the spread,
information injection amount and shift. The shorter shift duration, 120 minutes as highlighted in the figure, shows
the most variance. The remaining elements show only a slight change in the largest amount of information
injection, 1.9, with the exception of 503-300 which 12,072 medications processed for both shifts and all levels of
information injection.
The evaluation of the distribution of the dataset was done by performing a contingency analysis using JMP 13. The
analysis was partitioned by the duration/medication load and information injection amounts in order to provide a
more detailed assessment. Since there are two shifts, the contingency analysis was done for both shifts. Of the
three durations used, 120, 300, and 480 minutes, the 120-minute duration results in the MAP process execution
being terminated due to lack of time for completion, that is, nurse agents could not deliver all their medications
because they ran out of time in the simulation for both shifts. The highlighted areas in Figure 4. 5 show the
incomplete delivery for the 120-minute period, particularly for the higher number of medications. The 300 and
480-minute durations completed their medication deliveries for shift one, shift two saw only the 300-minute
duration at the 503 medication level completing the deliveries. The last shift of the overall shift, shift 288, had
slightly fewer medications processed for the 501-480, 600-480, 600-300 simulations of 23, 28, and 23 medications
respectively. The fewer medications processed is a function of the operations of the model.
While medications per nurse and duration of shift impact the likelihood of completing the administration of
medication, the overall input variable for the likelihood of administration effort is the information injection
function. As noted above, this variable is the input that modifies the effect or benefit of providing JIT information
to the nurse agent administering during the administration process. The information injection function acts as a
multiplier that modifies the individual probabilities of each of the check variables (e.g. marCheck, medCheck, etc.).
For example, if the value of marCheck, as assigned by the probability distribution function is 0.721231, and the
current information injection variable value is 1.5, the probability changes to 1.081846. Clearly a probability
cannot be more than 1, so the simulation modifies any value greater than 1 to 0.999. The value 0.999 was selected
as the high-end value to ensure no spurious events occurred in the simulation due to the unlikely occurrence of a
probability of 1. Plus, in a real-world event, the likelihood of a 100% chance lack of error does not exist.
The other variable to consider is the attribute multiplier. This variable is a composite effect of all the various
attributes that influence the behavior (likelihood to make an error) for each nurse. Similar to the information
injection function, the attribute variable functions by modifying the overall check probability by multiplying it by a
value that has the effect of changing the overall occurrence of that particular check probability. Unlike the
information injection function, the attribute multiplier is a function of various modifying values.
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Figure 4. 5: frequency analysis of medications processed, individual trials by shift number

The model is constructed to run controls for each level of information injection. The controls selectively “turn on”
and “turn off” the injection of information and attributes for the agents. This demonstrates the effects of each of
these factors on the nurse agents’ performance. The description of the controls is provided in Table 4. 4. As will
be noted, there are three separate control conditions, one data generation run for each iteration of the simulation
(i.e. for each level of information injection ranging from 1.0-1.9)
Table 4. 5 analyzes the association between two variables, the information injection (the amount of information
that is provided to the nurse) and the status of agent attributes and if the information injection is on or off. The
overall frequency of each of the conditions should be generally equal. Differences could result from truncated
medication administration periods due to limited time, or a greater number of medications distributed based on
more medications in a particular shift.
Multiple simulation runs were constructed with each having a defined duration and similar numbers of
medications to administer. As with the previous example simulations, there were low numbers of medications
and greater numbers of medications. Six model runs were designed to evaluate the model performance with
varying lengths and different numbers of medication. The actual numbers of medications vary between runs due
to the random selection of the number of medications. Table 4.6 lists the number of medications and time period
in minutes for each of the six simulations.
In these runs, in contrast to the previews model runs used for analysis, the number of medications were not set at
a specific scale. In the previous test runs, medications were set at five or six medications per patient to limit
variance. Rather, the distribution was kept at the native value in the model and the values were randomly
selected during model instantiation.

143

Table 4. 6: Distribution of medications randomly assigned to patients during Lo and Hi medication trials
No. Medications
per Patient
index

Lo

Hi

1

2

2

2

3

4

3

4

6

4

5

7

5

7

8

6

9

9

The Lo column is the number of
medications that are randomly
assigned to patients for the Lo
medication trials (500 medications
per shift). Similarly, the Hi column
represents the count of
medications assigned randomly
assigned to patients during the Hi
(600 medications per shift) trials.

The medication distribution for Lo and Hi number of medications per patient are seen in Table 4. 6. The total
number of medications per shift is set in the model by modifying the medications per patient distribution. The Lo
column totals 30, divided by six items in the column results in an average of five medications per patient. Likewise,
for the Hi column the total is 36 with an average of six. There are 100 patients in each shift resulting in an
expected value of 500 and 600 medications per shift respectively. As noted previously, the actual number of
medications in any simulation run might differ slightly from the expected value since the selection of medications
per patient is stochastic, following a uniform distribution. The medication distribution or the Lo and Hi values used
are noted in Table 4. 7.
Over 950,000 rows of data consisting of 10 million data elements, make up the full data set representing two levels
of total medication amounts, three shift durations, each having three internal control groups and the response
group for agent attributes and information injection levels. These levels and conditions result in 48 different subdatasets. A representative data subset was selected for the assessment of the variables for agent attributes and
their effect on the overall likelihood of medication error (Figure 4. 6). Three factors influenced the selection of the
sub-dataset for the final selection:
1) The consistency of the data throughout the ranges of each of the shift duration/medications per
shift/information injection combinations
2) The use of the data set(s) that reflected the application of the agent attributes and injection of
information
3) Balance of the influence of the other factors across the data subset such as shifts, medication loading per
nurse, agent attribute effects, and etcetera.
As will be seen, each of the data subsets was congruent with the literature MAE performance and the clinical case
study, the 503-300 data-subset more closely fit with the criteria outlined above.
Analysis of Clinical Case Study Data
While the sequence of steps in a standard MAP follows a specific sequence, as in Figure 4. 7, in practice the steps
can occur in a variety of sequences based on the preferences of the nurse and the particular condition being
experienced at that time. This set of standard steps was used to build a set of variables to track MAP performance
for the clinical simulations.
The activities of each nurse team were tracked through the MAP clinical simulation process using a set of variables
that measured performance for each individual step of the process. Table 4.8 provides the list and description of
variables used in the tracking of the medication administration steps followed by the nurses during the MAP
clinical simulations
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Table 4. 7: Matrix of trial runs for shift duration and no. of medications per shift
No. of medications

Administration/shift
time (minutes)

Lo

Hi

480

501

600

300

505

600

120

498

595

Figure 4. 6: Data reduction/down-select of demonstration trial for specific analysis
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Figure 4. 7: Notional MAP sequence steps for correct medication administration
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Table 4. 8: List of clinical case study tracking variables
Clinical Trial Variables

Variable Description

Pain Assessed/Med Needed

Patient evaluated to determine level of pain or
need for medication based on physiological or
observed condition

Dose Checked

Medication dose validated and appropriate dose
calculated

Correct Dose Calculation

Dose calculated by nurse is correct

Med Delivered

Medication administered appropriately

Patient Checked

Patient Identification checked

Med Checked

Medication type, form and other characteristics
validated as correct

Correct Med Delivered

The correct medication type, form, and dose
were administered

Labs Checked

Patient laboratory values checked in the EMR

Labs Understood

Laboratory values and associated implications
understood and appropriate actions taken

Route Checked

Delivery approach (e.g. oral, injection, tablet,
liquid) validated

Time Checked

Timeframe validated for correct medication
administration

Full/Stopped

MAP process terminated

MAR Checked

Medication Administration Record reviewed

Near Miss

Nurse actions were on path to error but
corrected before an error occurred

Med Delivered Correctly

All of the requirements for correct medication
administration have been complied with

Used App

JIT application used

Info

Qualitative assessment of degree to which JIT
app was used

Liked

Post simulation indication of app benefit

Performance

Overall performance measure of nurse
performance in administering medication
defined as successful or unsuccessful
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Table 4. 9: Clinical study tracking variable by group frequency table
Group
Clinical Study
Tracking Variable
Med Needed
Dose Checked
Correct Dose Calc
Med Delivered
Patient Check
Med Checked
Correct Med Deliv
Labs Checked
Labs Understood
Route Checked
Time Checked
Mar Checked

Control

Treatment

Total

No

0

0

0

Yes

18

20

38

No

4

10

14

Yes

14

10

24

No

10

15

25

Yes

18

5

23

No

1

10

11

Yes

17

10

27

No

5

10

15

Yes

13

10

23

No

1

10

11

Yes

17

10

27

No

2

10

12

Yes

16

10

26

No

12

9

21

Yes

6

11

17

No

7

9

16

Yes

11

11

22

No

7

12

19

Yes

11

8

19

No

2

0

2

Yes

16

20

36

No

0

0

0

Yes

18

20

38
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A frequency analysis of the response by variable for the control and treatment groups is provided in Table 4.9. It
can be generally observed that overall performance improves in the treatment group. Specific interpretation on a
by-variable basis is difficult because an outcome in the treatment group is the termination of the scenario based
on the recognition by the nurse that the medication dose is in error and/or the patient’s laboratory values are
inappropriate. This early termination can occur at any stage of the scenario and as a result the process steps
downstream from the termination event do not occur. While the fact that termination occurred was recorded, the
point at which it occurred and which process steps were affected was not.
Various methodologies were used in analyzing the CCS data. The methods selected were appropriately vetted
based on the data type and population size. The data was retrieved from standard score sheets used to collect the
data. It was collected into a spreadsheet and the descriptive statistics were generated. As described later the
population was relatively small. The primary methods selected were:
•
•
•

Binary logistic (logit) regression,
Chi square,
T test.

The collection of the data was validated via reviewing of the video and audio recordings. Each scenario was
reviewed three times. The data for each viewing was compared. For the scorings that resulted in different values
the section of the video was reviewed again to determine a final score.
The qualitative aspects of the assessment, principally the test subject’s assessment of the performance of the app
and suggestions for improvements were collated but are not reported as part of this study. The input was used
from the control group regarding the challenges in performing the training scenario to help in the design of the
app.
Several commercial statistics software computer programs were used in the analysis of the clinical data. The
software used was: JMP® 13.2.0, SPSS® 25, Minitab® 18 and Microsoft Excel® 2016. Each program offered specific
characteristics for certain analyses. The large data set created some unique challenges for the software. Excel is
limited to one-million rows: the data set had about 950,000, This made the manipulation cumbersome. Minitab
was used for subsets of the data since it did not load the entire model data set. SPSS and JMP both were able to
load the large data set.
JMP was used primarily for the analysis of the computer simulation data set while SPS was used primarily for the
clinical data set. The logit evaluations and other analysis was more streamlined. The style of the tables in SPSS
differs slightly from JMP. This difference was maintained in order to highlight the difference between the clinical
analysis and the computer simulation data analysis
Appendix 1 holds detailed tables for the analysis for the interested reader including tables 4. 58 through 4. 64.
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Table 4. 10: Summary of clinical case study data
Performance
JIT app usage
Control

Pre-Train

Unsuccessful

Successful

No app use

16

2

No app use

6

0

Limited app use

2

0

Significant app use

0

3

No app use

0

0

Limited app use

2

0

Significant app use

0

7

Treatment

Post-Train
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The evaluation of the data from the clinical case study will assess the association of the use of JIT information
delivered via a smartphone application on the overall success of completing the scenario. Success in the case of
the scenario could be accomplished via a variety of decision paths by the student nurse. The overall outcome
being measured is; of the control group (no information app), how many nursing students successfully complete
the scenario, contrasted with the intervention group that used the app and their success rate. A chi-square test is
used to indicate the likelihood of association between use of the smartphone app, implying JIT use of information
based on the structure of the scenario, and a successful outcome.
There are two data groups, the control group and the treatment group, as will be detailed more fully in the section
covering analysis of this portion of the data. The treatment group is broken down further into a pre-training group
and a post-training group. Pre-training/post-training refers to providing brief structured training on the use of the
app prior to the subjects performing the scenario. There were 18 subjects in the control group and 20 in the
treatment group. Table 4. 10 summarizes the clinical case study (CCS) data.
While performance of the subjects for each step of the MAP process was collected, the key measures for the
clinical case study are whether the app was used and the resulting performance of the test subject. In the control
group, 16 subjects were unsuccessful in executing the MAP process correctly leaving two that performed correctly.
Overall, the pre-treatment group had eight unsuccessful trials in executing the MAP process of which two used the
app; three successfully completed the scenario. In contrast, the post-training group demonstrated seven subjects
that completed the scenario successfully with two subjects being unsuccessful in their efforts.
Analysis
There are a number of interesting and challenging facets in analyzing this data generated from the simulations.
The sample sizes are large, and highly skewed. This skewness is expected and inherent to the beta probability
distribution used along with the structure of the model: the significant positive skew is by design replicating the
profile of mediation administration in an actual clinical setting. Because of the skew, the data does not fit a normal
profile and is a mix of balanced and unbalanced data. Much of the data is stochastic and, the design of the model
determines the value of the model’s variables during run-time. The inference is that it is generally not possible to
control most of the model’s variables to evaluate the impact of one variable on another variable.
Both parametric and nonparametric analysis was used in analyzing the data in consideration of the lack of
normality. Guidance in the literature suggest larger sample sizes provide flexibility in using parametric measure for
non-normal data; representatives of these tests were included in the assessment. Another motivation for
including parametric tests is their ability to perform better on data with different population sizes, as is the case
with this data. Several comparative methodologies are used, chiefly, the Tukey-Kramer Honest Significant
Difference (HSD), Dunn’s Method and the Steel-Dwass test.
Summary
A variety of statistical approaches are used in analyzing the model output. The approaches evaluated the data
obtained from within each simulation run (I.e. the control and test groups) and among the simulations performed
for each level of medication loading and shift duration combination.
Analysis methods included:
•
•
•
•
•

Analysis of variance within each simulation and among the simulation trials
Analysis of means
Equal Variances
All pairs (or joint pairs) parametric and non-parametric assessments
Chi-square tests

Tukey-Kramer HSD
A Tukey-Kramer HSD (Honest Significant Difference) pairwise comparison Connecting Letters Report provides a
concise indication of the comparative similarity among the means. The Tukey-Kramer range test is a parametric
test but is robust for non-normal distributions and reportedly provides a more powerful approach when doing an
all pairwise comparison when compared to the t-test. The Tukey-Kramer method considers the differences
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between and among the individual means (pairwise comparison) decided by the estimated standard deviation of
the mean. While not needed for this sample set, the Tukey-Kramer method compensates for unequal sample sizes
by calculating the standard deviation for each pair comparison.
Examination of the paired groupings indicates the 480-minute scenarios and the 120FixedLo have means that
appear similar.
𝐻𝑆𝐷 =

𝑥̅ i − 𝑥̅j
√𝑀𝑆𝑤
𝑛

𝑥̅ i, 𝑥̅j : sample means where xi greater than xj
MSw: mean square within
n: sample size
Steel-Dwass (all pairs)
The Steel-Dwass (SD) is another nonparametric test. As with Wilcoxon it uses rank. The Steel Dwass method
performs the multiple comparisons while controlling the overall experiment-wise error rate: in essence, it is the
non-parametric equivalent to the Tukey-Kramer All-Pairs method. The, Steel Dwass procedure in JMP is reported to
allow unequal treatment sizes. Each pair of treatments is compared by ranking only the observations in the two
treatments of the comparison, calculating the mean rank for each treatment, and then computing the "Score
Mean Difference", which is the difference in ranks with a continuity correction applied. The standardized statistic is
asymptotically normal. Steel Dwass is also reportedly good for large sample sizes.
Dunn Method - All Pairs for Joint Ranks
The Dunn’s method, also known as Bonferroni t, performs a comparison of each pair, similar to the Steel-Dwass All
Pairs option. The Dunn method computes ranks for all the data, not just the pair being compared. The reported pvalue reflects a Bonferroni adjustment which, in essence, is dividing the group alpha by the number of
comparisons which reduces the per comparison level of alpha. It is, in essence, creating an orthogonal set of
contrasts. The Dunn test is appropriate for unequal sample size and as a posthoc test, it is used to pinpoint which
are means significantly different from others.
Evaluation of data balance
A factor that is considered in analyzing data from various trials is data balance. Data balance is defined as the
number of elements in each trail. The balance of the data can affect the outcome of comparative statistical tests
Data sets begin compared that have near equal numbers of elements are “balanced” those with unequal numbers
are unbalanced.
The contingency test results provided a Likelihood ratio of 0.5716 and a Pearson Coefficient of 0.5709 this p value
is greater than the threshold alpha of 0.05 leading to the conclusion that there is not enough evidence to support
the null value assumption that there is a relationship between these two variables. This result matches the
expected outcome from the design of the model for the overall comparison of differences in trials.
Assessing the balance of the data within a trial and across the variable control values, the data is largely balanced
on a percentage basis (Table 4. 11 and Table 4. 12). The greatest deviation from balance is noted in the 120minute trials. Regarding the remaining trials, with the exception of the 503-300 trial, the only difference is with
the true-true variable control. The very last iteration has a slight decrease in the number of medications processed
resulting in 1/100th of one-percent point difference, less than 30 data elements; as a result, these trials are
considered near-balanced. The 503-300 trial data is balanced.
When analyzed among the trials, the data is unbalanced primarily due to the differences in the medications per
shift.
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The mosaic plot in
Figure 4. 8 is striking in
the visual similarity
among the elements.
As noted elsewhere,
there is only a modest
percentage difference
between comparable
entries

Figure 4. 8: Contingency analysis of variable control by spread mosaic plot

Table 4. 11: Contingency table evaluating unbalanced data - spread by variable control
Count
Row %
498-120
501-480
503-300
595-120
600-300
600-480
Total

false-false falsetrue
35734
35837
25.01
25.08
36072
36072
25.00
25.00
36216
36216
25.00
25.00
42053
42647
25.03
25.38
43200
43200
25.00
25.00
43200
43200
25.00
25.00
236475
237172

truefalse
35628
24.94
36072
25.00
36216
25.00
41480
24.69
43200
25.00
43200
25.00
235796

truetrue
35677
24.97
36049
24.99
36216
25.00
41836
24.90
43177
24.99
43172
24.99
236127

Total
142876
144265
144864
168016
172777
172772
945570

Table 4. 12: Tests for contingency matrix evaluating unbalance data
Contingency tests
N
945570

DF
15

-LogLike
6.6986494

Test
Likelihood Ratio
Pearson

RSquare (U)
0.0000
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ChiSquare
13.397
13.406

Prob>ChiSq
0.5716
0.5709

Figure 4. 9: Representative graph of success Likelihood by variable control demonstrating controls and response
data
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Figure 4. 9 is a graphical representation of the data profile of a representative simulation. The description of each
phase is labeled with a corresponding number label:
1. This represents the false-false control section. Note the smaller range on the vertical axis which is a result
of decreased variance from the agents not having attributes and no information being applied which
decreases the maximum likelihood of success.
2. This section is a control section and it is the false-true section of the simulation which “turns on” the
unique attributes of each agent but does not have additional information. The larger range, when
3. Compared to the initial section, this is a function of the increased variance from the application of
attributes to the agents.
4. Section 3 represents another control section referred to as true-false. This section does not have the
agent attributes functioning but includes the JIT information injection feature.
5. The final section, section 4, has both agent attributes and JIT information injection functioning. This
section is the key section representing the fully functional model demonstrating the simulated
performance of nurse, patient and medication agents.
6. Label 5 indicates the change in pattern which is a result of the injection of information. The decreasing
range along each step of this, progressing upward in a saw tooth pattern, indicates the effect of increasing
levels of information.
7. Label 6 indicates the increasing levels of performance, that is, the improving likelihood of success along
progressive increases in information.
8. The change in variance induced attributes is indicated by level 7.
9. The decrease in variance created by removing the influence of agent attributes is indicated by label 8, as
the simulation transitions from false-true to true-false.
10. The increase in variance from the presence of attributes being re-instituted for true-true is indicated by
label 9.
11. Label 10, similar to label 6, indicates the improvement in the Likelihood Success Factor as the information
level is increased from no information to the maximum amount (6 increments).
Figure 4. 9 serves as a segue into the specific analyses of the model starting with the three control sections and the
test or demonstration section. Each of the sections for each simulation run from false-false through true-false,
the simulation incorporating agent attributes and information true-true for each level of medication loading. Shift
duration is also analyzed to understand the dynamics of the model and the degree to which it appropriately
represents the clinical case study results.
Evaluation of Control Value False-False
The first evaluation considers the overall total likelihood index (i.e. this is the totalStatsCalcP variable representing
the composite statistic for the likelihood of the nurse agent successfully completing the MAP) for each of the trials
(number of medications-shift duration) with no effects introduced from either information or agent attributes (i.e.
the false-false variable control). Without the effects of attributes or additional information the expectation would
be that the mean values and variances should be consistent among the trials. If there were a variance between
trial data sets that would indicate an influence introduced by the model or an undefined effect from the shift
duration or total number of medications per shift. Oneway analysis was performed using JMP. As would be
expected, Figure 4. 10 indicates uniformity across the trials. The analysis of variance (ANOVA), having a probability
for the whole model test of 0.7381 indicates there is no significant difference among the mean values within the
model. Further analysis on pairwise comparisons was done using both the Tukey-Kramer HSD and the Steel-Dwass
Method. Both methods indicated no significant differences between the means of the trials at an alpha = 0.05
which provides the connecting letters report.
The results of the equal means and variance tests align with the original supposition that the variances would be
equal. Figure 4. 11 and Figure 4. 12 provides the detail of the test results. Specifically, the figures indicate that the
means and variances are similar. The conclusion, based on the relative uniformity of the data, is that the model is
generating consistent results through various shift durations and medication amounts when controlling for the
effects of attributes and information. Note in Figure 4.11 that the vertical axis has a quite small difference
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between the lower decision limit (LDL) and upper decision limit (UDL): this difference of less than five onethousandths highlights the similarity of the values.
The output of the ANOVA provided a p value is greater than the alpha = 0.05 leading to the acceptance of the null
hypothesis that the means are equal. Inspection of the mean and standard deviation for each of the trials for this
control group supports the ANOVA that there is no significant difference of the means

Likelihood Index

To summarize the analysis for the variable control value of false-false, there is no influence from either the
application from agent attributes nor from information. Based on this, the expected likelihood index values would
reflect a uniform range, near equivalent means and variances. Any differences would be a result of the stochastic
distributions within the model. This particular set of simulations made up of the each of the different shift
durations and medication amounts with both the information injection and agent attributes set at having no
influence, establishes the baseline from which the other potential influences from increasing the effects of
information or application of agent attributes might be determined. The analysis of the associated output from
these simulations implies equivalent means and variances among the trial groups and therefore aligns with the
expected outcomes.

Figure 4. 10: Oneway analysis of likelihood index (LI) by spread variable Control=false-false, information injection=1

Table 4. 13: Connecting letters report for Tukey-Kramer HSD and Steel Dwass all pairs
Trial
501-480
503-300
498-120
600-300
600-480
595-120

Tukey
A
A
A
A
A
A

Steele
A
A
A
A
A
A

Corresponding with the ANOVA the pairwise
comparison of the falsefalse variable control
demonstrated that there appears to be no
significant difference among the means.
comparison (Levels not connected by same
letter are significantly different)
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The analysis of means
indicates that there is no
difference among the means
of the trials falling beyond the
UDL and LDL.

Figure 4. 11: Tests for equal means

The equal variance tests
indicate, based on p>0.05,
that the null is accepted
and that the variances are
equal.

Equal variance test
O'Brien[.5]
Brown-Forsythe
Levene
Bartlett
Welch’s

Prob > F
0.8100
0.3657
0.3638
0.9335
0.7373

Figure 4. 12: Equal variance tests for variable control false-false information injection level = 1
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To summarize the analysis for the variable control value of false-false, there is no influence from either the
application from agent attributes nor from information. Based on this, the expected likelihood index values would
reflect a uniform range, near equivalent means and variances. Any differences would be a result of the stochastic
distributions within the model. This particular set of simulations made up of the each of the different shift
durations and medication amounts with both the information injection and agent attributes set at having no
influence, establishes the baseline from which the other potential influences from increasing the effects of
information or application of agent attributes might be determined. The analysis of the associated output from
these simulations implies equivalent means and variances among the trial groups and therefore aligns with the
expected outcomes.
Evaluation of Control Value False-True
The next trial data set explores the effects of incorporating agent attributes on the overall likelihood of success
probabilities. The introduction of agent attributes introduces significant variance by creating differences among
the agents. In contrast with the false-false data set, this shows a significant difference between the trial datasets
as indicated by the ANOVA p value of less the 0.0001 (recall that false-false had an ANOVA p value equal to
0.7381). Figure 4. 13 evinces an overall mean of 0.39632; a lower mean than the mean of 0.548748 for the
previous control. In addition to the overall means being different, there is also a difference noted among the
individual means between the two simulation runs. The Tukey-Kramer HSD and Steel Dwass pairwise comparison
have similar results indicating differences among various sets of the means. The summary of the results in
Table 4. 15 shows similar means between trials with 300-minute shift times and 120-minute shift times.
The results of the equal means and variances tests indicate unequal variances among the trials. Figure 4. 14 and
Figure 4. 15 provides detail of the test results.
The expectation was that the inclusion of agent attributes would contribute to increasing overall variance within
and among the trials. This result was borne out with the assessment of the differences among the means and
greater variances in the system. This indicates that the addition of attributes has the desired effect of creating
diversity in the agents and how the effect the overall system.
There is a decrease in the overall mean response from 0.54875 in the falsefalse control group to 0.39632 for the
false-true control group as expected due to the depression of performance by the application of attributes.
The p value calculated by the ANOVA is <0.001, is less than the alpha = 0.05 leading to the rejection of the null
hypothesis that the means are equal.
Corresponding with the ANOVA p value, the pairwise comparison of the false-true variable control demonstrated
that there appears to be significant differences among the means. In this comparison, 503-300 and 600-300 are
similar as are 498-120 and 595-120 (In contrast the 480-minute trials (501-480 and 600-480) is different within
itself and from the other trials, see Table 4. 14). In contrast the 480-minute trials (501-480 and 600-480) is
different within itself and from the other trials.

158

Figure 4. 13: Oneway Analysis of Likelihood Index (totalStatsCalcP) By Spread variableControl=false-true,
information injection=1

Table 4. 14: Connecting letters report for Tukey-Kramer HSD and Steel Dawes all pairs comparison
Level

Tukeys

Steel

501-480

A

A

600-480

B

B

503-300

C

C

600-300

C

C

498-120

D

D

595-120

D

D

(Levels not connected by same letter are significantly different). Levels not connected by same letter are
significantly different.
Table 4. 15: Connecting letters report for II = 1 variable control = true-false
Level

Tukey

Steel

Dunn

501-480

A

A

A

498-120

A

A

A

503-300

A

A

A

595-120
600-300

A
A

600-480

B
B
B

A
A

B
B

A
A

B

B
B
B
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In Table 4. 15 the TukeyKramer HSD and two nonparametric tests, Steel
Dwass and Dunn, for joint
ranking indicate largely
similar values with 600-480
being significantly different
from the largest grouping.

The analysis of means
indicates that there is
a difference among
the means of the
trials falling beyond
the UDL and LDL.

Figure 4. 14: Tests for equal variances and means

Test
O'Brien[.5]
Brown-Forsythe
Levene
Bartlett
Welch's

Prob > F
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*

The equal variance tests
indicate, based on p>0.05,
that the null is rejected and
the variances are among
the trials.

Figure 4. 15: Equal variance tests for variable control false-true information injection level = 1
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The false-true control controls the information injection to the value of 1. This means no additional information
input and the agent attributes is set to “on” meaning the agents’ attributes are active and are influencing their
behavior and therefore their effect on the likelihood index. The presumptive effect of incorporating the agent
attributes would be to increase the overall variance of the model by creating a wider spectrum of potential
outcomes or deviations from the beta distribution conditioning the base behavior of the agent. As an example,
without the attributes function, the agent behaves like an automaton zombie with its behavior strictly limited in a
very narrow band; the addition of attributes expands the potential breadth of behaviors and as a result an increase
in the variance of the likelihood index.
The analysis of the output for false-true demonstrates a considerable increase in variance from the false-false
baseline as expected. Each of the medication-shift time trials indicate differing variations between the means of
the likelihood index values for the trials, as well as deviations from the overall mean of the false-true runs. The
pairwise comparisons indicate unequal means among the trials with 501-480 and 600-480 being unique unto
themselves. 503-300 and 600-300 are similar to each other as are 498-120 and 595-120, but, differing from the
other trials. The means for 501-480 and 600-480 are higher and, the standard deviation is also larger. While the
reason for this is not entirely clear, some plausible causes could include a random effect generated by the model,
or less likely, an effect of shift length. Note that while there is a difference in the means between the 300 and 480
shift durations, the difference is less than 0.05. In contrast, the difference between the 300 and 480 shift
durations is considerably greater with the mean of the 120-shift duration at 0.3 and the other durations greater
than 0.4. This difference can be rationalized by considering the chart in
Figure 4. 5 which plots the frequency of medication administrations by shift. Of note is the saw tooth pattern for
the 120-minute shift durations indicating the full number of medications per shift are not being administered. We
are assuming this could decrease the likelihood index. However, as mentioned previously, there could be a
duration dependent relationship between shift duration and the likelihood index that is not entirely understood at
this point which warrants further investigation. Further evaluation of potential time dependency reveals a
potential linear relationship between shift duration and the overall mean of the LI for the given shift duration. The
plot of residuals reveals potential heteroscedasticity. The graph of Figure 4. 16 plots the curve for the consecutive
shift durations from 120-480 minutes for the false-true control which holds include agent attributes but has no
effect from information injection. This indicates a relationship of improved performance given longer shift times.
The R-square value is 0.973849 with the p value for the intercept and variable “time” have p values of <0.0001 and
0.0019 respectively.

Polynomial Fit Degree=2
mean = 0.3215651 + 0.0002929*time - 5.9518e-7*(time-300)2
Figure 4. 16: Graph and analysis of mean Likelihood Index for shift duration levels for the false-true control
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The (time-300)2 factor had a p value of 0.1169. Consideration of this relationship must be conditioned by several
factors: there are only three shift durations which should guard a firm conclusion of a relationship and, the
relationship is projected for the mean values of the LI. To be noted is graph Figure 4. 17 demonstrating an increase
in residual difference versus predicted indicating a divergence of actual versus predicted. The vertical bars
represent all the medications administered in that specific shift duration.
Evaluation of Control Value True-False
The next step in the analysis is to evaluate the third control group where the level of information changes and the
agent attributes are not included in the simulations. The expectation is that the mean of the Likelihood index for
each level of information injection should gradually increase as the amount of information increases. The variance
remaining relatively constant as the amount of information injected into the system is progressively increased.
At the initial level of information injection of 1.0, with no additional information being provided to the nurse agent,
each trial is relatively equivalent. Of note is the difference in the 600-480 trial in comparison to the other trials
having the indication that the mean is modestly lower than the other trial mean values. This is not completely
unexpected, the pairwise comparison tests indicate that the 680-480 trial is not shown to have significant
difference with two other values. A comparative frequency analysis was done of the individual response values,
the 600-480 trial indicates a slight positive skew of 0.04 while the other trials indicate a slight negative skewness.
This slight shift in the histogram implies larger values resulting from the probability distributions for the trials other
than the 600-480 trial. Since the data is not normally distributed, the analysis of means (ANOM) for variances with
Levene was used. This method provides a robust test that compares the group means of the absolute deviations
from the median (ADM) to the overall mean ADM. The use of ANOM for Variances with Levene (ADM) if it is
suspected that the data is non-normal. ANOM for Variances with Levene (ADM) is a nonparametric analog of the
ANOM for Variances analysis.

Figure 4. 17: Residual by predicated plot of trial LI means

The plots of the
individual trials
in Figure 4. 18
should be
roughly equal
and similar to
the falsefalse
trial.

Figure 4. 18: Oneway analysis of likelihood index by medication amount/shift duration variablecontrol=true-false,
information injection=1
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Test
O'Brien[.5]
Brown-Forsythe
Levene
Bartlett

Prob > F
0.1892
0.1463
0.151
0.5079

Figure 4. 19: Analysis of means for true-false=1, for II trials

Analysis of means using
ANOM in Figure 4. 19 for
variances with Levene
(absolute deviation from
mean/median) indicates
that all values fall within
the decision limits.

Figure 4. 20: Tests that the variances are equal for true-false II=1

Figure 4. 20 and the associated table indicates that the variances are equal for the simulated trials. In particular,
the Levene test is noted because its use is appropriate for testing variances from non-normal distributions. All p
values reported are greater than the alpha of 0.05 concluding that the null hypothesis that the group variances are
equivalent.
In analyzing the control group for the effect of information injection controlling for agent attributes (i.e. excluding
the effects for attributes), the effect of information injection increase can be summarized by
Figure 4. 21 which plots the change in the mean of likelihood of error avoidance and the associated decrease of its
standard deviation. This figure shows the average values for the combination of trials. This composite graph
provides a density map of the medications delivered for each information level (colored vertical cloud), along with
the associated box plot. A curve tracing the predicted average for each information level as well as a curve
indicating the rate of change of the standard deviation are also included.
The density map for injection level 1 shows the point cloud spread of the likelihood of error avoidance (i.e.
likelihood of success) for each medication that has gone through the MAP process. The trial to the far left, as the
internal control for this set, demonstrates grouping similar to that for the false-false control. The expectation is
that it would have the lowest overall mean of the trial sets which is represented by the beginning of the mean trial
curve. Table 4. 61 provides the detailed data set in the appendices.
Considering the Oneway analysis in Figure 4. 22, the overall mean can be observed slowly increasing as the level of
information injection increases from 1.1 to 1.9 as is expected. The data in each of the trials gets compressed closer
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to 1 as the injection of information increases the LI demonstrating the increase in MAP performance by the nurse
agent. The blue hash marks, representing the confidence interval, get progressively smaller as the II increases.
The analysis of means used the same approach as described previously, using the ANOM variances-Levene (ADM).
The values for each of the trials falls well within the boundaries of the upper and lower decision limits (Figure 4.
23). This highlights the minimal disturbance in the variance and small standard deviations. This set of trials is
similar in the amount of variance as the false-false control set of trials. As such, it is expected that the addition of
information does not increase the amount of variance.
The analysis of means/medians employing both parametric and non-parametric tests proceeded similarly to that
done for the false-true trial. The connecting letters report indicates that each of the medication amount/shift
duration trials have medians/means that are not significantly different, matching the expectation for the model
design for this control (detail in appendix Table 4.61 to Table 4.64). The Dunn method for joint ranking was not
included in the connected letters report, the results are consistent with the Tukey-Kramer and Steel Dwass reports.
Measurement for equal variance shown in Figure 4. 24 and Table 4. 65 indicates variance equality tests that
generally show that the variances are equal. Particular attention is given to the Welch’s due to the unequal sample
sizes of the trials which well suited for unequal sample sizes and indicates the variances appear similar.
No linear relationship was noted between the medication/shift duration trials. Oneway analysis was performed on
the true-false trials across the information injection levels 1.1-1.9. Tukey HSD and Dunn’s test were performed
(Table 16 shows the Tukey and Steel test). All values are greater than 0.5 with most values approaching 1.0 and
indicating that the means appear to be equal implying no linear relationship exists (abridged output is provided in
Table 4.66 in the appendix).

Standard deviation of trial

1

1.1

1.3

1.5

Trial information injection level
Figure 4. 21: True-false composite boxplot for true-false
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1.7

1.9

Information Injection 1.5

Information Injection 1

Information Injection 1.7

Information Injection 1.1

Information Injection 1.9
Information Injection
1.3

Figure 4. 22: Oneway analysis of likelihood index by medication amount/shift duration variablecontrol=true-false,
information injection=1 through 1.9.
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Information Injection 1

Information Injection 1.1

Information Injection 1.3

Information Injection 1.5

Information Injection 1.9

Information Injection 1.7

Figure 4. 23: Analysis of means for true-false=1-1.9, for II trials

Table 4. 16: Connecting letters report for true-false trial

Level
501-480

1
Tukey
A

1
Steel
A

498-120

A

503-300

A

595-120

A

B

A

600-300

A

B

A

600-480

B

1.1
Tukey
A

1.1
Steel
A

1.3
Tukey
A

1.3
Steel
A

1.5
Tukey
A

1.5
Steel
A

1.7
Tukey
A

1.7
Steel
A

1.9
Tukey
A

1.9
Steel
A

A

A

A

A

A

A

A

A

A

A

A

A

A

A

A

A

A

A

A

A

A

A

B

A

A

A

A

A

A

A

A

A

A

B

A

A

A

A

A

A

A

A

A

A

B

A

A

A

A

A

A

A

A

A

A
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Level 1

Level 1.5

Level 1.7

Level 11

Level 1.9

Level 1.3

Figure 4. 24: Equal variance graphs for each information level for true-false

Evaluation of Control Value True-True
The true-true set of trials represents the data generated by the model when both the information injection and
agent attributes effects are active. Whereas the other variable control simulation groups were intended to serve
as the controls to measure the effects of the individual items of information injection and agent behavior, this
variable control produces the results that are intended to resemble the behavior of the actual MAP process along
with the influences of providing JIT information and as such is the data group of central interest to this study.
The expectation is that the output should resemble the combination of both the information injection and agent
attribute control groups. The mean of the Likelihood index for each level of information injection should gradually
increase as the amount of information increases. The variance, being impacted by the effect of the agent
attributes, should be greater than that found when just the information injection effects were present. The
variance should decrease as the amount of information provided increases.
The internal control labeled Information Injection 1 has no effects from information injection nor agent attributes.
In contrast to the true-false equivalent internal control, it is noted that there is a difference among the means for
each of the trials groups. However, when compared to the false-true group it appears that the variance
approximately the same. With no additional information being provided to the nurse agent each trial is relatively
equivalent. A more direct way to visualize this is in Table 4. 67 in the appendix. Comparing the false-true and truefalse sets of columns, the means are large for the true-false, this is the effect of information injection increasing
the overall success of medication administration. The variance decreases for the true-false in comparison to the
false-true. The true-true group more closely resemble the false-true group which coincides what one would
expect based on the construction of the model.
The ANOM values indicate dissimilar means among the medication amount/shift duration trials for true-true=1.
This is corroborated by the Tukey, Steel and Dunn tests. Note that the 120-minute and 300-minute trials are
determined to be equivalent amongst themselves. The 480-minute trials are not equivalent based on these tests.
Not surprisingly, this matches the true-false control group. The variance equivalency tests have p values less than
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the alpha of 0.05 leading to the rejection of the null hypothesis leading to the conclusion that a significant
difference exists between the values.
While the initial impression would be that the mean values for the LI values for each of the medication/shift
duration trials for true-true would be an average of the false-true/true-false variable controls, upon further
reflection the resemblance of the true-true internal control to the false-true internal control makes sense based on
the design of the model. The information injection effect has, in essence a null effect, the agent attribute effect
induces residual variance. Combining the two effects leads to the results seen in the true-true control.
The composite boxplot in Figure 4. 25 provides an overall visualization of the influence of inserting JIT in the
simulation. Moving from left to right the mean and median increase at an increasing rate while at the same time
the standard deviation decreases at a relatively linear rate. Noting the trend of the LI values, as with the similar
true-false graph, the values increase the congregation around the maximum LI value of one as the information
injection value increases. This is a result of increasing the probability of the agent successfully completing each of
the MAP process stages as a function of the increased level of information.
Several differences worthy of note in a side by side comparison of the true-true and true-false composite box
plots.
1) The curves representing the mean have different initial slopes and rates of change. The true-true curve
begins with a shallower slope implying a slower increase in the benefit from additional information, but,
accelerates somewhat more at higher information levels. The terminus of the true-false curve is slightly
higher than the true-true curve. This coincides with the expectation that the true-true scenarios have
significantly more variability due to the influence of agent attributes thus have a broader range of success
outcomes. The log-dash light green curve on the bottom plot represents the standard deviation for the
true-false curve overlaid on top of the true-true for easier comparison.
2) The standard deviation curve for true-true has higher values and a steady linear decrease in contrast to
the true-false standard deviation curve. As with the mean values, the standard deviation is heavily
influenced by the variance induced by agent attributes. With no effect of agent attributes, the true-false
standard deviation curve starts at a moderately low level and descends as the injection of information
increases. The descent is moderated at the upper end of the injection of information amounts as a result
of the likelihood of success being driven to high levels by the effect of the LI multiplier. The effect is
similar for the true-true curve with the difference being that the standard deviation in this case has the
effect of agent attributes making the values larger while the starting and ending points are at higher levels
due to the presence of agent attributes driving the variance up. The short-dash light green curve on the
bottom plot represents the standard deviation for the true-false curve overlaid on top of the true-true for
easier comparison.
3) In comparing the graphs along each of the information injection levels, the difference in the spread or
range of the individual data points can be noted. Each dot represents the likelihood of a medication being
administered successfully. The wider spread in the data for true-true starting with the information
injection level of 1 represents the influence of the effect of agent attributes on the nurse agent’s
performance in administering medications. The difference in the boxplot dimensions indicate this
divergence continuing along the axis.
The bottom axis of both curves represents a categorical variable so the spacing is equal for each unit. This makes
for easier visualization of the data but must be considered when doing quantitative interpretation. Specifically, the
interval between 1 and 1.1 is less than 1.1 and 1.3. This has the effect of making it seem like the early parts of the
curve have faster rates of change than later parts of the curve. The vertical axis is numerical therefore the
interpretation requires no additional treatment. A numerical version of the x-axis is provided later in the
document (Figure 4. 35) for comparison by the interested reader.
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True-false

True-true

Figure 4. 25: Composite boxplot of information level vs likelihood of success probability for true-false and true-true
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Information Injection 1.5
Information Injection 1

Information Injection 1.7
Information Injection 1.1

Information Injection 1.9
Information Injection 1.3

Figure 4. 26: Oneway analysis of likelihood index by medication amount/shift duration variablecontrol= true-true,
Information Injection=1

Figure 4. 26 represents the mean, standard deviation and the all pairs Tukey-Kramer test for similarity of means.
As would be expected, it is similar to the similar true-false graphs in terms of the increase in mean values and
decrease in variance as the level of information increases. There is more divergence among the trials which
dissipates as the level of information applied is increased.
The means comparison in Figure 4. 27 provide the analysis of similar means. Review of these methods shows the
means across the trials becoming statistically similar as they reach the 1.9 information injection level. This is a
result of as the information level increases, the likelihood of success increases (that is, agent performance
increasing), and approaches the limit of 100% success.
The parametric Tukey-Kramer test and the non-parametric Steel Dwass and Dunn’s methods show similar although
not identical results (Table 4-17, 4-67, 4-68, 4-69) Any differences in the parametric versus non-parametric
method can be ascribed to the nature of the data being skewed (non-normal). The connecting letters report for in
Table 4.17 for the Tukey-Kramer and Steel Dwass methods are similar for information injection values 1-1.5. There
is a difference between the methods for the 1.7 level and then they converge back together for the 1.9 level; as
described previously this is attributed to the effect of skewness and non-normality effects on the two tests.
The conclusion on model performance as it relates to this portion of the analysis is that the model behaves in a
fashion that coincides with both the intent of the design and what would be expected in terms of the performance
or a nurse in an actual setting. The relatively slight differences in the levels of performance, as measured by LI, are
moderate by the increases in the amount of information provided.
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Information Injection 1

Information Injection 1.5

Information Injection 1.1

Information Injection 1.7

Information Injection 1.9

Information Injection 1.3

Figure 4. 27: Analysis of means for true-true=1-1.9, for II trials

The output for the ANOM tests coincides with the other evaluations highlighting the difference in means among
the medication/shift duration trials. Of note is trial 503-300 which consistently stays within the decision limits for
each of the information levels. The 600-300 trial also stays within the decision limit boundaries with the exception
of the 1.9 information level. The 120-minute duration trials fall outside the boundaries throughout the range of
information levels: the likely cause of this is the consistent lack of completion of the MAP process for man of the
medications which is assumed to be due to the shorter shift durations.
The 480-minute trials also fall out of the decision limits. The cause of this remained elusive until a more detailed
examination revealed that the overall means of the 480-minute runs are uniformly and significantly above the
other means. Since the ANOM is calculated based on the population mean, the divergence of the 480-minute
trials, outside of the decision limits, can be rationalized on their higher mean values-thus making their departure
from the population mean greater. Understanding this, the implication is that the longer shift duration leads to a
higher likelihood of success. Examining the other medication amount/shift duration, LI mean values showcases
this concept: the longer the shift duration the higher the overall LI mean. This concept falls in line with the logic
that allowing more time to complete MAP tasks will lead to higher overall success in the MAP process. Note that
one artifact of the method of the graph in Figure 4. 28 is the shape of the curve at the left which reflects a
polynomial feature. This is because of the treatment of the information injection values as nominal rather than
continuous; the actual shape of the curve more resembles a curve of a polynomial degree 2 .
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Figure 4. 28: Comparison of LI means by information injection level

The connecting letters report in Table 4. 18 shows that the Tukey and Steel analysis show that II levels of 1 and 1.1
are similar indicating that there are four groups of means with 501-480, 600-480, 600-300 and 503-300, and, 498120 and 595-120 trials each having common mean values. At II level 1.5 and 1.9 are also similar among the two
methods. II levels. II level 1.3 differs for the two analysis methods at the 120-minute trials. At the 1.7 II level the
300 and 120-minute trials also differ among the analysis methods. The detail is provided in Table 4.66 through
Table 4.70 in the appendix. The differences between the results of the two methods are ascribed to the effect of
the data on parametric versus non-parametric factors. Note that the two non-parametric tests are similar. The
conclusion is that given the nature of the data that the non-parametric tests are more representative of the
similarities of means.
An evaluation of equal variances was performed. The expectation based on the model design, would be that the
variances would change over the course of information increase. As the Figure 4.29 and Table 4.71 in the appendix
demonstrates, the p values are less than the 0.05 alpha value and indicate that the null hypothesis for the
variances being equal should be rejected.
As noted previously, the true-true data set attempts to represent the performance of nurses in administering
medications. It is intended to model a number of key attributes of nurses and medications. The role of JIT
information is the key variable being assessed. Based on the overall performance of the model as assessed by the
statistically relevant changes in the response variable it can be concluded that the model responds as expected
and effectively demonstrates the performance of the agents and the positive effect of the insertion of information
into the MAP process.
As noted previously, there are a number of key characteristics that can be derived from the simulation. The
predicative nature of the rate of change of performance from information injection could prove valuable for future
optimization studies. The observation that the rate of change of performance slows at higher information levels
and that issues related to time and medication load are mitigated provides interesting options for improved
performance in a clinical setting.
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Table 4. 17: Connecting letters report for true-true for LI means by trial
Level

501-480
A

600-300

503-300

C

C

498-120

595-120

D

D

D
595-120

D
498-120

B

Tukey
1

600-480

A
B

Steel
Level

501-480
A

600-480

C

C

600-300

503-300

C

C

B
Tukey

D
E

1.1

A
B
Steel

C

C
D

501-480
A
Tukey

600-480

503-300

600-300

B

B

B

1.3
Steel

A
501-480
A

B
600-480
A

Tukey
1.5

A

B
503-300

B

B

C
A

C
A

595-120

498-120

C

C

C
498-120

C
595-120

D
E

E

C
498-120

C
595-120

C

C

C

C

A

Steel
501-480
A

B
600-300

498-120

E
595-120

600-480

B

B

600-300

503-300

C

C
D

B
Tukey
1.7
A
Steel
501-480
A
Tukey
1.9

A
Steel

B

B

B

600-300
A
B

600-480
A
B

503-300

A
B

A
B

B

B
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Information Injection 1

Information Injection 1.1

Information Injection 1.3

Information Injection 1.5

Information Injection 1.7

Information Injection 1.9

Figure 4. 29: Equal variance assessment true-true

174

Notional Model Replicate
One way to assess the performance of the information injection portion of the model is to attempt to replicate this
function outside of the model. A 100-element data set was developed by first developing a random number set,
and then transformed via application of a beta distribution. As with the actual model, the input values were
truncated at 0.5 for the lower level and 0.999 for the upper level. The graphical representation in Figure 4. 30 is
similar to that generated by the simulation. As with the simulation, as the multiplier representing the information
injection function increases from 1 to 1.9 the same effects occur; the variance decreases and the values
progressively congregate at or below the maximum threshold of 0.999.
The analysis below indicates similar results to the MAP simulation; variances differ as the multiplier increases. The
variance comparison tests all confirm differences in variances exists (Figure 4.31). The pairwise comparison of
means supports the observation of differing means among the groups. The Tukey- Kramer test indicates
similarities between three sets of pairs (Table 4. 19). The non-parametric test indicates conflicting results with
the Dunn’s method indicating more values with p values greater than 0.05. The Dunn’s test can be very
conservative test, especially if there are a larger number of comparisons (Table 4. 21).

Pseudo Likelihood

Figure 4. 30 represents
similar behavior to the data
created from the MAP
simulation with reduction of
variance and compression to
0.999 as the information
injection multiplier increases

Figure 4. 30: Oneway analysis of Pseudo likelihood index by information injection level

Table 4. 18: Analysis of variance
Source
InfoInject
Error
C. Total

DF
5
594
599

Sum of
Squares
7.498820
13.281087
20.779908

Mean Square

F Ratio

Prob > F

1.49976
0.02236

67.0773

<.0001*

Test
O'Brien[.5]
Brown-Forsythe
Levene
Bartlett

Figure 4. 31: Pseudo likelihood tests that the variances are equal
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The ANOVA and variance
tests in Table 4. 18 indicates
a difference in variance
between the 1-1.9 levels.

F Ratio
54.1760
30.4187
80.2816
48.4441

Prob > F
<.0001*
<.0001*
<.0001*
<.0001*

Table 4. 19: Comparisons for all pairs using Tukey-Kramer HSD

Level

- Level

Tukey
p-Value

Steel Dwass
p-Value

Dunn
p-Value

1.1
1.3

1
1

0.9998
<.0001*

0.7766
<.0001*

1
0.0004

1.3
1.5

1.1
1

<.0001*
<.0001*

<.0001*
<.0001*

0.0013
<.0001

1.5
1.5

1.1
1.3

<.0001*
0.1308

<.0001*
0.0434*

<.0001
1

1.7
1.7

1
1.1

<.0001*
<.0001*

<.0001*
<.0001*

<.0001
<.0001

1.7
1.7

1.3
1.5

<.0001*
0.0172*

<.0001*
0.0012*

0.0002
0.1864

1.9
1.9

1
1.1

<.0001*
<.0001*

<.0001*
<.0001*

<.0001
<.0001

1.9
1.9

1.3
1.5

<.0001*
<.0001*

<.0001*
<.0001*

<.0001
0.0002

1.9

1.7

0.2227

0.0057*

0.9314

As one measure, these results provide confidence that the effect of the information multipliers is independent of
the data set that it is used upon and, that the effects, such as decreasing variance and compression of the results
at the 0.999, can be replicated.
Analysis of 503 True-True Values
While a detailed analysis of each of the medication amount/shift duration simulations could be analyzed, a data
set best representing the group of simulations is being used for the detailed analysis. A method of data reduction
was considered. After appropriate review the selection of a representative data was done as a means to get a
representative set of data. Each of the trials were considered and evaluated. Using the criteria defined earlier, the
503-300 simulation run was selected for the detailed variable review. Recall the three factors used for the
selection of the data set were:
1) The consistency of the data throughout the ranges of each of the shift duration/medications per
shift/information injection combinations
2) The use of the data set(s) that reflected the application of the agent attributes and injection of
information
3) Balance of the influence of the other factors across the data subset such as shifts, medication
loading per nurse, agent attribute effects, and so on.
The data set generated from this simulation run demonstrated the following characteristics:
Homogenous sizes of the sub data sets, such as the variable control values (i.e. true-true, false-false, true-false,
false-true), information injection trials and medication amount/shift duration. The data sets have uniform
frequency counts for medications processed without regard to the division of the data set. For example, the
frequency of medications processed for each of the information injection levels was 6026, the shift splits were
identical at 18,108, and each of the MAP process steps is 6036. This uniformity provides more options for selecting
statistical analysis tools which allows more straightforward interpretations.
The 503-300 is consistent with the expected design output from the model as noted in the earlier analyses. The
data set appropriately responds to influences of agent attributes and the injection of information as demonstrated
in the previous data analysis. The 503-300 data set consistently performs within the boundaries of the expected

176

limits. Comparison of LI means by information injection level provides a representation of this in the form of
tracking the means across the II levels.
Analysis of MAP Process Step
A key element of the model is the six MAP process steps that represent the sequential set of actions the nurse
agent takes as it works to complete the medication administration process. These steps are designed as
independent steps and the outcome of one step does not influence the action of any other step. While in an
actual clinical setting, there could be some influence or interaction, no studies have been identified that draw such
a correlation.
Table 4. 20 highlights the frequency of the nurse agent successfully completing each respective MAP process step
as the level of information used changes. The table shows that as the level of information goes up, the success
rate increases. The number of successful completions starts at the level set by the beta distribution of about 85%,
while the success rate increases for each level of information increase, reaching near 100% at the 1.9 information
level.
The graph in Figure 4. 32 illustrates the increase in likelihood for each process step across the information increase
amounts. Consistent with the model design, each of the steps is similar in their change along the information
increase profile. The slight variation can be explained by the stochastic nature of the beta distribution.

Figure 4. 32: Graph of likelihood of successful completion of MAP process step
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Table 4. 20: Frequency of success/failure of completion of each step of the MAP Process
Patient check
Information Injection
1
1.1
1.3
1.5
1.7
1.9
Med check
Information Injection
1
1.1
1.3
1.5
1.7
1.9
Dose check
Information Injection
1
1.1
1.3
1.5
1.7
1.9
MAR check
Information Injection
1
1.1
1.3
1.5
1.7
1.9
Route check
Information Injection
1
1.1
1.3
1.5
1.7
1.9
Time check
Information Injection
1
1.1
1.3
1.5
1.7
1.9

N(FALSE)
918
582
217
90
44
13

Row %(FALSE)
15.21%
9.64%
3.60%
1.49%
0.73%
0.22%

N(TRUE)
5118
5454
5819
5946
5992
6023

Row %(TRUE)
84.79%
90.36%
96.40%
98.51%
99.27%
99.78%

N(FALSE)
896
585
223
94
45
24

Row %(FALSE)
14.84%
9.69%
3.69%
1.56%
0.75%
0.40%

N(TRUE)
5140
5451
5813
5942
5991
6012

Row %(TRUE)
85.16%
90.31%
96.31%
98.44%
99.25%
99.60%

N(FALSE)
890
570
222
100
39
29

Row %(FALSE)
14.74%
9.44%
3.68%
1.66%
0.65%
0.48%

N(TRUE)
5146
5466
5814
5936
5997
6007

Row %(TRUE)
85.26%
90.56%
96.32%
98.34%
99.35%
99.52%

N(FALSE)
895
572
220
88
52
27

Row %(FALSE)
14.83%
9.48%
3.64%
1.46%
0.86%
0.45%

N(TRUE)
5141
5464
5816
5948
5984
6009

Row %(TRUE)
85.17%
90.52%
96.36%
98.54%
99.14%
99.55%

N(FALSE)
849
533
217
103
57
19

Row %(FALSE)
14.07%
8.83%
3.60%
1.71%
0.94%
0.31%

N(TRUE)
5187
5503
5819
5933
5979
6017

Row %(TRUE)
85.93%
91.17%
96.40%
98.29%
99.06%
99.69%

N(FALSE)
891
542
204
87
48
25

Row %(FALSE)
14.76%
8.98%
3.38%
1.44%
0.80%
0.41%

N(TRUE)
5145
5494
5832
5949
5988
6011

Row %(TRUE)
85.24%
91.02%
96.62%
98.56%
99.20%
99.59%
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An analysis was done to compare each of the process steps to validate this assumption of the model build. Similar
to the previous analyses performed, a comparison of means/medians was performed. Both parametric and nonparametric tests were done to ensure consistency of results and limit the likelihood of type 2 errors (Table 4.73 in
appendix). The analysis confirms that the Model’s MAP process steps are analogous as observed in Table 4. 23.
The mean likelihood of success values; the values for each of the information levels among the Map Process steps
are noted to be similar (Table 4. 72 in the appendix).
Agent Attribute Analysis
For an agent-based modeling system, the attributes imbued upon the agents play an important role in the
operation of the model. For this particular model, a number of attributes were designed to influence the behavior
of the nurse and medication agents. The quantitative influence of these attributes was described earlier. Table 4.
21 provides the relative breakdown of the occurrence of each attribute in terms of percent and frequency. The
table below illustrates the relative contribution of each of the agent attributes for each of the information injection
levels. The value for N represents the number of medications administered during the respective information
injection level and the Col% refers to the percentage of the elements of each attribute in a given information
injection level. In essence, the N value infers the number of nurses in a category and is a function of the number of
medications a nurse agent might have in that particular category.
The model construction intends that the agent attributes would have consistent values over each information
injection level. As Table 4. 22 shows, the values for each category of agent attribute remains relatively constant
across the information injection range.

Table 4. 21: Descriptive statistics of agent attributes by information injection level
1
nurseExperience
moderate
novice
senior
fatigueStatus
FALSE
TRUE
interruption
FALSE
TRUE
medicationSeverity
low
medium
high
medicationDifficulty
difficult
intermediate
minimal
PatientLoadOut
high
low
med

Information Injection Level
1.3
1.5
N
Col %
N
Col %
3735 61.88 3585 59.39
1330 22.03 1319 21.85
971 16.09 1132 18.75

N
3577
1328
1131

1.7
Col %
59.26
22.00
18.74

N
3575
1279
1182

1.9
Col %
59.23
21.19
19.58

N
3591
1292
1153

Col %
59.49
21.40
19.10

1.1
N
Col %
3637 60.26
1283 21.26
1116 18.49

3206
2830

53.11
46.89

3083
2953

51.08
48.92

3015
3021

49.95
50.05

3012
3024

49.90
50.10

3022
3014

50.07
49.93

3000
3036

49.70
50.30

2812
3224

46.59
53.41

2839
3197

47.03
52.97

2835
3201

46.97
53.03

2873
3163

47.60
52.40

2855
3181

47.30
52.70

2840
3196

47.05
52.95

2402
1964
1670

39.79
32.54
27.67

2399
1965
1672

39.74
32.55
27.70

2404
1965
1667

39.83
32.55
27.62

2399
1968
1669

39.74
32.60
27.65

2400
1968
1668

39.76
32.60
27.63

2405
1967
1664

39.84
32.59
27.57

909
2858
2269

15.06
47.35
37.59

914
2855
2267

15.14
47.30
37.56

910
2856
2270

15.08
47.32
37.61

912
2856
2268

15.11
47.32
37.57

910
2865
2261

15.08
47.47
37.46

913
2854
2269

15.13
47.28
37.59

1517
1533
2986

25.13
25.40
49.47

1516
1403
3117

25.12
23.24
51.64

1501
1224
3311

24.87
20.28
54.85

1434
1297
3305

23.76
21.49
54.75

1559
1262
3215

25.83
20.91
53.26

1744
1476
2816

28.89
24.45
46.65
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Table 4. 22: Average impact values of agent attributes by information injection level

medSeverity
medDifficulty
nurseExperience
fatigueOutput
interruptionOutput
patientLoadOutput

1
1.025961
1.030061
0.998849
0.953115
0.9327
1.012434

1.1
1.025895
1.029987
0.998617
0.951077
0.933263
1.013494

1.3
1.026019
1.03007
0.997026
0.94995
0.93318
1.014728

1.5
1.025919
1.03002
0.998451
0.949901
0.933973
1.013014

1.7
1.025944
1.02992
0.998368
0.950066
0.933597
1.015374

1.9
1.02606
1.030028
0.999196
0.949702
0.933284
1.016667

Table 4. 23: Variable Importance: agent attributes variable importance independent resampled inputs summary
report for averaged II values
Column
Interruption
Med Severe
Med Diff
Patient Load
Fatigue
Experience

Main Effect
0.230
0.174
0.158
0.114
0.145
0.05

Total Effect
0.246
0.211
0.190
0.113
0.161
0.062

Each agent attribute category is assigned a numerical value that influences the performance or behavior of the
nurse agent. The relative contribution of the assigned numerical values of each of the categories within an
attribute creates, in essence, a weighted value, that leads to an overall average value for the attribute. Table 4. 22
lists these values for each attribute by information injection value. A value greater than one implies a positive
contribution to the likelihood index, and conversely a value less than one implies a negative benefit for that
particular attributes contribution to the likelihood index. The values should remain relatively constant with only
modest changes in attribute values changing for each information injection level due to other random changes in
the model during simulation runs. Figure 4. 33 provides a graphical representation of each of these values by
attribute and information injection level (the axis labeled Data can be interpreted as the Likelihood index). Note
that the change in values are at the level of only several thousandths, which is insignificant in terms of the impact
to the overall model.
The agent attributes operate in a way that is consistent with the design of the model and contribute in ways that
are expected with overall model performance. The attributes contribute in a measured way and as evidenced in
the false-true control group have a significant impact on the likelihood index in spite of the small values each
individual agent attribute conveys to the overall multiplier that modifies the likelihood index.
Evaluation of Likelihood Index
The Likelihood Index (LI) is the overall measure of the success of a nurse agent completing the MAP process
without errors. Errors are defined as not successful accomplishing each of the MAP steps in whole or in part. The
MAP is a composite statistic that reflects the influences of each of the agent attributes and stochastic model
features. There is an LI value for each medication that goes through the administration process.
Figure 4. 34 demonstrates the change progression as the information levels migrate from low (1.1) to high (1.9).
As would be anticipated, the frequency shifts from a diffuse pattern to be heavily concentrated at the maximum
level of 1.0. The frequency distribution clearly shifts to higher values along the II profile. As noted in previous
analyses, the standard deviation measurably decreases for each II increase as well. The geometric mean was
included as an evaluation parameter because of the polynomial increase of the LI function. While its rate of

180

change is different than the mean, the overall interpretation of the effect of information on the LI does not
change.
Figure 4. 35 represents an overlay plot with the mean value represented by the curvilinear line. As with the earlier
analysis, the means and medians increase in a linear fashion that is approximated by a polynomial function. The
boxplot overlay demonstrates the variance that is typical for this plot. The higher value of the medians is
expected since there is a significant number of values at the higher end of the LI. The values at the lower end
depress the mean. Table 4. 74 provides detailed information on the mean, median, standard deviation and range
information in support of Figure 4. 35 in the appendix.
The colored dots represent the nurse agents, the range of performance, the congregation of colors indicates the
binning of nurse agents in certain performance areas resulting from the performance characteristics generated by
their respective attributes.
A line was fitted for the purposes of examining the potential predictive capability (Figure 4. 36). The line fit for this
function has an R-Square of over 0.99 and each of the coefficients has p values below the 0.05 threshold indicating
that there is enough evidence for each of the coefficients to be valid. The use of the linear relationship is
observational at this point and a subject for future study, the use of this function could possibly be used to
optimize the information injection value against other objective criteria such as cost and risk.
The relative impact of agent attributes was assessed by performing least squares analyses. The purpose of this
analysis is to get an overall impression of the relative effects or impacts of the agent attributes on the outcome.
The previous analyses indicated that there is no covariant nature with the attributes. The nature of the data, its
significant amount of skew and non-normal distribution makes detailed analysis and interpretation problematic.
However, for the purposes of understanding the relative impacts of the attributes on the LI output, a least squares
analysis will be suitable. The initial analysis performed considered the overall performance of the attributes
without inclusion of the individual effects of information injection.
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Data by II Label=fatigueOutput

Data by II Label=medSeverityV

Data by II Label=interruptionOutput

Data by II Label=nurseExperienceV

Data by II Label=medDifficultyV

Data by II Label=patientLoadOutput

Figure 4. 33: Oneway analysis of agent attribute values, data = the multiplier value for the particular
attribute
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Distributions II=1
Likelihood Index

Distributions II=1.3
Likelihood Index

Distributions II=1.7
Likelihood Index

Summary Statistics
Mean
0.4096544
Std Dev
0.2874504
N
6036
Median
0.337542
Geometric Mean 0.2972386
Distributions II=1.1
Likelihood Index

Summary Statistics
Mean
0.7916199
Std Dev
0.2184559
N
6036
Median
0.8554565
Geometric Mean 0.7492207
Distributions II=1.5
Likelihood Index

Summary Statistics
Mean
0.9478844
Std Dev
0.0960541
N
6036
Median
0.993021
Geometric Mean 0.9417622
Distributions II=1.9
Likelihood Index

Summary Statistics
Mean
0.5655787
Std Dev
0.2922344
N
6036
Median
0.5684525
Geometric Mean 0.4653085

Summary Statistics
Mean
0.8975023
Std Dev
0.1453512
N
6036
Median
0.993021
Geometric Mean 0.8820871

Summary Statistics
Mean
0.9747863
Std Dev
0.0557428
N
6036
Median
0.993021
Geometric Mean 0.9728778

Figure 4. 34: Summary statistics for 503-300 likelihood index by information injection level
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Nurse Agents

Figure 4. 35: Graph of likelihood index with mean values for LI by II and boxplot overlay for 503 true-true

Polynomial Fit Degree=3
Mean = 0.1328971 + 0.5154363*II - 1.0169364*(II-1.41667) 2 + 0.885933*(II-1.41667)3
Figure 4. 36: Bivariate fit of mean of LI by II for 503-300 trial
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A measure of variable performance was done using JMP Fit Model. Table 4.24 provides the list of each of the
agent attributes and the relative contribution of each to the changes in the model averaged over each of the II
levels. Interruption has the greatest effect at 0.241 for the Main Effect which is an importance index that reflects
the relative contribution of that factor alone, not in combination with other factors. The Total Effects value is 0.257
which is an importance index that reflects the relative contribution of that factor both alone and in combination
with other factors. The other attributes descend in level of contribution with the experience of the nurse having
the least in terms of its effect in terms of impact to changes in the LI given a change in experience. Table 4.26
provides a comparison for information injection at the level of 1 through 1.9. Two things can be drawn from these
tables:
1) that the impact of individual attributes to the LI is different; and
2) the magnitude of contribution can change as the II changes. Overall, the relative impact remains about
the same among the attributes.
Based on the analysis and in accordance with previous analysis, each of the attributes were found to have effect
values of less than the alpha value of 0.05 indicating that they do have an effect on the outcome of the model. The
analysis of each attribute value was performed two of the analyses are shown in Table 4.75 in the appendix. The
first data column shows the resultant effect of the attributes averaged across all II values, the second column
shows these results for the II value equal to 1.9. For the averaged II values only moderate nurseExperience is
shown to have no effect.
Nurse Agent Detail
The model tracks medication administration at nurse agent for each individual medication. This allows the
evaluation of the performance of each nurse agent. Figure 4. 37 charts the performance path of each of the 40
nurse agents in this simulation. The breadth of performance at II level 1 results from the difference in agent
attributes established by the model at the start of the simulation. As the simulation proceeds to higher levels of
information, the nurse agent moves up the Likelihood Index scale. It is worthy of note that despite the wide
divergence of nurse performance at the early II levels, the nurse agents approach the same level of performance at
levels 1.7 and 1.9. This has an interesting implication; with the higher levels of appropriate JIT information, overall
nurse agent performance increases to approximately the same levels without regard to their respective attributes.
The conclusion is that JIT information mitigates the negative effects of attributes as well as random errors and
enhances MAP performance.
As with the bivariate fit for the overall mean shown in Figure 4. 35, lines can also be fit for each nurse agent. The
axis in this case are nominal instead of ordinal. As a result it is expected that the rate of change will be somewhat
different than that calculated early for the ordinal/categorical scale.
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Table 4. 24: Variable Importance: agent attributes variable importance independent resampled inputs summary
report for II = 1 through 1.9
Main Effect
1
1.1
1.3
1.5
1.7
1.9
1
Fatigue
0.136 0.159 0.148 0.168 0.157 0.102 0.149
Interruption 0.265
0.25 0.214 0.252 0.263 0.137 0.278
Med Diff
0.148 0.153
0.18 0.161 0.174 0.228 0.161
Med Severe
0.18
0.2 0.227 0.158 0.188 0.214 0.192
Experience
0.047 0.045 0.031 0.046
0.04 0.073
0.06
Patient Load 0.143
0.11 0.082
0.11 0.081 0.157 0.156
(Green highlighting Table 4. 24 indicates the largest contributing factor)

1.1
0.173
0.263
0.167
0.214
0.058
0.124

Total Effect
1.3
1.5
0.17 0.186
0.235 0.269
0.202 0.179
0.248 0.176
0.05 0.061
0.104 0.128

1.7
0.174
0.281
0.191
0.205
0.057
0.099

Figure 4. 37: Representation of the performance of each nurse agent as measured by LI for each II level
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1.9
0.115
0.15
0.241
0.227
0.086
0.169

Clinical Case Study
Overview and initial analysis
The clinical case study (CCS), as described in the materials and Methods section, used a classic controlled clinical
trial approach to evaluate the benefit, if any, of JIT on improving the likelihood of success in the MAP process. The
results of the CSS are tabulated in Table 4. 26. The scenario was designed to assess the performance of each of the
MAP steps, as well as overall performance in medication delivery. One of the successful outcomes, and in fact the
optimal one, was termination of the process prior to completing all the steps since early recognition of overdosing
of acetaminophen was a key factor in use and interpretation of the available information. This early termination
of the process makes it somewhat difficult to make direct conclusions on successful completion of each of the MAP
steps listed in Table 4. 25 since early termination would lead to a number of the MAP steps which would not be
completed. However certain general observations can be made.
1.
2.
3.
4.
5.

Initial interfacing with the patient is done by all the nurse groups
All of the groups used the MAR to access information, but with a varying degree of success, implying
information could play a role in overall successful completion of the process
Use of JIT information early in the process leads to increased performance
Use and deciphering of information, such as laboratory results, can be enhanced by JIT information
Use of JIT information, via the app, was enhanced by providing more specific training on its use, which
also infers that the amount of information that is available influences overall performance success

Table 4. 26 summarizes the results of the CSS with a total of 38 observations in the population. Eighteen of the
observations were the control group, with the remaining 20 being the response group. The response group has
sub-groups for pre-training and post-training with use of the JIT app: there are eleven observations in the pretraining group and nine observations in the post-training app.

Table 4. 25: Compilation of clinical case study data for each MAP process step

Trial
Control
Post-train
Pre-train

Pain
Assessed
Yes No
18
0
9
0
11
0

Patient
Checked
Yes No
13
5
2
7
8
3

MAR
Checked
Yes
No
18
0
9
0
11
0

Med
Checked
Yes No
17
1
2
7
8
3

Dose
Checked
Yes No
14
4
2
7
8
3

Correct Dose
Calculation
Yes
No
8
10
2
7
3
8

Performance
Succ Unsucc
2
16
7
2
3
8

Trial
Control
Post-train
Pre-train

Time
Checked
Yes No
16
2
9
0
11
0

Labs
Checked
Yes No
6
12
7
2
4
7

Labs
Understood
Yes
No
2
16
7
2
4
7

Route
Checked
Yes No
11
7
2
7
6
5

Used
App
Yes No
0
18
9
0
6
5

Full/Terminated
Terminated Full
2
16
7
2
3
8

Performance
Succ Unsucc
2
16
7
2
3
8
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Table 4. 26: Summary of data for clinical case study on benefit of JIT for MAP successful completion

Group
Control

Subgroup

Pre-Train
Treatment
Post-Train

JIT app usage
No app use
Sub totals
No app use
Limited app use
Significant app use
Sub totals
No app use
Limited app use
Significant app use
Sub totals
Totals

Performance
Unsuccessful Successful
16
2
16
2
6
0
2
0
0
3
8
3
0
0
2
0
0
7
2
7
26
12

Row totals
18
18
6
2
3
11
0
2
7
9
38

Power and Sample Size
Retrospective analysis was performed to evaluate the power and sample size for the clinical case study. JMP k
Means was used to do the estimated calculations. A pooled standard deviation for unequal sample sizes was
developed using the following equation:
𝑠𝑝𝑜𝑜𝑙𝑒𝑑 = √

(𝑛1 − 1) ∗ 𝑠12 + (𝑛2 − 1) ∗ 𝑠22 + ⋯ (𝑛𝑘 − 1) ∗ 𝑠𝑘2
𝑛1 + 𝑛2 + ⋯ + 𝑛𝑘 − 𝑘

k = number of samples
nk = population in each sample
sk = standard deviation for sample population
spooled = pooled standard deviation
The standard deviations contributing to the pooled estimate were obtained by doing a one-way estimate of MAP
performance by trial. The means and standard deviations for this are highlighted in Table 4. 27. Note that PostTrain is the largest mean indicating the best performance in terms of the highest likelihood of success.

Table 4. 27: Means and standard deviations of Oneway analysis of performance by trial for power and sample size
evaluation
This table uses the numeric values of 0
(false) and 1 (true) to calculate the mean
Level
Number
Mean
Std Dev
and Std Dev as an indication of the central
Control
18 0.111111 0.323381
Post-Train
9 0.777778 0.440959
tendency and dispersion of the values
Pre-Train
11 0.272727 0.467099

188

The resulting pooled standard deviation equals 0.458778. The calculated sample size for a power of 0.8 is 29. The
individual sample size is estimated by n/k leading to 29/3 or about 10 per level. This is compared to an actual
sample size of 11 for pre-training and 9 for post-training. Using this same methodology, a power of 0.78 results in
a sample size projection of 27 or 9 samples per level. Based on this assessment, the sample size of each group is
suitable for making statistically relevant conclusions, particularly considering the constraints of other factors of the
research design.
Overall, 26 (77.6% of the total) of the participants were not successful in completing the MAP, 12 or 23.4% were
successful. Within the Unsuccessful category, 62% were from the control group, 30% were from the pre-training
(pre-train) group and the remainder were from the post-training (post-train) group. Conversely, 58% of the
successful category were made up of the post-train Treatment group, with 25% and 17% respectively from the
post-train Treatment group and Control group.
Table 4. 28 provides a tabulation of the percent contributions for the Control and Treatment groups for both the
Successful and Unsuccessful completion of the MAP by the nurses. The first column represents the percentage of
a groups MAP successful performance relative to the rest of the groups. For example, of all the successful
completions, the Control Group contributed 16.67% of them and they did not use the app. The logic for the
second column is similar but refers to unsuccessful attempts. Columns 3 and 4 represent the contribution to the
overall percentage. Again, as an example, the post-training treatment group had 18.4% of the 38 groups
successfully complete the exercise with significant use of the app, whereas only 7.9% of the pre-training group
performed in the same way.
With that as background, several observations can be made using Table 4. 28 and Table 4.26:
1) The majority of successes, <73%, used the app to a significant extent
2) Training (or familiarity with the app) appears to play some role in the app use
3) The use of information appears to contribute to greater success rates between the Control group and
Treatment group
4) The degree to which the app is used (i.e. the amount of JIT information) seems to influence the success
rate; the more JIT information yields greater success. Said differently, limiting JIT information leads to
lower MAP performance

Table 4. 28: Percent contributions for the control and treatment groups for both the successful and unsuccessful
completion of the MAP by the nurses

Group

INFO

Control

Treatment

No app use

Post-train

Pre-train

Relative Percent of MAP
Performance
Column 1
Column 2
Column
Column
%(Success)
%(Unsuccess)
16.67%
61.54%

Percent of Overall Total
Column 3
% of
Total(Success)
5.26%

Column 4
% of
Total(Unsucc)
42.11%

Limited app use

-

-

-

-

Significant app use

-

-

-

-

No app use

0.00%

0.00%

0.00%

0.00%

Limited app use

0.00%

7.69%

0.00%

5.26%

Significant app use

58.33%

0.00%

18.42%

0.00%

No app use

0.00%

19.23%

0.00%

13.16%

Limited app use

0.00%

7.69%

0.00%

5.26%

Significant app use

25.00%

3.85%

7.89%

2.63%

Percent Totals

100%

100%

31.57%

68.42%
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Detailed Analysis
To evaluate overall response to the use of JIT information, a binary logit model scoring against if the nurse
successfully performed the MAP (variable=Performance) and measuring the effect of the use of JIT information in
the form of the app. The model used all 38 observations. Of the total observations, 26 were unsuccessful, 12 were
successful (Table 4. 29). Of the 12 that completed successfully, 10 used the app to some degree. Of the 26
unsuccessful, four used the app in some fashion (Table 4. 28 above). The model converged appropriately.
Table 4. 30 provides a null model set that illustrates and assumes no effect from the covariate of using the app
leads to 68.4% classification accuracy. Furthermore, the frequency of 26 and 12 are represented as statistically
significantly different from one another in Table 4. 31 shown by the significance of the Walds test. The
interpretation of the Exp(B) interpretation is that there is a 53.8% greater likelihood of not being successful
without outside intervention46. The Variables Not in eqn. row of this table shows that USEDAPP, the variable
identifying whether or not the nurse used the app, is significant at the alpha=0.05 level.
With the previous information setting the stage for what the results are with no effect from using the app, the
information in Table 4. 32 shows the output from the binary logistic regression performed after the treatment (i.e.
information supplied). The use of the app increases the predicted likelihood of successfully completing the MAP as
seen below in the bottom right section of Table 4. 32. Based on the analysis, the number of unsuccessful events
predicted is 21 versus the 26 observed in the actual outcomes. The number of statistically predicted successful
completions increases to 10 from 0 in the control. The model failed to predict 2 outcomes, that is there were 2
cases observed and the model did not predict and it also failed to predict 2 successful events. The 10 predicted
successful events associate well with the value in the Treatment cases which is also 10. The predictive capacity by
using the app increases by a significant 12% over the null model.
The USEDAPP variable is statistically significant at the 0.05 alpha value as provided by the Wald statistic (Table 4.
33). The odds ratios of 21.0 infers that the use of the JIT information app has a 21 times greater likelihood of
successfully completing the MAP when using the app, controlling for other factors within the analysis.

Table 4. 29: Summary response profile for null model set for use of the app
Response Profile
Ordered
Value Performance
1 0: Unsuccessful MAP
2 1: Successful MAP

Total
Frequency
26
12

Table 4. 30: Classification Table
Selected Casesb
Predicted
Performance

Step 0

Observed
Performance

Unsuccessful
Successful

Unsuccessful
26
12

Overall Percentage

46

https://www.youtube.com/watch?v=zdJhydkcqv4
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Successful
0
0

Percentage
Correct
100.0
0.0
68.4

Table 4. 31: Variables in the equation step 0
B
S.E.
Constant
-.773
.349
Variables Not in eqn. USED APP

Step 0

Wald
4.908

df
1
1

Sig.
.027
.000

Exp(B)
.462

Table 4. 32: Crosstabulation of performance vs. info use for chi-square

Performance

unsuccessful
success

Total

Information Use
no
yes
5
0
1.7
3.3
0
10
3.3
6.7
5
10
5.0
10.0

Observed Count
Expected Count
Observed Count
Expected Count
Observed Count
Expected Count

Total
5
5.0
10
10.0
15
15.0

Table 4. 33: Classification table for inclusion of USEDAPP
Selected Cases
Predicted
Performance

Step 1

Observed
Performance

Unsuccessful
Successful

Unsuccessful
21
2

Successful
5
10

Overall Percentage

Percentage
Correct
80.8
83.3
81.6

Table 4. 34: Variables in the equation step 1

Step 1

a

USED APP
Constant

B
3.045
-2.351

S.E.
.921
.740

Wald
10.935
10.096
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df
1
1

Sig.
.001
.001

Exp(B)
21.000
.095

In order to determine if the degree to which the app was used, and therefore the amount of information used,
made a difference in the outcomes, the amount of usage of the app was measured during the MAP process. This
data is based on a qualitative assessment of the degree to which the nurses used the app during the performance
of the scenario and was recorded as “no use”, “limited use”, or “significant use”. Since the comparison is being
done on the degree to which the app is used, data from the control group was removed and only the treatment
group was evaluated. The “no use” observations were also excluded since the comparison is being focused on the
“limited use” and “significant use” observations. A chi-square analysis was done using SPSS v.25 and was
performed between the response variable (performance) and information use (InfoUse)(Table 4. 34).
As seen in Table 4. 34, the observed count for not being successful in performance of the MAP and using the lower
amount of information was 5, whereas the expected count of no association, that is no association between
performance information use, would be 1.7. The expected value for being successful in completing the MAP with
no information is 3.3, however, the observed value was that there were zero occurrences. In further evaluation of
the table, the observed count for being successful in the MAP while using information was 10, while the expected
value would be 6.7. There were no observations of being successful completing the MAP at the higher levels of
information usage.
The chi-square results, in Table 4. 35, indicate statistically significant results at the alpha = 0.05 level as noted in
Asymptotic Significance column, which is the significance value indicator. Examining the Fisher’s Exact test with a
significance value below 0.05, indicates that the null hypothesis is not valid and therefore there is an association
between information use at the higher level and performance in the MAP. That is, performance is dependent on
the amount of information used.
Examining results for nominal association in Table 4. 36, Phi is used since the test was for a 2x2 chi-square. The
significance value is less than the alpha value of 0.05 and the effect value is 1.000. This high effect size can be
explained by examining the detailed data for Performance and Info Use; there is direct correspondence between
the amount of information used and successful performance resulting in the high level of association.
The relationship between duration of the process and overall success was noted earlier. Duration of the process is
directly influenced by its early termination. To evaluate this, the control group and each of the treatment group’s
duration of performance was considered. The average duration for the control group was 11:43 (minutes). The
average duration for the treatment group was 9:06 with the post-training group being 8:13 and the pre-training
group duration averaging 9:49. The durations were also examined by successful and unsuccessful performance;
successful performance observations had an average duration of 7:32 and unsuccessful averaged 11:38. Twosample t-tests were performed on both the duration by trial and performance durations and the p-values were
below the 0.05 alpha confirming that a significant difference does exist. This leads to the conclusion in case that
JIT information lead to earlier decision making, as well as, an overall increase in successful performance.

Table 4. 35: Chi-square results for performance vs. info use

Pearson Chi-Square
Continuity Correction
Likelihood Ratio
Fisher's Exact Test
N of Valid Cases

Value
15.000a
10.838
19.095

df
1
1
1

Asymptotic
Significance
(2-sided)
.000
.001
.000

Exact Sig. (2sided)

.000
15
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Exact Sig. (1sided)

.000

Table 4. 36: Symmetric measures test for association for performance * info use for chi-square.

Nominal by Nominal
N of Valid Cases

Phi
Cramer's V

Value
1.000
1.000
15

Approximate
Significance
.000
.000

Analysis of JIT information effects on scenario duration
A more detailed analysis of the differences of durations among the trial groups validates these findings. Four
separate T tests were performed to compare the overall treatment group with the control and to compare each of
the treatment subgroups (pre and post training) with the control group. Time was converted to a decimal format
using excel in order to simplify the analysis. Table 4. 37 provides the summary tables of all the T-Test
combinations. Each of the p values are less than the alpha=0.05 with the exception of the T test of the pre and
post training. This is likely the influence of the JIT intervention.
Table 4. 38 provides a one-way ANOVA of the durations for each of the groups. The p value of 0.0081 indicates a
significant difference between the values. Figure 4. 38 provides a graphical representation of the values for each
of the groups which highlights the differences in means and standard deviations. The analysis of means in Figure
4. 39 indicates that the control and post training groups fall outside the UDL/LDL, demonstrating the effect of the
JIT information on the duration of the scenario execution.
Figure 4. 40 highlights the mean and standard deviation for the control group and overall treatment groups. Table
4. 39 is the ANOVA for this comparison and indicates statistically significant differences between the groups at an
α=0.05 versus the p value of 0.0047. The Analysis of Means in Figure 4. 41 indicates divergence of both groups
from the calculated UDL/LDL emphasizing the difference in durations of the two groups.
The design of the simulation scenario had the use and understanding of lab results as a key factor in successful
performance. Considering the frequency of checking labs first (Table 4. 40), the control group had the lab checked
seven times versus missing checking the labs 11 times. A chi-square test (Table 4. 41) comparing the association of
the control/treatment groups with checking of lab results indicates that this is significant at the 0.05 alpha value;
there is, in fact, a statistically significant difference between how the control group and treatment group checked
on lab results. The Crammer’s V result is 0.315 indicating a medium level effect size implying that using the JIT app
had a moderate effect on checking the labs.
The next consideration is the effect the JIT might have on the understanding of the lab results and what influence
it might have on the outcome of the MAP process. As with the activity of checking the lab results, a chi-square test
was performed. The observed versus expected table (Table 4. 42) indicates the difference in the occurrence of the
control and treatment group’s values; as expected, fewer in the control group understood the lab results. The
following table, Table 4.43, provides the Chi-square results. Here the results are more dramatic. The association
of the control/treatment groups with understanding of lab results indicates that this is significant at the 0.05 alpha
value; there is, in fact, a statistically significant difference between how the control group and treatment group for
the understanding of lab results. The Crammer’s V result is 0.462 indicating a moderate to large effect size
implying that the consideration of using the JIT app had a moderate effect on checking the labs.
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Table 4. 37: T test calculations for time comparison
Control-Post training T test
Trial

N

Mean

StDev

SE Mean

18

0.488

0.115

0.027

Post train

9

0.343

0.120

0.040

T-Value

DF

P-Value

3.01

15

0.009

Control

Pre train-Post training T test
Trial

N

Mean

StDev

SE Mean

Post Train

9

0.343

0.120

0.040

11

0.4090

0.0915

0.028

T-Value

DF

P-Value

-1.37

14

0.193

Pretrain

Pre train-Control T test
Descriptive Statistics: Duration
Trial

N

Mean

StDev

SE Mean

Control

18

0.488

0.115

0.027

Pretrain

11

0.4090

0.0915

0.028

T-Value

DF

P-Value

2.05

24

0.05

All Treatments-Control T test
Trial Total

N

Mean

StDev

SE Mean

Control

18

0.488

0.115

0.027

Treatment

20

0.379

0.108

0.024

T-Value

DF

P-Value

3.01

34

0.005
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Figure 4. 38: Mean and standard deviation for duration by trial

Table 4. 38 : Analysis of variance for duration by trial
Source

DF

Trial
Error
C. Total

2
35
37

Sum of
Squares
0.13473575
0.42469931
0.55943507

Mean Square

F Ratio

Prob > F

0.067368
0.012134

5.5519

0.0081*

Figure 4. 39: Analysis of means for duration by trial
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Figure 4. 40: Mean and standard deviation for Duration by Total Trial

Table 4. 39: Analysis of Variance for Duration by Total Trial
Source

DF

Trial Total
Error
C. Total

1
36
37

Sum of
Squares
0.11283748
0.44659758
0.55943507

Mean Square

F Ratio

Prob > F

0.112837
0.012405

9.0958

0.0047*

Figure 4. 41: Analysis of means for duration by total trial

Table 4. 40: Labs checked crosstabulation

Labs Checked

No
Yes

Total

Observed Count
Expected Count
Observed Count
Expected Count
Observed Count
Expected Count

Control vs. Treatment
Control Treatment
11
6
8.1
8.9
7
14
9.9
11.1
18
20
18.0
20.0
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Total
17
17.0
21
21.0
38
38.0

Table 4. 41: Chi-square test comparing control/treatment group with occurrence of checking lab results
Asymptotic
Significance Exact Sig. Exact Sig.
(2-sided)
(2-sided) (1-sided) Point Probability
.05
.101
.05
.101
.05

Value
df
Pearson Chi-Square
3.709a
1
Fisher's Exact Test
N of Valid Cases
38
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 8.05.

Table 4. 42: Labs understood crosstabulation

Labs Understood

No
Yes

Total

Control vs. Treatment
Control Treatment
16
9
11.8
13.2
2
11
6.2
6.8
18
20
18.0
20.0

Observed Count
Expected Count
Observed Count
Expected Count
Observed Count
Expected Count

Total
25
25.0
13
13.0
38
38.0

Table 4. 43: Chi-square test comparing control/treatment group with occurrence of understanding lab results

Value
8.108a

Pearson Chi-Square
Fisher's Exact Test
N of Valid Cases

df

Asymptotic
Significance (2sided)
1
.004

Exact Sig. (2sided)
.006

38

Table 4. 44: Used app and labs understood crosstabulation

Labs Understood

No
Yes

Total

Observed Count
Expected Count
Observed Count
Expected Count
Observed Count
Expected Count

USED APP
No
Yes
21
4
15.1
9.9
2
11
7.9
5.1
23
15
23.0
15.0
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Total
25
25.0
13
13.0
38
38.0

Exact Sig. (1sided)
.005

Table 4. 45: Chi-square test comparing Understanding labs and use of the JIT app

Pearson Chi-Square
Fisher's Exact Test
N of Valid Cases

Value
16.854a

df

Asymptotic
Significance (2sided)
1
.000

Exact Sig. (2sided)
.000

Exact Sig. (1sided)
.000
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One final analysis was done considering the interrelationship of use of the app on understanding the lab
results. The results are presented in Table 4. 44 and Table 4. 45. As can be seen, and what would be
expected from the previous analyses, is that there is an association between use of the app and the
understanding of the lab results. The p value is well below the 0.05 alpha threshold and the Crammer’s V is
calculated at 0.666 indicating a large effect of use of the app on the understanding of the lab results.
A binary logit regression was performed and provided a p value of <0.001, and odds ratio (Exp(B)) of 38.33
and Nagelkerke R square of 0.561. These results indicate a significant benefit provided by use of the smart
phone app in understanding the laboratory results (detailed results in Appendix 1).
Analyzing Control Group versus Treatment Group
The evaluation of Control vs. Treatment groups yielded the results seen below. In this analysis there is no
discrimination between pre and post-training. Table 4.46 provides the null model which uses no predictive
variables (i.e. does not include the effect of treatment, or, it is an intercept only model). This table indicates what
the expected results would be. Without the effect of treatment, the prediction would be that 26 of the
observations would result in unsuccessful completion of the MAP and 12 of the attempts would result in successful
attempts. The null model provides 68.4% predictive capability.
The only variable considered in the model is the consideration of treatment versus non-treatment (control). Table
4. 47 illustrates what significance the Treatment value will play when it is entered into the logistic regression. At
an alpha of 0.05, the significance of Treatment allows us to reject the null hypothesis that there is not an influence
contributed by the Treatment.
Table 4. 48 considers the performance of the logistic regression with inclusion of the Treatment variable, the
significance value of 0.008, which is less than the alpha of 0.05, indicates that the influence of the Treatment is a
good predictor for the regression results.
The output also provides a Nagelkerke R2 of 0.240. This value shows how much of the variance in the dependent
variable is a result of the effect of the Treatment variable in the regression. In this instance, 24% of the variance is
explained by the role of Treatment. While not extremely large, the effect is substantial enough to be of value.
The classification table results after incorporating treatment indicates better prediction of the individual outcomes,
while the overall predictive capability of 68.4% remains the same as the null hypotheses (Table 4. 49)
Based on this analysis, the conclusion can be made that the effect of the variable Treatment (addition of
information) does have a statistically significant effect on the MAP outcome. Furthermore, the coefficient of 2.079
indicates that there is a significant effect between the control group and the treatment group in terms of the MAP
being accomplished correctly. As noted previously, this analysis considers just the effect of overall use of the app
and does not include pre- and post-training effect. As noted in the assumption and limitations section the use of
information in this context conveys the implication that the insertion of information includes the ability to
effectively translate it into action.
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Table 4. 46: Classification table for effect of treatment
Predicted

Step 0

Observed
PERFORMANCE

PERFORMANCE
Unsuccessful
Successful
26
0
12
0

Unsuccessful
Successful

Overall Percentage

Table 4. 47: Variables not in the equation for treatment

Step 0

Variables
Treatment
Overall Statistics

Score
6.631
6.631

df
1
1

Table 4. 48: Omnibus tests of model coefficients for treatment

Step 1

Step
Block
Model

Chi-square
7.114
7.114
7.114

df
1
1
1

Sig.
.008
.008
.008
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Sig.
.010
.010

Percentage
Correct
100.0
0.0
68.4

Analysis of Training Effect
A chi-square test was performed to determine if an association exists between the amount of training and the
successful completion of the MAP. Table 4. 50 provides the cross tabulation of the chi-square test, the expected
count, that is, the responses we would get if there is no association, are 5.5 for each value of performance for Pretraining. The expected count for Post-training is 4.5 for each value of performance. The observed counts are
notably different than the expected counts.
Table 4. 51, the Asymptotic Significance which serves as the p-value 0.025, is clearly less than the α=0.05
therefore, the level training effect is statistically significant and there is an association between training level and
performance. The likelihood ratio is also significant at a value of 0.021. The Fisher’s Exact test of 0.07 is however
not significant, at an alpha of 0.05. The differences in significance could be a function of sample size, with two of
three indicators implying significance, the assumption is that the differences are significant. This assumption is
corroborated later in the binary linear regression analysis. The Phi value of 0.503 indicates that the amount of
training has a strong effect on performance.
Binary logistic regression was also performed to help understand the training effect further. The initial null model
(Table 4. 54) predicts a 50% chance of prediction with no predictor variables in the model.
Table 4.52 shows the null table. Table 4. 53 shows the result in the classification table with the inclusion of the
predictor variable of training. The value increases to 75% compared to the 50% of the classification table without
the inclusion of the predictor variable. The only variable considered in the logistic regression is pre versus post
training. Table 4. 54 illustrates what the significance of the Training value is in the logistic regression. At an alpha
of 0.05, the significance of Training at 0.025 allows us to reject the null hypothesis that there is not an influence
contributed by the Training.
Table 4. 55 considers the performance of the logistic regression with inclusion of the Training variable, the
significance value of 0.021, which is less than the alpha of 0.05, indicates that the influence of the Training is a
good predictor for the regression results.

Table 4. 49: Effect of treatment variable (Control versus Treatment groups)

Step 1a

Treatment
Constant

B
2.079
-2.079

S.E.
.873
.750

Wald
5.671
7.687

df
1
1

Sig.
Exp(B)
.017 8.000
.006
.125

Table 4. 50: Crosstabulation for training * PERFORMANCE

Training

Total

Pre-training Observed Count
Expected Count
PostObserved Count
training
Expected Count
Observed Count
Expected Count

PERFORMANCE
Unsuccessful Successful
8
3
5.5
5.5
2
7
4.5
4.5
10
10
10.0
10.0

Table 4. 51: Chi-square test for training amount effect on performance
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Total
11
11.0
9
9.0
20
20.0

95% C.I. for EXP(B)
Lower
Upper
1.445
44.297

Value
5.051
3.232
5.300

Pearson Chi-Square
Continuity Correction
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases
Nominal by Nominal
Phi
Cramer's V

Asymptotic
Significance (2sided)
1
.025
1
.072
1
.021

df

Exact Sig. (2sided)

.070
4.798
20
.503
.503

1

.028
.025c
.025c

Table 4. 52: Classification table for effect of training effect without predictor variable

Step 0

Observed
PERFORMANCE

Predicted
PERFORMANCE
Unsuccessful Successful
0
10
0
10

Unsuccessful
Successful

Percentage
Correct
.0
100.0
50.0

Overall Percentage

Table 4. 53: Classification table for effect of training effect with predictor variable

Step 1

Observed
PERFORMANCE

Predicted
PERFORMANCE
Unsuccessful Successful
8
2
3
7

Unsuccessful
Successful

Overall Percentage

Table 4. 54: Variables not in the equation for training

Step 0

Variables
Training
Overall Statistics

Score
5.051
5.051

df
1
1

Table 4. 55: Omnibus tests of model coefficients for training

Step 1

Step
Block
Model

Chi-square
5.300
5.300
5.300

df
1
1
1

Sig.
.021
.021
.021
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Sig.
.025
.025

Percentage
Correct
80.0
70.0
75.0

Exact Sig. (1sided)

.035

The output also provides a Nagelkerke R2 of 0.310 (Table 4. 56). This value shows how much of the variance in the
dependent variable is a result of the effect of the Treatment variable in the regression. In this instance, 31% of the
variance is explained by the role of Treatment. While not extremely large, the effect is substantial enough to be of
value.
The odds ratio and coefficient are displayed in Table 4. 52. The odds ratio of 9.333 implies a magnitude of over
nine times greater likelihood of having a successful outcome of MAP completion with a beta coefficient of 2.234.
Based on this analysis, the conclusion can be made that the effect of the variable Training (pre vs post training)
does have a statistically significant effect on the MAP outcome. Furthermore, the coefficient of 2.234 indicates
that there is a significant effect between the control group and the treatment group in terms of the MAP being
accomplished correctly.
Recapitulation
The goal of the clinical case study was to ascertain what role JIT information might play in affecting nurse
performance in the MAP process. The fundamental conclusion can be made, based on the analysis of clinical case
study information, that the use of the app and the associated access to JIT information increased the likelihood of
success of the MAP.
The results and observations from the analyses demonstrates the following:
•
•
•

•
•

The treatment group, using an app providing JIT information, had overall improved MAP outcomes
measured than the control group which had no access to the JIT app.
There is a direct association between using an app providing JIT information and improvement in the
outcome of the MAP process.
The difference in MAP outcomes for pre and post-training was statistically significant, post-training having
better performance, and it can be used as an indicator that the degree to which information is used
improves outcomes.
Early termination of the scenario by the nurse to check with the physician on the proper dosage
influenced the completion of other steps of the MAP process.
Use of the app improved the checking of lab values and the understanding of the implications of lab
values and lead to improved decision making for the MAP.

Table 4. 56: R-Square coefficient for training

Step
1

-2 Log likelihood
22.426a

Cox & Snell R
Square
.233

Nagelkerke R
Square
.310

Table 4. 57: Effect of training variable

Step 1

Training
Constant

B
2.234
-.981

S.E.
1.049
.677

Wald
4.530
2.099

df
1
1
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Sig.
.033
.147

Exp(B)
9.333
.375

95% C.I. for EXP(B)
Lower
Upper
1.193
72.991

The CCS used a modest sized cohort to assess the role of providing JIT information in MAP performance. The size
of the groups (control and treatment) and the sub-group (pre and post training subgroup within the treatment
group) were evaluated retrospectively and were determined to be of appropriate size to have sufficient power of
0.8 to provide meaningful statistics, although the post-training sub-group was at the margin of meeting the
number of samples.
A primary goal of the CCS was to inform the development of the agent-based modeling effort and to confirm the
hypothesis that JIT information would be effective in increasing the effort of administering medication. The
foregoing analyses does provide credence to the hypothesis that the application of JIT information is significant in
improving overall MAP success. While the methodology was not designed to identify the effect of information on
each step, it has been proven to increase performance in several key process steps. While one must be cautious
generalizing the benefit of JIT information for all of the MAP steps, it would not be unreasonable to assume that
information specifically tailored for each MAP process step would have some positive effect in reducing
medication administration error and improving MAP success rates.
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Chapter 5
Summary of Findings
Revisit of the Goal
There are two separate but related parts of this research effort; a clinical case study that assesses the effect of JIT
information on the successful completion of the administration of medication, and the construction, verification
validation of an agent-based model that represents the nurse MAP. The primary purpose of the clinical trial was to
provide the underpinning confirmation of the impact of JIT on nurse performance. The intent of building an ABM
was to first establish that an ABM could be constructed that effectively reflected nurse performance during the
medication administration process, and then to use the agent-based computer model to assess the effect of JIT
information on the likelihood of success in the MAP.
Clinical Case Study
A clinical study was developed to assess the effect of JIT information via a smartphone app on the performance of
administering medication by nurses. The study used student nurses in their senior year and the HITS lab to
perform a specifically designed scenario for the administration of medication. This approach provided controlled
experimental conditions that allowed direct monitoring via audio and video of the test subjects performance: the
physical environment, the scenario, and the “patient” mannequin were identical for each test run. The scenario
was detailed, scripted, rehearsed and conducted in the same fashion for each run. Using student nurses afforded
consistency of each of them having approximately the same level of experience; the scenario was performed by
small groups of two to three nurses. The testing took place over two semesters, the fall semester of 2015 and the
spring semester of 2016. The clinical study was performed in accordance with IRB guidelines. There was a total of
38 runs of the scenario, eighteen of which served as the control group and were not provided the JIT smartphone
app but had access to all other information including the EMR/MAR. The remaining 20 runs were the
treatment/response group, which used the smartphone JIT app. The response group was also divided into the pretraining group, which was provided a brief overview of the app and the post training group which was given the
same overview, but a worksheet to complete while using the app.
The clinical evaluation for the effect of JIT information on the MAP demonstrated that the information obtained
via the app increased the likelihood of the nurse performing the MAP correctly in contrast to the control group
which did not have access to information via the app. Furthermore, the degree to which the app was used
provided different outcomes. Increased use of the app resulted in improved likelihood of success. The initial
assessment, comparing the control group to the treatment group, demonstrated increased likelihood of successful
MAP performance with an odds ratio of 8.00 implying an 8-fold increase in likelihood of successful MAP
completion when considering the Treatment variable.
While all of the treatment groups had access to the use of information via the app, not all of the subjects used it,
or if they did use it some did not use it effectively. If one considers those who used the app versus those who did
not, the results show significant improvement in performance for those that used the app. The use of the app
results in an odds ratio of 21 for increased performance of using the app, and the beta constant of 3.045 when the
dependent variable is successful at completion of the MAP process, thereby demonstrating increased nurse
performance for those that used the app.
The treatment group had two sub groups, the pre-training group and the post-training group. The pre-training
group was given a brief verbal overview and approximately 15 minutes to use the JIT app prior to the participating
in the scenario. The post-training group was also provided the verbal overview but also completed a worksheet
that required them to use the JIT app. The amount of training had a statistically significant impact on
performance, influencing both the use of the JIT app as well as increasing their likelihood of success in
performance of the medication administration scenario. The chi-square and likelihood ratio results of 0.02
indicate statistical significance at the α=0.05. The binary logistic regression provided a significance level of 0.33
and an odds ratio of 9.33.
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Other insights have been gained from the clinical portion of the research. An observation obtained from
evaluating the performance of the control group was the lack of use and understanding of the patient’s laboratory
results. In the clinical scenario used, laboratory results provided key information on the correct decision path. The
response group demonstrated increased review with a chi-square significance value of 0.05 and a better
understanding, with a chi-square significance of 0.00, for the laboratory results.
The use of the app resulted in shorter scenario times indicating the nurses were reaching decisions more quickly
when information from the app was used. Both the t test and ANOVA confirmed a statistically significant
difference in the duration of the scenarios between the control and treatment groups. The implication is that the
JIT information can serve as an effective decision-making aid helping to guide the nurse to better informed
decisions more quickly.
A primary goal of the CCS was to inform the development of the agent-based modeling effort and to confirm the
hypothesis that JIT information would be effective in increasing the effort of administering medication. The
foregoing analyses does provide credence to the hypothesis that the application of JIT information is significant in
improving overall MAP success: specifically, the app was successful in transferring information to the user and the
information improved overall performance in MAP execution. While the methodology was not designed to
identify the effect of information on each step, it has been proven to increase performance in several key process
steps. While one must be cautious generalizing the benefit of JIT information for all of the MAP steps, it would not
be unreasonable to assume that information, specifically tailored for each MAP process step, would have some
positive effect in reducing medication administration error and improving MAP success rates.
Medication Administration Process Model
A computer simulation that modeled the nurse related process of medication administration was developed using
the program AnyLogic. An agent-based modeling approach was used because it afforded the ability to have
multiple interactions among a variety of entities and allowed for incorporation of multiple attributes and a
dynamic structure for the interactions amongst the objects within the model.
Three agent types were used in the model: nurses, patients and medications. Each agent type had a set of
attributes that conveyed individuality to each particular agent. The attributes modified the agent’s behavior and
influenced their performance while executing the MAP. The numbers of nurse and patient agents where held
constant while the number of medication agents were allowed to change depending on the attributes of the
patients and nurses. The interactions between patients and nurses changed over time as the simulation ran, the
number of patients a nurse agent would have was assigned randomly at the start of the simulation run. The
number and type of medications assigned to a patient was assigned randomly based approximately on a uniform
distribution. Nurse agents were assigned to one of two shifts; shift duration was the length of time a nurse agent
was allowed to distribute medications to their allotted patients.
The MAP portion of the model was made up of each of the key MAP steps medication check, MAR check, dose
check, patient check, route check, and time check. In a figurative sense, for every medication, a nurse agent would
pass sequentially through each of this process steps. A probability engine inside each step would determine the
likelihood of successful completion of each step. At the end of all of the steps a composite Likelihood Index would
be calculated that determined the overall probability of the nurse agent’s successful completion of the overall
medication administration process. The effect of agent attributes and the impact of JIT information was controlled
as part of the overall simulation process.
The validation and verification of the model was performed using a variety of methods. Numerous tracking
variables were built into the model in order to track its execution and ensure that the model’s processes
performed as intended. Considerable effort was placed on statistical analysis of simulation output to verify the
model’s performance.
Six simulations were designed to evaluate model performance and to represent the influence of JIT information on
nurse agent performance. A combination of shift durations and total medication amounts (which influences
medications per nurse) was used. Three different durations and two levels of total medication amounts were
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selected, giving a total of six scenarios that were run and analyzed. The levels for duration and total medications
were selected to represent amounts that were believed to stress the model, as well as appropriately reflect levels
that represent amounts found in a typical acute care setting.
Each of the six scenarios performed largely as expected. The shorter duration shift time reflected a higher rate of
incomplete medication runs and lower overall likelihood of success probabilities. As duration increased, the
overall probability of success increased. As the number of total medications increases, the overall likelihood of
success decreases. The lower time amount was found to have considerable “jitter” in the response due to
incomplete delivery of medications which was due to the short time period.
The influence of JIT information was done via a multiplier. As with the clinical trial, information had a dramatic
effect on nurse agent performance. The rate of increase followed a polynomial increase, with the rate of
performance increase, decreasing as more information was inserted into the system. As the overall performance
increases, the associated standard deviation decreases by roughly a proportionate amount. This is expected since
as more information is injected into the system, overall performance congregates near 1.00 which depresses the
variance.
With all six simulations, there were over 950,000 lines of data with each line having over 100 variables resulting in
95 million data elements. It was necessary to reduce the data set to a manageable amount for more detailed
analysis. One simulation was selected that best represented model performances. This selection was based on a
comparative assessment within and among the six simulations based on a specific set of selection criteria.
The data was appropriately tortured for this more detailed analysis. The specific influence from each of the agent
attributes, the performance at each MAP process step, as well as overall model performance was analyzed.
Several specific conclusions can be reached from this analysis. As the amount of information increases, the effect
of agent attributes on overall performance decreases, reaching the point of no discernable impact at the highest
level of information. The implication here is that information can mitigate the negative effects of attributes such
as inexperience, fatigue, higher patient loads and medication complexity on performance.
Another consideration, discerned from the detailed analysis, is that the effect of information behaves in a
predictable pattern. This can be used to support building a predictive model to project outcomes based on
changes in attributes and the addition of information.
Each of the individual process steps was analyzed in terms of the effect of information on the overall likelihood of
success. The observation is that, for this model, each of the steps behaves similarly. This result is expected since
the model design did not add any feature that would create differences among the process steps.
Of note is the ability of the model to consider the performance of each individual nurse agent. The performance of
each agent can be mapped over the profile of increasing information injection in order to see the response of the
individual as information increases. Of particular interest is the effect of information on the individual agents as
the information increases. While not the purpose of this study, it is possible that this ability can be used to
optimize how information can be used to improve MAP processes in consideration of costs and other factors.
In summary, the MAP computer simulation model and the data from the clinical case study align: the model
accurately reflects nurse performance and appropriately represents the effect of JIT information. The model
provides utility in being able to discern overall nurse agent performance as well as individual performance of nurse
agents. While not explored in detail, the model appears to have inherent predictive capability as well as the ability
to support optimization of the MAP process.
Future Work
This area of research provides rich opportunities for additional pursuit. As with this research effort, the
consideration of future work foals within two main categories: the use of simulated clinical environment like the
HITS lab to perform clinical trials and the use of computer simulation to provide a richer understanding of real
world phenomena and to explore a diversity of scenarios. Ideally these two facets would be combined.
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Clinical Simulation Environment
The HITS lab is an excellent resource to perform modest clinical trials. Resource limitations make it difficult to use
multiple patients (mannequins) or test subjects. Expansion of these resources would provide a richer environment
to perform a wide array of clinical trials with a greater degree of experimental control while eliminating many of
the barriers faced in using an actual clinical setting.
As a first step constructing the clinical trial to provide differing levels of information to the test subjects in order to
specifically assess the role of the amount of information injected into the performance of the MAP would be
valuable. This could be accomplished be either providing additional categories of information for different test
groups or providing increasing content for each category of information.
It can be envisioned to use a larger HITS-like environment with larger numbers of patients to more realistically
represent an acute care setting. The scenarios could be enhanced to allow multiple medications along with various
ward types (pediatrics, medical-surgical, oncology, etc.).
While student nurses proved to be well-suited for this study, repeating this research with nurses with various
levels of experience and training would broaden the value of this research. In the same vain, using multiple
medications over a greater period of time would also add a richness to this research.
Reconstructing the scenario to be open-ended, that is, to allow various integrated scenarios using multiple
medications to run simultaneously would more closely mimic actual MAP operations.
Computer Simulation
The development of the MAP computer model, developed for this research effort, provides insight on areas for
additional development. ABM is an excellent simulation tool for the MAP. Augmenting this with additional agent
types and more interaction among the agents would provide a model that has increased capability for prediction
and optimization.
While prediction and optimization were not part of this research, it would be a natural next step. The ability to use
objective functions to measure the value and optimize to gain better efficiencies in terms of risk, cost and
utilization of resources would be of direct benefit to the health care community.
Expanding the model’s agents’ emergent attributes and properties would provide an enhanced approach to
simulate the complex system of MAP. Also, in line with this and the concept of complex adaptive systems would
be integration of a MAP computer model with outside influences ranging from other hospital functions, such as a
pharmacy operation, to other more general influences such as procedures, policies and economic drivers.
Broader Context
The use of JIT information appears to improve outcomes in high consequence environments where human
performance plays a key role. Areas where immediate decision making regarding factors influencing health and
safety and rapid response, particularly where small mistakes can cascade to have a large impact could benefit from
a JIT information approach. Applications including nuclear, aviation, chemical processing, finance, and healthcare
are likely candidate areas. Conceivable small apps developed for specific purposes could provide the same positive
benefit as was identified with this research. Furthermore, the application of artificial intelligence into the apps
could aid in identifying incipient errors and provide timely course correction without being obtrusive.
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Table 4. 58: Mean, median and standard deviation (SD) values for Figure 4. 28
Trial
1
1.1
1.3
1.5
1.7
498-120

501-480

503-300

595-120

600-300

600-480

1.9

Trial mean

mean

0.54957

0.73258

0.87278

0.94573

0.97782

0.99157

0.84501

median

0.54435

0.74966

0.93588

0.99302

0.99302

0.99302

0.86816

SD

0.18304

0.19773

0.14206

0.08151

0.03772

0.00683

0.10815

mean

0.55043

0.732

0.87296

0.94332

0.9788

0.99146

0.84483

median

0.5445

0.74695

0.93807

0.99302

0.99302

0.99302

0.8681

SD

0.17926

0.19715

0.14375

0.08416

0.03624

0.00712

0.10795

mean

0.54937

0.73087

0.87335

0.94514

0.97759

0.99157

0.84465

median

0.54638

0.7441

0.94009

0.99302

0.99302

0.99302

0.86827

SD

0.18105

0.19887

0.14292

0.08285

0.03852

0.00684

0.10851

mean

0.54825

0.73168

0.87381

0.94583

0.97865

0.9917

0.84499

median

0.54328

0.74763

0.93973

0.99302

0.99302

0.99302

0.86828

SD

0.18248

0.19884

0.14333

0.08211

0.03668

0.00655

0.10833

mean

0.54455

0.728

0.87494

0.94446

0.97811

0.99155

0.8436

median

0.53644

0.74027

0.9412

0.99302

0.99302

0.99302

0.86616

SD

0.18063

0.19995

0.14041

0.08184

0.03745

0.00691

0.10787

mean

0.5397

0.73187

0.87515

0.94532

0.97838

0.99158

0.84367

median

0.53016

0.74114

0.94413

0.99302

0.99302

0.99302

0.86575

SD

0.18286

0.19812

0.1423

0.08136

0.037

0.00673

0.10806

Info level mean

0.54698

0.73117

0.87383

0.94497

0.97822

0.99157

Info level median

0.54085

0.74496

0.93985

0.99302

0.99302

0.99302

Info level SD

0.18155

0.19845

0.14246

0.08231

0.03727

0.00683
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Table 4. 59: Tukey report for true-false trial

Level
501-480
503-300
503-300
595-120
595-120
595-120
600-300
600-300
600-300
600-300
600-480
600-480
600-480
600-480
600-480

- Level
498-120
498-120
501-480
498-120
501-480
503-300
498-120
501-480
503-300
595-120
498-120
501-480
503-300
595-120
600-300

p-Value
1
0.9998
1
0.9989
0.9979
0.9799
0.9996
0.6231
0.4293
0.7056
0.8522
0.0217
0.0069
0.0279
0.0544
0.5352

1.1
1
0.9992
0.9998
1
1
1
0.8484
0.8923
0.969
0.9103
1
1
0.9998
1
0.8818

1.3
0.9993
0.9801
0.9992
0.8929
0.9818
0.9995
0.945
0.9947
1
1
0.787
0.9398
0.9944
0.9999
0.9986

1.5
0.5982
0.9988
0.9513
0.9998
0.831
0.9971
1
0.5108
0.9969
0.9211
0.9991
0.9689
0.7321
1
0.989

1.7
0.9991
0.9878
0.9132
0.9674
0.9982
0.6814
1
0.9931
0.9966
0.9057
0.9983
1
0.8838
0.9985
0.9884

1.9
0.9997
0.9811
0.9175
0.2773
0.1461
0.7348
0.9987
0.9814
0.9994
0.4564
0.9993
0.9868
0.9987
0.4199
1

Table 4. 60: Steel Dwass report for true-false trial

Level
501-480
503-300
503-300
595-120
595-120
595-120
600-300
600-300
600-300
600-300
600-480
600-480
600-480
600-480
600-480

- Level
498-120
498-120
501-480
498-120
501-480
503-300
498-120
501-480
503-300
595-120
498-120
501-480
503-300
595-120
600-300

Steel Dwass p-Value
1
1.1
1.3
0.9998 1
0.9993
1
0.9992 0.9801
0.9989 0.9998 0.9992
0.9979 1
0.8929
0.9799 1
0.9818
0.9996 1
0.9995
0.6231 0.8484 0.945
0.4293 0.8923 0.9947
0.7056 0.969
1
0.8522 0.9103 1
0.0217 1
0.787
0.0069 1
0.9398
0.0279 0.9998 0.9944
0.0544 1
0.9999
0.5352 0.8818 0.9986

1.5
0.5982
0.9988
0.9513
0.9998
0.831
0.9971
1
0.5108
0.9969
0.9211
0.9991
0.9689
0.7321
1
0.989
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1.7
0.9991
0.9878
0.9132
0.9674
0.9982
0.6814
1
0.9931
0.9966
0.9057
0.9983
1
0.8838
0.9985
0.9884

1.9
0.9997
0.9811
0.9175
0.2773
0.1461
0.7348
0.9987
0.9814
0.9994
0.4564
0.9993
0.9868
0.9987
0.4199
1

Table 4. 61: Dunn report for true-false trial

Level
501-480
503-300
503-300
595-120
595-120
595-120
600-300
600-300
600-300
600-300
600-480
600-480
600-480
600-480
600-480

- Level
498-120
498-120
501-480
498-120
501-480
503-300
498-120
501-480
503-300
595-120
498-120
501-480
503-300
595-120
600-300

1
1
1
1
1
1
1
1
0.967
1
1
0.0239
0.0083
0.0351
0.0699
1

1.1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

Dunn p-Value
1.3
1.5
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

1.7
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

1.9
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

Table 4. 62: True-false equal variance tests
Test
Information
Injection
Level
1
1.1
1.3
1.5
1.7
1.9

O'Brien[.5]
Prob > F F Ratio

Brown-Forsythe
Prob > F F Ratio

Levene
Prob > F

0.1892
0.7332
0.4856
0.4428
0.2964
0.6433

0.1463
0.3551
0.9203
0.5333
0.4229
0.561

0.151
0.3666
0.791
0.0668
0.0024
0.0121

1.4904
0.5569
0.8914
0.9568
1.2206
0.6738

1.6373
1.1053
0.2873
0.8226
0.9886
0.784

F Ratio

Bartlett
Prob > F

1.6194
1.0845
0.4806
2.0632
3.7029
2.9234

0.5079
0.8967
0.4508
0.071
<.0001
<.0001
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F Ratio

Welch's
Prob > F

F Ratio

0.8588
0.3274
0.9443
2.0305
5.7911
10.33

0.0037
0.7969
0.8925
0.5464
0.4281
0.551

3.4878
0.4726
0.3342
0.8043
0.9803
0.7978

Table 4. 63: Dunn method for joint ranking and Tukey Kramer HSD
Tukey Kramer HSD
Level
- Level
1.1
1.3
1.5
1.7
498-120
501-480
1
0.9333
0.5982
0.9994
498-120
503-300
0.9971
0.9516
0.9988
0.71
498-120
595-120
0.9998
0.9543
0.9513
0.4814
498-120
600-300
0.7761
0.9683
0.9998
0.9999
498-120
600-480
1
0.9789
0.831
0.9019
501-480
503-300
0.9996
0.9878
0.9971
0.988
501-480
595-120
1
0.9935
1
0.8094
501-480
600-300
0.8583
0.997
0.5108
0.5893
501-480
600-480
1
0.9986
0.9969
0.9571
503-300
600-300
0.9622
0.9994
0.9211
0.9981
595-120
503-300
0.9999
0.9999
0.9991
0.9978
595-120
600-300
0.8806
1
0.9689
0.9665
600-480
503-300
0.9997
1
0.7321
0.9574
600-480
595-120
1
1
1
0.8303
600-480
600-300
0.8518
1
0.989
0.9982

1.9
0.9613
1
1
0.9662
1
0.8948
0.3794
0.8797
0.7896
0.8955
0.9808
1
0.9389
1
0.9999

Dunn Method for Joint Ranking
1.1
1.3
1.5
1.7
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

1.9
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

Table 4. 64: Means and standard deviations comparing internal control simulations for false-true, true-false and true-true

Level
498-120
501-480
503-300
595-120
600-300
600-480

II=1 false-false
Mean
Std Dev
0.54802
0.181908
0.550751 0.181477
0.547369 0.180963
0.546668 0.18064
0.549679 0.182455
0.550432 0.183078

II=1 false-true
Mean
Std Dev
0.338235 0.261968
0.455126 0.289493
0.411632 0.288068
0.336618 0.260076
0.407224 0.28239
0.430598 0.289155

II=1 true-false
Mean
Std Dev
0.549566
0.183039
0.550433
0.179257
0.54937
0.181047
0.548249
0.182483
0.544548
0.180633
0.539702
0.182861
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II=1 true-true
Mean
Std Dev
0.34291
0.265639
0.455272 0.28855
0.409654 0.28745
0.337111 0.261619
0.414181 0.282848
0.430885 0.284693

Table 4. 65: Tukey Kramer method for comparison of means for true-true

Level
498-120
501-480
501-480
501-480
501-480
501-480
503-300
503-300
600-300
600-300
600-300
600-480
600-480
600-480
600-480

- Level
595-120
498-120
503-300
595-120
600-300
600-480
498-120
595-120
498-120
503-300
595-120
498-120
503-300
595-120
600-300

1
0.8439
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*
0.9386
<.0001*
<.0001*
0.0002*
<.0001*
0.0043*

1.1
<.0001*
<.0001*
<.0001*
<.0001*
0.0165*
<.0001*
<.0001*
0.0137*
<.0001*
1
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*

p-Value
1.3
1.5
0.973
<.0001*
<.0001* 0.0001*
<.0001* <.0001*
<.0001* 0.0007*
<.0001* 0.8495
<.0001* <.0001*
<.0001* <.0001*
<.0001* 1
0.9993
<.0001*
<.0001* 0.9914
<.0001* <.0001*
<.0001* <.0001*
0.1997
0.0067*
<.0001* <.0001*
0.0631
0.0304*

1.7
0.3037
<.0001*
<.0001*
<.0001*
<.0001*
0.0481*
0.0779
<.0001*
0.0067*
0.9844
<.0001*
<.0001*
0.0065*
<.0001*
0.0383*

1.9
0.1479
<.0001*
0.0169*
<.0001*
0.6448
0.3135
0.0013*
<.0001*
<.0001*
0.4554
<.0001*
0.9942
<.0001*
0.7889
<.0001*

Table 4. 66: Steel Dwass method for comparison of means for true-true

Level
501-480
503-300
503-300
595-120
595-120
595-120
600-300
600-300
600-300
600-300
600-480
600-480
600-480
600-480
600-480

- Level
498-120
498-120
501-480
498-120
501-480
503-300
498-120
501-480
503-300
595-120
498-120
501-480
503-300
595-120
600-300

1
<.0001*
<.0001*
<.0001*
0.9009
<.0001*
<.0001*
<.0001*
<.0001*
0.5891
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*
0.0032*

1.1
<.0001*
<.0001*
<.0001*
0.0085*
<.0001*
<.0001*
<.0001*
<.0001*
1
<.0001*
<.0001*
0.0114*
<.0001*
<.0001*
<.0001*

Steel Dwass p-Value
1.3
1.5
<.0001* <.0001*
<.0001* <.0001*
<.0001* 0.0010*
0.9894
1
<.0001* <.0001*
<.0001* <.0001*
<.0001* <.0001*
<.0001* 0.0010*
0.9523
1
<.0001* <.0001*
<.0001* <.0001*
<.0001* 0.9716
0.0783
0.0103*
<.0001* <.0001*
0.0025* 0.0115*
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1.7
<.0001*
0.0043*
<.0001*
0.3487
<.0001*
<.0001*
0.0006*
<.0001*
0.9995
<.0001*
<.0001*
0.0097*
0.0951
<.0001*
0.1556

1.9
<.0001*
0.0005*
0.0014*
0.2129
<.0001*
<.0001*
<.0001*
0.0865
0.7145
<.0001*
<.0001*
0.0682
0.7806
<.0001*
1

Table 4. 67: Dunn method for comparison of means for true-true

Level
501-480
503-300
503-300
595-120
595-120
595-120
600-300
600-300
600-300
600-300
600-480
600-480
600-480
600-480
600-480

- Level
498-120
498-120
501-480
498-120
501-480
503-300
498-120
501-480
503-300
595-120
498-120
501-480
503-300
595-120
600-300

1
<.0001
<.0001
<.0001
1
<.0001
<.0001
<.0001
<.0001
1
<.0001
<.0001
<.0001
<.0001
<.0001
0.0043

Dunn p-Value
1.3
1.5
<.0001
<.0001
<.0001
<.0001
<.0001
0.0012
1
1
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
0.0013
1
1
<.0001
<.0001
<.0001
<.0001
<.0001
1
0.1161
0.0133
<.0001
<.0001
0.0033
0.0156

1.1
<.0001
<.0001
<.0001
0.0173
<.0001
<.0001
<.0001
<.0001
1
<.0001
<.0001
0.0221
<.0001
<.0001
<.0001

1.7
<.0001
0.0036
<.0001
0.6222
<.0001
<.0001
0.0005
<.0001
1
<.0001
<.0001
0.0196
0.1427
<.0001
0.2607

1.9
<.0001
0.0003
0.0031
0.2347
<.0001
<.0001
<.0001
0.1945
1
<.0001
<.0001
0.1451
1
<.0001
1

Table 4. 68: Equal variance test for true-true
Test
Information Injection Level
1
1.1
1.3
1.5
1.7
1.9

O'Brien[.5]
Prob > F
<.0001*
0.0125*
<.0001*
<.0001*
<.0001*
<.0001*

Brown-Forsythe
Prob > F
<.0001*
0.0293*
<.0001*
<.0001*
<.0001*
<.0001*

Levene
Prob > F
<.0001*
0.0276*
<.0001*
<.0001*
<.0001*
<.0001*

Bartlett
Prob > F
<.0001*
0.3328
<.0001*
<.0001*
<.0001*
<.0001*

Welch's
Prob > F
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*

Table 4. 69: Mean values for probabilities of process step success

MAP Process Step
probabilityOfMarCheck
probabilityOfMedCheck
probabilityOfDoseCheck
probabilityOfPatientCheck
probabilityOfRouteCheck
probabilityOfTimeCheck

1
0.854199
0.853891
0.852195
0.853473
0.852448
0.852499

1.1
0.905865
0.904806
0.907873
0.906854
0.906575
0.906331

Information Injection Level
1.3
1.5
0.96383
0.984696
0.964349
0.984378
0.964104
0.984125
0.963017
0.984379
0.964041
0.983765
0.964874
0.98435
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1.7
0.992045
0.992686
0.992369
0.991647
0.992063
0.992345

1.9
0.996209
0.996488
0.996388
0.996476
0.99623
0.99611

Table 4. 70: Pairwise comparison of probability of success of MAP process steps
Methods: 1Tukey-Kramer HSD, 2Dunn’s, 3Steel-Dwass.
Information Injection Level
Probability Pairwise Comparison
Level

- Level

DoseCheck
DoseCheck
DoseCheck
DoseCheck
DoseCheck
DoseCheck
MarCheck
MarCheck
MedDelivered
PatientCheck
PatientCheck
PatientCheck
PatientCheck
PatientCheck
RouteCheck
RouteCheck
RouteCheck
RouteCheck
TimeCheck
TimeCheck
TimeCheck

MarCheck
MedCheck
MedDelivered
PatientCheck
RouteCheck
TimeCheck
MedCheck
MedDelivered
MedCheck
MarCheck
MedCheck
MedDelivered
RouteCheck
TimeCheck
MarCheck
MedCheck
MedDelivered
TimeCheck
MarCheck
MedCheck
MedDelivered

1.1
Tukey1
pValue
0.9721
0.8124
0.8942
0.9993
0.9973
0.993
0.9991
0.9999
1
0.9994
0.9692
0.9899
1
1
0.9999
0.9854
0.9963
1
1
0.9934
0.9988
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Dunn2
pValue
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

Steel3
pValue
0.9768
0.884
0.9999
0.7414
0.9958
1
0.9861
1
0.9994
0.9916
0.9975
0.9999
0.9948
0.9652
1
0.9699
1
0.9999
0.9971
1
0.9999

Tukey
pValue
0.9783
0.9998
0.9977
0.9999
0.7881
0.9999
0.9691
0.9999
1
0.9252
0.9966
1
1
1
0.9248
0.9966
1
0.9988
1
0.9334
0.9974

Table 4. 71: Descriptive statistics for II for 503-300
II
1
1.1
1.3
1.5
1.7
1.9

Mean
0.409654
0.565579
0.79162
0.897502
0.947884
0.974786

Median
0.337542
0.568452
0.855457
0.993021
0.993021
0.993021

SD
0.287450393
0.292234388
0.218455928
0.14535118
0.096054074
0.05574277

Min
0.009452
0.009297
0.058107
0.150787
0.208027
0.461074
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Max
0.993472
0.994015
0.994015
0.994004
0.994015
0.994015

Dunn
pValue
0.348
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

1.9
Steel
pValue
0.1972
0.9269
0.8606
0.9784
0.7336
1
0.8573
0.9254
1
0.9996
0.7662
0.968
0.9999
0.997
1
0.6716
0.9866
0.9989
0.9897
0.9999
1

Tukey
pValue
0.999
1
0.9995
0.9887
1
1
0.9887
0.9987
1
0.9924
0.9471
1
1
0.9986
1
0.9912
0.9992
0.9942
0.9552
1
0.9999

Dunn
pValue
1
1
1
1
1
1
1
1
1
1
1
1
0.6235
1
1
1
1
1
1
1
1

Steel
pValue
1
0.809
0.863
1
1
0.8085
1
1
0.8114
1
0.9827
0.9694
0.2946
0.9835
0.9821
0.9993
0.998
0.5215
0.9994
0.9993
0.9998

Table 4. 72: Least squares analysis of agent attributes – impact by II level 1 and 1.9 for 503-300
Term
interruption[FALSE]
interruption[TRUE]
medicationSeverity[low]
medicationSeverity[medium]
medicationSeverity[high]
medicationDifficulty[difficult]
medicationDifficulty[intermediate]
medicationDifficulty[minimal]
nurseExperience[moderate]
nurseExperience[novice]
nurseExperience[senior]
fatigueStatus[FALSE]
fatigueStatus[TRUE]
PatintLoadOut[high]
PatintLoadOut[low]
PatintLoadOut[med]

Avg. II Prob>|t|
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*
0.0002*
<.0001*
0.1149
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*
0.0296*

II = 1.9 Prob>|t|
<.0001*
<.0001*
<.0001*
0.3155
<.0001*
<.0001*
0.2514
<.0001*
0.9023
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*
0.4959

True-false equal variance tests
Test
Informati
on
Injection
Level
1
1.1
1.3
1.5
1.7
1.9

O'Brien[.5]
Prob > F

F Ratio

Brown-Forsythe
Prob > F F Ratio

Levene
Prob > F

F Ratio

Bartlett
Prob > F

F Ratio

Welch's
Prob > F

F Ratio

0.1892
0.7332
0.4856
0.4428
0.2964
0.6433

1.4904
0.5569
0.8914
0.9568
1.2206
0.6738

0.1463
0.3551
0.9203
0.5333
0.4229
0.561

0.151
0.3666
0.791
0.0668
0.0024
0.0121

1.6194
1.0845
0.4806
2.0632
3.7029
2.9234

0.5079
0.8967
0.4508
0.071
<.0001
<.0001

0.8588
0.3274
0.9443
2.0305
5.7911
10.33

0.0037
0.7969
0.8925
0.5464
0.4281
0.551

3.4878
0.4726
0.3342
0.8043
0.9803
0.7978

1.6373
1.1053
0.2873
0.8226
0.9886
0.784
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Appendix 2: Medical Training Simulation ScenarioN404 6yo Pain Assess Tibia-Fibula Fx
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Scenario developed by: Susan Henley
Hébert, MSMS, RN, CHSE, Simulation
Director/Clinical Faculty, Stephanie
Hopper, BSN, RN, Learning Lab
Coordinator, Deb Chyka, DNP, RN Clinical
Assistant Professor, University of
Tennessee, Knoxville , College of Nursing
Ms, Hébert is a Medical Simulation
professional with extensive experience
working with student nurses in the
medical simulation environment she is a
Certified Healthcare Simulation Educator,
holds a Master of Science degree in
Medical Simulation and has worked a
registered nurse in pediatrics,
Dr. Deb Chyka earned a BSN, MSN, DNP
in 1981,1985 and 2012 respectively from
the University of Tennessee Health
Science Center in Memphis, Tennessee.
She has extensive experience in pediatric
nursing, growth and development. As a
faculty member for the UTK CON she is
accomplished in nurse education and
training.

237

File Name: N404 Pain Management in 6yo Fx Tibia/Fibula
Date: 11/15/15
Authors: Deb Chyka, Susan Fancher and Stephanie Hopper
Brief Summary: 6yo Pediatric male with tibia/fibula fx to be assessed and managed for pain.
Objectives:

Cognitive (Knowledge)

Technical (Skills)

Behavioral (Psychomotor)

Knowledge of safe dose for
acetaminophen/kg for patient.

Calculates acetaminophen dose
correctly.

Communicates effectively w/pt.
with developmental
appropriate communication for
6yo.

Knowledge of developmental
stages of pediatric patient.

Prepares acetaminophen
correctly.

Integrates parent assessment
of medication administration
into patient care.

Knowledge of different
pediatric pain scales.

Administers acetaminophen
using developmentally
appropriate route of delivery.

Communicates effectively with
healthcare provider in regards
to unsafe dose.

Follows medication rights (right
patient, right med, right time,
right route, right dose, etc.)
Objectives of training scenario

Roles/Guidelines for Roles:
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1. 2 Student Nurses
2. Simulated actor for mother

Supplies

Medication and Fluids

Manikins[sic]/Equipment

Oral Syringes and medication
cups for liquid med

Oral tablets (chewable and
non-chewable) and liquid
Acetaminophen with scan
labels

SimJr

Cup for water

D5 1/2NS + 20KCL @ 55ml/hr

Computer for
Docucare(control group)

Incident reports

Ibuprofen liquid

Computer and Smart phone
(intervention group)

External fixator for tibia/fibula
fx

Pediatric pt room

Faces Pain scale

Medication scanner

Materials for training scenario
Scenario Prompt:
RN Report:
Frank is 6 y/o male who was brought in yesterday to the ER by Mom and Dad after falling off the trampoline at
home three days ago. His parents did not realize the severity of the injury and thought he just had a bad bruise.
They treated his injury with elevation, ice and Tylenol for pain. X-ray revealed a right tibia/fibula fracture. Pt had
surgery yesterday to repair the fracture. Frank has a 22G angiocath in his right AC with D5 1/2NS with 20KCL
infusing at 55 ml/hr. He has been getting scheduled morphine q2 hours and Tylenol q4hr PRN for breakthrough
pain. Frank is complaining of pain. His mom just called right before report and I have not had a chance to assess his
pain yet. I gave him his morphine an hour ago but he hasn’t had Tylenol in 6 hours. Labs were drawn last night and
they are in the computer but I haven’t look at them yet.
VS: HR 118, RR 32, BP 121/56, Temp 37.7 C, Faces Pain Scale showing 4/5
Diagnostic Results:
Hepatic Panel: albumin 4.0; Alkaline phosphatase 200; ALT 84 (H); AST 43 (H)
Standardized Mother/Father Role:
-

Comfort crying child - Rub patient’s abdomen when comforting child, continue rubbing periodically
throughout scenario so child can complain of abdominal pain
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-

-

If asked about abdominal pain mother says, “I don’t know, he hasn’t been complaining of his stomach
hurting, just his leg…”
Assist patient in identification of name/DOB and Pain scale if asked
If RNs say they will get medicine ask “What are you giving him for his pain?”
o If RN says “acetaminophen/Tylenol” → mother, “Ok good, that’s what I’ve been giving him at
home.”
o If questioned about Tylenol use at home (amount/frequency) mother to say “I’ve been giving him
a couple spoonful’s whenever he complains of pain”
If students bring Tylenol to give to child mother to say, “Is that all you’re giving him? I usually give him
more than that at home.”
If students bring ibuprofen (orange) mother to say, “The medicine I give him at home is grape flavored”

SCENARIO: SIMULATOR/Standardized Pt.:

MONITOR DISPLAY

ACCESS

ECG

BP

PIV site:

Sa02

ART line BP

Central Line:

RR

Special Notes:
PICC site:

UVC/UAC:
INTRAVENOUS FLUIDS

IV fluids:

Rate:

IV fluids:

Rate

TPN

Rate:
MEDICATIONS

OXYGEN SUPPLIES AT BEDSIDE

Self-inflating Bag/Mask

T-Piece resuscitator

Wall
Oxygen/Suction
with tubing

Nasal Cannula

Flow-inflating Bag/Mask

Vapotherm
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Mechanical vent with settings:

CPAP
AIRWAY MANAGEMENT

Laryngoscope

Blade sizes:

ETT

Sizes:

LMA
CARTS AND EQUIPMENT
Airway tote

Stethoscope

Radiant warmer

Bulb syringe

Code cart

UVC kit

Defibrillator

Portable I-stat

Needle
thoracentesis kit

Transilluminator

EZ IO kit

Pleurevac

Needle aspiration kit

Chest Tube

Pigtail catheter

MISC ITEMS
Patient chart

Footprint page with BW

Code Sheet

Antibiotic order sheet

Scenario

Blank order
sheets

Lab Results

X-Ray results

Tape

Blood

Moulage:

Manikin
attachments

C-section drapes
ROOM SET UP AND EQUIPMENT: R210
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Debriefing Questions

1.
2.
3.

In 10 words or less what happened in the scenario?
What would you consider a strength in the scenario, what was a weakness?
Did the participants properly assess the pt’s pain? If so, did they acknowledge the developmental stage
of the child?
4. Did the participants correctly calculate the safe dosage range of the medication?
5. Did the participants complete the 5 rights of medication administration?
6. Did the participants administer the medication using a developmentally appropriate route for the pt?
7. In what ways did the participants use their knowledge of development to communicate with the pt?
8. Do you think the participants properly communicated with the pt’s mother? If so, how?
9. Was SBAR used in reporting concerns to the healthcare provider?
10. How will your practice change after this scenario?

Active Observer Checklist
1.

Did the participants properly assess the patient’s pain? What scale did they use? How did they
incorporate the developmental age/stage of the child?

2.

Did the participant ask the parent how the child takes medicine at home? Did the participant make sure
there was a fresh drink for the child?

3.

Did the participants accurately calculate the safe dosage range of the medication? Did the participant
complete the 5 rights of medication administration?

4.

Did the participants administer the medication using a developmentally appropriate route for the patient?
Did the participant ask the parent if they wanted to administer the medication?

5.

In what ways did the participants use their knowledge of development to communicate with the patient?
Do you think the participants properly communicated with the patient’s mother? If so, list some
examples.

6.

Was SBAR used in reporting concerns to the healthcare provider?
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Training scenario flow chart
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Debriefing Questions
1.
2.
3.
4.

What just happened in the scenario?
How were the rights of medication administration carried out?
How was the right medication dose determined for this patient? How is the safe dose of
acetaminophen determined for a child?
How do you follow the developmentally appropriate dose of medication for a child?

5.

How did the nurses communicate effectively? With the child? With the parent? With the physician on
the phone if they called?

6.

What about this scenario will change the care you provide to patients in the future?
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Appendix 3: Score Sheet for Evaluation of Student Nurse Performance
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Score Sheet for Evaluation of Student Nurse Performance

1

2

3

4

5

6

7

8

9

Pain level
not assessed

Pain
assessment
attempted
with some
consideratio
n of
appropriate
method

Pain accurately
and effectively
assessed using
the right tool
and method

EMR Not
Reviewed

EMR/MAR
reviews in
part/key
information
not checked
(e.g. labs)

Comprehensiv
e Review of
EMR and query
of
questionable
information

Pt. not
assessed for
ability to
take med

Pt. observed
and assumed
suitable to
take med

Explicit
assessment of
pt. ability to
take med by
prescribed
dose, route,
and

Asses Pain/Med Need Ascertained

Review Orders/MAR/EMR (e.g.
labs)
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contraindicatio
ns

Asses Pt. condition suitable to rcv
med
Right time
for
medication
not assessed

Timing of
medication
checked but
not verified

Medication
time window
validated

Form Factor
not
considered

Form
factor/route
corrected
after dose
preparation

Form factor
validated via
EMR and
patient
preference as
appropriate

Chk Correct time for med

Suitable form factor/route
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Need to do
dose
calculation
not
considered

Dose calc
attempted
but accuracy
not
confirmed.
Follow-up
not done*

Dose calc
performed and
double
checked. Calc
done correctly
with correct
follow-up
action*

Med not
verified

Med verified
after dose is
prepared

Med verified at
beginning of
administration
process

Patient not
re-verified
prior to
giving med

Patient re
verified but
correct
process is
not used

Patient
reverified via
bracelet, DOB

Med not reverified at
bedside

Med only
partially reverified

Med reverified
correctly
(dose, route,
patient, etc.)

Dose Calculation

Retrieve Med/Verify

Verify Pt.
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Verify Med (at patient location)
Med not
given to
patient

Med
administered
inappropriat
ely (partial
dose, wrong
or poor
technique,
etc.)

Med correctly
administered
to patient

Administrati
on of med
not
documented

Information
partially
documented

Med
administration
correctly
entered into
MAR

Deliver Med

Document
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Example: Filled out data form

Duration 11:54. 2
Nurses
Session 9 (1)

Stephanie Hopper as Mom

1

2

3

4

5

6

7

8

9

Asses Pain/Med Need
Ascertained

9

Mentioned they were going to give
Lortab. Got indication from mom
that level was 6-8

Review
Orders/MAR/EMR
(e.g. labs)

9

Checking noted can't take Lortab
but can take APAP

Asses Pt. condition
suitable to rcv med

9

PT OK to receive med

Chk Correct time for
med

9

Correct time verified

Suitable form
factor/route

9

Retrieved Tylenol cups, did not
query mom about form factor but
did select suspension
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Dose Calculation

9

Calculated correct dose, although
they struggled with the calculation,
they looked up the correct dose in
the computer called MD

Retrieve Med/Verify

9

Giving APAP

Verify Pt.

9

Verified via scan and DOB and name
from mom

Verify Med (at patient
location)

9

Verified via mom and scan

Deliver Med

9

Provided med via syringe with drink

Document

Considered
Contraindications

1

Did not note Lortab contained APAP

Other Notes
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Appendix 4: MAE Error App Final Version for Nursing Student Simulation
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http://ilab.engr.utk.edu/hits/tberg/frank
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Appendix 5: MAE Error App Practice Version for Nursing Student Simulation
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http://ilab.engr.utk.edu/hits/tberg/frannie
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Appendix 6: Overview of APP for Student Nurses prior to simulation
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What Do They Mean – What Should You Do?

Overview
• Liked the simplicity and ease of use

• Provided the right amount of information

APP OVERVIEW

• Easier to use than the EHR
• The calculator was useful

Description of Smartphone App for Nursing
Simulation

We discovered that the app was simple
and easy to use, practice on
interpreting the information was needed

2 Steps
1.

2.

Overview of the App
Hands-on practice

Our Goal: See if this app prevents MAEs

Things to Remember

App Overview

• Patient info

• http://ilab.engr.utk.edu/hits/tberg/frannie

• Important information (e.g. new Lab Results)
• Most recent medications given
• Lab results & indications

• Med Orders
• Med Reference
• Handy Dandy Dose Calculator AND comparison to

Ordered Amount
App store QR Code Reader
MixerBox
QR Code Reader
Scan, Inc.
https://play.google.com/store/apps/details?id=me.scan.and
roid.client&hl=en
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Encounter

LAB

Med Calculation
Yippee

What
would
you do?

Oops/Oho
h

What
would
you do?

What
would
you do?
12.375ml

Navigation
Tabs

Things to Remember
•
•
•
•
•
•
•

Patient info
Important information (e.g. new Lab Results)
Most recent medications given
Lab results & indications
Med Orders
Med Reference
Handy Dandy Dose Calculator AND
comparison to Ordered Amount

http://ilab.engr.utk.edu/hits/tberg/frank
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Appendix 7: App Worksheet

1.

Identify the patient’s name, DOB/age and weight?

2.

What are the most recent medications, when where they last taken and in what amounts?

3.

What is the status of the most recent laboratory results?

4.

What medications are ordered?

5.

For medication 1, what dose and amount is ordered?

6.

What information regarding cautions or alerts is there for the ordered medications?

7.

For medication 1 provide the dose range, concentration and computed dose range?

8.

What is a maximum dose for medication 1?

9.

Perform a dose calculation using the dose calculator, how does it compare to the amount ordered in the
Calculation Confirmation section?

10. Is there anything notable in the Laboratory Test Results Section?
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Appendix 8: Medication Administration Error Decision Tree (Partial)
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Appendix 9: Representative drug packaging with similar appearance
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